RNA recognition by fluoro aromatic substituted nucleic acid analogues by Zivkovic, Aleksandra
RNA Recognition by Fluoro Aromatic Substituted Nucleic 
Acid Analogues  
  
 
 
 
 
 
Dissertation 
zur Erlangung des Doktorgrades 
der Naturwissenschaften 
 
vorgelegt dem Fachbereich  
Chemische und Pharmazeutische Wissenschaften 
 der Johann Wolfgang Goethe-Universität 
in Frankfurt am Main 
 
von 
Aleksandra Živković 
aus 
Niš, Yugoslavia 
 
 
 
Frankfurt am Main 
März 2005 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I do not think there is any thrill that 
can  go  through  the  human  heart  like 
that  felt  by  the  inventor  as  he  sees 
some creation of the brain unfolding to 
success....Such emotions make a man 
forget  food,  sleep,  friends,  love, 
everything. 
 
Nikola  Tesla,  1856-1943,  inventor, 
electrical engineer and scientist 
 
 
 
  
Acknowledgments 
 
 
 
I would like to express my gratitude to Prof. Dr. J. W. Engels for his invaluable supervision, 
guidance  in  every  progress  of  project,  discussions,  review  of  my  thesis  manuscript  and 
especially for his kindness and patience. 
I owe my warm gratitude to Astrid Klöpffer, Jelena Božilović, Jörg Parsch and Martina 
Adams for review of my thesis manuscript and useful discussions about thesis. 
I express my thanks to Dalibor Odadzić for translation of summary into German. 
My sincere thanks also go to: 
•  Dr. Zimmerman and his coworkers for NMR measurements 
•  Dr. J. W. Bats for crystallographic data 
•  Dr. G. Dürner and his coworkers for preparative HPLC-separations of nucleosides 
•  Beate  Conrady  for  nice  collaboration  while  performing  oligonucleotide  synthesis 
and HPLC separations of oligonucleotides 
•  Hannelore Brill and Ilona Priess for MALDI and ESI measurements 
•  Marianne Christof for elementary analysis 
I  express  my  sincere  thanks  to  all  members  of  AK  Engels  for  creating  a  nice  working 
atmosphere. I also want to express my thanks to our secretary Mrs. Eva Rheinberger for her 
help. 
Thanks  to  many  friends  for  support  and  friendship:  Jelena  Božilović,  Astrid  Klöpffer, 
Katharina Strube and Dalibor Odadzić etc. 
I would like here to thank all other people whose name has not been mentioned here, who 
gave me a lot of support and courage in my work. 
This list would not be complete without the big appreciations to my parents and my brother 
for their continued support, encouragement and love. 
 
 
 
 
 
 
 Table of Contents 
 
1  Introduction...................................................................................1 
2  Molecular Design of Life.............................................................7 
2.1  Structure and Function of Nucleic Acids ........................................................7 
2.2  DNA Structures....................................................................................................10 
2.3  RNA Structures....................................................................................................13 
2.4  Stability of a Double Helix ...............................................................................16 
2.4.1  Hydrogen Bonds..........................................................................................16 
2.4.2  Base Stacking ...............................................................................................17 
2.4.3  Solvation........................................................................................................19 
2.5  Universal Bases....................................................................................................21 
3  Organic Fluorine.........................................................................25 
3.1  Fluorine- Properties and Hydrogen Bonding Ability.................................25 
3.1.1  Crystal Structures of Fluoro Benzenes...................................................27 
3.2  Fluorine in Nucleic Acids..................................................................................30 
3.2.1  Fluoro Modifications on Sugar Moiety..................................................31 
3.2.1.1  C 2’- Fluoro Nucleosides .............................................................................31 
3.2.1.2  C3’-Fluoro Nucleosides ...............................................................................32 
3.2.1.3  C4’-Fluoro Nucleosides ...............................................................................33 
3.2.1.4  C5’-Fluoro Nucleosides ...............................................................................33 
3.2.2  Fluoro Modification on Phosphate Group.............................................34 
3.2.2.1  Fluoro Phosphonates....................................................................................34 
3.2.2.1.1  Fluoro Alkyl  Phosphonates .........................................................34 
3.2.3  Fluoro Modifications on Nucleobases....................................................36 
3.2.3.1  Fluoro Modified Pyrimidines.......................................................................36 
3.2.3.2  Fluoro Modified Purines ..............................................................................37 
3.2.3.3  Fluoro Modified Nucleobase Analogues......................................................37 
4  Overview.....................................................................................39 
5  Chemical Synthesis.....................................................................43 5.1  Modified Nucleobases Containing Fluorine.................................................43 
5.2  Fluorobenzimidazoles ........................................................................................46 
5.3  Benzimidazole, Fluoro-benzimidazole and Trifluoromethyl-
benzimidazole  Nucleosides..........................................................................................49 
5.3.1  Glycosilation.................................................................................................49 
5.3.2  Deprotection..................................................................................................53 
5.4  C-Nucleosides ......................................................................................................54 
5.4.1  γ-Lactone.......................................................................................................54 
5.4.2  Benzene, Fluoro- and Chloro  Benzene-Nucleosides.........................56 
5.4.2.1  C-Glycosilation and Dehydroxylation .........................................................56 
5.4.2.2  Debenzylation...............................................................................................60 
5.5  Protection of Nucleosides for Solid Phase RNA Synthesis......................61 
5.5.1  Dimethoxytritilation Reaction..................................................................61 
5.5.2  Protection of 2’-OH Group.......................................................................62 
5.5.3  Phosphitilation..............................................................................................63 
5.6  Abasic Site.............................................................................................................64 
5.7  Overview on Synthesis.......................................................................................66 
5.8  Partition Coefficients and HPLC Retention Times.....................................71 
5.8.1  Partition Coefficients..................................................................................71 
5.8.2  HPLC-Retention Times .............................................................................72 
6  Crystallography...........................................................................75 
6.1  What do we Learn from Crystals?...................................................................75 
6.2  Theoretical Background.....................................................................................75 
6.2.1  Lattice Planes and Bragg’s Law..............................................................76 
6.3  Crystal Structure of Fluorine-modified and Chlorine-modified  Benzene 
Nucleosides.......................................................................................................................78 
6.4  Crystal Structure of  5’-O-(4,4’-dimethoxytriphenylmethyl)-2’-O-tert.-
butyldimethylsilyl-1’-deoxy-1’-(4,6-difluoro-1-N-benzimidazolyl)-β-D-
ribofuranose......................................................................................................................83 7  Oligonucleotides.........................................................................87 
7.1  Synthesis of Oligonucleotides..........................................................................87 
7.1.1  Phosphoramidite method...........................................................................87 
7.2  Synthesised Oligonucleotides...........................................................................90 
7.3  Purification of Oligonucleotides......................................................................91 
7.4  Characterizations of Oligonucleotides...........................................................93 
8  Spectroscopic Measurements of Oligonucleotides....................99 
8.1  UV-Spectroscopic Measurements...................................................................99 
8.1.1  Calculations from UV- Melting Curves...............................................101 
8.1.1.1  Determination of the Melting Point ...........................................................101 
8.1.1.2  Determination of Thermodynamical Data..................................................104 
8.1.1.2.1  Van't Hoff Plot...............................................................................104 
8.1.2  Results of the UV-Melting Curves........................................................106 
8.1.3  Enhalpy-Entropy Compensation............................................................124 
8.2  CD Spectroscopic Measurements..................................................................126 
8.2.1  CD-Spectroscopy.......................................................................................126 
8.2.2  Results of CD-Spectroscopy...................................................................129 
9  Summary...................................................................................133 
9  Zusammenfassung....................................................................141 
10  Experimental Part.....................................................................149 
10.1  Main Methods.................................................................................................149 
10.1.1  Chromatography........................................................................................149 
10.1.2  Spectroscopy...............................................................................................150 
10.1.3  Mass spectrometry.....................................................................................151 
10.1.4  Elementary Analysis.................................................................................151 
10.1.5  Melting Point Determination..................................................................151 
10.2  List of Chemical Reagents..........................................................................151 
10.2.1  For the synthesis of oligonucleotides...................................................155 
10.3  The Buffer solutions.....................................................................................156 10.4  List of Synthesised Compounds ................................................................156 
10.5  Synthesis, spectral data and other characteristics of synthesised 
compounds ......................................................................................................................162 
10.6  Synthesis of Oligonucleotides....................................................................295 
10.7  Purification and Analytics of Oligonucleotides.....................................295 
10.7.1  HPLC-purification.....................................................................................295 
10.7.2  The amounts of synthesised oligonucleotides....................................296 
10.7.3  The Extinction coefficient of Oligonucleotides.................................296 
10.8  UV-Melting Curves ......................................................................................297 
10.9  CD-Spectroscopy of Oligonucleotides.....................................................298 
10.10  Determination of Partition Coefficient.....................................................298 
10.11  Determination of HPLC Retention Times...............................................299 
11  References.................................................................................301 
12  Attachment................................................................................323 
12.1  Crystal Data of Crystalized Compounds.................................................323 
12.1.1  Crystal data of  1’-deoxy-1’-(2,4,6-trifluorophenyl)-β-D-
ribofuranose................................................................................................................323 
12.1.2  Crystall data of 1’-deoxy-1’-(2,4,5-trifluorophenyl)-β-D-
ribofuranose................................................................................................................331 
12.1.3  Crystal data of 1’-deoxy-1’-(4-chlorophenyl)-β-D-ribofuranose..338 
12.1.4  Crystal data of  5´-O- (4,4´-Dimethoxytriphenylmethyl) -2´-O-tert.-
butyldimethylsilyl-1´-deoxy-1´- (4,6-difluoro-1-N-benzimidazolyl) -β-D-
ribofuranose 106 at -123 C......................................................................................346 
12.2  Abreviations....................................................................................................359 
Curriculum vitae ............................................................................363 
Publications.....................................................................................365 
 
   Introduction   
- 1 - 
 
1 Introduction 
 
 
 
 
 
Nucleic acids are the memory of all the information of life of every plant and living 
beings in general. Deoxyribonucleic acids (DNA) consist of long double-stranded chains of 
nucleotides. The nucleotides themselves consist of a sugar moiety (ribose for ribonucleic acid 
(RNA) and 2’-deoxyribose for DNA), a phosphate group and a nucleobase.  Generally only 
four  nucleobases  can  be  found  in  natural  DNA  and  RNA.  There  are  guanine,  cytosine, 
adenine and thymine in DNA, and uracil instead of thymine in RNA.  These double stranded 
DNA strands are held together by highly specific hydrogen bonds between the nucleobases. 
The base pairs are guanine-cytosine and adenine-thymine (Figure 1.1),  and their ratio was 
first defined by Chargaff (Chargaff, 1951).    
 
 
         Adenosine-Thymidine          Guanosine-Cytosine   
  
Figure 1.1.  Watson –Crick base pairs R=2’-deoxyribose (Watson & Crick, 1953) 
 
The information saved in the DNA must be translated into proteins. Therefore the DNA 
must be first transcribed into messenger RNA (mRNA), which leaves the nucleus. The 
mRNA will be translated into proteins at the ribosomes (Watson & Crick, 1953a). 
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Figure 1.2.  Central dogma of molecular biology 
All these processes are possible points of attack of nucleic acid drugs. Targeting at the RNA 
level is an economical approach to address non-drugable proteins and targets that have failed 
to give leads, as it can build on biological knowledge gathered over years (Zaman et al., 
2003). Several different concepts or mechanisms of action of nucleic acid drugs are now 
under investigation. The most important are: antisense concept, the triple helix concept, the 
RNA interference (RNAi) concept and ribozymes as drugs (Figure 1.3). 
 
 
 
Figure 1.3. Oligonucleotide interference (Engels & Parsch, 2004) 
 
The  antisense  concept  follows  the  most  important  way  of  action  to  modulate  the 
transfer of genetic information to proteins. Antisense oligonucleotides can be classified in to 
main classes on the bases of their mechanism of action: Rnase H dependant oligos, which 
induce the degradation of mRNA by Rnase H, and steric blocking oligonucleotides, which   Introduction   
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physically  prevent  or  inhibit  the  splicing  or  the  translation.  In  original  concept,  the 
antisense method for the sequence-specific inhibition of gene expression was quite simply 
steric blockage of translation by binding of oligonucleotide to the mRNA target. However, it 
is now generally accepted that mode of action is more complicated. Even some of antisense-
oligonucleotides act by this mechanism, the most commonly used antisense-oligonucleotides 
act by degradation of RNA target by Rnase H in the hybrid formed upon annealing of the 
antisense-oligonucleotide.  The  phosphothioate  analogues  played  a  crucial  role  in  this 
development (Engels & Eckstein, 2003; Zamenick et al, 1978; Stephenson et al., 1978): 
The triplex concept is one possibility to regulate gene expression in vivo. In this concept 
the third nucleic acid strand should hybridise with the DNA double helix in the nucleus and 
inhibit translation of the DNA to the corresponding RNA (Engels & Eckstein, 2003; Batey et 
al., 199; Gewirß et al., 1998). 
Ribozymes are catalytically competent RNAs that occur either in nature or have been 
obtained by in vitro selection. The most popular are hammerhead  (figure 1.4) and hairpin 
ribozyme. They have been applied for the inhibition of gene expression on the RNA level. 
They catalyse mostly ligation and cleavage reactions. Their principle of action is based on 
sense-antisense principle. The fundamental difference between classical antisense method and 
that of RNA ribozyme is that ribozymes have the inherent catalytic power to cleave the target 
RNA rather than to have to rely on cellular proteins for this step (Engels & Eckstein, 2003; 
Klöpffer, 2004); 
 
 
 
 
 
 
Figure  1.4  X-ray  structure  of      an 
Hammerhead ribozyme 
  
RNA interference (RNAi) is a recently detected approach for targeting mRNA and is 
also called posttranscriptional gene silencing. That is the process by which double-stranded 
RNA in the way shown in figure 1.5 destroys mRNA and thus silence further transcription 
from a specific gene.   Introduction   
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Chemical  variation  of  natural  oligonucleotide  structures  is  necessary  to  render  these 
compounds useful in biological systems. For a good nucleic acid drug we need to take care 
about the following characteristics: modifications must be sufficiently stable against serum 
nucleases in serum within cells, they should enter various organs of the body and be able to 
penetrate cellular membranes to reach their site of action and they must form stable Watson-
Crick  or  Hoogsteen  complexes  with  complementary  sequences  under  physiological 
conditions. 
There are different possibilities for modifications: they could be on the sugar or on the base. 
There are also completely backbone-modified nucleic acids like polypeptide nucleic chains 
(PNAs) or locked nucleic acids (LNAs). Unmodified oligonucleotides  are widely used as 
tools in molecular biology. However, in cellular and animal experiments it was observed that 
oligonucleotides with a natural phosphodiester internucleoside linkage are degraded in serum 
within few hours, mainly by the action of fast cleaving 3’-exonucleases that are accompanied 
by slower cleaving endonucleases (Tuschl, 2003; Schwarz et al., 2003; Hannon et al., 2002). 
 
Figure 1.5. RNAi mechanism (www.alnylam.com)   Introduction   
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So, in general the nucleic acid synthesis opens up broad possibilities for future progress in 
modern medicine. We still learn a lot about nucleic acids and the synthesis of new nucleic 
acid analogues is in the field one of the main tools.  
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1 Molecular Design of Life 
 
 
 
1.1  Structure and Function of Nucleic Acids 
 
Nucleic acids appear in nature in two different forms as DNA   (2’deoxyribonucleic acid) and 
RNA (ribonucleic acid).  DNA is a polymer of deoxyribonucleotide units and RNA is a polymer 
of ribonucleotide units.  A nucleotide consists of a nitrogenous base, a sugar and one or more 
phosphate groups. The sugar in DNA is deoxyribose and in RNA the sugar is ribose.  
The  nitrogenous  base  is  a  derivative  of  purine  or  pyrimidine.  The  C-1  atom  of  ribose  or 
deoxyribose is bonded to N-1 of a pyrimidine or N-9 of a purine. The configuration of this N-
glycosidic linkage is β (the base lies above the plane of the sugar ring). The nucleobase might 
have two main orientations concerning sugar and glycosidic C1-N bond. This position is defined 
with torsion angle χ (by purines O4’-C1’-N9-C4 and by pyrimidines: O4’-C1’-N9-C2 (figure 
2.1) (IUPAC, 1983). By natural nucleosides anti conformation is favourable, but an exception are 
purines in Z-DNA.  
 
χ
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θ2 θ3
θ4 θ0
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δ
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O
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O
O
H, OH
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O
 
 
Figure 2.1. Torsion angle at nucleotides (Blackburn & Gait, 1996)   Introduction   
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Purines in DNA are adenine (A) and guanine (G) and pyrimidines are thymine (T) and cytosine 
(C). In RNA only thymine is exchanged with uracil (U).   
The four nucleosides that exist in DNA are deoxyadenosine, deoxyguanosine, deoxythymidine 
and  deoxycytidine.  In  RNA  they  are  called:  adenosine,  guanosine,  uridine  and  cytidine. 
Nucleotides are phosphor esters of nucleosides. A DNA chain is shown in  figure 2.2. 
 
 
 
Figure 2.2.  DNA structure with numbering of the bases 
 
Phosphate  groups  are  charged  negatively  and  that  explains  their  good  water  solubility.  The 
nucleobases  can  have  different  tautomeric  forms.  Existing  tautomers  are  keto-enol  and  also 
amino-imino-tautomers. Spectroscopic investigations have shown that all five natural bases exist 
as amino- and keto- tautomers in a rate >99.99% 
DNA consists of two helical polynucleotide chains that are coiled around a common axis. The 
chains run in opposite directions. The purine and pyrimidine bases are on the inside of the helix   Introduction   
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where  as  the  phosphate  and  sugar  units  are  on  the  outside.  The  planes  of  the  bases  are 
perpendicular to the helix axis. The planes of the sugars are nearly at right angles to those of the 
bases. The two chains are held together by hydrogen bonds between pairs of bases. So known 
Watson-Crick-pairs are adenine and thymine and guanine is paired with cytosine. The double 
helix is also stabilized through π-π interactions in-between the bases of the same chain. As a 
consequence  of  non-diametric  positions  of  glycosidic  bonds  exist  major  and  minor  grooves. 
Except this B-DNA form that was established by Watson and Crick there are also some other 
forms and structures that DNA forms in nature (chapter 2.4). 
Conformation of the sugar unit has a big influence on the DNA structure because the furanose 
ring is not planar. It can form E-conformation (envelope) or T-conformation (twist). In envelope 
conformation four atoms of the furanose ring are in one plane and the fifth is 0,5 Å above or 
under that plane. In the twist conformation three atoms are in one plane, one of two other atoms 
is under that plane while the other one is above. Atoms that are above that plane are called endo 
and the ones under the plane are exo (figure 2.3). 
The sugar of the DNA is in C2’-endo (S) conformation and in RNA is usually favourable C3’-
endo conformation.  
 
 
( 2E )
O
N C5´
1´
2´
4´ 3´
C2´ endo 
3
2T (      )
twist (C2´ exo, C3´ endo)
O
N C5´ 3´
2´
1´ 4´
( 3E )
O
N 3´
2´ 4´ 1´
C5´
C3´ endo 
 
 
Figure 2.3.  Conformations of the furanose ring 
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2.2  DNA Structures 
 
The  structures  of  DNA  double  helices  exist  in  different  conformational  types.  The  most 
important are A-DNA, B-DNA and Z-DNA.   
The helix axis is located in the major groove side of the base pairs in A-DNA form.  Base 
pairs are titled towards helix axis in A-DNA.  
 
 
 
 
Figure 2.4. A and B forms of DNA double helix 
 
The radius of the helix is 2,55 nm and the height pro base pair is 0,23 nm. In the right-
handedness helix the glycosidic linkage is always anti. 11 base pairs build one turn of the 
helix. The special characteristics of A-DNA are strong slope (inclination) of the base pair 
towards the helix axis. The major groove is narrow and deep; the minor groove is wide and 
plane. The sugar conformation is C3’-endo. The orientation of the C1’-N-glycosidic linkage is 
characterized by torsion angle χ of –160° (Saenger, 1984; Stryer, 1991).   Molecular Design of Life   
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.  
Figure 2.5. Different forms of DNA   a) B-DNA form b) A-DNA form c) Z-DNA form  
 
 
Figure 2.6.  Z and B forms of DNA helix   Molecular Design of Life   
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The radius of the B-DNA helix is 2,37 nm; the height per base pair is 0,34 nm. The helix is 
right-handed with anti conformation of the glycosidic linkage. The number of base pairs per 
turn is 10. The major groove is wide and deep while the minor groove is deep but narrow. The 
sugar conformation is C2’-endo. The orientation of theC1’-N-glycosidic linkage has a torsion 
angle χ of –120°.  
Opposite to A-DNA and B-DNA (figure 2.5) that are right-handed the Z-DNA (figure 2.6) is 
left-handed. The sugar phosphate backbone is zigzagged and the repeat unit is a dinucleotide. 
The radius of the Z-DNA helix is 1,84 nm. The height per base pair is 0,38 nm. 12 base pairs 
make one full turn of the helix. The pyrimidine bases have anti conformation to the glycosidic 
linkage. The major groove is plane and the minor groove is narrow and deep.  
For better comparison data of all three types are given in figure 2.7. 
 
 
 Figure  2.7. Comparison of A-DNA, B-DNA and Z-DNA 
 
Beside  hydrogen  bonds  of  the  Watson-Crick  base  pairs  there  are  more  factors  that  have 
influence on the structure and stability of nucleic acids. The most important are: hydratation 
of helix and base stacking effects. More explanations on this subject can be found in the 
subchapter 2.4. 
 
   Molecular Design of Life   
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2.3  RNA Structures 
 
Inside the cells, there are three major types of RNA: messenger RNA (mRNA), transfer RNA 
(tRNA) and ribosomal RNA (rRNA). There are a number of other types of RNA as well, 
including small nuclear RNA (snRNA), the 4.5S signal recognition particle (SRP) RNA etc. 
Novel species of RNA continue to be identified.  
Although RNA molecules are linear polymers, they fold back on themselves to make intricate 
secondary and tertiary structures that are essential for them to perform their biological roles. 
RNA  double  helix  has  always  A-form.  A  characteristic  structural  feature  of  A  family  of 
double helices of nucleic acids is the 3’-endo-conformation of the sugar.  Insofar as helical 
RNA is concerned, such a conformation of the ribose seems to be the only possible one and, 
consequently, transition A-B for this class of nucleic acids is forbidden. The fact that the 
ribose can not change from C3’-endo- into C2’-endo-conformation is caused by the contacts 
between the hydroxyl group at C2’ and other atoms (primarily oxygen in the phosphor diester 
bond). Its major groove is deep and narrow while the minor groove is shallow and wide. As a 
result, in contrast to DNA, the main site of interaction with ligands in double-stranded RNA is 
its minor groove. Secondary structures of RNA are internal loops, hairpin loops bulges and 
junctions (figure 2.8) 
 
 
 
Figure 2.8. RNA secondary structures 
Hairpin loops (figure 2.8) are elements invariably present in the secondary structure of any 
single  stranded  RNA.  There  is  every  reason  to  assert  that  stability  of  hairpin  loops  is 
determined by stacking interactions and hydrogen bonding within the loops. Analysis of the   Molecular Design of Life   
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thermodynamic stability of many synthetic hairpins has shown that the most stable structures 
are those with loops of four or five nucleotides especially the UUCG tetraloop is very stable. 
The  bulges  (figure  2.8)  are  short  single  stranded  parts,  non-paired,  where  the  complete 
complementary chain is involved in pairing. The bulges can have only one nucleotide but can 
also  have  more.  These  internal  sequences  are  usually  rich  with  purines.  They  are  also 
considered as potentially functional sites. Very little is known about larger bulges. There is a 
reason to believe that they are destabilizing RNA in greater extent than single base bulges.  
Internal loops (figure 2.8) arise whenever bases that are not complementary in the Watson-
Crick  sense  find  themselves  opposite  each  other  in  a  double  stranded  segment  of  RNA. 
Therefore, the stability of an internal loop will depend on whether the bases in the opposite 
strands become paired as well as on the degree to which such pairing disturbs the geometry of 
the helix. The least disturbance in the double helix is caused by formation of the G-U pair 
from the mismatches. 
 
 
 
Figure 2.9.  RNA secondary structure-a  junction 
Next known secondary RNA structure is junction. In the junction more helical parts meet at 
one point (figure 2.9). The big junctions vary from four to five helices that are meeting at a 
point.  
   Molecular Design of Life   
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Figure 2.10. a) Secondary structure of one of tRNA-clover-leaf model b) three dimensional 
tertiry structure of tRNA (Blackburn&Gait, 1996) c) space filling model 
 
Beside secondary structures RNA builds also tertiary structures.  The tertiary RNA structures 
are stabilised with hydrogen bonds and base stacking. Figure 2.10   shows secondary structure 
of tRNA and in part b) shows the real three-dimensional structure of t-RNA (Blakburn&Gait, 
1996). The defined tertiary structure of RNA molecules is important for their function. 
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2.4  Stability of a Double Helix 
 
2.4.1  Hydrogen Bonds 
 
Hydrogen bonds can be formed between uncharged molecules as well as between charged 
ones. In a hydrogen bond, two atoms share one hydrogen atom. The atom to which hydrogen 
is more tightly linked is called hydrogen bond donor, whereas the other atom is a hydrogen 
bond acceptor. The acceptor has a partial negative charge that attracts the hydrogen atom. In 
fact, a hydrogen bond can be considered as an intermediate in the transfer of proton from an 
acid to a base. It is reminiscent of a ménage a trois. 
The hydrogen bond donors in biological systems are usually oxygen or nitrogen. The acceptor 
is either oxygen or nitrogen. The length of hydrogen bonds differs from 2,63Å (O-H…O
-) to 
3,10 Å (N-H …N) and the energy from 3 to 7 kcal/mol. Hydrogen bonds are stronger than van 
der Waals bonds but weaker than covalent bonds. The length of a hydrogen bond is between 
that of a covalent bond and van der Waals bond. The important feature of a hydrogen bond is 
that  they  are  highly  directional.  The  strongest  hydrogen  bonds  are  those  in  which  donor, 
hydrogen and acceptor atoms are collinear.  (Stryer, 1991) 
 
 
 
Figure 2.11.  Donors and acceptors in hydrogen bonds in natural nucleosides 
R=ribose or 2’-deoxyribose 
   
The distance between donor and acceptor in one hydrogen bond is between 2,8 and 2,95 Å. 
The donor and acceptor atoms in building Watson Crick base pairs are shown in figure 2.11. 
Beside  Watson-Crick  base  pairs  there  are  Hoogsteen  base  pairs  (Hoogsten,  1959).  In 
Hoogsteen base pair hydrogen bonds are built between the Watson-Crick side of pyrimidine   Molecular Design of Life   
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and the opposite side of purine (Hoogsten side).  In the double helix they  are not of  any 
importance.  On  the  other  hand  there  are  also  Wobble  base  pairs.  The  bases  in  there  are 
opposite one another but just a bit moved so that it is again possible  to have donor and 
acceptor in one line again. Examples are uridine-guanosine and uridine-inosine Wobble base 
pairs (figure 2.12).  
 
 
 
Figure 2.12.  Hoogsteen and Wobble base pairs 
 
 
2.4.2  Base Stacking 
 
Besides hydrogen bonding base stacking is one of the most important stabilizing effects in the 
double helix. Among the most significant aromatic-aromatic interactions are those found in 
nucleic acids (Guckian et al., 1996). The base stacking are the π-π  interactions between 
bases  of  the  same  chain  and  is  crucial  for  the  stabilization  of these  structures.    Stacking 
interactions play an essential role in mRNA-cap recognition by proteins (Castellano et al., 
2003). The nucleobases are not exactly one over another because that is not possible from the 
structural characteristics.  How much they are moved depends on the type (A, B or Z) and 
sequence.  Also  modifications  affect  the  neighbouring  nucleobases.  Figure  2.13.shows 
different possibilities of orientation and positioning of two neighbouring bases (Cambridge 
DNA Nomenclature; Dickerson et al., 1989).  
Hunter (Hunter, 1993) has recognized four energetically principles, for base stacking in DNA 
and those are: 
1.  van der Waals forces (vary with r
-6)   Molecular Design of Life   
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2.  Electrostatic forces between partial atom charges (atom-atom; vary with r
-1) 
3.  Electrostatic forces between  π electron density above and under the plane of the 
nuceobase (atom- πσ ; vary with r
-4) 
4.  Electrostatic forces between π electron density and charged atoms (atom-πσ; vary 
with r
-4)  
 
 
Figure 2.13.  Possible positions of pairing nucleosides (Blackburn&Gait, 1996) 
 
Studies about associations of nucleobases and nucleosides in water solutions show that the 
process of base stacking is reversible and has a constant value of free enthalpy for every step. 
Enthalpies are additive and not cooperative values. The strength of base stacking is different 
for purines and pyrimidines. The base stacking between two purines is stronger than between 
a  purine  and  a  pyrimidine  and  that  one  is  also  stronger  than  stacking  between  two 
pyrimidines.  (Saenger, 1984).  Base stacking keeps one chain of RNA in helical structure 
(Haasnoot&Altona, 1979). 
To  separate  stacking  from  hydrogen  bonding  usually  used  method  for  determination  of 
theromodynamical stacking parameters is placing the wanted base in so called ‘’ dangling’’ 
position (without a pairing partner). The resulting stabilisation of the duplex can be measured 
by denaturising experiments. The results of such investigations show that not only the surface   Molecular Design of Life   
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area is responsible for good stacking but also substituents are of great importance. The results 
also indicated that the  natural bases are not particularly effective  for stacking,  at least in 
global comparison with aromatic structures. Evolution may not favour the bases, which stack 
to strongly, since helix unwinding is requirement for DNA replication (Guckian et al., 1996). 
These results were interpreted as indicating that hydrophobic interactions provide the greatest 
contribution to stacking interaction. The plot of polarizability versus stacking energy appears 
to  show  a  rough  qualitative  correlation  between  increasing  polarizability  and  increasing 
stacking ability.  
Quadrupole-quadrupole interactions were also proposed to be important for electron-
poor rings such as 4-nitroindole. Rosemayer and Seela have also shown that the polarizability 
of  the  dangling  base  correlates  with  stability  of  the  duplex  better  than  hydrophobicity 
(Rosemayer & Seela, 2002). A general difficulty with interpreting the results from dangling-
base studies is that geometry of interaction in these systems typically is not known (Waters, 
2002). The greater difference (of opposite sign) of quadrupole moments of two compounds 
greter is the attractive interaction in-between them (Castellano et al., 2003).  
The example, which shows how significant quadrupole-quadrupole interactions are, is 
the structure of 1:1 mixture of benzene: hexafluorobenzene. Those two compounds have large 
quadrupole moments, but of opposite sign, and the mixture has higher melting point than both 
pure  benzene  and  pure  hexafluorobenzene  (Ladig,  1991;  Williams,  1993;  Castellano  et 
al.,2003). 
The current known data suggest that a quadropolar effect may be a significant factor in 
stacking, particularly with no natural bases having strong electron-donating or –withdrawing 
groups (Guckian et al., 2000). 
 
2.4.3   Solvation 
 
Water solvates nucleic acids in nature.  Water is however not only a  medium that keeps 
nucleic acids in solution it is also important for stabilizing secondary and tertiary structures  
(Edelhoch&Osborne, 1976). The level of hydratation of DNA plays also an important role for 
the secondary structure of DNA. High hydratation is characteristic for B-DNA form and low 
hydratation is characteristic for A-DNA. 
The hydratation of macromolecules is expressed with Г. Г is the number of water molecules 
per mol of nucleotide. The secondary structure depends also on Г. This value is in direct 
connection with the water activity aw, which can be adjusted by addition of salt. At and above   Molecular Design of Life   
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complete  hydratation,  B-DNA  prevails.  It  changes  to  some  other  conformations  if  the 
hydratation is reduced, to an attainable minimum of 3.6 water molecules per nucleotide. If 
water is added in excess, the sample swells but remains in B-DNA form.  The effect of ions 
on aw is determined through ion strength and depends mostly on the nature of ions.  
Experiments with DNA have shown that the DNA double helix is strongly solvated. The 
hydratation  of  DNA  is  not  homogeneous.  It  can  be  described  in  terms  of  two  shells,  as 
suggested by sedimentation equilibrium studies and gravimetric and infrared spectroscopic 
investigations. These experiments indicate that the structure of the primary hydratation shell is 
not ice-like. It is impermeable to ions and consists of 11-12 water molecules per nucleotide. 
These water molecules can be grouped in three classes with decreasing binding affinity for 
phosphate, phosphodiester plus sugar oxygen atoms and functional groups of bases.  
The primary hydratation shell is different from bulk water. Of the 20 water molecules per 
nucleotide, only 11-12 are directly bound to DNA. They form a shell, which is impermeable 
to cations and does not freeze into an ice-like state. These water molecules are observed in 
crystal structure analyses and are hydrogen-bonded to DNA oxygen and nitrogen atoms.  
 
 
 
Figure 2.14.  Hydratation regions in B-DNA 
 
The  secondary  hydratation  shell  is  permeable  to  cations.  At  subzero  temperatures,  it 
crystallizes in the form of ice and therefore resembles bulk water (Saenger, 1984). 
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2.5  Universal Bases 
 
A  universal  base  analogue  forms  ‘base  pairs’  with  each  of  four  natural  bases  with  little 
discrimination  between  them.  A  number  of  such  analogues  have  been  prepared  and  their 
applications as biochemical tools were investigated. Most of those bases are hydrophobic, 
aromatic  bases,  which  stabilise  duplex  (DNA  or  RNA)  by  stacking  interactions  (Loakes, 
2001).  The  desirable  requirements  for  a  universal  base  have  been  defined  (Loakes  et  al., 
1997). They should: 
•  Pair  with  all  the  natural  bases  equally  when  opposite  them  in  an  oligonucleotide 
duplex 
•  Form a duplex which primes oligonucleotide synthesis by a polymerase 
•  Direct incorporation of the 5’-triphosphate of each of the natural nucleosides opposite 
when copied by a polymerase 
•  Be a substrate for polymerase as the 5´-triphosphate 
•  Be  recognised  by  intracellular  enzymes  such  that  DNA  containing  them  may  be 
cloned. 
At present no analogue has been shown to fulfil all these requirements and it may be that no 
single analogue does it. However, each of analogues prepared so far has set of properties that 
enable their use or some of these purposes. 
There are no universal nucleobases that fulfil all conditions. There are only nucleosides that 
fulfil some of those conditions (Loakes, 2001). Here we are going to show some of them. 
The first universal base analogue was 3-nitropyrrole (1, figure 2.15), described by Bergstrom 
and  co-workers  (Bergrstrom  et  al.,  1995).  The  design  of  this  analogue  was  aimed  at 
maximising  base  stacking  interactions;  the  presence  of  nitro  group  enhances  stacking  by 
polarisation of the π-aromatic system of the pyrrole ring. Compound 1 was shown to behave 
indiscriminately in base pairing with four natural bases, there was significant destabilisation 
of duplexes containing it. It was concluded that the pyrrole ring does not stack as well as 
expected and the design of future analogues should aim at replacing the nitro group by less 
bulky substituents. A related analogue is 5-nitroindole (2). This analogue has been shown to 
be less destabilising and is not discriminating towards the natural bases. A large number of 
non-hydrogen bonding base analogues has been investigated, though mainly in hybridisation 
applications.  These include 4-nitrobenzimidazole (3) analogue that behaves indiscriminately 
towards  the  natural  bases  but  is  more  destabilising  than  2.    Similar  preferences  show  4-
aminobenzimidazole (4).    Molecular Design of Life   
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Figure 2.15. Universal nucleobases 
 
One  of  the  earliest  analogues  to  be  investigated  was  phenyl-C-ribonucleoside  (5).  These 
earlier findings of Millican et al. showed that phenyl-C-ribonucleoside is quite destabilising 
and it was essentially the same as an abasic site. Thus, the presence of phenyl ring offers little 
to  no  contribution  to  stacking  interactions.  Nevertheless,  those  analogues  show  little 
discrimination  towards  pairing  with  each  of  the  natural  bases.  Compound  6  stacks  more 
strongly than it is expected from surface area alone (Schweitzer et al., 1994). These results 
show  that  surface  area  is  not  the  only  factor  affecting  stacking  affinity,  but  increased 
hydrophobicity  must  also  in  some  way  enhance  the  stabilisation  of  oligonucleotides 
containing such analogues. Compound 7 directs the insertation of natural triphosphates by 
Klenow fragment with a 4-fold lower variation in efficiency and, at high dNTP concentration, 
full length DNA is synthesised. Compounds 8 and  9 give with all natural bases base pairs 
with almost the same stability (Parsch, 2002). The triphosphates of both compounds were   Molecular Design of Life   
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incorporated  by  RNA  polymerase  (Kloepffer,  2004).  Some  more  details  of  those  two 
compounds are going to be given further in this dissertation.  
There is a little known about RNA universal bases and behaviour of bases is different in A- 
and B- helix. 
 
Universal Nucleobase  Reduction of the stability 
∆Tm [°C] 
Difference in Tm when pairing 
with A, C, G and U [°C] 
1  8-11  3 
2  4-7  3 
6  14-19  5 
7  3-5  2 
8  9-10  1 
9  10-10,5  0,5 
 
Figure 2.16. Influence of the universal nucleobases on the melting point of RNA duplexes 
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3 Organic Fluorine  
 
 
 
 
3.1   Fluorine- Properties and Hydrogen Bonding Ability 
 
Special properties of fluorine are as follows: 
•  High electro negativity 
•  Relatively small size 
•  Very low polarizability 
•  Tightly bound, three non-bonding electron pairs 
•  Excellent overlap between F 2s and 2p with corresponding orbitals of other second 
period elements 
Fluorination usually but not always increases lipophilicity but on the other hand aromatic 
fluorination always increases lipophilicity. Also, fluorination always increases hydrogen 
bond acidity. Perfluoroalkyl groups are always electron withdrawing. Fluorination also 
increases the steric size of alkyl groups. (Smart, 1994; Smart, 2001) 
The van der Waals radii of fluorine (1.47 Ǻ) can be compared to that of hydrogen (1.20 Ǻ) 
or  oxygen  (1.57  Ǻ)  and  it  emerges  that  fluorine  has  a  close  isosteric  relationship  to 
oxygen. To be a successful hydroxyl mimic in bioorganic chemistry the fluorine atom 
must  replace  the  hydrogen  bond  acceptor  ability  of  the  hydroxyl  oxygen  (Sein  et  al., 
2000).  
Pauling discussed the strong hydrogen bond in hydrofluoric acid (HF)n and the very strong 
one in the hydrogendifluoride ion [HF2]
- and concluded that the proton in the latter should 
lie in a single minimum potential well or in a double minimum potential with a very small 
barrier ( Pauling, 1960). 
  Theoretical calculations variously estimate the strength of an F…H bond to be between 2 
and 3.2 kcal mol
-1. This can be compared to an O…H hydrogen bond, which is typically 
between 5-10 kcal mol
-1. Thus the greater electro negativity and lower polarisability of 
fluorine  over  oxygen  suppresses  its  electrostatic  influence  and  renders  it  a  poorer   Organic Fluorine   
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hydrogen bond acceptor. There is also a significant increase in short contacts to C (sp
3)-F 
over  C  (sp
2)  bound  fluorine  atoms  (Figure  3.1).  A  further  intensive  search  of  CSD 
(Cambridge  Structural  Database),  confirmed  that  organic  fluorine  hardly  ever  accepts 
hydrogen bonds, that is, it does so only in the absence of a better acceptor. 
. 
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Figure 3.1. The F…H bond is stronger to a C (sp
3) rather than a C (sp
2)-F acceptor (Howard 
et al., 1996) 
 
This observation implies that aliphatic fluorine atoms are better hydrogen bond acceptors than 
olefinic or aromatic fluorine atoms. A clear conclusion from this data is that vinyl (and aryl) 
fluorines are less effective than aliphatic fluorines as hydrogen bond acceptors. However if 
the hydrogen bond donor can find stabilization with an alternative acceptor to fluorine then it 
will do this and adversely influence the binding interaction (Howard et al., 1996).  
Despite the larger van der Waals radii for fluorine over hydrogen, the experimental evidence 
suggests  that,  in  general  terms,  the  substitution  of  a  single  fluorine  for  a  hydrogen  atom 
introduces  only  small  steric  and  geometric  perturbations  relative  to  the  hydrocarbon 
counterpart. However it is generally appreciated that the methyl and trifluoromethyl groups 
bear very little steric resemblance. A comparison of the molar volumes of a series of related 
compounds  with  various  substituents,  and  with  a  CF3  group,  reveals  a  size  closer  to  an 
isopropyl than a methyl group (O’Hagan et al., 1997).  Fluorination increases the strength of 
C-C single bonds but weakens the strength of  C=C double bonds (Dunitz&Taylor, 1997; 
Dunitz, 2005). 
It has become a common practise in bioorganic chemistry to replace a hydrogen atom or a 
hydroxyl group for fluorine to generate a fluorinated enzyme substrate analogue, which may 
act as substrate or inhibitor in a given enzymatic process. The rationale for such a strategy is 
that the size of fluorine atom is intermediate between that of hydrogen and oxygen. The 
substitution of hydrogen by  fluorine is one of the most commonly  employed monovalent 
isosteric  replacements.  Not  so  commonly  used,  but  supported  by  Grimm’s  hydride 
displacement law, are exchanges of -NH2, -OH and -CH3 groups with fluorine. (Patani & 
LaVoie, 1996).   Organic Fluorine   
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3.1.1   Crystal Structures of Fluoro Benzenes 
 
Hydrogen  bonding,  the  master  key  of  molecular  recognition,  is  the  most  reliable  design 
element in crystal engineering (Thalladi et al., 1998). On the other hand very little is known 
about hydrogen bonds that involve fluorine. Hydrogen bonds of the C-H...X-C type has been 
increasingly implicated in the stabilization of crystal structures. The C-H group is known to 
be a hydrogen bond donor, and C-H...O, C-H...N and C-H...Cl hydrogen bonds have been 
used in crystal engineering. This raises the question to the existence and nature of the C-H...F-
C hydrogen bonds.  
Thalladi was investigating crystal structures of fluorobenzenes. All of those crystal structures 
involve C-H...F-C hydrogen bonds of approximately 2.4 Å. To clear up the nature of those 
interactions  the  structures  of  fluoro  benzenes  were  compared  to  structures  of:  pyridinium 
fluoride (Boenigk  & Mootz, 1998), pyridine-N-oxide (Ulku et al., 1971) and benzonitrile 
(Fauvet et al., 1978). Those structures are stabilized with C-H...F
-, C-H...O- and C-H...N- 
interactions. However, there are similarities in between them and crystal structures of fluoro 
benzenes (Figure 3.2). 
 
 
 
 
Figure 3.2. Crystal structures of: a) fluoro benzene, b) pyridinium fluoride, c) pyridine-N-
oxide and d) benzonitrile (Thalladi et al., 1998)   Organic Fluorine   
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The structural similarity at this very fine level, that is, at the level of individual interactions, 
between  fluoro  benzenes  on  the  one  hand  and  other  mentioned  structures  on  the  other, 
indicates that the nature and character of the structure-determining intermolecular interactions 
in these four structures are identical. Therefore, it has been shown that C-H…F interactions 
can be as important as C-H…O and C-H…N hydrogen bonds in stabilizing specific crystal 
structures. Fluorine would form rather C-H…F-C interactions than F…F contacts, whereas 
the heavier halogens seem to prefer the formation of halogen halogen interactions. In Figure 
3.3. scatter plots of H…F distances versus C-H…F angles for C-H…F interactions are shown 
and there can be seen differences in distances when the C atom is sp or sp
2 hybridised. 
 
 
 
 
Figure 3.3. a) C-H…F-C distances (433 examples); b) C (sp
2)-H…F-C (sp
2) distances (155 
examples (Thalladi et al., 1998) 
Crystal structures of fluorobenzenes show that only when carbon acidity is enhanced and only 
in absence of competing acceptors the hydrogen bonding accepting ability of organic fluorine 
revealed (Desiraju, 2002). 
Very recently by Lancaster and co workers were reported intra- and inter-molecular C-H...F-C 
and N-H...F-C hydrogen bonds in secondary amine adducts of B(C6F5)3 with H...F distance of 
2.10 Å. Evidence that the N-H...F-C interactions exist in solution is provided by 
19F NMR 
spectroscopy. The large C-H...F angle of 151° and the short F...H distance places it within the 
shortest C-H...F-C hydrogen bonds ( Mountford et al., 2003). 
   Organic Fluorine   
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Figure 3.4. The hydrogen bridge. The composite nature of the interaction is highlighted by 
the three extreme situations of widely differing energies. The sketch is not strictly quantitative 
but the colouring attempts to provide a visual scale of energies. This figure serves as a rough 
guide to the balance of electrostatics, van der Waals nature, and covalency in any X-H...A 
interaction.  For  the  week  interactions,  the  covalent  character  is  very  small  and  may  be 
interpreted as charge transfer. A van der Waals interaction is considered to have dispersive 
and repulsive components. (Desiraju, 2002) 
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3.2   Fluorine in Nucleic Acids 
 
 
Fluorine substituted analogues of nucleic acids are known for antiviral and antitumor activity. 
5-Fluorouridine 10 , FLT 11  (3’-fluoro-2’,3’-dideoxythimidine) (Etzold et al., 1971) and 
FMAU  12  (  2’-fluoro-5-methyl-1-β-arabinofuranosyluracil)  (Watanabe  et  al.,  1979) 
compounds  with  potential  antiviral  activity,  .  are  shown  in  figure  3.5. There  are  a  lot  of 
substances at a time that are under investigation for their biochemical activity.  
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Figure 3.5. Fluorinated Nucleic Acids with potential antiviral activity 
 
Fluorine  substitution  is  not  generally  detrimental  for  binding,  however  the  high 
electronegativity of fluorine can have dramatic mechanistic consequences, which can lead to 
mechanistic deviations and enzyme inhibition. ( O’Hagan et al., 1997). 
Significant  role  in  bioactivity  of  those  compounds  plays  fluorine  because  of  its  high 
electronegativity and polarity (Bergstrom & Swartling, 1988). Fluorine is also a mimic for 
hydrogen and also is in the pool of hydrogen bond acceptors (Pankiewitch, 2000). 
In the next parts some different fluoro modifications of nucleic acids will be shown. Basically 
there are three different kinds: fluorine on the sugar moiety, on phosphate or on the base of 
the nucleoside. 
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3.2.1   Fluoro Modifications on Sugar Moiety 
 
Fluoro atoms on the ribose of nucleosides can be seen on the C atom from C 2’ to C 5’. The 
most of the known compounds have F on the C 2’ atom but also not rare are the nucleosides, 
which have F on C 3’ or C 5’ carbon. On the other hand the nucleic acids analogues with 
fluorine on C 4’ atom are very rare. 
 
3.2.1.1  C 2’- Fluoro Nucleosides 
 
There are two main scientific reasons why C 2’ fluoro analogue are interesting. One is their 
significant biological activity and the other that the fluorine takes the role of the 2’ OH group 
in nucleic acids.  
The  effect  of  the  fluorine  atom  on  the  conformation  of  ribose  is  intensively  under 
investigation since this is very important as for binding of oligonucleotides to enzymes as for 
activity.  Roentgen  structure  analysis  shows  that  there  are  two  main  conformations  of  the 
ribose.  They  are:  C  2’-endo  form  in  B-DNA  and  C  3’-endo  form  in  A-DNA.  NMR 
investigations have shown that the conformation is more dependant on electronegativity of the 
substituent than on its size or ability to build hydrogen bonds ( Ikehara, 1984; Uesugi et al., 
1983; Cheng et al., 1983). As example we can take 2’-fluoro-deoxyadenosine which has 67% 
in C3’-endo conformation where 2’-iodine-2’-deoxyadenosine and 2’-deoxy adenosine have 
only 19% and 7% C 3’-endo conformation. ( Uesugi et al., 1979) 
The synthesis of 2’ –fluoronucleosides can be done in three different ways: 
•  Direct fluorination of the protected nucleosides 
•  Fluorination of the protected sugar, and than nucleoside synthesis 
•  The  synthesis  of  the  fluorinated  sugar  from  the  beginning  compound  containing 
fluorine, and than nucleoside synthesis 
The  mostly  used  method  today  is  fluorination  of  protected  nucleosides.  The  often  used 
reagents  for  fluorination  are:  hydro  fluoride  (HF)  and  its  complexes  (f.e.  HF*pyridine), 
potassium  fluoride  (KF),  potassium  hydrogen  difluoride  (KHF2),  diethylaminosulphur 
trifluoride (DAST) and tris-(dimethylamino)-sulphur-(trimethylsilyl)-difluoride (TASF). 
The  most  common  nucleosides  that  belong  to  this  group  are:  2’-fluoro-5-methyl-1-β-D-
arabinofuranosylcytosine 13 (FIAC) and 2’-fluoro-5-iodine-1-β-D-arabinofuranosyluracil 14 
(FIAU) (Figure 3.6). They are active and selective inhibitors for herpes simplex virus type I   Organic Fluorine   
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and  type  II  etc.  (Watanabe  et  al.,  1983;  Watanabe  et  al.,  1984).  Their  triphosphates  are 
incorporated in virus DNA with viral polymerases. (Harada et al., 1987).  
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Figure 3.6. Antiviral 2’-fluoro nucleosides 
 
There are also fluorinated nucleosides with two fluorines on the  C-2’ atom. Good known is 
2’-deoxy-2’,2’-difluoroguanosine 15 (Gemcitabin) ( Figure 3.5.). The hydrochloride of the 
gemcitabin is used as a medicine in a lot of countries under the name Gezar. Gemcitabin 
shows  a  complicated  mechanism  of  inhibiting  DNA  and  also  RNA  synthesis  through 
inhibition of ribonucleotide reductase (Schmid et al., 2005). Gandhi showed that 2’-deoxy-
2’,2’-difluoroguanosine is similar to gemcitabin (Gandhi et al., 1995). 
 
3.2.1.2  C3’-Fluoro Nucleosides 
 
The  3’-fluoro  substitution  of  the  ribose  has  almost  the  same  effect  as  the  2’-fluoro 
substitution. NMR investigations show, that 2’-fluoro-2-deoxyuridine is 78 % in C 2’-endo 
conformation where 3’-fluoro-2’,3’-dideoxyuridine adopts with 88%  C 3’-endo conformation 
(Joecks et al., 1983). The commonly known representative of this group is 3’-fluoro-2’,3’-
dideoxythimidine 11 (FLT, Figure 3.1.). 
In 1988 it was discovered that FLT has a strong activity against HIV. After investigation it 
was shown that the activity of FLT is greater than that of the AZT ( Balzarini et al, 1988.). 
Unfortunately, it has also higher cytotoxicity. 
3’-Fluoronucleosides are active as 5’-triphosphates as strong inhibitors of DNA polymerases, 
for  example  the  ones  from  Micrococcus  lutens,  Streptomyces  hygroscopicus 
(Waehnert&Langen, 1979) or E.coli DNA polymerase I (Chidgeavadze et al., 1985). 
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3.2.1.3  C4’-Fluoro Nucleosides 
 
Antibiotic nucleocidine 16 (figure 3.7.), from the group of C4’-fluoronucleosides, exists as a 
natural compound.  Nucleocidine was isolated in 1957 and synthesised in 1976 by Moffat for 
the first time (Jenkins et al., 1976). 
 
 
 
N
N N
N
NH2
O
OHOH
F
O S
O
O
H2N
Nucleocidine
16  
 
Figure 3.7. Antibiotic with C 4’-fluoro atom 
 
The compounds that belong to this group don’t have only instead of hydrogen or hydroxyl 
group a fluoro atom in C4’ position to differ from C2’ and C3’ fluorinated nucleosides, but 
also other functional groups. By Nucleocidine that is a sulphonamide group. 
 
 
3.2.1.4  C5’-Fluoro Nucleosides 
 
The last group containing fluorine on the sugar moiety is the group of C5’-fluoronucleosides. 
Different 5’-fluoronucleosides were synthesised to observe their activity. The synthesis of 
those nucleosides starts with glycosilation of 1-O-acetyl-2,3-di-O-benzoyl-5-deoxy-5-fluoro-
α,β-D-ribofuranose and nucleobase. The direct fluorination of C5’ is also possible. 
Synthetic  improvement  was  to  exchange  the  5’-hydroxyl  group  with  a  CF2-group  for  the 
synthesis of difluoromethylene phosphonate nucleotide 17 (Figure 3.8.). With introduction of 
difluoromethylene  group  into  the  nucleoside  we  get  –CH2-CF2-P-  bond,  which  is  a  good 
mimic for natural  –CH2-O-P-. This exchange should mean that the CF2-P bond cannot be 
hydrolysed under physiological conditions. Those molecules are under investigation (Harada 
et al., 1987). 
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Figure 3.8.  5’-Deoxy-5’-difluoromethyl-adenosine-triphosphate 17 
 
3.2.2   Fluoro Modification on Phosphate Group 
 
There are two possibilities to modify phosphate group of a nucleoside with fluorine. When we 
exchange one hydroxyl group of the phosphate with fluorine we become fluorophosphonate. 
When we exchange hydroxyl group with CF2 or CHF group we get fluoro alkyl phosphonate. 
 
 
3.2.2.1  Fluoro Phosphonates 
 
Fluoro phosphonate analogues of nucleosides were synthesised to investigate the role of the 
phosphate group in enzyme studies. When a hydroxyl group of one phosphate is exchanged 
with fluorine than the nucleotide has only one negative charge. Than there is a possibility to 
investigate  the  influence  of  charges  on  enzyme-substrate  bond.  The  other  phosphonate 
modifications (methyl phosphonates) are not recommended for this because the introduction 
of  methyl  group  makes  the  molecule  bigger  and  the  steric  factor  is  than  also  important. 
Because of the high electronegativity, fluorine has also another important influences on the 
phosphate group. The pKa becomes smaller with fluorination. As a consequence of this for 
example Mg
2+ ions bind stronger to phosphate group ( Vogel&Bridger, 1982). 
 
3.2.2.1.1  Fluoro Alkyl  Phosphonates 
 
Phosphate esters and phosphate anhydrides belong to important groups in living organisms. 
Transfer  and  exchange  of  phosphate  groups  are  essential  biochemical  reactions.  In  those 
molecules methylene or fluoromethylene groups exchange hydrogen atoms. It was shown that 
the CH2 group is the best isosteric exchange of a hydrogen atom in phosphonates. Blackburn   Organic Fluorine   
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has shown that fluoro alkyl phosphonates are better analogues than methylene phosphonates 
(Blackburn, 1981).  
The synthesis of fluoromethylene-modified triphosphates 18 (Figure 3.9) is performed over 
pyrophosphate. 
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Figure 3.9. Difluoro methylene adenosine-triphosphate 18 
 
The investigations of β, γ-difluoromethylene-triphosphates have shown that those compounds 
have  biological  activity  as  the  β,γ-methylene-triphosphates  but  smaller  than  natural 
phosphates. Experiments with pCF2ppA 18 ( Figure 3.9.) have shown that  pCF2ppA is a good 
inhibitor for some enzymes and a good substrate for the other ones (Blackburn et al., 1986). 
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3.2.3   Fluoro Modifications on Nucleobases 
 
There are three main groups of fluoro-modified nucleobases. They are modified pyrimidines, 
purines and fluoro modified nucleobases similar to either purine or pyrimidine nucleobases. 
 
3.2.3.1  Fluoro Modified Pyrimidines 
 
Fluoro substituted pyrimidine nucleosides, as for example 5-fluoro-2’-deoxy uridine (FdU) 19 
or trifluoromethyl-2’-deoxy uridine 20 (F3CdU) are used as therapeutic compounds (Figure 
3.10) .  
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Figure 3.10. Fluoro modified pyrimidine nucleobases 
 
New studies consider more pharmacokinetics and the influence of fluorine on the structure 
and activity and less synthetic methods. 
Fluorination on the 5 position is done in reaction with F2 or CF3OF in water as a solvent. The 
fluorination is not simple. The CF3 group is introduced in the reaction  of trifluoromethyl 
iodide with 5-iodo-pyrimidine in the presence of copper (Kobayashi et al., 1977), and for 
longer  alkyl  chains  another  strategy  is  developed.  Primary,  position  5  is  methylated  and 
brominated (Matulic-Adamic et al., 1986). Than fluoro compounds are added with different 
alkyl chains.   
In the last years compounds with longer alkyl chains are becoming the main point of interest 
since those compounds have a great activity against herpes viruses. It is  important that those 
compounds are more selective against herpes viruses than classical antiherpes medicines (for 
example FdU 19 and F3CdU 20 , Figure 3.10.) (Bergstrom et al., 1984). However, it is also 
shown that not only fluoro substitution is responsible for selectivity (some compounds are   Organic Fluorine   
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inactive even if they contain fluorine). The introduction of single fluorine in an alkyl side 
chain on nucleobasis is basically improving antiviral activity.  
 
 
3.2.3.2  Fluoro Modified Purines 
 
Only a few of the fluorinated purines are published. 2-Fluoro adenosine (2FA) 22 and 6-
fluoro nebularine 23 (6FN) are shown in the figure 3.11. They were synthesised in the late 60s 
(Hashzimie et al., 1968). 
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Figure 3.11.  Fluoro modified purines 
 
There are no significant results for antiviral effects of those compounds. 
 
3.2.3.3  Fluoro Modified Nucleobase Analogues 
 
Two groups of fluoro modified nuclebase analogues exist. The first ones are developed with 
chemical  reactions  on  natural  nucleobases  and  the  second  are  similar  in  some  points  to 
nucleobases. 
In Figure 3.12. we can see two examples of nucleobases that are synthesised from natural 
nucleobases. Molecule 24  (Figure 3.12) is synthesised from uridine and chloro fluoro carben 
in the presence of silver.  However, this molecule shows no significant biological activity 
(Thieller  et  al.,  1977).  If  4-O-trimethylsilyl  thymidine  reacts  with  difluorocarbene  the 
compound 25 (Figure3.12) is obtained (Pein & Cech, 1985). That one shows antiviral activity 
against herpes simplex viruses of type1. 
   Organic Fluorine   
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Figure 3.12. Fluoro modified bases synthesised from natural nucleobases 
 
In  Figure  3.13.  there  are  three  different  modified  nucleobases  that  are  synthesised.  The 
fluoropyridine  26 is tested in mice against leukaemia (McNamara&Cook, 1987). Compound 
27  was  synthesised  by  Matulic-Adamic  and  Beigelman  and  incorporated  in  ribozyme  to 
investigate their influence on enzyme activity ( Matulic-Adamic&Beigelman, 1997). 
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Figure 3.13. Fluoro modified nucleobases 
 
The  difluorotoluene  6  (Figure  3.13)  was  synthesised  as  an  isostere  of  thymine 
(Schweitzer&Kool,  1994).  It  was  used  for  investigation  of  hydrogen  bonds  in  the  DNA 
double helix. Because of its similarity to thymine it is mostly incorporated against adenine 
(Moran et al., 1997).  
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4  Overview  
 
 
 
Chemically modified bases are frequently used to stabilize nucleic acids, to study the driving 
forces  for  nucleic  acid  structure  formation  and  to  tune  DNA  and  RNA  hybridization 
conditions. In particular, fluorobenzene and fluorobenzimidazole base analogues can act as 
universal bases able to pair with any natural base and to stabilize RNA duplex formation. 
The noncovalent interactions affecting the thermodynamic stability of natural and modified 
RNA  have  been  topics  of  broad  interest  in  recent  years.  The  effects  of  sterics,  stacking, 
hydrogen bonding, and minor-groove solvation have been considered as contributing factors. 
Probably the dominant stabilizing factors in helical RNA are base stacking and hydrogen 
bonding. In order to probe the physical factors that contribute to the stability of this stacking 
in water, we wanted to measure melting data of short RNA oligomers, both naturally and 
nonnaturally substituted. Understanding these issues could allow better design of modified 
RNAs, but relatively little experimental information is available on such electrostatic factors. 
Quadrupolar  interactions  have  also  been  documented  in  specialized  cases;  for  example, 
benzene is capable of electrostatic interactions with molecules containing a positive charge, as 
demonstrated  by  well-documented  cation-   interactions,  even  in  aqueous  systems.  By 
contrast, perfluorobenzene, with its opposite quadrupolar sign, can stack well (in low polarity 
environments) with electron-rich aromatic rings. 
We now describe a series of fluorinated aromatic nucleoside analogues having a wide range 
of dipole and quadrupole moments and also substituents of different size and positions(figure 
4.1.). We wanted to study the stacking thermodynamics of these compounds in short synthetic 
RNA duplexes, with all four neighbouring nucleobases. We also wanted to show examine 
how different substitution pattern influences stability of modified oligonucleotides.  
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Figure 4.1. Synthesized fluoro-modified bases 
 
2,4 DFB and 4,6 DFBI are isosters for natural bases and have been shown (Parsch & Engels, 
1999; Parsch & Engels, 2000) to be universal. In addition we decided to synthesise different 
benzene modifications with different number (1, 2, 3 and 5) and positions of fluorine atoms. 
We  wanted  to  synthesise  a  series  of  fluorobenzenimidazole  modifications  and  also  a 
modification with trifluoromethyl group (4 TFM). All of those modifications we synthesised 
aimed at a better understanding of base stacking and H bonding ability of ‘organic’ fluorine, 
which  although  discussed  at  great  length,  is  complex  and  remains  considerably  less  well 
understood.    We  wanted  to  underline  favourable  characteristics  for  better  base  stacking 
abilities in one series of compounds specially substituents and their arrangement. Fluorine 
substitution may be critical for stacking and RNA pairing pattern as fluorine affects dipole 
moment and polarizability of nucleobases. We also wanted to examine self-pairing of those 
bases.  
Interesting issue in these studies would have been also the possibility of forming C-F...H-C 
bridges in double helix of RNA.   Interactions  were  ``organic fluorine``  accepts hydrogen 
bonds are less examined and up to discussions in scientific committee.  
Therefore we wanted to crystallise our nucleosides and allow crystal engineering to help us to 
predict behaviour and pairing pattern of those bases in RNA.   Overview   
- 41 - 
For  the  oligonucleotides  studies  we  wanted  to  use  UV  and  CD  –spectroscopy  in  defined 
12mer sequences shown in figure 4.2. Those sequences were used in our group by Parsch 
(Parsch & Engels, 1999) and would give us the ability to compare our results.  
 
5'-CUU UUC XUU  CUU-3' 
3’-GAA AAG YAA GAA-5’ 
Figure 4.2. The sequences for spectroscopic investigation of RNA ( X and Y are for 
modifications) 
 
The results shed light on the importance and origins of electrostatic interactions in DNA base 
stacking, and reveal some previously unrecognised structural and electrostatic effects that will 
be useful in future molecular designs. 
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5  Chemical Synthesis 
 
 
 
 
5.1   Modified Nucleobases Containing Fluorine 
 
We wanted to synthesise different modified nucleobases containing fluorine that don’t build 
hydrogen  bonds  with  adenosine,  guanidine,  cytidine  or  uridine.  Therefore  we  wanted  to 
choose molecules that don’t contain N or O. Some of the molecules that we synthesised are 
isosteric to natural nucleobases (Figure 5.1). 
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Figure 5.1. Comparison of natural nucleosides with fluoro- modified ones 
 
1’deoxy-1’-(2,4-difluorophenyl)-β-D-ribofuranose 9 is isosteric to natural uridine  28 and 1’-
deoxy-1’-(4,6-difluoro-1-N-benzimidazoyl)-β-D-ribofuranose 8 is isosteric to natural xantine 
29. Both of them have  no nitrogen or oxygen  atoms that could be involved in hydrogen 
bonding. As it is already mentioned fluorine is a very good mimic for hydrogen and oxygen   Chemical Synthesis   
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atom  (Parsch&Engels,  2000).  Additionally  we  synthesised  also  different  fluoro  modified 
benzimidazoles to observe how the position of the fluorine atom influences oligonucleotide 
characteristics (Figure 5.2.). 
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Figure 5.2. Synthesised fluoro- modified benzimidazoles 
 
We  also  decided  to  synthesise  a  series  of  the  trifluoromethyl-modified  benzimidazoles 
(Figure  5.3.).  As  F  is  a  good  isosteric  exchange  for  hydrogen  and  the  methyl  group  we 
decided to try how the exchange of hydrogen atoms with fluorines in the methyl group will 
influence the stability of oligonucleotides. 
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Figure 5.3. Synthesised trifluoromethyl- modified nucleosides 
 
We were aware that the size of trifluoromethyl group resembles more to isopropyl group than 
to that of methyl group, but if the size wouldn’t have been deciding point than we would have 
improved F as acceptor for C-F…H-C hydrogen bonding. 
We also synthesised a series of fluoro-modified benzenes, which differ not only in number of 
fluorine atoms but also in their positions (Figure 5.4.). 
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Figure 5.4. Fluoro modified benzenes 
 
With an increasing number of fluorine atoms we are increasing the acidity of the hydrogen 
atoms that could be involved in hydrogen bonding. We also have one modification that has no 
hydrogen atoms on the base to observe differences in thermodynamical measurements. The 
mono-fluoro-benzene  modifications  with  all  possible  different  positions  for  fluorine  were 
synthesised previously in our group and the ones with best characteristics were resynthesised. 
These were incorporated in oligonucleotides to measure thermodinamical parameters when 
paired with different new modifications (Parsch&Engels, 2000).  
In order to observe the influence of fluorine and trifluoromethyl group on stability of RNA 
duplexes we synthesized 1’-deoxy-1-benzimidazolyl-β-D-ribofuranose  40  and 1’-deoxy-1’-
phenyl-  β-D-ribofuranose    41.  We  also  synthesised  an  abasic  site    42    (  1-deoxy-D-
ribofuranose) for use in the investigating of stacking effects (Figure 5.5.). 
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Figure 5.5. Modified nucleobases without fluorine 
 
We  also  synthesised  one  modification  containing  a  chlorine  atom  (  1’-deoxy-1’-(4-
chlorophenyl)- β-D-ribofuranose 43) to compare the crystal structures of fluoro benzenes with 
this structure ( Figure 5.5.). 
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5.2   Fluorobenzimidazoles 
 
The synthesis of 54 4-fluorobenzimidazole and 51 4,6-difluorobenzimidazole starts from the 
corresponding fluoro acetanilides. The first reaction to be done is the nitration of the fluoro 
acetanilides. Because of different reactivity, different reaction conditions were required. The 
more active 2,4-difluoro acetanilide was treated with a mixture of 65% nitric acid, sulphuric 
acid and acetic acid over 90 min. at 40-50°C (Finger et al., 1951) (Figure 5.7). To nitrate the 
less reactive 4-fluoro acetanilide we used 100% nitric acid, acetic acid anhydride and acetic 
acid. The reaction time is than 48 h and is significantly longer than for difluoroacetanilide 47. 
From difluoroacetanilide  47 we got 96% yield of 2,4-difluoro-6-nitro-acetanilide 48. The 
nitration of 2-fluoro acetanilide gave two products (isomers): 2-fluoro-4-nitro acetanilide 45  
and 2-fluoro-6-nitro-acetanilide 46 in ratio 1:1 (Figure 5.6.).  Separation of those two isomers 
was done on the basis of different solubility in Witt-Utermann solution (Witt & Utermann, 
1906; Wepster & Verkade, 1949). This solution consists of  50 % water solution of potassium 
hydroxide, 4 parts of water and one part of ethanol. Adding ice-cold Witt-Utermann solution 
separated  the  isomer  mixture.  The  solution  dissolves  o-nitro  acetanilide  but  not  p-nitro 
acetanilide.  After  filtration  we  separated  the  isomers  and  obtain  pure  2-fluoro-6-nitro 
acetanilide 46. 
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Figure 5.6.  Nitration of 2-fluoro-6-nitro acetanilide 
 
Deprotection of the amino group was done for both compounds with acid. 2-Fluoro-6-nitro 
acetanilide 46 reacted over 3 h with 3 M HCl and gave 2-fluoro-6-nitro aniline 52 in a yield of 
89%.  Because  of  the  higher  solubility  of  2,4-difluoro-6-nitro  aniline  49  in  water  the 
corresponding acetanilide 48 was deprotected in conc. sulphuric acid. To precipitate 49 the 
reaction mixture was poured into ice water, filtered on vacuum and washed with cold water.   Chemical Synthesis   
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49 is quite soluble in water and this procedure makes the yield of this reaction lower (Finger 
et al.,1951). 
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Figure 5.7. Schema for the  synthesis of 4,6-difluorobenzimidazole 
 
The reduction of the nitro group to an amino group was done by a metal catalysed reaction 
under  hydrogen  (Montgomery  &  Hewson,  1965).  Therefore  the  nitro  compounds  were 
dissolved in ethanol, catalyst was added and the reaction performed in hydrogen atmosphere. 
The reaction was vigorously stirred to get the biggest possible contact surface of the catalyst. 
The reaction is accomplished when the solution is not yellow any more from nitro compound 
(TLC control). The reaction was also done using Pd as a catalyst, but there the reaction times 
vary greatly and in the experimental part is the experiment with highest yield. Times vary 
from 2 to 36 h. After the reaction was complete the catalyst was filtered over celite and the 
left reaction mixture was evaporated to dryness. Both phenylene diamines 50 and 53 were 
immediately used for the next reaction.  
The synthesis of the corresponding imidazoles were done from 50 and 53 refluxing them with 
formic acid for 1,5 h and 2 h respectively (Kirk & Cohen, 1969). Then the formic acid was 
evaporated  and  the  product  was  dried.  Both  4-fluoro  benzimidazole  54  and  4,6-difluoro 
benzimidazole  51 were obtained as colourless solids. Since on TLC and in NMR only small 
impurities could be seen and the solubility of both compounds in eluents was very small we 
used both compounds without further purifications for the next reactions ( Parsch, Doctor 
thesis, 2001).  
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Figure 5.8. Scheme for synthesis of 4-fluoro benzimidazole 
 
Synthesis  of  4-trifluoromethyl  imidazole  61  was  done  as  shown  in  figure  5.9.  and  the 
procedures are rather similar to those already described.  
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Figure 5.9.  Scheme of the synthesis of 4-trifluoromethyl benzimidazole 
 
3-trifluoromethyl acetamide 55 was nitrated with a mixture of equal parts of 100% nitric acid 
and acetic anhydride over 4h. 2-nitro-3-trifluoro  acetanilide 56 precipitates as white solid and 
two other isomers 57 and 58 stay in solution. They were extracted with methylene chloride, 
separated by FC and characterized. The white precipitate 56  was filtered, dried and used for 
the next reaction (Pouterman & Girardet, 1947).   Chemical Synthesis   
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5-trifluoromethylbenzimidazole  63  was  synthesized  from  4-trifluoromethyl  phenylene 
diamine 62 after refluxing with formic acid for 3h with a yield of 90 %. The product was 
purified by FC. The same procedure was used for the synthesis of 5-fluorobenzimidazole 65 
(Figure 5.10). 
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Figure 5.10. Synthesis of 5-trifluoromethybenz imidazole 63 and 5-fluorobenzimidazole 65 
 
 
 
 
5.3   Benzimidazole,  Fluoro-benzimidazole  and  Trifluoromethyl-
benzimidazole  Nucleosides 
 
5.3.1   Glycosilation 
 
The glycosilation of all benzimidazole nucleosides was done with 1,2,3,5-tetra-O-acetyl-β-D-
ribofuranose  69  after  the  procedure  of  Vorbrüggen  (Vorbrüggen  &  Höfle,  1981).  The 
mechanism of the reaction is given in Figure 5.11. using the example of 4-trifluoromethyl 
benzimidazole 61. In this compound in solution the H atom is migrating from N1 to N3 and 
also the compound 66 exists. The equilibrium of this reaction is on the side of the N1 isomer. 
This  equilibrium  is  influenced  with  the  number  and  kind  of  substituents  on  the  benzene 
aromatic ring. The Silyl-Hilbert-Johnson reaction begins with silylation of the N-H function 
with N,O-bis-(trimethylsilyl)-acetamide (BSA). Because of the existence of both isomers, N1 
and N3, we get also two silylated products. 
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Figure 5.11. Possible silylations of 4-trifluoromethyl imidazole 
BSA=N,O-bis-(trimethylsilyl)-acetamide 
 
In the mean time 1,2,3,5-tetra-O-acetyl –β-D-ribofuranose  69  is set up with Lewis acid, 
trimethylsilyltrifluoromethane  sulphonate  (TMSOTf).  Than  the  sugar  builds  a  cation  70 
through an intramolecular attack of the 2-acetyl group on C1 position and at the same time the 
acetyl  group  leaves  (Figure  5.12).  The  C1-acetyl  group  leaves  the  reaction  as 
trimethylsilylacetate ester. Therefore five membered ring, in α position of the sugar ring, is 
formed. When the sugar cation is added to the silylated base solution, this nucleophile attacks 
the sugar-cation on C1. The attack can only be on the β side of the sugar ring. After the attack 
on the five membered ring, which is formed with an intramoleculare reaction of the C2-acetyl 
group, the ring is again opened and a nucleobase is covalently bonded to the sugar ring. 
The big advantage of this reaction is that only β-nucleoside can be formed. Because of the 
existence of two silylated isomers of nucleobase 67 and 68 we get two regioisomers anyway. 
The reaction of 67 with sugar-cation 70 gives the N1-isomer 2’,3’,5’-tri-O-acetyl-1’-deoxy-
1’-(4-trifluoromethyl-1-N-benzimidazolyl)-β-D-ribofuranose 71 and the reaction of 70 with 
68  gives  the  N3  isomer  2’,3’,5’-tri-O-acetyl-1’-deoxy-1’-(4-trifluoromethyl-3-N-
benzimidazolyl)-β-D-ribofuranose 72. The ratio of the obtained isomers is the same as the   Chemical Synthesis   
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ratio  of  4-trifluoromethyl  imidazole  isomers  61  and  66  in  solution.  For  4-trifluoromethyl 
benzimidazole the ratio is 10:1.  
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Figure 5.12.  Glycosilation reaction 
 
 
Under the reaction conditions only β-nucleosides can be formed, but there are N1 and N3 
isomers to be separated and identified. Therefore we measured ROESY-NMR spectra. The 
difference in between those two isomers can be seen in figure 5.13.  and for the  N1 (a) isomer 
there is a ROE-signal in between the H7 proton of the base and the  H1’ proton of the sugar 
moiety. As expected (figure 5.13,b) for the N3 isomer there is no ROE-signal in between 
those two protons. 
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Figure 5.13. Part from 400MHz ROESY-NMR-spectra of 2’,3’,5’-tri-O-acetyl-1’-deoxy-1’-(4-
trifluoromethyl-1-N-benzimidazolyl)-β-D-ribofuranose 71  and 2’,3’,5’-tri-O-acetyl-1’-deoxy-
1’-(4-trifluoromethyl-3-N-benzimidazolyl)-β-D-ribofuranose  72 
 
 
 
While  glycosilating  benzimidazole  with  1,2,3,5-tetra-O-acetyl-β-D-ribofuranose  69  we  did 
not become N1-N3 isomers, because those two positions do not differ. However, there is 
another side product of the silylated benzimidazole, that is the twice silylated product 75 
(figure 5.14.). When we add this mixture to the Hilbert-Johnson-reaction and we add the sugar 
cation to silylated benzimidazole we get a mixture of wanted product 2’,3’,5’-tri-O-acetyl-1’-
deoxy-)-β-D-ribofuranose  77  and  76,  a  side  product  with  two  sugar  moieties  and  one 
benzimidazole.  
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Figure 5.14. Glycosilation reaction of 1,2,3,5-tetra-O-acetyl-)-β-D-ribofuranose 69 with 
benzimidazole 73 
 
 
 
5.3.2   Deprotection 
 
There are two common methods for the deprotection of acetylated nucleosides. The first one 
is using a methanolic ammonia solution (Nielson et al., 1971) and the second one is with 
sodium metoxide in methanol (Wolfrom & McWain, 1965). We decided to use the second 
method because of shorter reaction times (instead of 20 h for the first method the reaction is 
finished after 90 minutes) and high yields. All yields are over 90 %.  
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Figure 5.15.  Deacetylation 
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5.4   C-Nucleosides 
 
 
5.4.1   γ-Lactone 
 
For  the  synthesis  of  C-nucleosides  we  used  the  protected  γ-Lactone  83.  However,  the 
protecting groups on γ-lactone have to be stable under the conditions of glycosilation and 
dehydroxylation. The reaction conditions of the glycosilation are strong basic (n-BuLi or t-
BuLi) where for dehydroxylation conditions are strong acidic (BF3*Et2O). Furthermore that 
the  protecting  groups,  have  to  be  removed  after  the  glycosilation  to  become  unprotected 
nucleoside  for  further  synthesis.  Those  were  our  reasons  to  choose  benzyl  groups  for 
protection (Engels & Parsch, 2001). The synthetic pathway for the synthesis of γ-lactone is 
shown in figure 5.16. 
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Figure 5.16 . γ-Lactone synthesis 
 
The synthesis of  γ-lactone begins with methylation of D-ribose 79 on the anomeric hydroxyl 
group. D-ribose is a natural product and cheap starting material for this reaction. Methylation 
of the anomeric hydroxyl group is done in methanol with a catalytical amount of sulphuric 
acid at 4°C (Heath et al., 1983). The low reaction temperature is needed for the selectivity of 
this reaction. Sulphuric acid does not only catalyse the methylation but also the epimerisation 
of methyl-D-ribofuranose. During this reaction the furanose ring of ribose can be opened and 
closed again. The reaction lasts 24 hours to give a quantitative yield of methyl-D-ribofuranose  
81. The ratio of β- and α- isomers is usually around 3:1.The epimers were not separated after   Chemical Synthesis   
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the  reaction  because  they  can  be  both  used  in  further  synthesis  to  give  γ-lactone  83. 
Benzylation  of  both  epimers  was  done  with  benzyl  chloride  and  potassium  hydroxide  in 
tetrahydrofurane (Barker & Fletcher, 1961). Potassium hydroxide was used as a powder for 
the reaction. We used a large excess of the benzyl chloride for this reaction. Wanted product, 
1-methyl-2,3,5-tri-O-benzyl-ribofuranose  81,  was  obtained  in  85.7  %  of  yield  after 
purification. 
In the next step the anomeric hydroxyl group was again deprotected. Therefore, 1-methyl-
2,3,5-tri-O-benzyl-ribofuranose 81 was dissolved in dioxane, 0.1M HCl was added and the 
mixture was refluxed. After 20 h we got our product, 2,3,5-tri-O-benzyl-ribofuranose 82 , 
with 93.6 % yield (Barker & Fletcher, 1961).  
The last step in synthesis of γ-lactone was oxidation of both epimers (Timpe et al., 1975). The 
oxidation  was  done  with  dimethyl  sulphoxide  (DMSO)  and  acetic  acid  anhydride.  This 
oxidation is called Pfitzner-Moffatt-oxidation (Pfitzner & Moffatt, 1965), which was modified 
by Goldman (Albright & Goldman, 1967). The reaction was performed 24 hours at room 
temperature. After extraction of reaction mixture with methylene stirred and FC purification 
γ-lactone 83 was obtained in 95 % yield.  
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5.4.2   Benzene, Fluoro- and Chloro  Benzene-Nucleosides 
 
In this part we are going to describe the synthesis of seven different benzene and fluoro-
benzene-nucleosides. Six of them were synthesised as phosphoamidites and used for RNA 
synthesis, and 1’-deoxy-1’-(4-chlorophenyl)-β-D-ribofuranose 43 was only recrystalised and 
its structure is given in another chapter (chapter 6-Crystal structures). 
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Figure 5.17. Synthesised C-nucleosides 
 
5.4.2.1  C-Glycosilation and Dehydroxylation 
 
The synthesis of all C-nucleosides has the same mechanism (Krohn et al., 1992).  As reagents 
we  used  bromo-fluoro-benzenes,  bromo-benzene  or  fluoro-benzenes  in  the  reaction  with 
2,3,5-tri-O-benzyl-ribono-γ-lactone 83. In   figure 5.18. the synthesis of 2’,3’,5’-tri-O-benzyl-
1’-deoxy-1’-(2,4,5-trifluoro phenyl)- β-D-ribofuranose 86 is shown. For this reaction 2,4,5-
trifluoro bromo benzene 84 was dissolved in diethyl ether and cooled to –78°C, with  acetone/ 
liquid nitrogen mixture. Than n-BuLi in hexane was slowly  added. While adding n-BuLi 
bromine  on  bromo-fluoro-benzene  is  being  exchanged  with  Li.  Afterwards  γ-lactone  83 
dissolved in diethyl ether is added. The bromine-lithium exchange allows nucleophil attack of 
fluorobenzene on γ-lactone 83. The nucleophilic attack is on the si-side of the lacton and   Chemical Synthesis   
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therefore we get fluoro-benzene only in β-position on the sugar (figure 5.18.). The obtained 
lactol 85 was immediately worked up and set up in the dexydroxylation reaction (Kraus et al., 
1988; Krohn et al., 1992).  
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Figure 5.18. C-glycosilation and dehydroxylation 
 
The dehydroxylation reaction is done with bortrifluoride-ethyletherate and triethylsilane in 
methylene chloride at –78°C. In this reaction bortrifluoride attacks the hydroxyl group of the 
lactol 85 and it cleaves from the molecule.  The intermediate cation  87 , is stabilised with 
acid ( Brückner et al., 1988). Triethylsilane is a hydride donor in this reaction. The H atom 
attacks the re-side of the sugar, because of the anomeric effect, and leaves benzene in β-
position.  Even though transition cation is planar we become only β-nucleoside as a product 
(figure 5.19). 
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Figure 5.19.  Dehydroxylation with BF3 
 
The syntheses of the monofluoro benzene modification 36 , mono-chloro- 43 and benzene 
nucleoside 41 were done in tetrahydrofurane and all other syntheses were done in ether. The 
reason for that is that in tetrahydrofurane not only the bromine-lithium exchange can take   Chemical Synthesis   
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place but also the (acidic) hydrogen –lithium exchange (Coe et al., 1990; Bridges et.al, 1990; 
Schirley et al., 1968; Haidic et al.,1967). In ether as a solvent we became higher yields of the 
wanted products ( Figure 5.20).  
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Figure 5.20.: Influence of the solvent on the reaction of n-BuLi and fluoro benzenes 
 
Reactions  of  2,3,5-trifluorobromobenzene  with  different  solvents  and  lithiated  bases  gave 
very poor yields. Therefore we performed the reaction of 1,3,5-trifluorobenzene 88 with t-
BuLi in n-pentane. In this reaction we obtained the wanted product in 55 % yield (figure 
5.21.). The enhanced metalating abilities of t-BuLi vs. n-BuLi has been attributed to a greater 
tendency of the less stable t-butyl anion to donate an electron to an aromatic system and to 
give more stable t-butyl radical. It was shown that there is little steric requirement difference 
in metalation of aromatic systems with t-BuLi vs. n-BuLi. However the rate of alkilation is t-
butyl>  sec-butyl>  n-butyl,  but  usually  for  alkilation  products  higher  concentrations  of 
alkyllithium  compounds  are  required  (Howells  et  al.,  1974;  Adamson  et  al.,  1996).  An 
overview over the glycosilation reactions is given in figure 5.22.   Chemical Synthesis   
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Figure 5.21. Synthesis of 2,3,5-tri-O-benzyl-1’deoxy-1’-(2,3,5-trifluoro phenyl)-β-D-
riboranose 90 
It is important to stress at this point that in the reactions described in experimental part no 
aryne formation was observed (Gilman et al., 1957). 
 
Reagent  Base  Solvent  Yield of wanted 
product 
4-fluoro-bromo 
benzene 
n-BuLi  THF  75.8 %
1 
4-chloro-bromo 
benzene 
n-BuLi  THF  73 %
1 
2,4-difluorobromo 
benzene 
n-BuLi  Et2O  84.6 %
1 
1,3,5-trifluorobenzene  t-BuLi  Et2O  55 %
1 
2,4,6-trifluorobromo 
benzene 
n-BuLi  Et2O  32 % 
1,3,5-trifluorobenzene  n-BuLi  Et2O  10 % 
1,3,5-trifluorobenzene  n-BuLi  THF  7 % 
2,4,5-trifluorobromo 
benzene 
n-BuLi  Et2O  65 %
1 
Bromo benzene  n-BuLi  THF  74.7 %
1 
Pentafluorobromo 
benzene 
n-BuLi  Et2O  50 %
1 
Pentafluorobromo 
benzene 
t-BuLi  Et2O  10 % 
Pentafluorobromo 
benzene 
n-BuLi  THF  12 % 
 
Figure 5.22. Yields on C-glycosilation reactions of the synthesised C-nucleosides under 
different conditions; 
1-reactions described in experimental part 
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5.4.2.2  Debenzylation 
 
The debenzylation of the protected nucleosides was done with palladium hydroxide on carbon 
and cyclohexene (Hanessian et al.,1981). As a catalyst Pearlmans catalyst, 20 % palladium 
hydroxide on carbon was used (Pearlman, 1967). In this reaction cyclohexene is a hydrogen 
donor. An example is given in figure 5.23. 
Yields for all synthesised compounds were over 90%. 
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Figure 5.23. Debenzylation of 2’,3’,5’-tri-O-benzyl-1’-Deoxy-1’-(2,3,5-trifluoro phenyl)-β-D-
ribofuranose  84 
Debenzylation of 2’,3’,5’-tri-O-benzyl-1’-deoxy-1’-phenyl -β-D-ribofuranose 91 under these 
conditions doesn’t lead to the wanted product, 1’-deoxy-1’-phenyl -β-D-ribofuranose 41 , but 
to 1-deoxy-1-phenyl-D-ribitole 92 (Parsch, 2001). Wanted product,  1’-deoxy-1’-phenyl -β-D-
ribofuranose 41 , was obtained in reaction with bortribromide (Krohn et al., 1992)(figure 
5.24.). 
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Figure 5.24.  Debenzylation of 2’,3’,5’-tri-O-benzyl-1’-deoxy-1’-phenyl -β-D-ribofuranose 91       Chemical Synthesis   
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5.5   Protection of Nucleosides for Solid Phase RNA Synthesis 
 
For RNA synthesis sequential formation of phosphodiester group between the 3’OH group 
and the 5’OH group has to be performed. We have to install a temporary protecting group 
either at 3’OH or 5’OH, which has to cleave in every step during the synthesis. Today it is 
most common to protect the 5’OH group with DMTr group, which is cleaved in an E1-type 
mechanism with acid. For RNA synthesis we also need a protecting group for the 2’OH group 
and therefore we used TBDMS group. 
  
5.5.1   Dimethoxytritilation Reaction 
 
For the 5’-OH group of phosphoamidites as protecting group the dimethoxytriphenylmethyl-
protecting group was used (Smith et al., 1962; Schaller et al., 1963). Triphenylmethyl- and 
monomethoxytriphenylmethyl- (MMTr) protecting groups are also used for phosphoamidites. 
The advantage of DMTr-protecting group is that it can be easily cleaved with trichloro acetic 
acid (TCA) and absorbs at the 498 nm after cleavage on the DNA-/RNA-synthesizer. That 
allows to observe and calculate yields of each coupling step on the synthesizer (Fisher & 
Caruthers,  1983).  For  this  reaction  we  dissolve  nucleoside  in  pyridine  and  triethylamine. 
Triethyl amine is a base that supports the reaction. The dimethoxytriphenyl methyl-group has 
a high selectivity for primary 5’-OH group. Using 1,2 equivalents of DMTrCl we don’t get 
any 2’-OH or 3’-OH product. 
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Figure 5.25. Dimethoxytritilation 
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The reactivity of the nucleosides varies. For example in the reaction of  1’-deoxy-(5-fluoro-3-
N-benzimidazoyl)-β-D-ribofuranose 32 we get the tritilated product in 83 % over 7h and in 
reaction  of  1’-deoxy-(4-trifluoromethyl-1-N-benzimidazolyl)-  β-D-ribofuranose  33  (figure 
5.25.)  we get 68 % over 20 h. An explanation would be the size of the trifluoromethyl group 
makes the reaction slower. Fluoro-benzene modifications were usually protected over shorter 
time and with higher yields than fluoro-benzimidazoles.  
 
5.5.2  Protection of 2’-OH Group 
 
For  RNA  synthesis  we  need  a  protecting  group  at  the  2’-OH  group.  For  this,  either  the 
TBDMS-protecting  group  or  TOM-protecting  group  are  in  use,  which  are  cleaved  with 
fluoride after RNA synthesis (Stawinski et al., 1988; Gasparutto et al.,1992; Westman & 
Strömberg,  1994).  Recently  the  ACE-  (acethoxyethoxy-)  protecting  group  is  developed, 
whose easy cleavage and high purity of the oligonucleotides are main advantages (Scaringe et 
al., 2004).   We used the TBDMS-protecting group because in our hands it gave better results 
than the TOM-protecting group and it is cheaper ( Ogilvie et al., 1974; Ogilvie et al., 1978; 
Pitsch,  1999).  The  problem  with  the  TBDMS  group  is  that  in  reaction  we  get  two 
regioisomers  as  products,  2’  and  3’  protected  OH  groups  (Hakimelaki  et  al.,  1981; 
Hakimelaki et al., 1981) and the group also migrates from one position to another (Jones & 
Reese, 1979). Using  silver nitrate in the reaction we got more of 2’-protected nucleoside 
(Hakimelahi et al., 1981; Hakimelahi et al., 1982).  
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Figure 5.26.  RNA protecting groups in common use today TBDMS-, TOM-   and ACE- 
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The reaction time was 20 h for all our modifications (an example is given in Figure 5.27. ).  
The main problem in isolating the wanted 2’-protected nucleoside is migration of the 
TBDMS-group and that influences the yields of the wanted isomers. Since in polar solvents 
(Figure 5.28.) this migration is greater we avoided using them and therefore most of the 2’-
protected nucleosides were isolated by means of preparative HPLC. 
The isomers were identified with 1H,
1H-COSY-NMR measurements. 
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Figure 5.27.  Protection with the  TBDMS-group 
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Figure 5.28.  Migration of the  TBDMS-group in polar solvents 
 
5.5.3   Phosphitilation 
 
 
To  avoid  migration  of  the  TBDMS-protecting  group  in  the  synthesis  of  phosphoamidites 
instead  of  N,N-diisopropylethyl  amine  (DIPEA)  sym.-collidine  was  used  as  a  base.  As  a 
catalyst N-methylimidazole was used.  
In this reaction a very high dryness of the reagents is important. As a solvent acetonitrile was 
used. The nucleoside was dissolved in acetonitrile and sym.-collidine and N-methyl imidazole   Chemical Synthesis   
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were  added.  Than  the  reaction  mixture  was  cooled  to  0°C  and  cyanoethyl-
diisopropylchlorophosphoramidite 96  (Sinha etal., 1983) was added. The reaction mixture 
was left 15 min. at 0°C and than left 25-60 minutes at room temperature (an example is shown 
in figure 5.29) ( Parsch & Engels, 2000). 
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Figure 5.29.  Synthesis of phosphoramidite for solid phase synthesis of RNA 
 
The purification was done as fast as possible. First the reaction mixture was extracted with 
methylene  chloride  three  times  and  than  the  collected  organic  layers  was  extracted  with 
0.01M  citric  acid  to  remove  sym.-collidine.  This  concentration  of  the  citric  acid  in  this 
solution is important because it is high enough to remove sym.-collidine but low enough not 
to cleave DMTr-protecting group.   
The synthesis of phosphoramidite of benzene modification was done in 1996 by Matulic-
Adamic and coworkers (Matulic-Adamic et al., 1996; Matulic-Adamic et al., 1996a). 
 
5.6   Abasic Site  
 
For the investigation of base stacking we had to synthesise an abasic site for comparison. An 
abasic site has no nucleobase on the sugar. 
The synthesis of the abasic site amidite  102 for solid phase synthesis of RNA begins with 
2,3,5-tri-O-benzyl-ribofuranose 82. 2,3,5-tri-O-benzyl ribofuranose 82 is synthesised from D-
ribose and is the third step in the synthesis of 2,3,5-tri-O-benzyl-ribono-γ-lactone 83. To get 
the abasic building block the hydroxyl group on C1 has to be removed. Therefore  82 was 
dissolved in acetonitrile and bortrifluoride-ethyleterate and triethylsilane were added (Purdy   Chemical Synthesis   
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et al.,1994). After 1,5 h the reaction was finished. The product, 2,3,5-tri-O-benzyl-1-deoxy-D-
ribofuranose 98, was obtained in 88.4 % yield.  
The next step was to deprotect the benzyl groups and therefore we dissolved 98 in ethanol and 
cyclohexene and we added palladium hydroxide (20 %) on carbon. ( Hanessian et al.,1981).  
After work up we obtained the wanted product 42 in 95.3 % yield (Engels & Parsch, 1999).  
The following steps to synthesise the corresponding amidite are shown in in figure 5.30  and 
details are described in the experimental part. 
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Figure 5.30.  Synthesis of the abasic building block for RNA synthesis 
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5.7   Overview on Synthesis 
In figures 5.31, 5.32, 5.33, 5.34 .and 5.35.   are overviews on the all syntheses given (yields 
and other precise information on experiments are given in the experimental part).  
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Figure 5.31. Overview of fluoro- benzimidazole syntheses 
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Figure 5.32.: Overview of trifluoromethyl-benzimidazole synthesis 
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Figure 5.33. Overview on 4- fluoro- and 4-chloro-benzene nucleosides for RNA synthesis   Chemical Synthesis   
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Figure 5.35. Overview over 2,4,6-trifluoro-benzene modification synthesis for RNA solid 
phase synthesis with t-BLli, Et2O 
   Chemical Synthesis   
- 71 - 
5.8   Partition Coefficients and HPLC Retention Times 
 
From all synthesised modified nucleosides partition coefficients and HPLC retention times 
were determined. We used unprotected nucleosides for determinations. 
 
5.8.1   Partition Coefficients 
 
Octanol/water  partition  coefficients  are  measure  of  the  lipophilicity  of  molecules  and 
therefore are in correlation with penetration across biological membranes (Csizmadia et al., 
1997).  Octanol-water partition coefficient, log P, is defined as the ratio of the equilibrium 
concentration of a solute in octanol to that in water. More lipophilic molecules have bigger 
values  for  partition  coefficient.  Investigation  of  lipophilicity  of  molecules  is  of  great 
importance in drug research. This is the main reason why programmes for predicting partition 
coefficients are designed (Haeberlein & Brinc, 1993).  
Unprotected  nucleosides  were  dissolved  in  water  in  concentrations  that  correspond  to 
extinction between 0,8 and 1,2. Than, 2ml of 1-octanol and 2ml of these solutions were 10 
minutes strongly mixed. The probes were than 10 minutes centrifuged at 10 000 U/min. The 
phases  were  carefully  separated  and  extinctions  of  both  phases  were  measured.  From  the 
measured values partition coefficient was calculated using following equation [5-1]: 
[5-1]        log P = Eoctanol /Ewater 
where Eoctanol  is measured extinction of octanol phase and Ewater is measured extinction of 
water phase. Measured partition coefficients are shown in figure 5.36. 
Measure partition coefficients log P were between 0,149 and 5,884. As expected smallest 
value we have for non-substituted imidazol and the biggest for trifluoromethyl substituted 
imidazoles.  From  our  data  it  is  also  clear  that  aromatic  fluorination  always  increases 
lipophilicity as perfluorination also does ( Smart, 2001). It also can be noticed that position of 
fluorines is important (look at the data for 2,4,6 TFB and 2,4,5 TFB) as previosly showed by 
Parsh for monofluorinated derivatives (Parsch, 2000). For both derivatives that have bis-ortho 
substitution (PFB and 2,4,6 TFB) values for log P are lower than expected. 
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Nucleoside  Partition Coefficient (log P) 
I  0,149 
4 FBI  1,789 
5 FBI  1,802 
6 FBI  1,799 
4,6 DFBI  4,240 
4 TFM  6,762 
5 TFM  6,757 
6 TFM  6,688 
B  1,050 
4 FB  1,497 
2,4 DFB  1,695 
2,4,6 TFB  1,398 
2,4,5 TFB  1,825 
PFB  2,156 
Figure 5.36. Partition coefficients of nucleosides 
 
5.8.2   HPLC-Retention Times 
 
Another method for investigating lipophilicity of compounds is the determination of HPLC 
retention time ( Balzarini et al., 1989). Substances that have longer retention times on reverse 
phase HPLC column are more lipophilic (Lien et al., 1991). Hydrophilic substances are eluted 
very fast from those columns. 
We used RP-18 (5 m) column from Merck company (LiChrospher EcoCART 125-3, Nr. 
647318).  Acetonitrile  in  5%  concentration  in  water  was  used  as  eluent.  The  flow  was 
0,6ml/min.  
Retention  times  are  given  in  figure  5.37.  Measured  retention  times  vary  from  10  to  62 
minutes. 
As already is seen from partition coefficient more lipophilic are trifluoromethyl modifications 
(TFM). Those are followed by 4,6 DFBI modification. Benzene modifications are in generally 
less lipophilic and their retention times are from 10,1 (for B) to  17,8 (for PFB). 
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Nucleoside  Retention time 
(min) 
I  16,4 
4 FBI  16,8 
5 FBI  17,0 
6 FBI  17,4 
4,6 DFBI  24,6 
4 TFM  62,3 
5 TFM  61,9 
6 TFM  63,0 
B  10,1 
4 FB  14,9 
2,4 DFB  13,6 
2,4,6 TFB  14,0 
2,4,5 TFB  15,8 
PFB  17,0 
Figure 5.36. HPLC Retention times of nucleosides 
Data given in figure 5.37. correlate very well with values obtained for partition coefficients. 
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6 Crystallography 
 
 
 
 
 
6.1   What do we Learn from Crystals? 
 
A crystal is an ordered spramolecular system and according to Dunitz ‘’ a supermolecule par 
excellence’’ (  Dunitz, 1996). X-Ray  crystallography  provides  accurate  information on the 
structures of molecular complexes and the nature of the nonbonded interaction between the 
binding partners in the solid state. The technique has become the central one in molecular 
recognition studies. 
 All databases containing information on crystal structures are growing at exponential rate, 
and have been vaults for finding information on chemical interactions: they have been the 
bases for extensive investigations of classical H bonds in the past and more recently have 
been used to explore weaker H bonds such as C-H...O, C-H...N, C-H...Cl and nowadays more 
and more often mentioned C-H...F hydrogen bond. Directionality, energetics, distance relative 
to van der Waals radii, and bond length are useful criteria for classifying H bonds. In this 
context C-H/ π interaction has been defined as hydrogen bond.  
Parallels can be drawn between molecular recognition events that occur within model systems 
in the liquid phase and those that define the supramolecular nature of a molecular network in 
the solid state. Crystal structures of benzene and different fluoro-benzenes follow herringbone 
pattern (edge-to-face) so we wanted to see if our nucleosides would allow the same pattern or  
a different one ( Castellano et al., 2003). 
 
 
6.2   Theoretical Background 
 
X-Ray crystallography is a standard technique for solving crystal structures. Its basic theory 
was developed soon after x-rays were discovered more than a century ago. However, over the   Crystallography   
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years it has gone through continual development in data collection instrumentation and data 
reduction  methods.  Today  X-ray  crystallography  is  widely  used  in  material  science  and 
structure determination. For crystallography the proper wavelength is 10
-8cm Strähle, 1990). 
X-rays are produced generally by either x-ray tubes or synchrotron radiation. In a x-ray tube, 
which is the primary x-ray source used in laboratory x-ray instruments, x-rays are generated 
when a focused electron beam accelerated across a high voltage field bombards a stationary or 
rotating solid target. As electron collide with atoms in the target and slow down, a continuous 
spectrum of x-rays are emitted, which are termed Bremsstrahlung radiation. The high-energy 
electrons also eject inner shell electrons in atoms through the ionisation process. When a free 
electron fills the shell, an x-ray photon with an energy characteristic of the target material is 
emitted. Common targets used in x-ray tubes include Cu and Mo, which emit 8 keV and 14 
keV x-rays with corresponding wavelengths of 1.54 Å and 0.8 Å, respectively. (The energy E 
of a x-ray photon and it's wavelength is related by the equation E = hc/λ, where h is Planck's 
constant and c the speed of light). In recent years synchrotron facilities have become widely 
used as preferred sources for x-ray diffraction measurements. Synchrotron radiation is emitted 
by  electrons  or  positrons  travelling  at  near  light  speed  in  a  circular  storage  ring.  These 
powerful sources, which are thousands to millions of times more intense than laboratory x-ray 
tubes,  have  become  indispensable  tools  for  a  wide  range  of  structural  investigations  and 
brought advances in numerous fields of science and technology. 
 
6.2.1   Lattice Planes and Bragg’s Law 
 
X-rays primarily interact with electrons in atoms. When x-ray photons collide with electrons, 
some photons from the incident beam will be deflected away from the direction where they 
originally travelled, much like billiard balls bouncing off one another. If the wavelength of 
these scattered x-rays does not change (meaning that x-ray photons did not lose any energy), 
the process is called elastic scattering (Thompson Scattering) in that only momentum has been 
transferred  in  the  scattering  process.  These  are  the  x-rays  that  we  measure  in  diffraction 
experiments,  as  the  scattered  x-rays  carry  information  about  the  electron  distribution  in 
materials. On the other hand, in the inelastic scattering process (Compton Scattering), x-rays   Crystallography   
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transfer some of their energy to the electrons and the scattered x-rays will have different 
wavelength than the incident x-rays.  
Diffracted waves from different atoms can interfere with each other and the resultant intensity 
distribution is strongly modulated by this interaction. If the atoms are arranged in a periodic 
fashion, as in crystals, the diffracted waves will consist of sharp interference maxima (peaks) 
with the same symmetry as in the distribution of atoms. Measuring the diffraction pattern 
therefore allows us to deduce the distribution of atoms in a material.  
The peaks in an x-ray diffraction pattern are directly related to the atomic distances. Let us 
consider an incident x-ray beam interacting with the atoms arranged in a periodic manner as 
shown in 2 dimensions in the following illustrations. The atoms, represented as green spheres 
in the graph, can be viewed as forming different sets of planes in the crystal (coloured lines in 
the graph on the left). For a given set of lattice plane with an inter-plane distance of d, the 
condition for a diffraction (peak) to occur can be simply written as 
2dsinθ = nλ 
which is known as the Bragg's law, after W.L. Bragg, who first proposed it (Bragg & Bragg, 
1913). In the equation, λ is the wavelength of the x-ray, θ the scattering angle, and n an 
integer  representing  the  order  of  the  diffraction  peak.  The  Bragg’s  Law  is  one  of  most 
important laws used for interpreting x-ray diffraction data.  
 
Figure 6.1. Lattice planes(left)  and Bragg’s Law(right) 
 
   Crystallography   
- 78 - 
6.3   Crystal  Structure  of  Fluorine-modified  and  Chlorine-modified  
Benzene Nucleosides 
In this work all fluorine modified benzene nucleosides were crystallized (2,4,6 TFB, 2,4,5 
TFB and also 4 ClB). Crystal structures of 4FB and 2,4 DFB were done in our group and 
published previously ( Bats et al., 1999).  
Nucleoside  Crystallized 
from… 
Temperature 
(°C) 
Crystal 
system 
Space 
Group 
Sugar 
Conformation 
Benzene (B)  Toluol/ethylacetate  -18  monoclininic  P 21  C2’endo 
4-Fluoro-
benzene (4FB) 
methanol  20  orthorhombic  P 
212121 
C1’exo 
C2’endo 
4-Fluoro-
benzene (4FB) 
methanol  4  orthorombic  P 
212121 
Between 
C2’endo  and 
C2’endoC3’exo  
4-Fluoro-
benzene (4FB) 
water  20  monoclininic  C 2  Between 
C2’endo  and 
C1’exoC2’endo 
2,4-difluoro-
benzene 
(2,4DFB) 
water  20  monoclininic  C 2  C2’exo 
C3’endo  
2,4,6-
trifluorobenzene 
(2,4,6 TFB) 
methanol  4  orthorombic  P22121  C2’endo 
2,4,5-
trifluorobenzene 
(2,4,5 TFB) 
methanol  4  monoclinic  C2  C2’endo 
4-chloro-
benzene- 
(4ClB) 
water  4  orthorombic  P22121  Between 
C2’endo and 
C3’exo  
 
Figure 6.2. Crystal data of C-nucleosides   Crystallography   
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Crystal  structure  of  B,  1’-deoxy-1’-phenyl-β-D-ribofuranose  was  published  from  Matulic-
Adamic  and  co  workers  and  is  used  for  comparison  here  (Matulic-Adamic  et  al.,1996). 
Crystals were obtained either from water or from methanol. Complete tables with results are 
given in the attachment. In figure 6.2 are crystallographic data of C-nucleosides given. 
All  crystals  crystallised  in  either  orthorhombic  or  monoclinic  crystal  group.  The  five-
membered furanose ring of 1’-deoxy-1’-(2,4,6-trifluorophenyl)-β-D-ribofuranose (2,4,6 TFB) 
has approximately  a C2’-endo-envelope conformation. The hydroxyl group attached to C2’ is 
in an equatorial position, the hydroxyl group attached to C3’ is in a pseudo-axial position and 
the  phenyl  group  attached  to  C1’  is  in  a  pseudo-equatorial  position  with  respect  to  the 
furanose  ring.  The  trifluorophenyl  group  adopts  a  position  with  an  almost  syn-periplanar 
orientation of the C11-F3 bond and the C1-H1 bond. The intramolecular H1...F3 distance of 
2.34 Å  is slightly shorter than the van der Waals contact distance. The phenyl group shows a 
small  deviation  from  planarity:  substituent  atoms  C1  and  F1  deviate  0.11  Å  in  opposite 
directions  from  the  phenyl  plane.  This  deviation  from  planarity  may  result  from  a  steric 
interaction between atoms F1 and O4. The observed F1...O4 distance of 2.819 Å is slightly 
shorter than the van der Waals contact distance. The ribofuranose groups are connected by 
intermolecular O-H...O hydrogen bonds to a two-dimensional network parallel to the a,b - 
plane. These molecular layers are connected in the c - direction by an  intermolecular C-H...O 
interaction  with  a  H...O  distance  of  2.48  Å  and  two  intermolecular  C-H...F  interactions 
(involving the para-F atom) with H...F distances of 2.54 and 2.63Å(figure6.3.). 
 
Figure 6.3. Crystal structure of 1’-deoxy-1’-(2,4,6-
trifluorophenyl)-β-D-ribofuranose (2,4,6TFB) 
The crystal structure of  1’-deoxy-1’-(2,4,5-trifluorophenyl)-β-D-ribofuranose (2,4,5 TFB) is 
isomorphus with the structure of 1’-deoxy-1’-(2-fluorophenyl)-beta-D-ribofuranose (Bats et 
al.  1999).  The  five-membered  furanose  ring  approximately  has  a  C2-endo-envelope   Crystallography   
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conformation. The phenyl group attached to C1 and the hydroxyl group attached to C2’ are in 
pseudo-equatorial positions, the hydroxyl group attached to C3’ is in a pseudo-axial position 
with respect to the furanose ring. The phenyl group is planar within experimental uncertainty. 
The ribofuranose groups are connected by intermolecular O-H...O hydrogen bonds to a two-
dimensional network parallel to the a,b - plane. The molecules are further stabilized in the a,b 
-direction  by  a  number  of  weak  C-H...F  interactions  (involving  F1  and  F3)  with  H...F 
distances  between  2.60  and    2.75  Å.  Neighbouring  molecules  are  connected  in  the  b  - 
direction by a rather short intermolecular C-H...O interaction with a H...O distance of 2.32 Å. 
No significant intermolecular interactions are observed in the crystallographic c - direction: 
the shortest intermolecular C8-H8...F2 interactions have a H...F distance of 2.90 Å which is 
too long to be significant. Surprisingly the C-H...π (phenyl) interaction which was observed 
in  the  isomorphous  2-fluoro-phenyl  compound  is  replaced  in  the  title  compound  by  an 
intermolecular  C10-F3...C9  interaction  with  a  F...C  distance  of  3.05  Å,  which  is  slightly 
shorter than the van der Waals contact distance. The nature of this interaction is unclear. 
Similar C-H...C interactions with F...C  distances between 2.96 and 3.15 Å are found in the 
crystal structure of  hexafluorobenzene (Boden et al.,1973; Bertolucci et al., 1974). 
 
 
Figure 6.4. Crystal structure of 1’-deoxy-1’-(2,4,5-
trifluorophenyl)-β-D-ribofuranose (2,4,5TFB) 
 
The  crystal  structure  of  the    1’-deoxy-1’-(4-Chlorophenyl)-ß-D-ribofuranose  compound  is 
isomorphous with the crystal structure of one of the two modifications of 1’-deoxy-1’-(4-
fluorophenyl)-ß-D-ribofuranose reported by Bats, Parsch and Engels (Bats et al.,2000).The 
ribofuranose ring has a conformation which is intermediate between a C2'-endo,C3'-exo twist 
and  a  C2'-endo  envelope.  The  conformation  of  the  molecule  is  rather  similar  to  the   Crystallography   
- 81 - 
conformation observed in 1’-deoxy-1’-(4 -fluorophenyl)-ß-D-ribofuranose ( Bats et al., 1999) 
and the conformation observed in 1’-deoxy-1’-phenyl-ß-D-ribofuranose Matulic-Adamic and 
coworkers ( Matulic-Adamic et al., 1996).The phenyl group attached to C1’ and the hydroxyl 
group attached to C2’ are in pseudo-equatorial positions, the hydroxyl group attached to C3’ 
and the methanol group attached to C4’ are in a pseudo-axial positions with respect to the 
five-membered ring. The shortest intramolecular contact distance is 2.43 Å between O4 and 
H11. The crystal packing shows three intermolecular hydrogen bonds. 
In this way each molecule is connected by hydrogen bonding to six different neighboring 
molecules leading to a two-dimensional network in the a,b - direction.The bonding in the c - 
direction consists of weak intermolecular C8-H8...Cl interactions with a H...Cl distance of 
2.74 Å and a C-H-Cl angle of 150° . A search of the Cambridge Data Base for structures 
containing  intermolecular  C(phenyl)-Cl...H-C(phenyl)  interactions  with  a  Cl...H  distance 
shorter than 2.8 Å revealed 149 possible crystal structures. Intermolecular C-H...Cl contacts 
with a H...Cl distance of 2.78 Å, very similar to those in the title compound, occur in the 
crystal structure of N-(4-chloropheny)-mannopyranosylamine (Ojala et al.,2000). 
 
 
Figure 6.5. Crystal structure of 1’-deoxy-1’-
(4-Chlorophenyl)-ß-D-ribofuranose 
 
Important in our crystal structures is the fact which was also established by Parsch & Engels 
(Parsch & Engels, 1999), that in crystal structures of our fluoro-benzenes F…H hydrogen 
bond, which is important for crystal packing of those compounds, can be recognized. The 
Cl…H bond is already very developed for investigating the crystal structures and  we can 
conclude here that that bond has the same nature as the F…H bond because of the similarity 
in  structures  of    1’-deoxy-1’-(4-fluorophenyl)-ß-D-ribofuranose  and  1’-deoxy-1’-(4-
chlorophenyl)-ß-D-ribofuranose (figure 6.6.). 
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Figure 6.6. Crystal packing of 1’-deoxy-1’-(4-fluorophenyl)-ß-D-ribofuranose (a) 
and 1’-deoxy-1’-(4-chlorophenyl)-ß-D-ribofuranose (b) 
 
 
 
Figure 6.7. Crystal packing of: a) 1’-deoxy-1’-(2,4-difluorophenyl)-ß-D-ribofuranose b) 1’-
deoxy-1’-(2,4,6-trifluorophenyl)-ß-D-ribofuranose  c)  1’-  deoxy-1’-(2,4,5-trifluorophenyl)-ß-
D-ribofuranose d)1’-deoxy-1’-(4-chlorophenyl)-ß-D-ribofuranose 
 
a) 
b) 
c)  d) 
a) 
b) 
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Figure 6.8. F…H distances and angle of hydrogen bonds of Csp
2-F…H-Csp
2 ( Thalladi et al., 
1998) filled  with distances found and mentioned  in this work( red circles) ( Parsch, 2000) 
 
 
6.4   Crystal Structure of  5’-O-(4,4’-dimethoxytriphenylmethyl)-2’-O-tert.-
butyldimethylsilyl-1’-deoxy-1’-(4,6-difluoro-1-N-benzimidazolyl)-β-D-
ribofuranose 
 
Unfortunately,  we  couldn’t  crystallize  any  of  our  fluoro-benzimidazole  modificatios. 
However,  one  of  our  derivatives,  while  preparing  phosphoramidite  (TBDMS  protected 
derivative),  crystallized  after  HPLC  separation  from  the  mixture  isopropanol:hexane.  The 
properties of the crystal structure of the title compound were the following: 
The five-membered furanose ring has a twisted O4-endo, C1-exo conformation. The C1-N1, 
C2-O2 and C4-C5 bonds are in pseudo-equatorial positions, the C3-O3 bond is in a bisecting 
position  with  respect  to  the  furanose  ring.  A  different  conformation  (C2-endo)  has  been 
reported  for  the  related  2-chloro-(β-D-ribofuranosyl)-benzimidazole  (Sprang  & 
Sundaralingam, 1973). The bond distances in the ribofuranosyl group are very similar in the 
title compound and in the 2-chloro-(β-D-ribofuranosyl)-benzimidazole structure, with rather 
short O4-C1 and C4-C5 bonds and a long O4-C4 bond. The benzimidazole group adopts a syn 
orientation  about  the  glycosyl  bond  with  a  torsion  angle  O4-C1-N1-C12  of  62.5  .  The   Crystallography   
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benzimidazole group is planar (mean deviation from the plane: 0.008 Å). The orientation 
about the exocyclic C4-C5 bond is +sc (gauche,gauche). The shortest intramolecular contacts 
are O5...H3 2.40 Å, O5...H32  2.42  Å and O5...H35 2.41 Å. The angles between the planes of 
the three phenyl  groups attached to C19  are 64.5°, 74.5° and 85.2 °.   The molecules are 
connected by intermolecular hydrogen bonds between the hydroxyl group and the imidazole 
group to chains running in the crystallographic b-direction, which also corresponds to the long 
macroscopic dimension of the crystal. The hydrogen bonded chains are also stabilized by 
intermolecular C3-H3...F1 contacts with an H...F distance of 2.43 Å and a C-H..F angle of 
150°.  The  crystal  packing  also  shows  an  additional  intermolecular  C-H...F  contact,  an 
intermolecular C-H...O contact and three intermolecular C-H...π(phenyl) contacts.  
•   
 
Figure 6.9. Crystal Structure of  5’-O-(4,4’-dimethoxytriphenylmethyl)-2’-O-tert.-
butyldimethylsilyl-1’-deoxy-1’-(4,6-difluoro-1-N-benzimidazolyl)-β-D-ribofuranose 
As one can see from figure 6.9. this crystal structure is also stabilized with F…H hydrogen 
bonds which are also one of the shortest hydrogen F..H bonds known( similar to that in 4-
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fluorobenzimidazole modification). We represented this distance, as all distances F…H for 
fluoro-benzene  modifications,  in  a  graph  to  compare  this  one  with  other  known  F…H 
distances. 
 
 
 
 
Figure 6.10.  F…H distances and angle of hydrogen bonds of Csp
2-F…H-Csp
2 ( Thalladi et al., 
1998) fulfilled  with distances found and mentioned  in this work ( Parsch, 2000)-green for 
title compound, red for fluoro benzene modifications 
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7  Oligonucleotides 
 
 
 
 
 
7.1   Synthesis of Oligonucleotides 
 
 
Oligonucleotides are long-chain molecules built from nucleotides. The reaction conditions 
differ slightly for DNA- and RNA- synthesis. By RNA- synthesis coupling times are longer 
and in the synthesis of nucleotides the 2’-position has to be protected. The connection of the 
building blocks (nucleotides) is from 3’ to 5’ direction. 
In the 70s Letsinger developed solid phase synthesis of oligonucleotides (Letsinger et al., 
1975; Letsinger et al., 1976) on the base of solid phase synthesis of polipeptides (Merrifield, 
1963). Solid phase synthesis of oligonucleotides has great advantages over the synthesis in 
solution. Oligonucleotide synthesis lasts significantly shorter and there is no need to purify 
products after every synthesis step. The synthesis process is automated.  
Nucleotides for the synthesis have to be protected at free OH and NH2 groups, to avoid side 
products  in  the  synthesis.  Known  automatic  methods  are:  phosphodiestere  method, 
phosphotriestere method (Narang et al., 1980), H-phosphonate method (Garegg et al., 1986), 
today mostly used is phosphoramidite method (Beaucage & Caruthers, 1981; Sinha et al., 
1983; Eckstein, 1991).    
 
 
7.1.1   Phosphoramidite method 
 
The most important method for synthesising  oligonucleotides, using automatic solid phase 
synthesis, is the phosphoamidite method (phosphite-triester-method) (Beacage & Caruthers, 
1981; Sinha et al., 1983; McBride & Caruthers, 1983; Gait, 1984; Caruthers, 1985; Caruthers 
et al., 1987; Eckstein, 1991; Beaucage & Iyer, 1992; Beaucage & Iyer, 1993). In the coupling, 
one protected nucleoside is activated with an activator (usually 1H-tetrazole) reacts with 5’-  Oligonucleotides   
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OH group of the next nucleoside. After every step the oxidation of phosphitetriester is done 
(Figure 7.1. ). Activation with 1H-tetrazole gives from phosphoamidite a reactive species, 
which doesn’t make any known side products.  
The synthesis cycles of the phospho-amidite-solid phase method is given in figure 7.2. . As 
starting nucleoside the 5’-dimethoxytritile protected nucleoside can be used, which is bound 
to the solid phase over 3’-hydroxyl group with a spacer (usually succinate linker).  
 
 
O
DMTrO
O OTBDMS
B
P O
O
O
NC
O
O OTBDMS
B
CPG
HO
O
O OTBDMS
B
CPG
HO
O
O OTBDMS
B
P
N O
NC
+ 2) oxidation
1) 1H-tetrazole
 
 
Figure 7.1.  Phosphoramidite method 
 
In  most cases solid phase support is made from glass balls, with defined pore size, known as 
controlled pore glass (CPG). Steps of the oligonucleotide synthesis are the following: 
•  Deprotection of 5’-dimethoxytritile group with 3% trichloro acetic acid in methylene 
chloride 
•  Activation of the amidite with 1H-tetrazole in acetonitrile 
•  Coupling 
•  Protection of the unreacted 5’-OH group with acetanhydride/2,6-lutidine/THF and 1-
methylimidazole in THF, known as ‘’capping’’ 
•  Oxidation of the phosphite to phosphate with iodine in water/pyridine/THF 
 
After  complete  synthesis  the  separation  from  the  solid  phase  support  is  done  with  conc. 
ammonia solution.  
After every synthetic step washing with acetonitrile is done. Exocyclic amino groups on the 
nucleobases are protected with acyl protecting groups like benzoyl (for A and C), isobutyroyl 
(for G). Sometimes  the tac protecting group (tac= tert. Butylphenoxyacetyl), which main 
advantage is fast deprotection (3 h), is also used. Those protecting groups are deprotected 
together with cleavage from the solid phase support, over night at 55°C in ammonia solution.   Oligonucleotides   
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Figure 7.2.  Synthesis of RNA using phosphoramidite chemistry 
 
The  mechanism  of  1H-tetrazole  catalysis  is  not  yet  completely  explained.  It  is  however 
thought that tetrazole reacts as acid and protonates the nucleoside at phosphor or nitrogen. 
The resulting cation reacts with a second tetrazole molecule to make tetrazolide. This is the 
reactive species, which reacts with 5’-OH-group on the support (Dahl et al., 1987). 
31P NMR 
investigations of Berner confirmed this mechanism (Berner et al.,1989).  
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7.2   Synthesised Oligonucleotides 
 
All  oligonucleotides  synthesised  in  this  work  were  synthesised  with  the  phosphoamidite 
method on 1  mol synthesis on PerSeptive Biosystems (Modell Expedite 8905). We used 
columns from PerSeptive Biosistems with CPG support. All the used chemicals and reagents 
are given in chapter 11. Standard coupling time of 10 minutes was used for all modified and 
unmodified nucleotides. Final dimethoxytritile group was cleaved on all oligonucleotides. All 
nucleotides incorporated in the RNA are shown in figure 7.3  . 
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Figure 7.3. Incorporated nucleosides in RNA and their abbreviations 
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The  nucleotides  synthesised  in  this  work  were  incorporated  in  A-rich  strands  and  U-rich 
strands. Modifications were incorporated in the middle and paired with each other and natural 
nucleotides  to  measure  Tm  values  and  other  thermodynamical  parameters.  In  figure  7.4. 
synthesised modified RNA oligonucleotides are given. 
 
'Name''  Sequence  'Name''  Sequence 
           
S1  5'-CUU UUC UUU CUU-3'  S20  5'-AAG AAG GAA AAG-3' 
S2  5'-CUU UUC CUU CUU-3'  S21  5'-AAG AAU GAA AAG-3' 
S3  5'-CUU UUC AUU CUU-3'  S22  5'-AAG AAA GAA AAG-3' 
S4  5'-CUU UUC GUU CUU-3'  S23  5'-AAG AAC GAA AAG-3' 
S5  5'-CUU UUC 4FBUU CUU-3'  S24  5'-AAG AA4FBI GAA AAG-3' 
S6  5'-CUU UUC 2,4DFBUU CUU-3'  S25  5'-AAG AA5FBI GAA AAG-3' 
S7  5'-CUU UUC 2,4,6TFBUU CUU-3'  S26  5'-AAG AA6FBI GAA AAG-3' 
S8  5'-CUU UUC 2,4,5TFBUU CUU-3'  S27  5'-AAG AA4,6DFBI GAA AAG-3' 
S9  5'-CUU UUC PFBUU CUU-3'  S28  5'-AAG AA4TFM GAA AAG-3' 
S10  5'-CUU UUC BUU CUU-3'  S29  5'-AAG AA5TFM GAA AAG-3' 
S11  5'-CUU UUC ASUU CUU-3'  S30  5'-AAG AA6TFM GAA AAG-3' 
S12  5'-CUU UUC 4FBIUU CUU-3'  S31  5'-AAG AABI GAA AAG-3' 
S13  5'-CUU UUC 5FBIUU CUU-3'  S32  5'-AAG AAB GAA AAG-3' 
S14  5'-CUU UUC 6FBIUU CUU-3'  S33  5'-AAG AAAS GAA AAG-3' 
S15  5'-CUU UUC 4,6DFBIUU CUU-3'  S34  5'-AAG AA4FB GAA AAG-3' 
S16  5'-CUU UUC 4TFMUU CUU-3'  S35  5'-AAG AA2,4DFB GAA AAG-3' 
S17  5'-CUU UUC 5TFMUU CUU-3'  S36  5'-AAG AA2,4,6TFB GAA AAG-3' 
S18  5'-CUU UUC 6TFMUU CUU-3'  S37  5'-AAG AA2,4,5TFB GAA AAG-3' 
S19  5'-CUU UUC BIUU CUU-3'  S38  5'-AAG AAPFB GAA AAG-3' 
 
Figure 7.4.  Synthesised RNA oligonucleotides 
 
 
7.3   Purification of Oligonucleotides 
 
Purification of oligonucleotides was done with ion-exchange-HPLC. This method gives the 
highest  level  of  purity  of  wanted  oligonucleotides.  The  ion  exchange  HPLC  is  standard 
method for short RNA sequences. 
The ion exchange HPLC separates according to charge differences. Main principle of this 
effective method leans on forces between negative charges of oligonucleotide and stationary 
phase  immobilised  cationic  groups.  Bound  oligonucleotides  are  than  eluted  with  rising   Oligonucleotides   
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gradient of salt (rising ion strength)  where the wanted nucleotide is the last one. Therefore 
there is a lot of salt and oligonucleotides have to be desalted. For that are used: gel filtration 
and  dialysis.  We  used  gel  filtration.  The  main  principle  for  separation  in  this  method  is 
diffusion of molecules of the probes in the pores of stationary phase. Polymer separating 
material as for example  Sephadex G25, has small pores, in which diffused molecules of salt 
stay while the large oligonucleotide molecules stay in pores and are eluted.  For desalting in 
this work commercial columns packed with Sephadex G25 are used. 
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Figure 7.5. HPLC diagram from S 29 
 
Figure 7.5.  shows as an example a HPLC diagram from strain S 29 . It is easy to recognise 
the main signal around 20 minutes of clean 12-mer oligonucleotide. Other signals belong to 
shorter  sequences.  Details  of  HPLC  separations  are  described  in    the  experimental  part 
(chapter 11). 
After purification and desalting the amounts of synthesised oligonucleotides were measured 
using  UV-spectroscopy.  Therefore  the  extinction  of  the  probe  was  measured  at  260  nm. 
Measured optical density (OD) is used for calculating the concentration of the probes using 
Lambert-Beer equation ( Chapter 11). The calculation of extinction coefficients is given in 
chapter  10. For the synthesised oligonucleotides extinction coefficients are given in figure 
7.10 .     
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7.4   Characterizations of Oligonucleotides 
 
Even though retention times of oligonucleotides give an idea of their length all synthesised 
oligonucleotides were characterized by mass measurements. However, mass measurements 
tell us also if all protecting groups are cleaved completely. For the mass measurements there 
are  two  methods:  electron  spray-ionisation-(ESI)  and  matrix-  assisted  laser 
desorption/ionization  (MALDI).  Both  methods  could  be  used.  In  this  work  all 
oligonucleotides  were  characterized  by  MALDI.  As  ESI  was  used  for  characterization  of 
phosphoamidite modification synthesis we will represent it here shortly, also. 
•  Electron spray-ionisation-mass spectrometry (ESI) 
That is a special form of ionisation under atmospheric pressure. The phenomena of electro 
spray has been known for  hundreds  years (Chapman, 1937), but is not until the early parts of 
the 20th century that its significance to science was fully understood. Some 30 years later, the 
pioneering  experiments  by  Malcom  Dole  et  al  (Dole  et  al.,  1968;  Dole  et  al.,  1970) 
demonstrated the use of electro spray to ionise intact chemical species and the technique of 
electro  spray  ionisation  (ESI)  was  invented.  The  ESI  source  has  undergone  continued 
development since the earliest examples, but the general arrangement has remained basically 
the same - see figure  7.6. The analyte is introduced to the source in solution either from a 
syringe pump or as the eluent flow from liquid chromatography. Flow rates are typically of 
the order of 1µl min
-1. The analyte solution flow passes through the electro spray needle that 
has a high potential difference (with respect to the counter electrode) applied to it (typically in 
the range from 2.5 to 4 kV). This forces the spraying of charged droplets from the needle with 
a surface charge of the same polarity to the charge on the needle. The droplets are repelled 
from the needle towards the source-sampling cone on the counter electrode (shown in blue). 
As the droplets traverse the space between the needle tip and the cone and solvent evaporation 
occurs. As the solvent evaporation occurs, the droplet shrinks until it reaches the point that the 
surface  tension  can  no  longer  sustain  the  charge  (the  Rayleigh  limit)  at  which  point  a 
"Coulombic explosion" occurs and the droplet is ripped apart. This produces smaller droplets 
that can repeat the process as well as naked charged analyte molecules. These charged analyte 
molecules (they are not strictly ions) could be singly or multiply charged. This is a very soft 
method of ionisation as very little residual energy is retained by the analyte upon ionisation. 
This is why ESI-MS is such an important technique in biological studies where the analyst 
often  requires  that  non-covalent  molecule-protein  or  protein-protein  interactions  are 
representatively transferred into the gas-phase. The major disadvantage of the technique is   Oligonucleotides   
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that very little (usually no) fragmentation is produced. For structural elucidation studies, this 
leads to the requirement for tandem mass spectrometry where the analyte molecules can be 
fragmented. One of the main problems with the mass spectral analysis of proteins (and other 
macromolecules) has always been that their masses fall outside the mass ranges of most mass 
spectrometers. A problem that also occurs is presence of salts, especially sodium salts. In this 
way  products  with  negatively  charged  phosphorus  backbone  are  build  and  process  of 
ionisation  is  disturbed.  A  possible  solution  to  this  problem  is  exchange  of  sodium  with 
ammonium ion, which through ammonium acetate precipitation can be removed (Stults & 
Masters, 1991). 
 
 
 
Figure 7.6. A schematic of an ESI source (picture-University of Bristol) 
 
•  Matrix assisted desorption/ionisation mass spectrometry (MALDI) 
 
Matrix-assisted  laser  desorption/ionization  mass  spectrometry  (MALDI-MS)  has  been 
responsible for solving many problems in structural biology. It was discovered by Karas and 
Hillenkamp ( Karas and Hillenkamp, 1988) and Tanaka (Tanaka et al., 1988). Mass analysis 
is now used routinely to confirm proper expression and processing of proteins, and to locate 
and identify post-translational modifications. Innovative advances in instrumentation have led 
to higher mass resolution and mass accuracy. New sample preparation methods are likewise 
yielding higher sensitivity plus greater tolerance for buffer components that have in the past-
suppressed signals at higher concentrations. Advancements in the technique have also led to 
new  or  improved  applications  in  many  areas,  including  peptide  sequencing  and  the 
identification of proteins by database searching with peptide masses. Instruments with lower 
cost, smaller size, and higher performance are making mass measurements available to an   Oligonucleotides   
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increasing  number  of  laboratories.  MALDI-MS  is  poised  to  continue  to  improve  in 
performance and in its usefulness for current and new applications. 
To explain, we'll walk through the MALDI process to see just how it takes place. First of all, 
we take our probe, and we dissolve it in a solvent (water). We also add a special ingredient. 
The special ingredient is a compound like trans-cinnamic acid or 2,5-dihydroxybenzoic acid. 
It varies from polymer to polymer, but the important thing is that our special ingredient has to 
absorb  ultraviolet  light.  Usually  we  put  about  10
4  times  more  of  our  UV  absorber  than 
polymer. Once all this is mixed together, the sample is placed in an airtight chamber, on the 
tip of the sample probe (take a look at the picture below in figure 7.7.). With a vacuum pump 
we then suck all the air out of the chamber, or at least very close to all of it. When we do this 
the solvent evaporates, and we're left with layer of our UV-absorbing compound, with a little 
bit of our polymer in it. In fancy words, we like to say that the polymer is now dispersed in a 
matrix  of  the  UV-absorbing  compound.  That's  why  we  call  it  matrix-assisted  laser 
desorption/ionization mass spectrometry.  
 
Figure 7.7.  A diagram of a MALDI apparatus  
Usually an ultraviolet laser is used in the 330-360 nm range ( Karas & Hillenkamp, 1988; 
Tanaka et al, 1988; Bahr et al, 1994; Fitzgerald & Smith, 1995; Piels et al.,1993; Kirpekar et 
al., 1994). MALDI is in comparison with ESI less sensitive to the existence of salt in probes. 
RNA  oligonucleotides  show  higher  stability  in  MALDI  measurements  than  DNA 
oligonucleotides (Lehmann, 1996).    Oligonucleotides   
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Figure 7.8.  MALDI-spectra of  oligonucleotide S 28 (incorporated 4TFM in G,A-
reachsequence) 
               
Figure 7.9.  MALDI-spectra of modified oligonucleotide S 9(PFB incorporated in C,U-reach 
sequence) 
In figures 7.8. and 7.9.  two MALDI-spectra of unmodified two modified oligonucleotides, one 
with  fluoro-benzene  modification  and  the  other  with  trifluoromethyl  benzimidazole 
modification are shown.    Oligonucleotides   
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'Name''  Sequence  Calculated mass Measured mass  Extinction  
      [Da]   [Da]  coeff. (260 nm) 
S1  5'-CUU UUC UUU CUU-3'  3609.07  3610.54  110.28 
S2  5'-CUU UUC CUU CUU-3'  3608.12  3609.1  99 
S3  5'-CUU UUC AUU CUU-3'  3632.15  3633.15  104.08 
S4  5'-CUU UUC GUU CUU-3'  3648.15  3650.1  102.3 
S5  5'-CUU UUC 4FBUU CUU-3'  3593.07  3614.56  110.26 
S6  5'-CUU UUC 2,4DFBUU CUU-3'  3611.07  3634.4  110.26 
S7  5'-CUU UUC 2,4,6TFBUU CUU-3'  3629.07  3630.14  110.26 
S8  5'-CUU UUC 2,4,5TFBUU CUU-3'  3629.07  3630.15  110.26 
S9  5'-CUU UUC PFBUU CUU-3'  3665.07  3665.60  110.26 
S10  5'-CUU UUC BUU CUU-3'  3575.08  3595.46  110.26 
S11  5'-CUU UUC ASUU CUU-3'  3499  3514.24  100.25 
S12  5'-CUU UUC 4FBIUU CUU-3'  3633.11  3634.23  104.08 
S13  5'-CUU UUC 5FBIUU CUU-3'  3633.11  3632.81  104.08 
S14  5'-CUU UUC 6FBIUU CUU-3'  3633.11  3656.11  104.08 
S15  5'-CUU UUC 4,6DFBIUU CUU-3'  3651.11  3652.1  104.08 
S16  5'-CUU UUC 4TFMUU CUU-3'  3685.11  3687.01  104.08 
S17  5'-CUU UUC 5TFMUU CUU-3'  3685.11  3686.21  104.08 
S18  5'-CUU UUC 6TFMUU CUU-3'  3685.11  3709.23  104.08 
S19  5'-CUU UUC IUU CUU-3'  3615.11  3615.1  104.08 
S20  5'-AAG AAG GAA AAG-3'  3952.55  3952.69  143.92 
S21  5'-AAG AAU GAA AAG-3'  3913.51  3959.28  142.51 
S22  5'-AAG AAA GAA AAG-3'  3936.52  3964.32  145.18 
S23  5'-AAG AAC GAA AAG-3'  3912.5  3911.45  140.16 
S24  5'-AAG AA4FBI GAA AAG-3'  3937.52  3954.62  145.18 
S25  5'-AAG AA5FBI GAA AAG-3'  3937.52  3938.5  145.18 
S26  5'-AAG AA6FBI GAA AAG-3'  3937.52  3941  145.18 
S27  5'-AAG AA4,6DFBI GAA AAG-3'  3955.52  3978.79  145.18 
S28  5'-AAG AA4TFM GAA AAG-3'  3989.6  3989.05  145.18 
S29  5'-AAG AA5TFM GAA AAG-3'  3989.6  4008.9  145.18 
S30  5'-AAG AA6TFM GAA AAG-3'  3989.6  3984.82  145.18 
S31  5'-AAG AAI GAA AAG-3'  3919.54  3919.43  142.51 
S32  5'-AAG AAB GAA AAG-3'  3879.49  3881.4  145.18 
S33  5'-AAG AAAS GAA AAG-3'  3803.41  3804.24  133.2 
S34  5'-AAG AA4FB GAA AAG-3'  3897.51  3920.6  142.51 
S35  5'-AAG AA2,4DFB GAA AAG-3'  3915.51  3936.78  142.51 
S36  5'-AAG AA2,4,6TFB GAA AAG-3'  3933.51  3934  142.51 
S37  5'-AAG AA2,4,5TFB GAA AAG-3'  3933.51  3936.51  142.51 
S38  5'-AAG AAPFB GAA AAG-3'  3969.51  3968.9  142.51 
 
Figure7.10.   Overview over synthesised oligonucleotides, their calculated and found masses 
and also their extinction coefficients   Oligonucleotides   
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In figure 7.10.  calculated and measured masses by MALDI and extinction coefficients of those 
oligonucleotides  are  shown.  For  all  synthesised  oligonucleotides  measured  masses  were  in 
good  accordance  with  calculated  ones  and  therefore  we  can  conclude  that  the  wanted 
oligonucleotides were synthesised in the wanted sequence. 
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8  Spectroscopic Measurements of 
Oligonucleotides 
 
 
 
 
 
 
8.1   UV-Spectroscopic Measurements 
 
 
 
Employing UV spectroscopic measurements, the melting points of nucleic acids duplexes 
could be measured. The melting point of a duplex is the temperature at which exactly half of 
the molecules of one sample are still in a duplex. The other half of the molecules is at this 
temperature already melted and is single stranded in the sample. By UV measurements we use 
the characteristic that absorbance of the sample that contains a duplex and a single stranded 
sample is changed. 
The  change  of  absorbance  is  the  reason  of  temperature  dependence  of  UV-Spectroscopy. 
Through rising of the temperature the duplex is melted and pairing of bases, of heterocycles 
of nucleotides is disturbed, absorbance is also changed. While changing from duplex structure 
(high  order)  to  single  stranded  structure  the  absorbance  is  rising.  This  is  known  as 
hyperchromicity. The melting point is not only dependent on the length and sequence of the 
duplex. It also depends on the salt concentration and pH value of the solution in which the 
sample is measured. With higher salt concentrations the melting point rises. We measured all 
the melting curves with phosphate puffer with 140 mM NaCl at pH 7.00. First we measured 
unmodified sequences of 12mer and one of those with the middle base pair of 2,4,5 TFB: 2,4 
DFB is shown in the figure 8.1., and has melting point of 33.2°C.  
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Figure 8.1. UV melting curve of S8 and S35 RNA duplex (2,4,5TFB-2,4DFB middle base pair) 
 
The change of absorbance depends on the wavelength. The maximum for the A-T base pair is 
on 260 nm and for the G-C base pair is on 276 nm (Figure). The optimal value of wavelength 
for UV measurement is between those two values. Most samples were measured at 260 nm 
and 274 nm. Characteristic of the melting of nucleic acids is the cooperativity of the process 
(Saenger, 1984) that means that a nucleotide has an influence on the conformation of the 
neighbouring  nucleoside.  When  one  base  pair  is  separated  the  hydrogen  bonds  of  the 
neighbouring base pair are quickly broken. The structure of double helix is than ruined and 
we get non-paired single strands. The breaking down of double helices usually begins from 
one  end  of  a  helix  and  is  moving  fast  through  the  helix.  The  consequence  of  this 
''cooperativity'' is that the small oligonucleotides exist only either as duplexes or as single 
strains.  
The UV- and CD-spectroscopy was our choice for determination of Tm values because of its 
easiness, the small amounts of substances and the reproducibility.    Spectroscopic Measurements of Oligonucleotides   
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Figure 8.2.  Wavelength dependence of the absorbance coefficient (ε) of CG- and AT-base 
pairs in DNA ( Felsenfeld & Hirschman, 1965) 
 
In principle, the higher Tm value is the higher stability of the structure. From the melting 
curves we were also able to calculate other thermodynamic parameters  H°,  S° and  G°. It 
is important to stress at this point that the calculated data only have value when we consider 
as existing the model '' all-or-none''.  
Measuring the UV melting curves with the heating rate 0.2°C and 0.5°C did not show any 
differences in thermodynamical calculations and parameters so we measured all the curves 
with the heating rate of 0.5°C. 
 
 
8.1.1   Calculations from UV- Melting Curves 
 
8.1.1.1  Determination of the Melting Point 
 
The  UV-melting  curves  were  measured  using  a  UV-/VIS-spectrophotometer  Cary  from 
Varian company. As buffer we used phosphate buffer 140 mM NaCl, 10 mM Na2HPO4 and 
10 mM NaH2PO4with pH value of 7.00.  
For measuring, we added from both samples of oligonucleotides the amount that makes a 
concentration of 2  M in sample vial. The measurement of UV melting curve was done at 260 
and 274 nm with a heating rate of 0.5°C/min. Details for measurements are given in chapter 
10.   Spectroscopic Measurements of Oligonucleotides   
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For the calculations from the melting curves it is important to know whether the sequences are 
self-complementary or not. The sequences that we used were not self complementary.  
For the thermodynamical analysis the melting curve of a duplex (absorbance as the function 
of temperature) (figure 8.1) is transformed in the dependence of α, which equals the fraction 
of single strands in the duplex state, as the function of temperature. (Markey & Breslauer, 
1987). For this purpose we observe the melting process considering the model  “all-or-none” 
as the existing one. This model considers that there is no transition state in-between ordered 
and disordered state. For the transformation from OD=f (T) to α= f (T) the correction of the 
base  line  has  to  be  done  (after  and  before  ''melting'')  (figure  8.3).  This  takes  in  to  the 
calculations the temperature dependence of absorbance. The correction of the base line has a 
linear relation to temperature and could be expressed with the following equations: 
 
[8-1]        ODd= md· T + bd 
[8-2]        ODu= mu·T + bu 
 
where OD is absorbance, m is slope, T is temperature, b is X-axis intercept, d-is down base 
line and u is upper base line.  
When any of the base lines is too short the error of determination of Tm value is greater. In 
this case the thermodynamical analysis of the curve is not possible because a bad correction of 
the base line is one of the biggest mistakes in determination  (Puglisi & Tinoco, 1989). 
As the measured absorbance is direct measure of the number of base pairs we can transform 
OD = f (T) curve into the α = f (T) curve, where α is fraction of single strands in a duplex 
state. The melting temperature is defined as a value of temperature at which exactly half 
molecules is in the duplex and the other half is denatured, where is also α (Tm) = 0,5. 
 
[8-3]    α = [oligonucleotide in duplex]/[all present oligonucleotides] 
[8-4]    α ={[OD0]-[OD(T)]}/ {[OD0]-[ODd]} 
 
For association of not self-complementary sequence in a double helix is valid: 
 
[8-5]    S  + S   D   (D= duplex, S= single strand) 
and 
[8-6]    K=[D] / [S]
2   Spectroscopic Measurements of Oligonucleotides   
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The concentrations of both present single strands in the equilibrium constant K are equal and 
when we exchange that to express α  
[8-7]    {(1-α)·ct/n} · {(1-α)·ct/n} <==> α · ct/n 
and 
[8-8]               K = {α · ct/n} / {{(1-α)·ct/n} · {(1-α)·ct/n}} 
 the general expression for the corresponding equilibrium constant, in terms of α and n, is 
 
[8-9]        K = {α · ct/n} / {(1-α) · (ct/n)}
n 
where ct is the strand concentration= [strand 1] + [strand 2] and n is the molecularity of the 
reaction. Reformulation of the previous equation gives us: 
 
[8-10]        K = α / {(1-α)
n · (ct/n)
(n-1)} 
For K at T= Tm α=0,5 and then: 
 
[8-11]         KT=Tm = 0,5 / {(0,5)
n · (ct/n)
(n-1)} = 1 / (ct/2n)
(n-1) 
 
The last [8-11] equation gives a possibility to calculate K at the melting point of the reaction 
of association of not self-complementary sequences. In the case of bimolecular reaction (n=2) 
and equation [8-11]  is simpler: 
[8-12]  KT=Tm = 1 / (ct/4) = 4 / ct 
 
This means that the equilibrium constant K at Tm of bimolecular reactions is the function of 
the total concentration of single strands.  
S6 : 5’-CUU UUC 2,4DFBUU CUU-3’ and S22: 5’-AAG AAA GAA AAG-3’ 
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UV Melting curve with base lines
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Figure  8.3. a) UV-melting curve of double helix     b) Fitting of melting curve, c) melting 
curve with down and upper base line, d) transformed curve α= f (T) 
 
 
 
8.1.1.2  Determination of Thermodynamical Data 
 
 
In this part it will be explained how we calculated other thermodynamically parameters from 
spectroscopic measurements.  
When the molecularity of the reaction is known, the thermodynamical parameters could be 
calculated  using  different  approaches.  The  method  that  we  used  is  the  known  van't  Hoff 
method from R ln K as the function of 1/T. The other possibility results out from numerical 
differentiation of α at the point when T=Tm, expressing 1/Tm in terms of lnct and curve fitting 
with help of algorithms. 
 
8.1.1.2.1  Van't Hoff Plot 
 
Values for the equilibrium constants K can be calculated with equation [8-10] and could be 
calculated for the value of two for molecularity. Only the points that have 0,15 ≤ α ≤ 0,85 are 
considered for the van't Hoff calculation because the values for K in between these values are 
most precise. Equation [8-13] gives the connection between ∆G
0 and K : 
 
[8-13]  ∆G
0 = –RT ln K 
 
With rearrangement of the basic equation: 
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[8-14]  ∆G
0 = ∆H
0 – T∆S
0 
to: 
[8-15]  ∆S
0 = (∆H
0 – ∆G
0) / T 
 
and exchange in equation [8-15]  gives: 
 
[8-16]  ∆S
0= (∆H
0 + RT ln K) / T 
 
simple rearrangement gives following equation: 
 
[8-17]    R ln K = –∆H
0 · 1/T + ∆S
0 
 
Determination of R ln K to 1/T gives –∆H
0 as slope and ∆S
0 as X-axis intercept. An example 
is shown in figure 8.4 . When ∆H
0  doesn't depend on temperature than the graph should be a 
straight line. A not linear graph could have several reasons: temperature dependence of ∆H
0, 
bad correction of base line or the model “all-or-none” is not a suitable model. 
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Figure 8.4.  R ln K to 1/T graph (r
2=0,998) 
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8.1.2   Results of the UV-Melting Curves 
 
 
Melting curves of RNA-duplexes were measured and the melting points (Tm) were calculated 
using van’t Hoff plot. Given values are for the dissociation reaction. We measured always 
RNA 12mers. The position of the modification was not changed. Tm values mentioned in the 
next chapters are on the 12mers if it is not stressed differently. The abbreviations for the 
modifications are given in  figure 8.5. and are used every time the bases are mentioned in 
discussion.  
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Figure 8.5.  Abbreviations for synthesised nucleobases 
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First  measurements  were  done  on  unmodified  RNA  chains.  Uridine  was  paired  with  all 
natural bases. Natural U-A base pair did not build the most stable base pair but U-G did (so 
called Wobble base pair). In Wobble base pair the bases are slightly moved a side, so that   
donors and acceptors are in good positions for hydrogen bonding (Figure 8.6).  
 
 
N
N
O
O R
H U O
H
N
N
H2N
N
N
R
G
 
 
Figure 8.6.  Wobble base pair-(uridine-guanosine) 
 
Both  other  duplexes  U-C  and  U-U  are  significantly  less  stable.  In  both  RNA  duplexes 
containing those two base pairs there aren’t hydrogen bonds in between them and that makes 
those duplexes around 7.5°C or 2.1 kcalmol
-1 less stable (figure 8.10.).  
Next measurements were done with fluoro-benzene and benzene nucleosides (figure 8.10).  
The  electrostatics  vary  widely  over  the  series  of  benzene-nucleoside,  with  the  phenyl 
nucleoside  showing  a  negative  potential  at  the  center  of  the  flat  aromatic  face,  and  the 
pentafluorinated case having a strongly positive potential. Thus the quadrupoles are gradually 
inverted over this series. By comparison natural bases are not so strongly polarized in the 
quadrupole  sense  and  their  quadrupole  moments  are  close  to  zero.  In  this  series  of 
fluorobenzenes  also  could  be  seen  a  broad  range  of  dipole  moments  though  the  dipole 
orientations are quite similar over the series (figure  8.7.). 
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                                             B               4 FB            2,4 DFB 
 
                                     2,4,5 TFB          2,4,6 TFB              PFB 
Figure  8.7.  Calculated  electrostatic  surface  potentials  of  six  progressively  fluorinated 
aromatic base analogues, with an attached methyl group to approximate effect of ribose (red 
shows negative potential and blue-positive)( Lai et al., 2003)  
 
      
                                        B                           4 FB                      2,4 DFB 
 
                                    2,4,5 TFB                 2,4,6 TFB                PFB 
Figure  8.8.  Calculated  dipole  moments  (debye)  of  aromatic  fluorinated  base  analogues; 
dipole orientations are shown with yellow arrows, fluorine atoms are in green.  Electrostatics 
was calculated with Spartan’02 (wavefunct. Incl) employing AM1 Hamiltonian (Lai et al., 
2003)   Spectroscopic Measurements of Oligonucleotides   
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When B is incorporated in RNA against A there is 14.8°C destabilization comparing to A-U 
base pair. That can be explained with the absence of hydrogen bonds and less solvation. With 
fluoro-modified benzenes the destabilizing effect is smaller. Tm values for 2,4 DFB are lower 
up to 10.5°C. The difference for pairing of 4FB with natural bases is bigger and is more 
destabilizing than 2,4 DFB. All synthesised fluoro-benzene modifications, except 2,4 DFB, 
differ between natural bases. For two trifluoro-benzene modifications (2,4,6 TFB and 2,4,5 
TFB) there are great differences in pairing and that tells us that not only the number but also 
the positions of fluorines are important. The surface area of those two compounds is very 
similar  and  also  their  polarisability  (Makochkannwa  et  al.,  2004),  their  dipole  moments 
(1,3,5-trifluorobenzene  has  dipole  moment  of  zero)  and  their  quadrupole  moments  differ 
significantly.   In figure 8.10.  one can see that 2,4,5 TFB builds 5-6°C more stable base pairs 
than 2,4,6 TFB. On the one side 2,4,5 TFB is almost as good as 2,4 DFB  on the other  2,4,6 
TFB is as bad as the benzene modification itself. Therefore we think that position 5 of the 
benzene  ring  is  not  of  great  importance  for  base  pairing  but  the  2  and  6  positions,  first 
positions next to the glycosidic linkage) are significant for base pairing pattern of benzenes. 
When 2,4,5 TFB is incorporated against natural bases can be noticed that stability slanders in 
order G>U>>C>A what suggests that 2,4,5 TFB might be able to form Wobble base pair with 
G (figure 8.9). 
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Figure 8.9. Assumed Wobble base-pare (2,4,5 TFB-guanosine) 
 
PFB modification also differs between natural bases. The stabilities of PFB-natural base (A, 
C, G and U) base pairs are around 13°C lower than natural base pairs. The deciding points for 
low stability are: steric reasons and all five positions exchanged with fluorine. 
DFB is a universal base, developed in our group (Parsch & Engels, 2001) that is less stable 
than natural bases but doesn’t differ between A, C, G and U.  In figure 8.10. one can see 
differences in the pairing of natural bases with fluoro-benzene nucleosides.  
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1
st Base 
2
nd 
Base  Tm  (°C) 
 H° 
(kcal/mol) 
T S° 
(kcal/mol)   G°(kcal/mol) 
            T = 298 K    
   A  37.8  87.8  75.9  11.9 
U  C  30.4  84.5  74.8  9.7 
   G  38.6  8.  71.1  11.9 
   U  30.1  89.5  79.8  9.7 
   A  23.8  81.6  73.7  7.9 
4FB  C  24.1  83  75  8 
   G  24.2  80.2  72.2  8 
   U  25.6  85.8  77.4  8.4 
   A  27.4  88.6  79.6  9 
2,4 DFB  C  27.3  84.8  75.9  8.9 
   G  27.6  83.6  74.6  9 
   U  27.9  91.2  82.1  9.1 
   A  23.3  81.2  73.4  7.8 
2,4,6 TFB  C  20.6  82  74.9  7.1 
   G  22.8  70.2  62.5  7.7 
   U  22.9  77.9  70  7.9 
   A  25.6  71.5  63.1  8.4 
2,4,5 TFB  C  26.7  83.2  74.4  8.8 
   G  28.7  83.8  74.5  9.3 
   U  27.5  74.7  65.8  8.9 
   A  22.9  69.7  62  7.7 
PFB  C  21.7  68.9  61.7  7.2 
   G  23  69.8  62.1  7.7 
   U  23.1  69.4  61.9  7.5 
   A  23  80.5  72.8  7.7 
B  C  22.6  84.4  76.8  7.6 
   G  23.5  69.8  61.9  7.9 
   U  23.1  73.3  65.6  7.7 
 
Figure 8.10. Pairing of fluoro-benzene modifications with natural bases 
Uncertainty of the given values: Tm=± 0.5°C; ∆H°=±5%; ∆G°=±2% 
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Figure 8.11.  Graphical overview of  Tm  values of  base pairs of fluoro-benzimidazole 
modifications and natural bases 
 
However,  base  stacking  is  a  complicated  and  not  completely  explained  interaction  that 
consists of number of interactions such as: electrostatic (dipole-dipole and dipole-induced 
dipole) interactions, dispersion (momentary dipole- induced dipole) effects, solvation effects, 
stacking surface area, polarizability (that does not depend only on the size of the molecule but 
also on its shape and geometry overlap with the neighbouring base pair) and shape (Guckian 
et al., 2000). The plots of those factors did not show qualitative correlation, at least within the 
bigger series of compounds so it is very complicated to define the factor responsible for the 
different stacking abilities of modified fluorobenzenes since the supraposition of all factors is 
in theory very complicated (Guckian et al., 2000). It is known in physical chemistry that 
electron-withdrawing substituents are increasing the magnitude of quadrupole-moment and 
that they do especially if ortho- positioned (Rashkin et al., 2002; Goodman et al., 2001). 
Therefore we can conclude that in this series of fluorobenzenes positions of fluorines have 
influence on base pairing pattern in RNA oligonucleotides as expected from the quadrupole 
moments  of  those  compounds  and  their  polarizability.  Another  factor  that  leads  to 
destabilization are electrostatic repulsions between fluorines and π-cloud of non-fluorinated 
phenyl system (this is obvious on the example of PFB modification) (Reichenbächer et al., 
2005). 
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Figure 8.12. Plot showing trends in stacking free energies as a function of the number of 
fluorine substituents ( 2,4,6 TFB is omitted here)-compared with benzene 
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Figure 8.13. Test of possible linear relationship between stacking free energies and number 
of fluorine substituents ( bis-ortho effects are omitted)- y= 0.87x-0.13 
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In  addition,  with  2,4  DFB  modification  was  done  a  study  aimed  at  characterizing  the 
influence of  2,4 DFB and a phenyl base analogue (B) opposite to an adenine base on the 
flexibility of RNA (Zacharias & Engels, 2004).  In this study no stable ‘base-paired’ geometry 
was  found  for  the  base  analogue:  adenine  pairs,  which  explains  in  part  universal  base 
character of these analogues. Instead the conformational fluctuations of the base analogues 
lead to enhanced accessibility of the bases in major and minor grooves of the helix compared 
with a regular base pair. 
The simulations indicate that the 2,4 DFB can only form weak transiently stable  `` hydrogen 
bonds`` to the opposing base in the RNA duplex.  This result offers an explanation for the 
experimental observation that 2,4 DFB is a universal base and the stabilization effect of the 
helix  is  primarily  due  to  the  stacking  effects.  Any  stable  hydrogen  bonding  is  likely  to 
interfere with the characteristics of a universal base (Zacharias & Engels, 2004).   
 
 
Figure 8.14. Conformational snapshots (A-2,4 DFB) observed during the simulation of the 
RNA with a central A-2,4 DFB base pair. The view is along the helical axis of the RNA. For 
clarity, only the central base pair (thick lines) and the neighbouring base pairs (thin lines) 
are shown (Zacharias & Engels, 2004)   Spectroscopic Measurements of Oligonucleotides   
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In the next table (figure 8.15.) results for pairing benzimidazole modifications with natural 
bases are shown.  
 
1
st Base 
2
nd 
Base  Tm  (°C) 
 H° 
(kcal/mol) 
T S° 
(kcal/mol)   G°(kcal/mol) 
            T = 298 K    
   A  28  86.7  77.6  9.1 
4 FBI  C  27.5  81.8  72.9  8.9 
   G  28.7  84.1  74.8  9.3 
   U  28.5  85.8  76.6  9.2 
   A  28.9  85.7  76.6  9.1 
5 FBI  C  31  89  79.8  9.2 
   G  31.7  88.7  79.4  9.3 
   U  28.2  86.4  77.5  8.9 
   A  34  53.6  46.1  7.5 
6 FBI  C  31.3  56.2  46.1  10.1 
   G  32.4  86.1  75.8  10.3 
   U  28.6  85.2  75.9  9.3 
   A  28.4  81.4  72.2  9.2 
4,6 DFBI  C  28.7  81.5  72.3  9.2 
   G  29.4  84.8  75.3  9.5 
   U  29.3  85.3  75.8  9.5 
   A  30.1  81.1  70.1  11 
4 TFM  C  27.4  82  72.1  9.9 
   G  29.2  81.2  71.5  9.7 
   U  25.1  80.3  72  9.3 
   A  30.2  52.1  43  9.1 
5 TFM  C  28.1  55  46.2  8.8 
   G  29.3  48  39.3  8.7 
   U  24.1  70.2  62.1  8.1 
   A  30.1  53  42.1  10.9 
6 TFM  C  28  79.8  70.9  8.9 
   G  27.1  79.8  70.2  9.6 
   U  24.8  73.3  64.9  8.2 
   A  28.7  81  71.8  9.2 
BI  C  25.6  82.3  73.8  8.5 
   G  28.9  97.4  88  9.4 
   U  29.1  73.1  63.8  9.3 
 
Figure 8.15.  Pairing of benzimidazole nucleosides with natural bases 
Uncertainty of the given values: Tm=± 0.5°C; ∆H°=±5%; ∆G°=±2% 
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It is obvious that they all destabilize the double helix in almost the same range. The least 
destabilizing was 6FBI and it still did differ in between natural bases. On the other hand 2,4 
DFBI and 4FBI are universal (Parsch & Engels, 2001). The existence of either fluorine or the 
trifluoromethyl  group  made  only  minor  differences  comparing  to  benzimidazole  BI  (no 
substituents). In the pairing of AS (abasic site) with modified nucleosides one can see that all 
base pairs are more stable than AS-natural base pairs. Therefore we can conclude that the 
enhanced stacking of fluorinated nucleosides leads to a smaller loss of stabilisation. 
 
 
Figure 8.16. Graphical overview of  Tm values of  base pairs of fluoro-benzimidazole 
modifications and natural bases 
 
In  this  series  of  substituted  benzimidazoles  there  is  hardly  a  difference  in  between  the 
substituted  and  non-substituted  analogue  (figure  8.17.).  In  figure  8.17.  one  can  see  that 
imidazole ring has the largest influence on charge distribution in the benzimidazoles and that 
influence of the substituents is very small. Also dipole moments do not vary in this series so 
widely as in series of fluorobenzenes. 
 Knowing that in the series of bigger molecules (larger surface area) the influence on the 
quadrupole moment is smaller in magnitude very small differences in Tm-values can be easily 
explained. For example the position of trifluoromethyl  group is of no importance for the 
magnitude of quadrupole moment of those compounds (Rashkin et al., 2002) and our results 
with any of TFM modifications hardly differ. However the great loss of stability is also due to 
hydrophobic effect, size of trifluoromethyl group suggested to be 2.5 times larger than methyl 
group (Seebach, 1990) and results for 6-trifluoromethyl purine (Veliz et al., 2001) indicate 
that this nucleotide does not form base pair in duplex RNA and already exists in flipped out 
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conformation.  In  figure  8.16.  one  can  see  pairing  of  natural  bases  with  benzimidazole 
modifications. 
 
 
 
Figure 8.17. Calculated electrostatic surfaces potentials and dipole moments of fluorinated 
benzimidazole analogues with an attached methyl group to approximate effect of ribose  
 
In addition, all benzimidazole compounds that we synthesised were used for investigation of 
DNA polymerase α, Klenow fragment (DNA polymerase I) and primase ( Moore et al., 2004; 
Kinckaid et al., 2005).  All of triphosphates were incorporated, however after incorporation 
all used compounds were not efficiently elongated. Where as pol α and Klenow fragment 
exhibited minimal discrimination against 5- and 6- regioisomers, they discriminated much 
more effectively against the 4- and 7-regioisomers. All of the compounds inhibited primase 
activity with remarkably similar potency.  Changing the shape and size of compounds was not 
an important issue (Kinckaid et al., 2005). 
When the abasic building block is pairing with A and G, Tm values are 20,6°C and 20,9°C 
respectively, and for C and U those values are 18,6°C and 18,2 °C respectively. This dramatic 
loss of stability can be explained in loosing hydrogen bonding ability (AS has no base) and 
disturbed  stacking  in  the  middle  of  the  oligonucleotide  (figure  8.18).  Both  forces  are 
responsible for the double helix stability. Interestingly in figure 8.18. one can see that 2,4,5 
TFB and 4,6 DFBI stack equally good even one would think that due to it’s larger stacking 
area 4,6 DFBI would stack better. Addition of fluorine in position 5 of benzene ring adds as 
much stacking energy as imidazole ring.   Spectroscopic Measurements of Oligonucleotides   
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1. Base  2.Base  Tm  (°C) 
∆H° 
(kcal/mol) 
T∆S° 
(kcal/mol)  ∆G°(kcal/mol) 
            T = 298 K    
   A  20.6  67.2  60  7.2 
   C  18.6  51.3  44.6  6.7 
   G  20.9  65.1  57.8  7.3 
   U  18.2  58.9  52.3  6.6 
   4 FB  20.9  81.9  74.8  7.1 
   2,4 DFB  22.6  59.7  52  7.7 
AS  2,4,6 TFB  19.8  66.5  59.7  6.8 
   2,4,5 TFB  26.4  83.7  75.1  8.6 
   PFB  19.6  80.3  73.2  7.1 
   B  19.5  78.3  72  6.8 
   4 FBI  25.3  58.1  49.8  8.3 
   5 FBI  25.4  60  51.7  8.3 
   6 FBI  26.6  58.5  50.1  8.4 
   4,6 DFBI  26.3  55.1  44.6  8.5 
   4 TFM  28.3  66.6  57.5  9.1 
   5 TFM  28.4  70.8  61.8  9 
   6 TFM  28.7  70.1  60.8  9.3 
   I  26.2  110.9  102.4  8.5 
 
Figure 8.18. Abasic site (AS) paired with natural and modified nucleosides 
Uncertainty of the given values: Tm=± 0.5°C; ∆H°=±5%; ∆G°=±2% 
 
Modified  base  pairs  have  lower  melting  points  than  natural  ones  but  besides  TFM 
modifications they all had higher melting points than pairs of modified and natural bases. 
By exchanging of the first nucleobase in a natural base pair with modification there is a loss 
of stability because of loosing hydrogen bonding ability but also rising stability caused by 
stronger stacking. Because of the higher negative effect Tm values of those pairs are sinking. 
When the second base is exchanged with modification there is no further destabilizing effect 
and Tm values are rising (no loosing of hydrogen bonding). 
In the case of the TFM modifications the situation seems to be more complicated since those 
base pairs are less stable when they have a modification on the other side than pairing with 
natural  bases.  Our  educated  guess  would  be  that  since  we  know  that  the  size  of 
trifluoromethyl  group  is  more  like  isopropyl  than  the  methyl  group,  some  other  negative 
effects are involved when there are modifications on the other side.  
 
 
   Spectroscopic Measurements of Oligonucleotides   
- 118 - 
1
st Base  2
nd Base  Tm  (°C) 
∆H° 
(kcal/mol) 
T∆S° 
(kcal/mol)  ∆G°(kcal/mol) 
            T = 298 K    
   4 FBI  30.6  82.2  72.4  9.8 
   5 FBI  30.1  82  72.3  9.7 
   6FBI  30.4  82.2  72.4  9.8 
4 FB  4,6 DFBI  31.3  85  75  10 
   4 TFM  25.1  81.3  73.4  7.9 
   5 TFM  25.2  82.6  74.5  8.1 
   6 TFM  25  81.7  73.8  7.9 
   4 FBI  33.5  88.1  77.4  10.7 
   5 FBI  33.2  89.2  78.8  10.4 
   6FBI  33.6  84.9  74.1  10.8 
4,6 DFB  4,6 DFBI  34.6  94.4  83.2  11.2 
   4 TFM  25.1  75.1  66.6  8.5 
   5 TFM  26.5  77.2  68.6  8.6 
   6 TFM  26.1  98.2  89.2  9 
   4 FBI  29.6  84.9  75.5  9.4 
   5 FBI  28.1  83.9  75.2  8.7 
   6FBI  28.2  96.7  87.4  9.3 
2,4,6 TFB 4,6 DFBI  29.1  80.1  70.7  9.4 
   4 TFM  24.1  64  56.5  7.5 
   5 TFM  25  83.5  75.2  8.3 
   6 TFM  24.8  83.9  74.9  9 
   4 FBI  32.9  73.1  63  10.1 
   5 FBI  31  72.1  62.4  9.7 
   6FBI  34.7  96.7  85.3  11.4 
2,4,5 TFB 4,6 DFBI  33.5  76.7  66.3  10.4 
   4 TFM  26  79.1  70  9.1 
   5 TFM  26.1  86.9  78.4  8.5 
   6 TFM  26.8  110.6  101.7  8.9 
   4 FBI  23.2  88.8  80.6  8.2 
   5 FBI  23.5  89.2  81  8.2 
   6FBI  23.5  91.1  82.8  8.3 
PFB  4,6 DFBI  24.5  91.3  82.5  8.8 
   4 TFM  20.1  73.1  65.4  7.7 
   5 TFM  21.2  74.1  66.2  7.9 
   6 TFM  22.1  80.5  72.8  7.7 
I  B  28.9  67.1  58  9.1 
 
Figure 8.19. Pairing of fluoro- modified benzenes with fluoro- modified benzimidazols 
Uncertainty of the given values: Tm=± 0.5°C; ∆H°=±5%; ∆G°=±2% 
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In  an  unmodified  RNA,  the  nucleobases  in  oligocnucleotides  are  surrounded  with  water 
molecules, which build hydrogen bonds with nucleobases. When they form a double helix, 
hydrogen bonds are lost and new ones are built to the opposite nucleobases. When a natural 
nucleobase is pairing with a modified it is different. In single stranded RNA the modified base 
is  bad  or  not  solvated  but  the  natural  one  is.  When  building  a  base  pair  of  those  two 
compounds the hydrogen bonds of natural one are lost but no other are built. In the sum that 
makes higher negative effect on the stability on the new double helix. When building a base 
pair from both modified nucleobases both fluorinated bases are badly or not solvated and 
therefore there is no decrease in stability as result of loosing solavation (figure 8.20).  
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Figure 8.20. Solvation of natural and modified bases 
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1. Base  2.Base  Tm  (°C) 
∆H° 
(kcal/mol) 
T∆S° 
(kcal/mol)  ∆G°(kcal/mol) 
            T = 298 K    
4 FB  4FB  27,3  80,4  71,5  8,9 
2,4 DFB  2,4 DFB  32,5  82,4  72,2  10,2 
2,4,6 TFB 2,4,6 TFB  29,1  87,1  77,7  9,4 
2,4,5 TFB 2,4,5 TFB  35,8  99,7  87,9  11,8 
PFB  PFB  25  79,8  72,1  7,7 
 
 
 
 
Figure 8.21. Pairing of flour-benzene modifications in-between two same bases b) linear 
dependence between Tm values and number of fluorines (if bis-ortho cases are omitted) 
Uncertainty of the given values: Tm=± 0.5°C; ∆H°=±5%; ∆G°=±2% 
 
 
From the presented data one can see that with fluorine substitution in this self-pairs (number 
of fluorines, but also their orientation (mentioned bis- ortho effect) change the stability of 
double RNA helix. That is in contrast from Romesberg and co-workers, who investigated self 
pairing (but with different fluorine substitution) of fluorobenzenes in DNA and concluded that 
once fluorine is in helix it’s position is not important (Henry et al., 2004). 
   From the measured melting points of the base pairs one can calculate values for solvation 
and the stacking ability of all synthesised modifications. We will explain the calculation on 
the example of 2,4,5 TFB. The values for other modifications were calculated in the same 
manner.  
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Number  Base pair  Tm (°C)   G° (kcalmol
-1) 
1  AS-U  18.2  6.6 
2  U-U  30.1  9.7 
3  U-2,4,5 TFB  27.5  8.9 
4  2,4,5 TFB-2,4,5 TFB  35.8  11.8 
5  2,4,5 TFB-AS  26.4  9.4 
 
Figure 8.22.  Calculating stacking and solvation thermodinamical data for 2,4,5 TFB 
modification 
Uncertainty of the given values: Tm=± 0.5°C; ∆H°=±5%; ∆G°=±2% 
 
For calculating solvation and stacking for 2,4,5 TFB the values given in  figure  8.22.  were 
used.  For the calculations we used values for following base pairs: abasic site and U (1), U-U  
base pair (2), U and 2,4,5 TFB (3), 2,4,5 TFB-2,4,5 TFB pair(4) and 2,4,5 TFB-AS (5). The 
different  stacking  ability  of  2,4,5  TFB  base  one  can  calculate  in  comparison  to  U  from 
difference between (5) and (1). Exchange of U with 2,4,5 TFB rises the Tm for 8.2 °C. This 
rise of Tm corresponds to rise in stability of 2.9 kcalmol
1-. With this exchange there is no 
need to take care about solvation effects because both bases are paired with abasic site that 
has no base and therefore cannot be solvated. There is also no loss of hydrogen bonding and 
therefore no negative effect of solvation on the stability of the double helix. 
The influence of the solvation on the stability of the double helix with incorporated 2,4,5 TFB 
nucleoside can be calculated comparing values for (3) and (2). When one exchanges a base 
pair from two U with U-2,4,5 TFB base pair, the melting point sinks for 2.6°C (corresponds to 
0.8 kcalmol
-1). The destabilizing effect through solvation is 2.6°C+ 8.2°C=10.8°C altogether 
which corresponds to 3.7 kcalmol
-1.  
The calculated value can be checked through comparing (3) and (4) in figure 8.22. When 
second U is exchanged with 2,4,5 TFB no other destabilisation through solvation effects take 
place. Because of enhanced stacking the Tm of 2,4,5 TFB-2,4,5 TFB should rise for 8.2°C (2.9 
kcalmol
1-)  comparing  to  2,4,5  TFB-U  base  pair.  The  expected  melting  point  is  therefore 
35.7°C and free enthalpy 11.7 kcalmol
1-. The measured values are 35.8°C and 11.8 kcalmol
1- 
and in excellent agreement with calculated ones. 
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Nucleoside 
 
Stabilizing through stacking  Destabilizing though 
solvation 
4 FB  2.7°C; 0.5 kcalmol
-1  -7.2°C;- 1.8 kcalmol
-1 
2,4 DFB  4.4°C; 1.1 kcalmol
-1  -6.6°C;- 1.7 kcalmol
-1 
2,4,5 TFB  8.2°C; 2.9 kcalmol
-1  -10.8°C;- 3.7 kcalmol
-1 
2,4,6 TFB  1.6°C; 0.2 kcalmol
-1  -8.8°C;- 2.1 kcalmol
-1 
PFB  1.4°C; 0.2 kcalmol
-1  -8.4°C;- 2.2 kcalmol
-1 
B  1.3°C; 0.2 kcalmol
-1  -8.3°C;- 2.2 kcalmol
-1 
4 FBI  4.4°C; 1.0 kcalmol
-1  -6.3°C;- 1.6 kcalmol
-1 
5 FBI  4.5°C; 1.1 kcalmol
-1  -6.4°C;- 1.8 kcalmol
-1 
6 FBI  5.7°C; 1.3 kcalmol
-1  -6.9°C;- 1.7 kcalmol
-1 
4,6 DFBI  5.4°C; 1.2 kcalmol
-1  -6.5°C;- 1.5 kcalmol
-1 
4 TFM  7.4 °C; 1.8 kcalmol
-1  -14.0°C;- 3.3 kcalmol
-1 
5 TFM  7.5 °C; 1.7 kcalmol
-1  -13.5°C;- 3.3 kcalmol
-1 
6 TFM  7.8 °C; 2.0 kcalmol
-1  -14.0°C;- 3.1 kcalmol
-1 
I  5.3°C; 1.2 kcalmol
-1  -6.3°C;- 1.7 kcalmol
-1 
 
Figure 8.23.  Calculated thermodynamical parameters for stacking and solvation for 
synthesised modifications 
 
Figure  8.23.  shows the calculated values for the solvation and the stacking of all synthesised 
bases and their influence on stability of double helix. Values for the benzene nucleosides were 
calculated comparing to U and for benzimidazole modifications to G.  
All  modifications  raise  stability  of  double  helix  through  base  stacking  but  destabilize  it 
because  of  the  solvation.  By  TFM  modifications  there  are  additional  destabilizing  effects 
when they are paired with fluorinated bases. We think that for that the size of CF3 group and 
the presence of great number of negatively charged fluorine atoms towards one another are 
responsible. That destabilizes double helix further more. Surprisingly there is a big difference 
to notice between 2,4,5 TFB and 2,4,6 TFB. While 2,4,5 TFB stabilizes double helix with 
8.2°C  for  2,4,6  TFB  that  value  is  only  1.6°C.  The  difference  in  destabilization  through 
solvation is not so dramatically, -10.8°C for 2,4,5 TFB and -8.8 °C for 2,4,6 TFB.  That 
shows  that  not  only  the  number  but  also  the  orientation  of  fluorine  atoms  influences  the 
double helix stability. 
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Wobble base pair 
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Figure 8.24. Wobble base pair and modified base pairs stabilized with C-F…H-C bonding (a 
and b are two possible orientations of modified bases in base pairs) 
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A base pair from U and 6FBI, in a 12mer RNA sequence, has a melting point of 28.5°C and a 
free enthalpy  G° of 9.3 kcalmol
-1. If U is replaced with 2,4 DFB the Tm value should rise for 
4.4°C (1.1 kcalmol
-1). Therefore the melting point of the RNA duplex, with central base pair 
6FBI-2,4DFB, should have melting point of 33.0°C and free enthalpy  G° of 10.4 kcalmo
-1. 
Measured melting point is however 33.6°C with free enthalpy   G° of 10.8 kcalmol
1-, that 
means 0.6°C and 0.4 kcalmol
1- higher than expected. The same is for base pairs with 2,4 DFB 
on the one side and 4FBI (Parsch & Engels, 2000) and 5 FBI on the other side. If the same 
calculation is made for 2,4 DFB and 4,6DFBI we get difference from 0.9°C and 0.6 kcalmol
-1 
(Parsch  &  Engels,  2000).  In  all  four  base  pairs  there  are  stabilizing  forces  and  for  those 
fluorine is of main importance. These weak interactions can be assigned as the C-F…H-C 
hydrogen bonding, which is already known to be present in crystal structures (chapter 6). 
For stabilization of 0.4 kcalmol
-1 in 4FBI-2,4DFB, 5FBI-2,4DFB and 6FBI-2,4DFB one C-
F…H-C hydrogen bond is responsible while by 4,6DFBI-2,4DFB two hydrogen bonds of the 
same time are responsible for difference of 0.6 kcalmol
-1. Slight movement of nucleobases 
like in Wobble base pairs, allows forming of C-F…H-C hydrogen bond. 
 
8.1.3   Enhalpy-Entropy Compensation 
 
The phenomenon of entropy-enthalpy compensation, an empirical observation that in many 
chemical  processes  the  change  in  enthalpy  is  partially  compensated  by  a  corresponding 
change in entropy, resulting in a smaller net free energy change, has been widely documented 
(Searle & Williams, 1993; Gallicchio et al.,1998).  
The enthalpy change measures a change in the strength of the interactions between molecules 
while  entropy  change  measures  a  change  in  the  order  of  the  system.  It  is  more  difficult, 
however, to interpret free energy  changes.  Invariably, in fact, the  analysis of free  energy 
changes must involve the analysis of the relative importance of the corresponding enthalpy 
and entropy changes. Following equations are expressing these facts mathematically (Chen & 
Russu, 2004). 
 
[8-18]         Ghelix=  Gr+  Gh+  Gs+  Ghb 
[8-19]         Hhelix=  Hr+  Hh+  Hs+  Hhb 
[8-20]         Shelix=  Sr+  Sh+  Ss+  Shb 
 
r-internal rotations, h-hydrophobic interactions, s-stacking interactions, hb-hydrogen bonding.   Spectroscopic Measurements of Oligonucleotides   
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Factorisation  of  experimental  free  energies  for  helix  formation  in  terms  of  approximate 
contributions  from  the  restriction  of  rotations,  hydrophobic  interactions,  electrostatic 
interactions due to base stacking, and contributions from hydrogen bonding, and estimate the 
adverse free energy cost per rotor (mainly entropy) of ordering the phosphate backbone is 
expressed with equations [8-18], [8-19] and [8-20]. 
The phenomenon of enthalpy-entropy compensation agrees with our intuition that a stronger 
interaction between molecules will also result in a reduction of the entropy. Correspondingly, 
weaker molecular interactions as also higher extent of free rotation will produce a looser 
molecular association and an increase of entropy.  
The  thermodynamics  of  self  association  (stacking)  of  free  bases  and  nucleotides, 
intramolecular stacking in dinucleotides, nearest-neighbour base pair stacking interactions in 
duplex  DNA  and  RNA,  and  the  formation  of  hairpin  loops  illustrate  enthalpy-entropy 
compensations.  Large  stacking  exothermicities  are  associated  with  large  negative  entropy 
changes that ensure that  G is small, permitting readily reversible associations in solution.  
There are also exceptions of this enthalpy-entropy compensations (Gallicchio et al.,1998) but 
Figure  8.25.    shows  the  correlation  between  enthalpy  and  entropy  changes  for  all  our 
modified RNA duplexes. The correlation coefficient of our measurements is 0.990, which is 
an ideal value. 
 
 
   H°[kcal/mol] 
                                                        T S°[kcal/mol] 
Figure 8.25. Enthalpy-entropy compensation of all synthesised RNA duplexes 
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8.2   CD Spectroscopic Measurements 
 
8.2.1   CD-Spectroscopy 
 
 
CD-spectroscopy  (circular  dichroism  spectroscopy)  is  a  method,  which  uses  chirality  of 
molecules  for  measurements.  The  beginning  point  for  those  measurements  is  that  chiral 
molecules differently interact with right and left polarized light.  
Plane  polarized  light  E  can  be  resolved  into  two  components  R  and  L.  As  long  as  the 
intensities and phases of two circularly polarized components remain the same, their resultant 
will lie in the plane and oscillate in magnitude. If the right circularly polarized component is 
less intense (absorbed more) than the left circularly polarized component, the electric vector 
of  the  light  follows  an  elliptical  path  corresponding  to  elliptically  polarized  light.  (figure 
8.26).  
 
 
 
Figure 8.26.: Circular  polarized light (Winter & Noll, 1998) 
 
CD-spectroscopy leans on the fact that extinction coefficients for right and left polirized light, 
εr and  εl are different. The difference in absorption can have positive or negative value. 
 
[8-21]       ε= εL- εR 
In CD-spectroscopy we measure, however, not  ε but the ellipticity Θ.  Elipticity is another 
effect that circular dichroism causes. When coming into the sample I0L=I0R but when leaving 
the sample those intensities are different. If we design than a sum vector it oscillates no more   Spectroscopic Measurements of Oligonucleotides   
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along the line and describes an ellipse. The originally linearly polarized light is becoming 
elliptically polarized ( Berova et al., 2000).  
 
[8-22]   tan Θλ = (IR – IL) / (IR + IL) 
 
IR and IL are intensities of right and left polarized light. The ellipticity itself does not depend 
on wavelength.  For quantitative and standardized description we refer to Lambert-Beer’s law. 
With exchange of [8-23] in  Lambert-Beer´s equation: 
[8-23]                                 A=log (I0/I)= l · cm · d 
we get: 
 
[8-24   Θλ = ln 10 · (180° / 4π) · (εL – εR) · cm · d 
 
After we get specific ellipticity [Θ]λ : 
 
[8-25]  Θ]λ = Θλ / cm · d 
 
Specific  ellipticity  [Θ]λ has  as  unit:  grad  ·  cm²  ·  dmol
-1  (cm  =  g  ·  cm
-3,  d  =  dm).  Molar 
ellipticity therefore is: 
 
[8-26]   ΘM]λ = [Θ]λ · M / 100 
 
M is molecular mass in g/mol. For faster calculation of extinction coefficients from molar 
ellipticity, whan we calculete in all constants we get: 
 
[8-27]  ΘM]λ = 3298 · ∆ε 
 
In  CD spectra ellipticity as function of wavelength is measured. By CD measurements we get 
positive and negative values. Typical values for ellipticity are around 10
5 Grad · cm² · dmol
-1.  
The CD spectroscopy is very useful for the investigations of biomacromolecules. It is also 
often used for investigating the structure of nucleic acids. In nucleic acids the sugar molecule 
is responsible for chirality, as bases have a plane of symmetry. CD spectra, however, gives no 
defined structure information but only helps to complete picture formed using other structural 
methods.  The  intensities  and  positions  of  absorption  bands  can  be  only  discussed  in 
comparison with known structures.  
We have to be very careful in comparing two CD-spectra of different sequences. This method 
also has some advantages like: sensitivity on structure change, not destructive method, simple   Spectroscopic Measurements of Oligonucleotides   
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measurements  and  small  amounts  of  oligonucleotides  for  the  measurements  (Gray  et  al., 
1992). 
The first CD measurements in DNA were done in 1963 by Brahms (Brahms, 1963). The 
differences  in  CD-spectra  of  RNA  and  DNA  were  widely  studied  in  the  following  years 
(Brahms, 1964; Brahms, 1965; Brahms & Mommaerts, 1964; Bush & Brahms, 1967; Brahms 
et al., 1967) Figure 8.27  shows  CD spectra of A-DNA and B-DNA. The change of structure 
gives big changes in CD spectra. The CD of B-DNA has maximum at 282 nm and minimum 
at 245 nm. One more maximum is at 220 nm. At 258 nm the ellipticity changes from positive 
to  negative  value  and  at  282  nm  again  to  positive  values.  On  the  other  hand  main 
characteristics of A-DNA are: long wavelength band centred around 260 nm, a fairly intense 
negative band around 210 nm, and a very intense positive CD at about 190 nm. This CD 
spectrum is quite similar to CD of natural RNAs that normally exist only in A form. CD 
measurements  done  in  this  work  were  measure  on  a  JASCO  J-710  spectrometer  with 
thermostate.  For the CD measurements same samples as for UV-spectroscopy were used. 
Details are given in experimental part (chapter 10). 
 
 
 
 
Figure 8. 27. CD-spectra of A-DNA and B-DNA (Winter & Noll, 1998) 
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8.2.2   Results of CD-Spectroscopy 
 
CD-spectroscopic  measurements  were  done  on  single  strands  of  RNA  and  also  RNA 
duplexes.  Some  examples  are  given  in  figures  8.28-33.  The  measurements  were  done  on 
different temperatures. In figure 8.28 are given CD of single strands at 10°C of S 7 and S 8  . 
Those CDs have maximum at 265-270 nm and no defined structure can be seen.  
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Figure 8.28. CD of single stranded RNA S 7 (2,4,6 TFB) and S8  ( 2,4,5 TFB) 
 
The investigations of RNA duplexes  (figure 8.29 , figure 8.30., figure 8.31  and figure 8.32 ) 
All  of  those  duplexes  show  A-DNA  structure  and  modified  structures  do  not  differ  from 
unmodified ones. When stabilities of duplexes are lower the intensity is from 210 to 270 nm, 
also smaller.  
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Figure 8.29.CD of RNA unmodified duplex ( S 1  and S 22 ) 
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Figure 8.30. CD of RNA duplex of   S1  and S 36 
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2,4,6 TFB with A,C,G and U
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Figure 8.31.: CD spectrum of RNA duplex which at middle positions has 2,4,6 TFB paired 
with natural bases at 10°C, 20 °C and 30°C 
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Figure 8.32.  RNA duplexes at 10°C containing 2,4,5 TFB as middle base in C,U-rich 
sequence and A,C, G, U and 4 FBI in A,G-rich sequence   Spectroscopic Measurements of Oligonucleotides   
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Figure 8.33.  CD of RNA duplexes containing 2,4,5 TFB-4 FBI (S8+S24) and 2,4,6 TFB-4FBI 
(S7+S24) as middle base pairs 
 
From all figures (8.28-8.33) can be seen that RNA duplexes with one and two modifications 
do not differ from unmodified ones. There from we can conclude that incorporation of our 
modifications  has  no  influence  on  RNA  structure,  even  our  CDs  have  minor  differences 
compared to ideal one but in our hands it was also the case with unmodified RNA duplexes 
(figure 8.29) (Clark et al., 1997; Wörner et al., 1999).  
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9  Summary 
 
 
 
This  work  presents  synthesis  of  the  following  fluorobenzene-  and  fluorobenzimidazole- 
nucleosides.   
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All modifications shown in figure 9.1. were synthesised as phosphoramidites and incorporated 
in RNA oligonucleotides. In all cases ribose moiety is constant but the ``base` groups vary in 
the extent and orientation of fluorine substitution, from zero (as for B and BI) to 5 (for PFB).   
1’-deoxy-1’(4,6-difluoro-1-N-benzimidazolyl)- β-D-ribofuranose (2,4 DFBI) is an isoster of 
natural xantine and 1’-deoxy-1’-(2,4–difluorophenyl)- β-D-ribofuranose (2,4 DFB) is isoster 
for uracil.  
Fluorobenzimidazoles  were  synthesised  from  corresponding  fluoroacetanilides. 
Trifluoromethylbenzimidazole  nucleosides  were  from  diamines  synthesised  (except  4TFM 
which  was  synthesised  from  corresponding  trifluoromethylacetanilide).  Glycosilation  was 
done  by  Silyl-Hilbert-Johnson  reaction  and  followed  by  deacetilation  with  sodium 
methanolate  in  methanol.  For  glycosilation  of  C-nucleosides  we  used  2,3,5-tri-O-benzyl-
ribono-γ-lactone. It was synthesised in a four-step procedure. After glycosilation (with n-BuLi 
or  t-BuLi)  with  corresponding  fluorobromobenzenes  (or  fluoro  benzenes)  nucleoside  was 
deprotected with palladium hydroxide on carbon and with cyclohexene. The exception was 
AS,  that  was  deprotected  with  bortribromide.  Abasic  site  (AS)  was  obtained  after 
dehydroxylation and deprotection of 2,3,5-tri-O-benzyl-ribofuranose. 
From the crystal structures of fluorobenzonucleosides obtained, from water or methanol, we 
got  data  on  their  structures.  In  no  crystal  packing  was  seen  a  herringbone  structure 
characteristic  for  fluorobenzenes  themselves.  The  molecules  have  their  hydrophilic  part 
(ribose) and lipophilic part (base). The sugar parts are bonded with hydrogen bonds but for 
orientation of the molecules fluorine atoms are responsible. Short Csp
2-F...H-Csp
2
 distances 
were found in all crystal structures. In the bis-ortho-substituted trifluorobenzene modification 
(2,4,5  TFB)  was  found  also  one  intermolecular  distance  of  the  type  Csp
2-F...H-Csp
2  from 
2.34Å.  
   Summary   
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Figure 9.2. : F…H distances and angles of hydrogen bonds of Csp
2-F…H-Csp
2 (Thalladi et al., 
1998) filled with distances found and mentioned in this work (Parsch, 2000)-green for title 
compound, red for fluoro benzene modifications 
 
We  investigated  also  lipophilicity  of  synthesised  nucleosides.  Therefore  we  determined 
octanol-water partition coefficient and HPLC-retention times of nucleosides. All fluorinated 
nucleosides have significantly higher lipophilicity than non-fluorinated ones. 
The  unprotected  nucleosides  were  incorporated  in  RNA  as  phosphoamidites  by  standard 
methods. Migration ability of TBDMS group in the 3’-direction did not allow high yields of 
2’-TBDMS protected nucleosides. Obtained phosphoamidites were incorporated in RNA on 
the synthesiser by means of phosphoamidite chemistry. We synthesised 12mer RNA strands 
to  investigate  oligonucletides  with  UV-  and  CD-spectroscopy.  From  the  obtained  melting 
curves we determined melting points and thermodinamical data. 
The  electrostatics  vary  widely  over  the  series  of  benzene-nucleosides,  with  the  phenyl 
nucleoside showing a negative potential at the centre of the flat aromatic face, and the penta 
fluorinated  case  having  a  strongly  positive  potential.  Thus  the  quadrupoles  are  gradually 
inverted over this series. By comparison natural bases are not so strongly polarized in the 
quadrupole sense) and the quadrupole moments are close to zero. In this series also could be 
seen a broad range of dipole moments though the dipole orientations are quite similar over the 
series.   Summary   
- 136 - 
2,4,5 TFB builds 5-6°C more stable base pairs than 2,4,6 TFB. On one hand 2,4,5 TFB is 
almost as good as 2,4 DFB (not so “universal’’) on the other hand 2,4,6 TFB is as bad as the 
benzene modification itself. Therefore we think that position 5 of the benzene ring is not of 
great importance for base pairing but the 2 and 6 positions (bis-ortho), first positions next to 
the glycosidic linkage) are significant for base pairing pattern of benzenes. Both PFB and 
2,4,6 TFB are almost as poorly stabilizing as benzene itself (figure 9.3). 
Figure 9.3. Graphical overview of Tm values of base pairs of fluoro-benzene modifications 
and natural bases 
 
Therefore we can conclude here for this series that: 
•  Though  fluorine  is  a  very  small  substituent  it  can  alter  glycosidic  orientation 
preferences in nucleosides, presumably by steric interactions with neighbouring bonds 
and substituents  
•  Bis-ortho substitution was very poor in stabilization and there is a great change in 
stability when a fluorine atom is ‘moved’ from ortho to meta position ( see results for 
2,4,5  TFB  and  2,4,6  TFB).  This  could  be  due  to  a  sterically  induced  twist  in  the 
glycosidic bond and/or in the sugar. This would also explain large magnitutude of 
instability of oligonucleotides containing PFB. These bis-ortho substituted bases are 
certainly to be avoided in the future design of nucleobases. 
•  On the example of PFB one can see that electrostatic repulsions between fluorines and 
π-cloud of non-fluorinated compound lead to additional destabilization of double helix 
RNA structure. 
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•  When  natural  bases  are  involved  in  pairing  with  non-natural  fluorinated  bases 
quadrupole effect and dipole moment are small or nonexistent. However with to non-
natural stacking partners (stronger polarized than natural bases) they might exhibit 
quadropolar stabilization or destabilization in water. 
If we move now further, to the fluorinated benzimidazoles one can notice that there is a very 
small difference, if any, compared to benzimidazole (figure 9.4.). 
 
 
Figure 9.4: Graphical overviews of Tm values of base pairs of fluoro-benzimidazole 
modifications and natural bases 
 
Here we can conclude the following:  
•  In benzimidazole modifications containing fluorine atom in different positions there is 
almost no difference compared to non-substituted imidazole (figure 9.4.) 
•  When there is in a base trifluoromethyl group the destabilization of duplex is of large 
magnitude (due to the large size of trifluoromethyl group and it’s probable orientation 
in RNA duplex, we assume it is flipped out because results show clearly that stability 
of RNA duplex is higher when opposite TFM modification is an abasic site than any 
other base (figure 9.5) 
•  In general, that would mean that when the surface areas for stacking are larger (than in 
benzenes for example) the influence of constituents is almost of no importance. Only 
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when too large constituents are present the level of destabilization is larger (as for 
trifluoromethyl group) 
•  One can also notice that between the trifluoromethyl isomers (4 TFM, 5 TFM and 6 
TFM) there is almost no difference in stability which is in accordance with the fact 
that position of trifluoromethyl group has no larger influence on polarizability, 
polarity or quadrupole moments of such compounds (figure 9.5) 
 
                                °C 
 
 
 
 
 
 
 
Figure 9.5.  Graphical overviews of Tm values of base pairs of trifluoromethyl-benzimidazole 
modifications and natural bases compared to 6FBI modification 
 
°C 
  
 
 
 
 
 
 
  4FBI  5FBI  6FBI  4,6 DFBI 
2,4 DFB  33.5°C  33.2°C  33.6°C  34.6°C 
2,4,5 TFB  32.9°C  31°C  34.7°C  33.5°C 
 
Figure 9.6. Most stable modified base pairs (values are shown in table) 
 
If we compare than the non-natural base pairs we can say that most stable base pair from the 
ones we investigated is self-pair from 2,4,5 TFB which has Tm value of 35.8 °C and the 
natural A-U base pair (in defined sequence) has Tm of 37.8°C. From the base pairs formed in-
0
5
10
15
20
25
30
35
40
A C G U
4 TFM
5TFM
6TFM
6 FBI
0
5
10
15
20
25
30
35
40
4 FBI 5 FBI 6 FBI 4,6
DFBI
2,4 DFB
2,4,5 TFB
0
5
10
15
20
25
30
35
40
2,4,5 TFB-2,4,5 TFB
A-U  Summary   
- 139 - 
between  benzene  and  benzimidazole  modifications  the  most  stable  are  the  ones  that  are 
formed from 2,4 DFB and 2,4,5 TFB on the one side and 4 FBI, 5 FBI, 6 FBI and 4,6 DFBI 
on the other. Equally stable and the most stable are those two: 2,4 DFB -4,6 DFBI and 6 FBI-
2,4,5 TFB (figure 9.6.). 
In addition we found some additional stabilization forces (see chapter 8) with in following 
base pairs: 2,4 DFB on the one side and 4 FBI, 5 FBI, 6 FBI and 4,6 DFBI on the other side. 
The stabilization for the first three base pairs is 0.6°C and 0.4 kcalmol
1- and for the 2,4 DFB-
4,6  DFBI  this  stabilization  is  0.9°C  and  0.6  kcal  mol
-1.  We  assume  that  fluorine  is  very 
important  for  those  stabilization  forces  and  this  interaction  can  be  assigned  as  C-F...H-C 
hydrogen bonding, which is already known to be present in crystal structures. For stabilization 
of  0.4  kcalmol
-1  in  4  FBI-2,4  DFB,  5  FBI-2,4  DFB  and  6  FBI-2,4  DFB  one  C-F...H-C 
hydrogen  bridge  is  responsible  while  by  4,6  DFBI-2,4  DFB  two  hydrogen  bonds  are 
responsible for difference of 0.6 kcalmol
-1. Slight movement of nuleobases, like in Wobble 
base pairs, allows forming of C-F...H-C hydrogen bond.  
This work opens a few interesting further tasks in synthesis and investigation of modified 
nucleic acid analogues. An ‘unusual hydrogen bond’ as assumed is forming we would like to 
investigate employing NMR measurements of RNA oligonucleotides.  In addition one can 
study stable 2,4,5 TFB-2,4,5 TFB base pair and it’s characteristics and also try to design 
‘’better’’  modifications  (more  stable  ones)  than  benzimidazoles  (substituted  indols  etc.). 
Design  of  four-fluorinated  (with  one  ortho  position  without  fluorine)  benzene  nucleoside 
would be also an interesting task to check if that value corresponds our calculations (Tm value 
of this self-pair should than be 40°C-figure 8.19). 
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9  Zusammenfassung 
 
 
 
Im Rahmen dieser Arbeit wurden folgende Fluorobenzol- and Fluorobenzimidazol- 
Nucleoside synthetisiert. 
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Abbildung  9.1. Synthetisierte Nucleoside   Zusammenfassung   
- 142 - 
 
Alle  Modifikationen  die  in  Abbildung  9.1.  dargestellt  sind  wurden  synthetisiert  und  als 
Phosphoramidite in RNA Oligonucleotide eingebaut. Um den Einfluss der Fluorsubstitution 
untersuchen  zu  können  wurden  verschiedene  Nucleobasen  synthetisiert,  ohne  Fluor 
Substituenten (B, BI) bis zu fünf (PFB). 1’-Desoxy-1’(4,6-difluoro-1-N-benzimidazolyl)- β-
D-ribofuranose  (4,6  DFBI)  ist  isoster  zu  natürlichem  Xanthin  und  1’-Desoxy-1’-(2,4–
difluorophenyl)- β-D-ribofuranose (2,4 DFB) zu Uracil. 
Die  Fluorobenzimidazole  wurden  ausgehend  von  den  entsprechenden  Fluoracetaniliden 
dargestellt.  Die  Trifluoromethylbenzimidazole  wurden  den  entsprechenden  von  Diaminen 
dargestellt  (nur  4  TFM  von  Trifluoromethylacetanilid).  Die  Glykosilierung  erfolgte  nach 
Silyl-Hilbert-Johnson Reaktion mit anschließender Deacetylierung der  Hydroxylfunktionen 
mit Natriummethanolat in Methanol. Für die Glycosylierung der C-Nucleoside wurde 2,3,5-
Tri-O-benzyl-ribono-γ-lacton benötigt. Dies wurde über vier Stufen aus D-Ribose dargestellt. 
Nach  der  C-Glycosylierung  (mit  n-BuLi  oder  t-BuLi)  mit  dem  entsprechenden 
Fluorobrombenzol wurde das Nucleosid mit Palladiumhydroxid auf Kohle und Cyclohexen in 
einer  Transfer-Katalyse  entschützt.  Die  Ausnahme  bildete  AS,  das  mit  Bortribromid 
entschützt wurde. Der  abasische Baustein (AS) wurde aus 2,3,5-Tri-O-benzyl-ribofuranose 
durch Dehydroxylierung und anschließende Entschützung gewonnen. 
Von den Fluorobenzol-Nucleosiden gelang es Kristalle aus Wasser oder Methanol zu erhalten 
und  röntgenkristallographisch  zu  untersuchen.  Die  Kristallpackungen  zeigten  eine  sehr 
interessante Anordnung der Moleküle. Alle Fluor-Benzol Nucleoside zeigten nicht die für 
aromatische Systeme normale Fischgräten-Struktur, sondern eine Anordnung, in der sich die 
Moleküle gegenüberliegen. Kurze  Csp
2-F...H-Csp
2
  Abständewurden in allen Kristallstrukturen 
gefunden. In den bis-ortho-substituerten Trifluorobenzol-modifikation (2,4,6 TFB) wurde ein 
intermolekularer Abstand von 2,34 Å gefunden. 
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Abb. 9.2. : F…H Abstände und Winkel von Wasserstoffbrücken des Typs Csp
2-F…H-Csp
2 
(Thalladi et al., 1998) ergänzt mit den in dieser Arbeit gefundenen Werten (rote Kreise-
fluorobenzole, grüner Kreis Fluorbenzimidazol) 
 
 Die  Nucleoside  wurden  auf  ihre  Lipophilie  hin  untersucht.  Zu  diesem  Zweck  wurden 
Octanol-Wasser  Verteilungskoeffizienten  und  HPLC-Retentionzeiten  der  Nucleoside 
gemessen.  Die  fluorierten  Nucleoside  zeigten  im  Gegensatz  zu  den  nichtfluorierten 
Nucleosiden eine deutlich größere Lipophilie. 
Die  entschützten  Nucleoside  wurden  nach  Standardmethoden  für  RNA  Bausteine  in  ihre 
Phosphoramidite  überführt.  Dabei  stellte  sich  heraus,  dass  durch  eine  starke 
Wanderungstendenz  der  TBDMS-Gruppe  in  Richtung  3’-Hydroxylfunktion  bei  allen 
fluormodifizierten  Nucleosiden  das  gewünschte  2’-geschützte  Isomer  nur  in  niedrigen 
Ausbeuten erhalten werden konnte. 
Die  erhaltenen  Phosphoramiditbausteine  wurden  mittels  der  Phosphoramiditmethode  an 
einem Syntheseautomaten in Ribonukleinsäure (RNA) eingebaut. Dazu wurden RNA Stränge 
aus zwölf Nucleotiden mit einer Modifikation in der Mitte synthetisiert und aufgereingt. Um 
festzustellen. Ob die erhaltenen 12mer RNA Duplexe bilden, wurde mittels UV- und CD-
Spekroskopie  untersucht.  Aus  den  erhaltenen  Schmelzkurven  wurden  die  Schmelzpunkte 
bestimmt und die thermodynamischen Daten errechnet.  
Die elektrostatischen Wechselwirkungen varieren über eine Serie von Benzol-Nucleosiden 
(B), mit einem Phenyl-Nucleosid das ein negatives Potential in Zentrum des Aromaten zeigt 
und  dem  pentafluorierten-Nucleosid  (PFB)  das  dort  stark  positives  Potential  hat.  Beim 
Vergleich sind die natürlichen Basen nicht so stark polarisiert und die Quadrupol Momente 
sind fast Null.       Zusammenfassung   
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2,4,5 TFB  bildet 5-6°C stabilere Basenpaare als 2,4,6 TFB. Einerseits ist  2,4,5 TFB so gut 
wie  2,4 DFB (nicht so “universell’’) anderseits ist  2,4,6 TFB so schlecht wie die Benzol 
Modifikationen  (B).  Aufgrund  dessen  liegt  die  Vermutung  nahe,  dass  die  Position  5  des 
Benzols für die Basenpaarung nicht essentiell ist. Die Positionen 2 und 6 hingegen sind für 
die  Basenpaarung  essentiell.  Die  ersten  Positionen  in  nächster  Nähe  zur  glykosidischen. 
Bindung sind signifikant für die Basenpaarung des Benzols. Die Modifikationen PFB und 
2,4,6 TFB haben dieselben Tm – Werte wie die Benzolmodifikationen ( Abb.9.3 ).    
 
 
Abb. 9.3.: Graphische Darstellung der Tm Werte von  Fluorbenzol-mit Natürlichen Basen 
 
Somit können wir für diese Serie festhalten: 
•  Obwohl die Fluorsubstituenten klein sind können sie die glykosidische Orientierung 
beeinflussen. Dies liegt höchstwahrscheinlich an der sterischen Wechselwirkung mit 
benachbarten Bindungen und Substituenten. 
•   Die bis-ortho Substitution bewirkt keine gute Stabilisierung. Die Substitution eines 
Fluors in meta anstatt in der ortho-Stellung bewirkte einen großen Unterschied in der 
Stabilität( 2,4,5 TFB und 2,4,6 TFB). Der Grund dafür ist der sterisch induzierte Twist 
in  der  glykosidischen  Bindung  und/oder  in  der  Ribose.  Dies  wäre  ebenfalls  eine 
Erklärung  für  die  große  Destabilisierung  in  PFB  modifizierten  Oligonukleotiden. 
Diese bis-ortho substituierten Basen sollten in zukünftigem Design von Nukleobasen 
nicht verwendet werden.      
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•  Am Beispiel des PFB wurde ersichtlich, dass elektrostatische Repulsionen zwischen 
Fluor und dem delokalisierten π-System von nichtfluorierten Komponenten zu einer 
wachsenden Destabilisierung der Doppelhelix RNA führen.   
•  Bei der Basenpaarung von natürlichen Nukleobasen mit nicht-natürlichen fluorierten 
Basen wurde ersichtlich, dass der Quadrupol Effekt sowie das Dipolmoment sehr klein 
bzw.  nicht  vorhanden  sind.  Zwei  nicht-natürliche  Stacking  Partner,  die  stärker 
polarisiert  sind  als  natürliche  Nukleobasen,  können  zu  einer  quadruolaren 
Stabilisierung oder Destabilisierung in Wasser führen. 
Bei der Betrachtung der fluorierten Benzimidazole wird ersichtlich, dass es nur einen kleinen 
Unterschied zu Benzimidazolen gibt. (Abb. 9.4.). 
 
 
Abb. 9.4: Graphische Darstellung der Tm Werte von den Fluorbenzimidazol-Natürlichen 
Basenpaaren 
Folgende läßt sich zusammenfassen: 
•  In Benzimidazol Modifikationen die Fluor-Atome in verschiedenen Positionen 
enthalten ist fast kein Unterschid im Vergleich i nicht-substituierten Benzimidazolen 
(Abb.  9.4.) 
•  Beim Vorhandensein einenrifluoromethylgruppe ist die Destabilisierung groß, 
aufgrund der großen  Trifluormethylgruppe und der wahrscheinlichen Orientierung im 
RNA Duplex ( DieVermutung liegt nahe, dass diese Base sich außerhalb des Duplexes 
befindet ) (Abb. 9.5). 
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•  Allgemein würde das bedeuten, dass für größere π-Stacking Systeme ( z.B. größer als 
Benzol) der Einfluss der Substituenten von geringerer Wichtigkeit ist. Nur beim 
Vorhandensein sehr großer Substituenten ist die Destabilisierung größer.  
•  Es wurde ersichtlich, dass zwischen den Trifluor Isomeren ( 4TFM, 5TFM, 6TFM ) es 
keinen Unterschied in der Stabilität gibt. Die Position der Trifluormethylgruppe hat 
keinen bedeutenden Einfluss auf die Polarisierbarkeit, Polarität oder das Quadrupol 
Moment (Abb. 9.5). 
 
                         °C 
 
 
 
 
 
 
 
Abb.  9.5: Graphische Darstellung der Tm Werte  der Trifluoromethylbenzimidazol-
Natürliche Basenpaare im Vergleich zu 6FBI-Natürlichen Basenpaaren 
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  4FBI  5FBI  6FBI  4,6 DFBI 
2,4 DFB  33,5°C  33,2°C  33,6°C  34,6°C 
2,4,5 TFB  32,9°C  31°C  34,7°C  33,5°C 
 
Abb.  9.6.: Graphische Darstellung der Tm Werte von den Modifizierten Basenpaaren 
 
Beim Vergleich von nicht-natürlichen Basenpaaren sind die stabilsten Basenpaare von 2,4,5, 
TFB mit einem Tm von 35,8°C und das natürliche Basenpaar A-U mit einem Tm von 37,8°C. 
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Die  stabilsten  Basenpaare  zwischen  Benzol  und  Benzimidazol  Modifikationen  sind  die 
zwischen 2,4 PFB und 2,4,5 TFB auf der einen Seite und 4FBI, 5 FBI, 6 FBI auf der anderen 
Seite. Die stabilsten sind : 2,4 DFB – 4,6 DFBI sowie 6 FBI – 2,4,5 TFB (Abb. 9.6). 
Im  Falle  der  2,4  DFB-  4  FBI,  2,4  DFB-5  FBI,  2,4  DFB-6  FBI  und  2,4  DFB-4,6  DFBI 
Basenpaare sind die gemessenen Werte allerdings um 0,6°C (0,4kcal/mol) bzw. 0,9°C (0,6 
kcal/mol)  höher  als  die errechneten.  Da  sich  diese  Basenpaare  von  dem  Benzimidazol(I)-
Benzol  (B)  nur  durch  die  Fluoroatome  unterscheiden,  muss  die  Stabilisierung  der  RNA 
Duplexe durch Wechselwirkungen des Fluors zustande kommen. Bei dieser Wechselwirkung 
zwischen  zwei  modifizierten  Nucleobasen  könnte  es  sich  um  F…H  Wasserstoffbrücken 
handeln, wie sie auch schon in Kristallen von Nucleosiden nachgewiesen werden konnten.   
Als Ausblick für zukünftige Arbeiten auf diesem Gebiet ausgehend von den in dieser Arbeit 
erhaltenen Ergebnisse werden folgende Untersuchungen angeregt: 
Diese  Arbeit  eröffnet  ein  interessantes  Aufgabenfeld  für  die  Synthese  von  modifizierten 
Nukleinsäureanaloga. Die von uns vermutete unübliche Wasserstoffbrückenbindung wurde 
bestätigt  und  wird  in  nächster  Zeit  mittels  NMR-Messungen  von  RNA  Oligonukleotiden 
verifiziert. Des weiteren könnte man die Stabilität der 2,4,5 TFB-2,4,5 TFB Basenpaare und 
ihre  Charakteristiken  untersuchen.  Die  Synthese  von  verbesserten  Modifikationen,  d.h. 
stabilere  als  die  der  Benzimidazole  sowie  die  Synthese  von  vierfach  fluorierten  (  ortho 
Position  ohne  Fluor)  Benzol  Nukleosiden  und  die  anschließende  Untersuchung  der 
Schmelzpunkte sind ebenfalls lohnende Aufgabenstellungen für anstehende Arbeiten. 
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10  Experimental Part 
 
 
 
10.1   Main Methods 
 
10.1.1   Chromatography 
 
For the chromatography (TLC, pTLC and FC) the following solvents were used: 
 
•  Acetonitrile; p.a. 
•  Ethyl acetate; technical quality, dried over calcium chloride and distilled 
•  n-Hexane; technical quality, distilled under normal pressure 
•  Isopropanol; technical quality, distilled under normal pressure 
•  Methanol; technical quality, distilled under normal pressure over CaCO3 
•  Methylene chloride; technical quality, dried over calcium chloride and distilled 
•  Water; distilled 
 
Thin Layer Chromatography (TLC) 
 
For the analytical TLC silica gel 60 on the aluminum plates with fluorescence indicator was 
used (Merck Nr. 5554; 0,2 nm), that were cut to 2-5 × 10 cm dimensions. The eluent way is 
around 8-9 cm. UV-active substances were detected with UV-lamp by 254 nm. TLC with 
UV-inactive substances (sugar moieties) were put in reagent that consists of: 10% acetic acid, 
5% anisaldehyde and 5% of conc. sulphuric acid in 75 % of water and 25 % ethanol and then 
warmed up to around 300°C (heating gun). Then the compounds are coloured black.  
The dimethoxytrityle group could be detected with vapour of conc. HCl (orange colour).  
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Preparative Thin Layer Chromatography 
 
For the preparative thin layer chromatography was used chromatotron (company Harrison 
Research (Model 7924 T)). As the separating material was used silica gel (Merck 60 PF254, 
Nr. 7749), that was put on the glass plate (radius 20 cm) in the density of 1,2 or 4 mm. The 
detection was performed with the wavelength of 254 nm.  
 
Preparative Column Chromatography (Flash-Chromatography, FC) 
 
The FC (Still at al., 1978) was performed with silica gel 60 (40-63 µm, Merck Nr. 9385)   
The columns of different size and radius were used for separations.  
 
High Performance Liquid Chromatography (HPLC) 
The HPLC separations of oligonucleotides were done on the JASCO machine. Details are 
described in the chapter 7.   
 
10.1.2   Spectroscopy 
 
NMR-Spectroscopy 
The NMR spectra were recorded on the following machines: AM 250, WH 270, AMX 400 
and AMX 800 from Bruker company. As solvents were used: DMSO-d6 with δ = 2,49 ppm 
and CDCl3 with δ = 7,27 ppm for the  
1H-NMR-Spectra; DMSO-d6 with  δ = 39,5 ppm and 
CDCl3 with δ = 77,0 ppm for the  
13C-NMR-Spectra. For the  
19F-NMR-Spektra in DMSO-d6 
as standard CCl3F  δ =–162,9 ppm was used. All spectra were measured at 300K. 
 
UV/VIS-Spectroscopy 
 
The UV-Spectra were measured on a UV-Spectral photometer from Varian Company (Model 
Cary 1).  
 
IR-Spectroscopy 
 
The  IR  Spectra  were  recorded  on  an  IR-Spectrometer  from    Perkin  Elmer  (  1600  Series 
FTIR).   Exprerimental Part   
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10.1.3   Mass spectrometry 
 
The mass spectra were measured on the machines from the companies VG Analytical and VG 
Biotec (today: Micromass). For the electron spray-ionisation (ESI) was used VG Platform II 
with  Quadrupol  Analysator.  Spectra  with  matrix  support  laser  desorption/  ionisation 
(MALDI) were measured on VG Tofspec.  
 
10.1.4   Elementary Analysis 
 
The elementary analysis was done on the machine of the company Foss-Heraeus (CHN-O-
Rapid). 
 
10.1.5   Melting Point Determination 
 
The melting points were measured on an apparatus according to Tottoli from company Büchi 
(Model Büchi 510). The values are given as measured. 
 
10.2  List of Chemical Reagents 
 
Acetic acid; C2H4O2 [60,05]; Riedel-de Haën Nr. 33209, ≥ 99,8 %, Bp. 117-118°C, d =  1,049 
Acetic acid anhydride; C4H6O3 [102,09]; Fluka Nr. 45830, puriss. p.a., Bp. 138-140°C,  
d = 1,08 
Acetonitrile; C2H3N [41,05]; Roth Nr. 8825.2, 99,5 %, for HPLC, Bp. 81-82°C, d = 0,78  
Acetonitrile; C2H3N [41,05]; Fluka Nr. 00695, puriss., ≥ 99,5 %, absolute, over molecular 
sieve  H2O ≤ 0,01 %, Bp. 82°C, d = 0,782 
Acetonitrile; C2H3N [41,05]; Fluka Nr. 00709, puriss. ≥ 99,5 %, absolute, over molecular 
sieve H2O ≤ 0,001 %, Bp. 82°C, d = 0,782 (for the synthesis of phosphoramidites) 
Amberlite IRA 93; Fluka Nr. 06441, freebase 
Ammonium hydroxide; NH4OH [35,05]; Merck Nr. 1.05426, 32 %, d = 0,88 
Ammonium chloride; NH4Cl [53,49]; Fluka Nr. 09702, purum p.a., ≥ 99 % 
Argon; Quality 4.8 
Benzimidazole; C7H6N2 [118,14]; Fluka Nr. 12250, purum, ≥ 98 %, Mp. 171-173°C 
Benzene; C6H6 [78,12]; Fluka Nr. 12552, puriss. p.a., Bp. 80°C, d = 0,879 
Benzyl chloride; C7H7Cl [126,59]; Fluka Nr. 13280, purum, ≥ 99 %, d = 1,10   Exprerimental Part   
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N,O-Bis-(trimethylsilyl)-acetamide;  C8H21NOSi2 [203,43];  Fluka  Nr.  15241,  Bp.
(35  mm)  71-
73°C, d = 0,832 
Borontribromide;  1  M  solution  in  methylene  chloride;  BBr3  [250,54];  Fluka  Nr.  15692; 
purum, d= 1,46 
Borontrifluoride-Ethyletherat; BF3*C4H10O [141,93]; Fluka Nr. 15719, purum, acid free, Bp. 
128°C, d = 1,13 
Bromobenzene;  C6H5Br  [157,02];  Fluka  Nr.  16350,  puriss.,  ≥  99,5  %,  Sdp.  154-155°C, 
d=1,494 
1-Bromo-2,4-difluorobenzene; C6H3BrF2 [192,99]; Lancaster Nr. 0930, ≥ 98 %, Bp.
(20 mm) 53-
54°C, d = 1,708 
1-Bromo-2-fluorobenzene;  C6H4BrF  [175,01];  Lancaster  Nr.  2374,  99  %,  Bp.  155-157°C, 
d=1,611 
1-Bromo-3-fluorobenzene; C6H4BrF [175,01]; Lancaster Nr. 6478, 99 %, Bp.
(80 mm) 77-79°C, 
d = 1,594 
1-Bromo-4-fluorobenzene;  C6H4BrF  [175,01];  Lancaster  Nr.  3391,  99  %,  Bp.  152-155°C, 
d=1,604 
1-Bromo-2,4,6-trifluorobenzene;  C6H2BrF3  [210,98];  Lancaster  Nr.  2134,  98  %,  Bp.  140-
141°C, d = 1,790 
1-Butanol; C4H10O [74,12]; Fluka Nr. 19430, purum, ≥ 98 %, Bp. 116-118°C, d = 0,81 
tert.-Butyldimethyl chlorsilane (TBDMSCl); 1 M solution in THF; C6H15ClSi [150,73]; Fluka 
Nr. 19904, purum, d = 0,886 
n-Butyllithium; 1,6 M solution in n-hexane; C4H9Li [64,09]; Aldrich Nr. 18,617-1, d = 0,68 
Celite-Filtergel; Fluka Nr. 22139 
Citric acid monohydrate; C6H8O7*H2O [210,1]; Fluka 27490, puriss, p.a.; 
Chloroforme-d1; CDCl3 [120,37]; Deutero GmbH, 99,8 Atom % D, stabilisiert mit Silber 
Chrometrioxide; CrO3 [99,99]; Fluka Nr. 27083, purum p.a. 
sym.-Collidine = 2,4,6-Trimethylpyridine; C8H11N [121,18]; Fluka Nr. 27690, puriss. p.a., ≥ 
99 %, Bp. 170-172°C, d = 0,914 
Cyclohexene; C6H10 [82,15]; Fluka Nr. 29240, purum, ≥ 99 %, stabilised with ~0,01 % 2,6-
Di-tert.-butyl-p-kresol, Bp. 81-84°C, d = 0,81 
Deuterium oxide; D2O; Deutero GmbH, 99,9 Atom % D 
Dibutyltin dichloride; C8H18Cl2Sn [303,83]; Fluka Nr. 34920, pract. ≈97 % 
1,2-Dichlorethane = Ethylene chloride; C2H4Cl2 [98,96]; Fluka Nr. 03527, puriss., absolute,  
over molecular sieve  ≥ 99,5 %, H2O < 0,005 %, Bp. 84°C, d = 1,253   Exprerimental Part   
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Diethyl ether; C4H10O [74,12]; Fluka Nr. 31685, puriss., ≥ 99,5 %, over molecular sieve, 
stabilised with 2,6-Di-tert.-butyl-p-kresol, Bp. 35-36°C, d = 0,713 
Diethyl pyrocarbonate (DEPC); C6H10O5 [162,14]; Fluka Nr. 32490, purum, ≥ 97 %, Bp. 160-
163°C, d = 1,12 
2,4-Difluoroacetanilide; C8H7F2NO [171,15]; Lancaster Nr. 14152, Mp. 122-124°C 
Diisopropylazodicarboxilate  (DIAD); C8H14N2O4 [202,21]; Fluka Nr. 11626, pract. ≈ 95 %, 
Bp.
(0,25 mm) 75-77°C, d = 1,044 
Diisopropylamine; C6H15N [101,19]; Aldrich Nr. 47,122-4, ≥ 99,5 %, d = 0,722 
Diisopropylethylamine (Hünigs Base, DIPEA); C8H19N [129,25]; Aldrich Nr. D12,580-6, 99 
%, Mp. 127°C, d = 0,742 
4,4'-Dimethoxytriphenylmethylechloride  =  4,4'-Dimethoxytritylechloride  (DMTrCl); 
C21H19ClO2 [338,83]; Merck Nr. 818616, > 99 %, Mp. 120-123°C 
N,N-Dimethyl formamide (DMF); C3H7NO [73,10]; Fluka Nr. 40248, puriss., > 99,5 %, over 
molecular sieve, H2O ≤ 0,01 %, Bp. 153-155°C, d = 0,948 
Dimethyl  sulphoxide  (DMSO);  C2H6OS  [78,13];  Fluka  Nr.  41648,  puriss.,  absolute,  over 
molecular sieve, H2O ≤ 0,01 %, Mp. 190-192°C, d = 1,100 
Dimethyl sulphoxide-d6 (DMSO-d6): C2D6OS [84,13]; Groupe C. E Saclay, 99,8 Atom % D 
Disodium hydrogen phosphate Dodecahydrat; Na2HPO4*12H2O [358,14]; Fluka Nr. 71650, 
puriss. p.a., crystallized 
1,4 Dioxane; C4H8O2 [88,11]; Riedel-de Haën Nr. 33147, p.a. ≥ 99,5 % 
1,4 Dioxane; C4H8O2 [88,11]; Fluka Nr. 42510, puriss., absolute, over molecular sieve, ≥ 99,5 
%, Mp. 100-102°C, d = 1,034 
Ethanol; C2H6O [46,07]; Riedel-de Haën Nr. 32205, p.a. 
2-Fluoro acetanilide; C8H8FNO [153,16]; Lancaster Nr. 1201, ≥ 98 %, Mp. 75-77°C 
p-Formaldehyde; (CH2O)x [30,03]x; Riedel-de Haën Nr. 16005, puriss., 95-100 % 
Formic acid; CH2O2 [46,03]; Merck Nr. 2541884, 98-100 %, d = 1,22 
n-Hexan; C6H14 [86,17]; Fluka Nr. 52766, puriss., absolute, over molecular sieve, H2O ≤ 0,01 
%, Bp. 69°C, d = 0,659 
3-Hydroxypropionitrile = 2-Cyanoethanol; C3H5NO [71,08]; Fluka Nr. 56270, puriss., ≥ 99 
%, Bp. 106-108°C, d = 1,045 
Imidazole; C3H4N2 [68,08]; Fluka Nr. 56760, puriss. p.a., ≥ 99,5 % 
Potassium hydroxide; KOH [56,11]; Fluka Nr. 60370, puriss. p.a.,  ≥ 86 % 
Potassium hydroxide; KOH [56,11]; Fluka Nr. 60380, purum, pulver, ≥ 85 %   Exprerimental Part   
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Lithium chloride; LiCl [42,39]; Fluka Nr. 62480, purum p.a. 
Magnesium sulphate; MgSO4 [120,37]; Riedel-de Haën Nr. 13143, dry 
Methanol; CH4O [32,04]; Riedel-de Haën Nr. 32213, > 99,8 %, max. 0,05 % H2O, Bp. 64-
65°C, d = 0,792 
Methanol; CH4O [32,04]; Fluka Nr. 65542, puriss., > 99,5 %, over molecular sieve, H2O ≤ 
100 ppm, Bp. 64-65°C, d = 0,79  
Methylene chloride = Dichlormethan; CH2Cl2 [84,93]; Fluka Nr. 66749; puriss., > 99,5 %, 
over molecular sieve, H2O ≤ 50 ppm, Bp. 40°C, d = 1,325 
1-Methylimidazole; C4H6N2 [82,11]; Fluka Nr. 67560, puriss., ≥ 99 %, Bp. 195-197°C, d = 
1,033 
1-Methyl-2-pyrrolidinon; C5H9NO [99,13]; Aldrich Nr. 27,045-8, > 99 %, for HPLC, Bp.
(10 
mm)  81-82°C, d = 1,028 
Molecular sieve 3 Å; Fluka Nr. 69831 
p-Nitrophenylethanol; C8H9NO3 [167,16]; Aldrich Nr. 18,346-6, 99 %, Bp. 62-64°C 
1-Octanol; C8H18O [130,23]; Fluka Nr. 74848, for UV-Spectroscopy, ≥ 99,5 %, d = 0,82 
Sodium carbonate; Na2CO3 [105,99]; Merck Nr. 106395, mind. 99,5 %, dry 
Sodium chloride; NaCl [58,44]; Merck Nr. 1540, > 99,5 % 
Sodium dihydrogenphosphate Dihydrat; NaH2PO4*2H2O [156,01]; Fluka Nr. 71500, purum  
Sodium hydrogen carbonate; NaHCO3 [84,01]; Fluka Nr. 71630, purum, > 98 % 
Sodium hydroxide; NaOH [40,00]; Grüssing Nr. 12155, 99 % 
Palladium on carbon; Pd/C; ABCR Nr. PD-7150, ≈ 10 % Palladium 
Palladium  hydroxide  on  carbon  (Pearlman´s  catalyst);  Fluka  Nr.  76063,  puriss.,  ≈  20  % 
Palladium 
Phosphorpentoxide; P2O5 [141,94]; Riedel-de Haën Nr. 04113, 98,5 % 
Phosphortrichloride; PCl3 [137,33]; Riedel-de Haën Nr. 04603, ≥ 99 %, d = 1,57 
Platinum dioxide; PtO2 [227,09]; ABCR Nr. PT-5227, 99,9 %, 82 % Platinum 
Pyridine; C5H5N [79,10]; Grüssing Nr. 13057, > 99,5 %, Bp. 115°C, d = 0,978, was at least  
2h  CaH2 under reflux and than distilled 
Pyridine; C5H5N [79,10]; Fluka Nr. 82704, puriss., > 99,8 %, H2O < 50 ppm, over molecular 
sieve, Bp. 116°C, d = 0,983 
β-D-Ribofuranose; C5H10O5 [150,13]; Aldrich Nr. R175-7, 98 % 
Nitric acid; HNO3 [63,01]; Merck Nr. 1.00456; p.a., 65 %, d = 1,40 
Nitric acid, fuming; HNO3 [63,01]; Merck Nr. 1.00455; p.a., 100 %, d = 1,52 
Hydrochloric acid; HCl [36,46]; Riedel-de Haën Nr. 30721, p.a.,  37 %   Exprerimental Part   
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Sulphuric acid; H2SO4 [98,07]; Merck Nr. 100731, 95-97 %, Bp. 330°C, d = 1,84 
Silver nitrate; AgNO3 [169,88]; Fluka Nr. 85228, puriss. p.a., ≥ 99,5 % 
Nitrogen; N2 [28,01]; Quality 99,9 %, 
Sulphuryl chloride; SO2Cl2 [134,97]; Aldrich Nr. 15,776-7, 97 %, Bp. 68-70°C, d = 1,680 
Tetrahydrofuran; C4H8O [72,11]; Fluka Nr. 87371, puriss., absolute, over molecular sieve, ≥ 
99,5 % 
1,2,3,5  Tetra-O-acetyl-β-D-ribofuranose  =  β-D-Ribofuranose-1,2,3,5-tetraacetat;  C13H18O9 
[318,28]; Aldrich Nr. 15,902-6, 98 %, Mp. 81-83°C 
Toluol; C7H8 [92,14]; Fluka Nr. 89682, purum, ≥ 99 %, Bp. 110-112°C, d = 0,866 
Triethylamine (TEA); C6H15N [101,19]; Fluka Nr. 90340, puriss. p.a., > 99,5 %, Bp. 88-89°C, 
d = 0,726 
Triethylamine trihydrofluoride; C6H15N*3HF [161,21]; Aldrich Nr. 34,464-8, 98 %, d = 0,989 
Triethylsilane; C6H16Si [116,28]; Fluka Nr. 90550, purum, > 97 %, Bp. 105-110°C, d = 0,732 
Triisopropylchlorsilane; C9H21ClSi [192,81]; Aldrich Nr. 24,172-5, 97 %, Bp.
(739 mm) 198°C, d 
= 0,901 
Trimethylsilyltrifluormethane  sulfonate,  TMSTf  C4H9F3O3SSi  [222,26];  Fluka  Nr.  91741, 
purum, ≥ 98 %, Bp.
(11 mm) 39-40°C, d = 1,225 
Hydrogen; H2 [2,01];  
 
10.2.1  For the synthesis of oligonucleotides 
 
Acetonitrile; for DNA-synthesis, PerSeptive Biosystems 
Acetonitrile; amidite diluent, PerSeptive Biosystems 
Capping Reagent, PerSeptive Biosystems 
Columns with  CPG-material, PerSeptive Biosystems 
Deblock-Mix, PerSeptive Biosystems 
Oxidizer, PerSeptive Biosystems 
Phosphoramidite, PerSeptive Biosystems 
Sephadex PD10 Columns with  G25 material, Amersham Pharmacia Biotech 
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10.3  The Buffer solutions 
 
a)  For the ion-exchange HPLC: 
Buffer A: DEPC-water with  LiOH , pH 8,0 adjusted 
Buffer B: As buffer  A and 42,39 g (1 mol) of litium chloride 
b)  For recording  of  UV-melting curves and CD-spectra 
For recording UV-melting curves and the CD-spectra of oligonucleotides the following buffer 
system was prepared:  140 mM Sodium chloride (2,04 g NaCl), 10 mM disodium hydrogen 
phosphate  dodecahydrate  (895  mg  Na2HPO4*12H2O)  and  10  mM  sodiumdi  hydrogen 
phosphate dihydrate (390 mg NaH2PO4*2H2O). After filling water up to 250 ml the pH of the 
buffer was adjusted to 7 using hydrochloric acid (0,1 N).  In this way prepared buffer  was 
than worked up with diethyl pyrocarbonate (DEPC). For that 0,1 % solution was prepared, left 
over night and autoclaved at the end 30 minutes.  
 
10.4  List of Synthesised Compounds 
 
2,4-Difluoro-6-nitroacetanilide  (N-(2,4-Difluoro-r-nitro-phenyl)-acetanilide) 48 
2,4-Difluoro-6-nitroaniline 49 
4,6-Difluorobenzimidazole 51 
2´, 3´, 5´-Tri-O-acetyl-1´-deoxy-1´-(4,6-difluoro-1-N-benzimidazolyl)-β-D-ribofuranose 103 
2´, 3´, 5´-Tri-O-acetyl-1´-deoxy-1´- (4,6-difluoro-3-N-benzimidazolyl) -β-D-ribofuranose 104 
1´-Deoxy-1´-(4,6-difluoro-1-N-benzimidazolyl)- β -D-ribofuranose  8 
1´-Deoxy -5´-O- (4,4´-dimethoxytriphenylmethyl)-1´-(4,6-difluoro-1-N-benzimidazolyl)-β-D-
ribofuranose 105 
5´-O-  (4,4´-Dimethoxytriphenylmethyl)  -2´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-  (4,6-
difluoro-1-N-benzimidazolyl) -β-D-ribofuranose 106 
5´-O-  (4,4´-Dimethoxytriphenylmethyl)  -3´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-  (4,6-
difluoro-1-N-benzimidazolyl) -β-D-ribofuranose 107 
3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-  (4,4´-dimethoxy-triphenylmethyl)-
1´-(4,6-difluoro-1-N-benzimidazolyl) -2´-O-(tert.-butyl-dimethylsilyl)-β-D-ribofuranose 108 
2-Fluoro-6-nitroacetanilide 46 
2-Fluoro-4-nitroacetanilide 45 
2-Fluoro-6-nitroaniline 52 
4-Fluorobenzimidazole 54   Exprerimental Part   
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2´, 3´, 5´-Tri-O-acetyl-1´-deoxy-1´-(4-fluoro-1-N-benzimidazolyl)-β-D-ribofuranose 109 
2´, 3´, 5´-Tri-O-acetyl-1´-deoxy-1´- (4-fluoro-3-N-benzimidazolyl) -β-D-ribofuranose 110 
1´-Deoxy-1´-(4-fluoro-1-N-benzimidazolyl)- β -D-ribofuranose 30 
1´-Deoxy-5´-O-(4,4´-dimethoxytriphenylmethyl)-1´-(4-fluoro-1-N-benzimidazolyl)-β-D-
ribofuranose 111 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(4-fluoro-1-
N-benzimidazolyl)-β-D-ribofuranose 112 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(4-fluoro-1-
N-benzimidazolyl)-β-D-ribofuranose 113 
3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-triphenylmethyl)-
1´-(4-fluoro-1-N-benzimidazolyl)-2´-O-tert.-butyldimethyl-silyl-β-D-ribofuranose 114 
5-fluoro-1H-benzoimidazole 65 
2´, 3´, 5´-Tri-O-acetyl-1´-deoxy-1´-(4-fluoro-1-N-benzimidazolyl)-β-D-ribofuranose 115 
2´, 3´, 5´-Tri-O-acetyl-1´-deoxy-1´- (5-fluoro-3-N-benzimidazolyl) -β-D-ribofuranose 78 
1´-Deoxy-1´-(5-fluoro-1-N-benzimidazolyl)-β-D-ribofuranose 31 
1´-Deoxy-5´-O-(4,4´-dimethoxytriphenylmethyl)-1´-(5-fluoro-1-N-benzimidazolyl)-β-D-
ribofuranose  116 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(5-fluoro-1-
N-benzimidazolyl)-β-D-ribofuranose  117 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(5-fluoro-1-
N-benzimidazolyl)- β -D-ribofuranose 118 
3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-triphenylmethyl)-
1´-(5-fluoro-1-N-benzimidazolyl)-2´-O-tert.-butyldimethyl-silyl- β -D-ribofuranose 119 
1´-Deoxy-1´-(5-fluoro-3-N-benzimidazolyl)- β -D-ribofuranose 32 
1´-Deoxy  -5´-O-(4,4´-dimethoxytriphenylmethyl)-1´-(5-fluoro-3-N-benzimidazolyl)-  β  -D-
ribofuranose 93 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(5-fluoro-1-
N-benzimidazolyl)- β -D-ribofuranose 95 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(5-fluoro-3-
N-benzimidazolyl)- β -D-ribofuranose 94 
3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-triphenylmethyl)-
1´-(5-fluoro-3-N-benzimidazolyl)-2´-O-tert.-butyldimethyl-silyl- β -D-ribofuranose 97 
2´,3´,5´-Tri-O-acetyl-1´-deoxy-1´-benzimidazolyl- β -D-ribofuranose 77 
1´-Deoxy-1´-benzimidazolyl- β -D-ribofuranose 40   Exprerimental Part   
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1´-Deoxy -5´-O-(4,4´-dimethoxytriphenylmethyl) -1´-benzimidazolyl- β -D-ribofuranose  120 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-
benzimidazolyl- β -D-ribofuranose 121 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-
benzimidazolyl- β -D-ribofuranose 122 
3´-O- (2-Cyanethoxydiisopropylphosphin) -1´-deoxy-5´-O- (4,4´-dimethoxy-triphenylmethyl) 
-1´-benzimidazolyl-2´-O- (tert.-butyldimethylsilyl) - β -D-ribofuranose 123 
N- (2-nitro-3-trifluoromethyl-phenyl) acetamide 56 
2-Nitro-3-trifluoromethyl-phenylamine 59 
4-Trifluoromethyl-1H-benzoimidazole 61 
2',3,5’-Tri-O-acetyl-1’-deoxy-1’-(4-trifluoromethyl-1-N-benzoimidazole- 
1-yl)-β-D-ribofuranose 71 
2’,3’,5’-Tri-O-acetyl-1’-deoxy-1’-(4-trifluoromethyl-3-N-benzoimidazole- 
1-yl)-β-D-ribofuranose 72 
1’-Deoxy-1’-(4-trifluoromethyl-1-N-benzoimidazole-1-yl)-β-D-ribofuranose 33 
1’-Deoxy-1’-(4-trifluoromethyl-3-N-benzoimidazole-1-yl)-β-D-ribofuranose 124 
1´-Deoxy-5´-O-(4,4´-dimethoxytriphenylmethyl)-1´-(4,6-difluor-1-N-benzimidazolyl)-β-D-
ribofuranose 125 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(4-
trifluoromethyl-1-N-benzimidazolyl)- β -D-ribofuranose 126 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(4-
trifluoromethyl-1-N-benzimidazolyl)- β -D-ribofuranose 127 
3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-triphenylmethyl)-
1´-(4,6-difluor-1-N-benzimidazolyl)-2´-O-(tert.-butyl-dimethylsilyl)- β -D-ribofuranose 128 
5-Trifluoromethyl-1H-benzoimidazole 63 
2’,3’,5’-Tri-O-acetyl-1’-deoxy-1’-(5-trifluoromethyl-1-N-benzoimidazole- 
1-yl)-β-D-ribofuranose 129 
1’-deoxy-1’-(5-trifluoromethyl-1-N-benzoimidazole-1-yl)-β-D-ribofuranose 34 
1´-Deoxy -5´-O-(4,4´-dimethoxytriphenylmethyl)-1´-(5-trifluoromethyl-1-N-benzimidazolyl)- 
β -D-ribofuranose 130 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(5-
trifluoromethyl-1-N-benzimidazolyl)- β -D-ribofuranose 131 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(5-
trifluoromethyl-1-N-benzimidazolyl)- β -D-ribofuranose 132   Exprerimental Part   
- 159 - 
3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-triphenylmethyl)-
1´-(5-trifluoromethyl-1-N-benzimidazolyl)-2´-O-(tert.-butyl-dimethylsilyl)-β-D-ribofuranose 
133 
2’,3’,5’-Tri-O-acetyl-1’-deoxy-1’-(5-trifluoromethyl-3-N-benzoimidazole- 
1-yl)-β-D-ribofuranose 134 
1’-deoxy-1’-(5-trifluoromethyl-3-N-benzoimidazole-1-yl)-β-D-ribofuranose 35 
1´-Deoxy -5´-O-(4,4´-dimethoxytriphenylmethyl)-1´-(5-trifluoromethyl-3-N-benzimidazolyl)- 
β -D-ribofuranose  135 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(5-
trifluoromethyl-3-N-benzimidazolyl)- β -D-ribofuranose 136 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(5-
trifluoromethyl-3-N-benzimidazolyl)- β -D-ribofuranose 137 
3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-triphenylmethyl)-
1´-(5-trifluoromethyl-3-N-benzimidazolyl)-2´-O-(tert.-butyl-dimethylsilyl)- β -D-ribofuranose 
138 
1-Methyl-ribofuranose  80 
1-Methyl-2,3,5-tri-O-benzyl-ribofuranose  81 
2,3,5-Tri-O-benzyl-ribofuranose 82 
2,3,5-Tri-O-benzyl-ribono-γ-lacton 83 
2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-(2,4-difluorophenyl)- β -D-ribofuranose 139 
1´-Deoxy-1´-(2,4-difluorophenyl)- β -D-ribofuranose  9 
5´-O- (4,4´-Dimethoxytriphenylmethyl)- 1´-deoxy-1´-(2,4-difluorophenyl)- β -D-ribofuranose 
140 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(2,4-
difluorophenyl)- β -D-ribofuranose  141 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-tert.-butyldimethylsilyl-1´-deoxy-1´-(2,4-
difluorophenyl)- β -D-ribofuranose 142 
3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-triphenylmethyl)-
1´-(2,4-difluorophenyl)-2´-O-tert.-butyldimethylsilyl- β -D-ribofuranose  143 
2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-(4-fluorophenyl)- β -D-ribofuranose 144 
1´-Deoxy-1´-(4-fluorophenyl)- β -D-ribofuranose 36 
5´-O-(4,4´-Dimethoxytriphenylmethyl)- 1´-deoxy-1´-(4-fluorophenyl)- β-D-ribofuranose  145 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(4-
fluorophenyl)-β-D-ribofuranose  146   Exprerimental Part   
- 160 - 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(4-
fluorophenyl)- β -D-ribofuranose  147 
3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-triphenylmethyl)-
1´-(4-fluorophenyl)-2´-O-tert.-butyldimethylsilyl- β -D-ribofuranose  148 
2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-(2,4,6-triifluorophenyl)- β -D-ribofuranose  90 
1´-Desoxy-1´-(2,4,6-trifluorophenyl)- β -D-ribofuranose 37 
5´-O- (4,4´-Dimethoxytriphenylmethyl)-1´-deoxy-1´-(2,4,6-trifluorophenyl)-β-D-ribofuranose  
149 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(2,4,6-
trfluorophenyl)- β -D-ribofuranose 150 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-tert.-butyldimethylsilyl-1´-deoxy-1´-(2,4,6-
trifluorophenyl)- β -D-ribofuranose 151 
3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-triphenylmethyl)-
1´-(2,4,6-trifluorophenyl)-2´-O-tert.-butyldimethylsilyl- β -D-ribofuranose  152 
2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-(2,4,5-triifluorophenyl)- β -D-ribofuranose 86 
1´-Deoxy-1´-(2,4,5-trifluorophenyl)- β -D-ribofuranose 38 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-1´-deoxy-1´-(2,4,5-trifluorophenyl)-β-D-ribofuranose 
153 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(2,4,5-
trfluorophenyl)- β -D-ribofuranose 154 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-tert.-butyldimethylsilyl-1´-deoxy-1´-(2,4,5-
trifluorophenyl)- β -D-ribofuranose 155 
3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-triphenylmethyl)-
1´-Deoxy-1’-(2,4,5-trifluorophenyl)-2´-O-tert.-butyldimethylsilyl- β -D-ribofuranose 156 
2,3,5-Tri-O-benzyl-1-deoxy- D-ribofuranose 98 
1-Deoxy-D-ribofuranose 42 
5-O-(4,4´-Dimethoxytriphenylmethyl)-1-deoxy-D-ribofuranose 99 
5-O-(4,4´-Dimethoxytriphenylmethyl)-2-O-tert.-butyldimethylsilyl-1-deoxy-β-D-ribofuranose 
101 
5-O-(4,4´-Dimethoxytriphenylmethyl)-3-O-tert.-butyldimethylsilyl-1-deoxy-β-D-ribofuranose 
100 
3-O-(2-Cyanethoxydiisopropylphosphin)-1-deoxy-5-O-(4,4´-dimethoxy-triphenylmethyl)-2-
O-tert.-butyldimethylsilyl- β -D-ribofuranose 102 
2-Cyanethoxy-dichlorphosphin 157   Exprerimental Part   
- 161 - 
2-Cyanethyldiisopropylchlorphosphoramidit 96 
2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-phenyl- β -D-ribofuranose 91 
1´-Deoxy-1´-phenyl- β -D-ribofuranose 41 
5´-O-(4,4´-Dimethoxytriphenylmethyl)- 1´-deoxy-1´-phenyl- β -D-ribofuranose 158 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-phenyl-  β  -
D-ribofuranose 159 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-phenyl-  β  -
D-ribofuranose 160 
3´-O-(2-Cyanethoxydiisopropyl-phosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-triphenylmethyl)-
1´-phenyl-2´-O-tert.-butyldimethylsilyl- β -D-ribofuranose  161 
2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-pentafluorophenyl- β -D-ribofuranose 162 
1´-Deoxy-1´-pentafluorophenyl- β -D-ribofuranose 39 
5´-O-  (4,4´-Dimethoxytriphenylmethyl)-  1´-deoxy-1´-pentafluorophenyl-  β  -D-ribofuranose 
163 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-
pentafluorophenyl- β -D-ribofuranose 164 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-tert.-butyldimethylsilyl-1´-deoxy-1´-
pentafluorophenyl- β -D-ribofuranose 165 
3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-triphenylmethyl)-
1´-pentafluorophenyl-2´-O-tert.-butyldimethylsilyl- β -D-ribofuranose  166 
2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-(4-chlorophenyl)- β -D-ribofuranose 167 
1´-Deoxy-1´-(4-chlorophenyl)- β -D-ribofuranose 43  
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10.5  Synthesis,  spectral  data  and  other  characteristics  of  synthesised 
compounds 
 
 
 
 
2,4-Difluoro-6-nitroacetanilide 48 
 
 
F
F
NHAc
NO2  
 
C8H6F2N2O3 
216.14 g/mol 
 
7.8 g (39.4 mmol) 2,4-Difluoro acetanilide were dissolved  in a mixture of 9 ml conc. H2SO4 
and 3.1 ml CH3COOH. Slowly, a mixture of 3.1 ml conc. H2SO4  and 3.1 ml conc. HNO3 was 
added, taking care that the temperature stays below 40°C. At the end the mixture was stirred 
for 90 minutes at 45°C. The reaction mixture was poured in 25 ml of icewater and stirred over 
30 minutes (cooled in icebath for full recrystalization). Yellow precipitate was filtered in 
vacuum, washed with icewater and dried. 
 
 
Yield:              9.55 g (96.4 %) 
1H-NMR:  δ [ppm] (270 MHz, DMSO-d6) 
10.20 (s, 1H, NH); 7.85 (m, 2H, 3H, 5H); 2.05 (s, 3H, CH3) 
IR (KBr):  1119.8 cm
-1 C-F 
    1547.7 cm
-1 NO2
 
1676.6 cm
-1 C=O 
    3237.4 cm
-1; 3181.8 cm
-1 N-H     
Melting point: 135°C 
ESI(+):             m/z 216.7 ([M+H]
+)    Exprerimental Part   
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2,4-Difluoro-6-nitroaniline 49 
 
 
F
F
NH2
NO2 
 
C6H4F2N2O2 
174.1 g/mol 
 
9.5 g (44 mmol) 2,4-Difluoro-6-nitroacetanilide 48  were dissolved in 9 ml conc. H2SO4 and 
stirred over  2 h at 95°C. At the end the reaction mixture was poured into the ice and cooled 
30 min. in ice bath, for full recrystallization of the product. Yellow precipitate was filtered in 
vacuum, washed with ice-water and dried. The crude product was recrystallised from ethanol. 
 
Yield:                 4.37 g (57.1 %) 
1H-NMR:  δ [ppm] (270 MHz, DMSO-d6) 
7.65 (m, 2H, 3H, 5H); 7.20 (s br, 2H, NH2) 
IR (KBr):    1127.6 cm
-1 C-F 
      1531.7 cm
-1 NO2 
      3495.0 cm
-1; 3376.5 cm
-1 N-H     
Melting point.:  85 - 86°C 
ESI(-):                   m/z 172.8 ([M-H]
-) 
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4,6-Difluorbenzimidazole 51 
 
 
N
N
H
F
F
 
 
C7H4F2N2 
154.11 g/mol 
 
13 g (74.7 mmol) 2,4-Difluoro-6-nitroaniline 49 were dissolved in 200 ml abs. ethanol   and  
700 mg (3.1 mmol) PtO2 were added. The reaction mixture was stirred 24 h in H2 atmosphere 
at room temperature. The catalyst was filtered over celite and the reaction mixture evaporated 
to  dryness.  The  left  dark  coloured  oil  was  dissolved  immediately  in  200ml  HCOOH  and 
refluxed 1.5 h. At the end HCOOH was evaporated under reduced pressure and the product 
dried on the oil pump. For further reactions the product was used without further purification. 
For  analytical  purposes  a  part  of  the  product  was  sublimed  and  the  white  product  was 
obtained.  
 
 
Yield:    8.17 g (71.0 %) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
12.87 (s, 1H, NH); 8.28 (s, 1H, 2H); 7.25 (dd, J = 1.9 Hz, J = 8.8 Hz, 1H, 7H); 
7.03 (dt, J = 2.1 Hz, J = 10.6 Hz, 1H, 5H) 
IR (KBr):  1115.7 cm
-1 C-F 
    3073.6 cm
-1 N-H     
Melting point.: 233 – 234 °C 
ESI(+):   m/z 154.8 ([M+H]
+) 
El. Analysis:    Counted:  C: 54.55 %  H: 2.62 %  N: 18.18 % 
      Found:   C: 54.30 %  H: 2.90 %  N: 17.98 % 
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2´, 3´, 5´-Tri-O-acetyl-1´-deoxy-1´-(4,6-difluoro-1-N-benzimidazolyl)-β β β β-D-
ribofuranose 103 
 
 
O
AcO
N
N
AcO OAc
F
F
 
 
C18H18F2N2O7 
412.33 g/mol 
 
3.1 g (20 mmol) 4,6-Difluorobenzimidazole 51 were suspended in 80 ml abs. acetonitrile  and 
7.4 ml (30 mmol) N,O-Bis-(trimethylsilyl)-acetamide were added. The reaction mixture was 
refluxed for 15 min. After cooling to room temperature 6.4  g (20 mmol) 1,2,3,5-tetra-O-
acetyl-β-D-ribofuranose in 35 ml abs. acetonitrile and 4.5 ml (25 mmol) trimethylsilyltrifluoro 
sulphonate (TMSOTf) were added. The reaction mixture was than refluxed 2.5 hours and  
cooled to room temperature. After cooling the reaction mixture was treated with 10 ml 5% 
NaHCO3-solution and extracted with methylene chloride three times. The combined organic 
phases were dried over MgSO4 and evaporated to dryness. The product was purified by means 
of FC with methylene chloride/methanol 98:2. The product was obtained as white foam. 
 
 
Yield:    5.6 g (67.8 %) 
TLC:    Rf = 0.49 (CH2Cl2/MeOH 95:5) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
8.56 (s, 1H, 2H); 7.57 (dd, J = 9.0 Hz, J = 2.1 Hz, 1H, 7H); 7.19 (dt, J = 10.5 
Hz, J = 2.0 Hz, 1H, 5H); 6.33 (d, J = 6.1 Hz, 1H, 1´H); 5.64 (t, J = 6.3 Hz, 1H, 
2´H); 5.43 (dd, J = 6.3 Hz, J = 4.3 Hz, 1H, 3´H); 4.40 (m, 3H, 4´H, 5´H); 2.14 
(s, 3H, CH3-acetyl); 2.08 (s, 3H, CH3-acetyl); 2.04 (s, 3H, CH3-acetyl)
 
13C-NMR:  δ [ppm] (63.9 MHz, DMSO-d6) 
170.00  (C=O);  169.52  (C=O);  169.26  (C=O);  158.48  (C4);  152.67  (C6); 
143.67 (C2); 134.67 (C9); 128.94 (C8); 98.32 (C5); 95.09 (C7); 86.43 (C1´);   Exprerimental Part   
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79.57 (C4´); 71.69 (C3´); 69.43 (C2´); 62.95 (C5´); 20.48 (CH3-acetyl); 20.38 
(CH3-acetyl); 20.18 (CH3-acetyl) 
ESI (+):  m/z  413.0 ([M+H] 
+); 
 
 
2´, 3´, 5´-Tri-O-acetyl-1´-deoxy-1´- (4,6-difluoro-3-N-benzimidazolyl) -β β β β-D-
ribofuranose 104 
 
 
O
AcO
N
N
AcO OAc
F
F
 
 
 
C18H18F2N2O7 
412.33 g/mol 
 
2´,3´,5´-Tri-O-acetyl-1´-deoxy-1´-(4,6-difluoro-3-N-benzimidazolyl)-β-D-ribofuranose  104 
was obtained as a side product in preparing  2´,3´,5´-Tri-O-acetyl-1´-deoxy-1´-(4,6-difluoro-
1-N-benzimidazolyl)-β-D-ribofuranose 103.  
 
 
Yield:              0.94 g (11.4 %) 
TLC:    Rf = 0.42 (CH2Cl2/MeOH 95:5) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
8.63 (s, 1H, 2H); 7.45 (dd, J = 9.1 Hz, J = 2.1 Hz, 1H, 7H); 7.30 (dt, J = 10.8 
Hz, J = 2.2 Hz, 1H, 5H); 6.28 (d, J = 5.8 Hz, 1H, 1´H); 5.63 (t, J = 6.2 Hz, 1H, 
2´H); 5.39 (Ψt, J = 5.1 Hz, 1H, 3´H); 4.40 (m, 2H, 5´H); 4.24 (m, 1H, 4´H); 
2.11 (s, 3H, CH3-acetyl); 2.05 (s, 3H, CH3-acetyl); 2.03 (s, 3H, CH3-acetyl) 
13C-NMR:  δ [ppm] (63.9 MHz, DMSO-d6) 
170.41  (C=O);  169.82  (C=O);  169.57  (C=O);  158.35  (C4);  147.89  (C6); 
146.99  (C9);  145.56  (C2);  117.66  (C8);  102.63  (C5);  100.25  (  C7);  87.81   Exprerimental Part   
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(C1´); 79.57 (C4´); 73.57 (C3´); 69.62 (C2´); 63.00 (C5´); 20.83 (CH3-acetyl); 
20.71 (CH3-acetyl); 20.51 (CH3-acetyl) 
ESI (+):  m/z  413.0 ([M+H]
+); 
 
 
1´-Deoxy-1´-(4,6-difluoro-1-N-benzimidazolyl)-β β β β-D-ribofuranose  8 
 
 
O
HO
N
N
OHOH
F
F
 
 
C12H12F2N2O4 
286.23 g/mol 
 
5.59 g (13.5 mmol) 2´,3´,5´-Tri-O-acetyl-1´-deoxy-1´-(4,6-difluoro-1-N-benzimidazolyl)-β-D-
ribofuranose 103 were dissolved in 50 ml of methanol and 370 µl of MeONa/MeOH (5.4M, 
Fluka) were added at RT and the reaction was TLC controlled. After 60 min the reaction was 
complete  and  neutralised  with  DOWEX  50,  filtered  and  evaporated.  The  product  was 
obtained as white foam.  
 
 
Yield:               3.66 g (94.2 %) 
TLC:    Rf = 0.64 (CH2Cl2/MeOH 4:1) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
8.52 (s, 1H, 2H); 7.65 (dd, J = 9.1 Hz, J = 2.2 Hz, 1H, 7H); 7.13 (dt, J = 2.2 Hz, 
J = 10.5 Hz, 1H, 5H); 5.87 (d, J = 6.4 Hz, 1H, 1´H); 5.51 (d, J = 6.5 Hz, 1H, 2´-
OH); 5.25 (d, J = 4.6 Hz, 3´-OH); 5.22 (t, J = 5.0 Hz, 1H, 5´-OH); 4.34 (q, J = 
6.3 Hz, 1H, 2´H); 4.12 (m, 1H, 3´H); 4.00 (q, J = 3.1 Hz, 1H, 4´H); 3.66 (m, 
2H, 5´H) 
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13C-NMR:  δ [ppm] (63.9 MHz, DMSO-d6) 
158.13 (C4); 152.53 (C6); 143.70 (C2); 134.95 (C9); 129.01 (d, J = 17.7 Hz, 
C8);  97.66  (C5);  95.43  (C7);  89.07  (C1´);  85.83  (C4´);  73.63  (C2´);  70.04 
(C3´); 61.08 (C5´) 
19F-NMR:  δ [ppm] (254.2 MHz, DMSO-d6) 
–116.40 (m, 1F, 6F); –125.25 (m, 1F, 4F) 
ESI(–):    m/z 285.1 ([M-H]
-); 
 
 
1´-Deoxy -5´-O- (4,4´-dimethoxytriphenylmethyl)-1´-(4,6-difluoro-1-N-
benzimidazolyl)-β β β β-D-ribofuranose 105 
 
 
O
DMTrO
N
N
OHOH
F
F
 
 
 
C33H30F2N2O6 
588.62 g/mol 
 
640 mg (2.2 mmol) 1´-Deoxy-1´-(4,6-difluoro-1-N-benzimidazolyl)-β-D-ribofuranose 8 were 
dissolved in 10 ml abs. pyridine and 0.47 ml (3.3 mmol) triethylamine and 0.91 g (2.6 mmol) 
4,4´-Dimethoxytriphenylmethyl chloride were added. The reaction mixture was stirred under 
argon at RT 20 h. The reaction was stopped by adding  3 ml of methanol and a saturated water 
solution of NaHCO3. It was extracted with methylene chloride three times, organic phases 
were  collected  and  dried  over  MgSO4  and    evaporated  to  dryness.  The  product  was  co-
evaporated  with  toluene  twice.  Further  purification  was  done  by  FC  with  methylene 
chloride/methanol 95:5, as eluent. The product was obtained as yellow foam. 
 
 
Yield:    980 mg (74.8 %)   Exprerimental Part   
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TLC:    Rf = 0.52 (CH2Cl2/MeOH 95:5) 
1H-NMR:  δ [ppm] (270 MHz, DMSO-d6) 
8.43 (s, 1H, 2H); 7.47 (dd, J = 8.8 Hz, J = 1.9 Hz, 1H, 7H); 7.35 – 6.81 (m, 
14H, Har, 5H); 5.93 (d, J = 5.1 Hz, 1H, 1´H); 5.69 (d, J = 5.9 Hz, 1H, 2´-OH); 
5.30 (d, J = 5.5 Hz, 1H, 3´-OH); 4.49 (q, J = 5.5 Hz, 1H, 2´H); 4.21 (q, J = 5.2 
Hz, 1H, 3´H); 4.12 (m, 1H, 4´H); 3.72 (s, 6H, OCH3); 3.23 (m, 2H, 5´H) 
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
158.22  (C4);  158.04  (DMTr);  152.57  (C6);  146.82  (C2);  144.69  (DMTr); 
135.36 (DMTr); 135.31 (DMTr); 135.13 (C9); 129.05 (DMTr); 128.94 (C8); 
127. 75 (DMTr); 127.59 (DMTr); 126.66 (DMTr); 113.11 (DMTr); 97.83 (C5); 
95.17 (C7); 89.09 (C1´); 85.62 (DMTr); 83.50 (C4´); 73.26 (C2´); 69.90 (C3´); 
63.40 (C5´); 54.95 (OCH3) 
ESI (-):  m/z 587.4 ([M-H]
-); 
 
 
5´-O- (4,4´-Dimethoxytriphenylmethyl) -2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´- (4,6-difluoro-1-N-benzimidazolyl) -β β β β-D-ribofuranose 106 
 
 
O
DMTrO
N
N
OHOTBDMS
F
F
 
 
 
C39H44F2N2O6Si 
702.84 g/mol 
 
2.53  g  (4.3  mmol)  5´-O-(4,4´-Dimethoxytriphenylmethyl)-1´-deoxy-1´-β-D-(4,6-difluoro-
benzimidazolyl)-ribofuranose 105 were dissolved in 40 ml of a  1:1 mixture of  THF/Pyridine 
and with 900 mg (5.3 mmol) AgNO3 and 6.2 ml (6.2 mmol) 1 M tert.-butyldimethylsilyl 
chloride-solution in THF were added. The reaction mixture was stirred for 20 hours in the 
dark  at  RT  under  argon.  Adding  10  ml  of  saturated  water  NaHCO3-solution  stopped  the   Exprerimental Part   
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reaction. Left AgCl was filtered over celite and filtrate was extracted with methylene chloride 
three times. Collected organic phases were dried over MgSO4 and evaporated to dryness. 
Crude product was co-evaporated with toluene twice. Further purification of the product was 
done by HPLC (MN Nucleoprep 100-20 of Macherey-Nagel, n-hexane/isopropyl acetate 3:2). 
The product  (slow-Isomer) was obtained as a white foam. 
 
 
Yield:              970 mg (32.1 %) 
TLC:    Rf = 0.55 (CH2Cl2/MeOH 99:1) 
1H-NMR:  δ [ppm] (400 MHz, DMSO-d6) 
8.47 (s, 1H, 2H); 7.47 (dd, J = 8.9 Hz, J = 2.0 Hz, 1H, 7H); 7.39 – 6.84 (m, 
13H, Har); 7.12 (dt, J = 8.5 Hz, J = 2.0 Hz, 1H, 5H); 5.97 (d, J = 6.3 Hz, 1H, 
1´H); 5.24 (d, J = 5.5 Hz, 1H, 3´-OH); 4.59 (t, J = 5.8 Hz, 1H, 2´H); 4.19 (m, 
1H, 3´H); 4.14 (m, 1H, 4´H); 3.73 (s, 6H, OCH3); 3.31 (m, 2H, 5´H); 0.72 (s, 
9H, C(CH3)3); –0.08 (s, 3H, SiCH3); –0.24 (s, 3H, SiCH3) 
13C-NMR:  δ [ppm] (100.6 MHz, DMSO-d6) 
158.08  (C4);  158.02  (DMTr);  152.58  (C6);  144.63  (DMTr);  143.52  (C2); 
135.10 (DMTr); 135.05 (DMTr); 134.45 (C9); 129.64 (DMTr); 128.95 (C8); 
127.67 (DMTr); 127.43 (DMTr); 126.64 (DMTr); 113.07 (DMTr); 97.91 (C5); 
95.31 (d, J = 32.6 Hz, C7); 88.56 (C1´); 85.72 (DMTr); 84.23 (C4´); 74.59 
(C2´);  69.67  (C3´);  63.28  (C5´);  54.88  (OCH3);  25.31  (SiC(CH3)3);  17.61 
(SiC(CH3)3); –5.16 (SiCH3); –5.76 (SiCH3) 
ESI (–):  m/z 701.5 ([M-H]
-); 
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5-O-(4,4´-Dimethoxytriphenylmethyl) -3´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´- (4,6-difluoro-1-N-benzimidazolyl) -β β β β-D-ribofuranose 107 
 
 
O
DMTrO
N
N
OH TBDMSO
F
F
 
 
 
C39H44F2N2O6Si 
702.84 g/mol 
 
5´-  O-  (4,4´-Dimethoxytriphenylmethyl)-  3´-O-tert.-butyldimethylsilyl-  1´-deoxy-1´-(4,6-
difluoro-1-N-benzimidazolyl)-β-D-ribofuranose  107  was  obtained  as  a  side  product  (fast-
Isomer) in synthesizing 5´-O-(4,4´-Dimethoxytriphenylmethyl)- 2´-O-tert.-butyldimethylsilyl- 
1´-deoxy-1´-(4,6-difluoro-1-N-benzimidazolyl)-β-D-ribofuranose 106. 
 
 
Yield:              1.55 g (51.3 %) 
TLC:    Rf = 0.55 (CH2Cl2/MeOH 99:1) 
1H-NMR:  δ [ppm] (400 MHz, DMSO-d6) 
8.47 (s, 1H, 2H); 7.48 (dd, J = 8.7 Hz, J = 2.0 Hz, 1H, 7H); 7.36 – 6.82 (m, 
14H, 5H, Har); 5.90 (d, J = 5.6 Hz, 1H, 1´H); 5.53 (d, J = 6.4 Hz, 1H, 2´-OH); 
4.50 (q, J = 5.8 Hz, 1H, 2´H); 4.32 (t, J = 4.7 Hz, 1H, 3´H); 4.07 (q, J = 4.0 Hz, 
1H, 4´H); 3.72 (s, 6H, OCH3); 3.26 (m, 2H, 5´H); 0.81 (s, 9H, SiC(CH3)3); 
0.06 (SiCH3); –0.01 (SiCH3) 
13C-NMR:  δ [ppm] (100.6 MHz, DMSO-d6) 
158.20  (C4);  158.11  (DMTr);  152.59  (C6);  144.55  (DMTr);  143.32  (C2); 
135.22 (DMTr); 135.19 (DMTr); 134.86 (C9); 129.64 (DMTr); 129.04 (C8); 
127.77 (DMTr); 127.57 (DMTr); 126.72 (DMTr); 113.13 (DMTr); 97.87 (C5); 
95.40 (C7); 89.11 (C1´); 85.86 (DMTr); 84.00 (C4´); 72.71 (C2´); 71.65 (C3´);   Exprerimental Part   
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62.87  (C5´);  54.97  (OCH3);  25.69  (SiC(CH3)3);  17.93  (SiC(CH3)3);  –4.53 
(SiCH3);   –5.19 (SiCH3) 
ESI (–):  m/z 701.5 ([M-H]
-); 
 
 
3´-O- (2-Cyanethoxydiisopropylphosphin) -1´-deoxy-5´-O- (4,4´-dimethoxy-
triphenylmethyl) -1´- (4,6-difluoro-1-N-benzimidazolyl) -2´-O- (tert.-butyl-
dimethylsilyl) -β β β β-D-ribofuranose 108 
 
 
O
DMTrO
O OTBDMS
N
N
P
O
CN
N
F
F
 
 
C48H61F2N4O7PSi 
903.04 g/mol 
 
200 mg (0.29 mmol) 5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(4,6-difluoro-1-N-benzimidazolyl)-β-D-ribofuranose  106  were  dissolved  in  10  ml 
abs.  acetonitrile  and  380  µl  (2.9  mmol)  sym.  collidine  and  12  µl  (0.15  mmol)  1-
methylimidazole were added. The reaction mixture was cooled in an icebath to 0°C and 96 µl 
(0.43 mmol) 2-cyanethyldiisopropylchlorophosphoramidite 96 were added. The reaction was 
stirred for 15min. at 0°C and 25 min. at RT. The reaction was stopped by adding  10 ml of 
0.01  M  citric  acid  and  extracted  with  methylene  chloride  three  times.  Collected  organic 
phases were  washed with 0.01 M citric acid twice, dried over MgSO4 and evaporated to 
dryness. Purification was done by FC with methylene chloride/methanol 99:1 as eluent. The 
product (mixture of two diastereomers) was obtained as white foam. 
 
 
Yield:    200 mg (80.0%)   Exprerimental Part   
- 173 - 
TLC:    Rf = 0.65 (CH2Cl2/MeOH 98:2)
 
1H-NMR:  δ [ppm] (270 MHz, CDCl3)   
8.12, 8.11 (s, 2H, 2H); 7.46 – 6.73 (m, 30 H, Har, 5H, 7H); 5.85, 5.78 (d, J = 
7.6 Hz, J = 7.2 Hz, 2H, 1´H); 4.67 (m, 2H, 2´H); 4.41 (m, 2H, 3´H); 4.32 (m, 
2H, 4´H); 3.79, 3.78 (s, 12H, OCH3); 3.52 (m, 8H, 5´H, CH2CN); 2.67 (m, 4H, 
OCH2); 1.19 (m, 12H, CH (CH3) 2); 0.82, 0.76 (s, 18H, SiC (CH3) 3); –0.09,        
–0.10, –0.32, –0.34 (s, 12H, SiCH3) 
31P-NMR:  δ [ppm] (162 MHz, CDCl3) 
152.62 and 149.33 (Ratio 1: 2.75) 
ESI(+):  m/z 903.6 ([M+H]
+); 
 
 
2-Fluoro-6-nitroacetanilide 46 
 
 
F
NHAc
NO2  
 
C8H7FN2O3 
198.15 g/mol 
 
20.8  g  (135.8  mmol)  2-Fluoroacetanilide    were  dissolved  in  18.4  ml  (166  mmol)  acetic 
anhydride and 13.8 ml (219 mmol) acetic acid. The reaction mixture was cooled to –5°C and   
a mixture from 7.4 ml conc. HNO3 and 11.5 ml (182 mmol) CH3COOH was added  over 10 
minutes. While warming up to room temperature over 2 hours yellow crystals precipitated. 
The reaction mixture was left at room temperature for two days. Afterwards reaction mixture 
was poured in 200 ml of icewater and for two hours cooled in icebath. The yellow precipitate 
was filtered on vacuum, washed with icewater and dried. In crude product 90 ml of Witt-
Utermann-solution were added to the crude product and stirred for 3 minutes. The solution 
was filtered and washed with 30 ml Witt-Utermann-solution twice and with 60 ml of icewater 
once. The filtrate was neutralised with CH3COOH, 2 hours in icebath crystallized filtered and 
dried. The product was crystallized from ethanol and obtained as crème solid.  
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Yield:    11.34 g (42.1 %) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
7.79 (d, J = 8.2 Hz, 1H, 5H); 7.69 (dt, J = 1.3 Hz, J = 8.4 Hz, 1H, 4H); 7.48 (m, 
1H, 3H); 2.08 (s, 3H, CH3) 
IR (KBr):  1184.5 cm
-1 C-F 
    1539.1 cm
-1 NO2 
1674.7 cm
-1 C=O 
    3285.0 cm
-1 N-H     
Melting point.:  171 - 174°C 
El.Analysis:    Counted:  C: 48.49 %  H: 3.56 %  N: 14.14 % 
      Found:   C: 48.28 %  H: 3.78 %  N: 13.96 % 
 
 
 
2-Fluoro-4-nitroacetanilide 45 
 
F
NHAc
O2N  
 
C8H7FN2O3 
198.15 g/mol 
 
2-Fluoro-4-nitroacetanilde 45 was obtained as a side product in the preparation of 2-Fluoro-6-
nitroacetanilde  46  while  separating  isomers  with  Witt-Utermann-solution  2-Fluoro-4-
nitroacetanilde 45 does not dissolve and stays on the filter. After drying it was crystallized 
from ethanol. The product was obtained as crème solid. 
 
Yield:    9.77 g (36.3 %) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
8.41 (dd, J = 9.1 Hz, J = 7.8 Hz, 1H, 3H); 8.12 (m, 2H, 5H, 6H); 2.19 (s, 3H, 
CH3) 
IR (KBr):  1162.3 cm
-1 C-F   Exprerimental Part   
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    1559.9 cm
-1 NO2 
1688.3 cm
-1 C=O 
    3266.1 cm
-1; 3218.5 cm
-1 N-H     
Melting point.:  204°C 
El.Analysis:    Counted:  C: 48.49 %  H: 3.56 %  N: 14.14 % 
      Found:   C: 48.61 %  H: 3.31 %  N: 14.07 % 
 
 
2-Fluoro-6-nitroaniline 52 
 
 
F
NH2
NO2 
 
 
C6H5FN2O2 
156.11 g/mol 
 
12  g  (60.5  mmol)  2-Fluoro-6-nitroacetanilide  46    were  dissolved  in  60  ml  2  N  HCl  and 
refluxed for 3 hours. After cooling to room temperature the reaction mixture was neutralised 
with a saturated water solution of NaHCO3 and for 30 minutes cooled in icebath. The yellow 
to black precipitate was filtered on vacuum, washed with water and dried. The product was 
obtained as yellow solid.  
 
Yield:    8.46 g (89.5 %) 
1H-NMR:  δ [ppm] (270 MHz, DMSO-d6) 
7.83 (d, J = 8.9 Hz, 1H, 5H); 7.44 (dt, J = 1.0 Hz, J = 7.9 Hz, 1H, 4H); 7.24 (s 
br, 2H, NH2); 6.62 (m, 1H, 3H) 
IR (KBr):  1164.3 cm
-1 C-F 
    1532.9 cm
-1 NO2 
    3490.7 cm
-1;3368.7 cm
-1 N-H     
Melting point:   75 - 76°C    Exprerimental Part   
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El.Analysis:    Counted:  C: 46.16 %  H: 3.23 %  N: 17.95 % 
      Found:   C: 46.16 %  H: 3.14 %  N: 17.90 % 
 
 
4-Fluorobenzimidazole 54 
 
 
N
N
H
F
 
 
C7H5FN2 
136.12 g/mol 
 
4.59 g (29.4 mmol) 2-Fluoro-6-nitroaniline 52  were dissolved in 100 ml abs. ethanol and 300 
mg (1.3 mmol) PtO2 were added. The reaction mixture was stirred for 5 hours (TLC control) 
in hydrogen atmosphere.  The catalyst was filtered over celite and the filtrate evaporated to 
dryness  under  reduced  pressure.  The  left  dark  brown  oil  (53-diamine)  was  immediately 
dissolved  in  100  ml  of  HCOOH  and  refluxed  for  90  minutes.  Afterwards  HCOOH  was 
evaporated and the product purified by FC with methylene chloride/methanol 9:1 as eluent. 
The product was obtained as dark brown solid. 
 
 
Yield:    3.43 g (85.6 %) 
1H-NMR:  δ [ppm] (270 MHz, DMSO-d6) 
12.86 (s, 1H, NH); 8.29 (s, 1H, 2H); 7.40 (d, J = 8.0 Hz, 1H, 7H); 7.16 (m, 1H, 
6H); 6.98 (m, 1H, 5H) 
IR (KBr):  1169.0 cm
-1 C-F 
    3200 - 3000 cm
-1 N-H     
Melting point.:  185 - 187°C   
El.Analysis:    Counted:  C: 61.76 %  H: 3.67 %  N: 20.58 % 
      Found:   C: 61.69 %  H: 3.92 %  N: 20.50 % 
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2´,3´, 5´-Tri-O-acetyl-1´-deoxy-1´-(4-fluoro-1-N-benzimidazolyl)-β β β β-D-
ribofuranose 109 
 
 
O
AcO
N
N
AcO OAc
F
 
 
 
C18H19FN2O7 
394.34 g/mol 
 
4.8 g (35.3 mmol) 4-Fluorobenzimidazole  54 were suspended in 120 ml abs. acetonitrile and 
11.1 ml (45 mmol) N, O-Bis- (trimethylsilyl)-acetamide were added. The reaction mixture 
was refluxed for 15 min. After cooling to room temperature 9.6 g (30 mmol) 1,2,3,5-Tetra-O-
acetyl-β-D-ribofuranose in 50 ml abs. acetonitrile and 6.7 ml (37 mmol) trimethylsilyltrifluoro 
sulphonate (TMSOTf) were added. The reaction mixture was then refluxed for 2.5 h and  
cooled to room temperature. After cooling the reaction mixture was treated with 20 ml of 5% 
NaHCO3-solution and extracted with methylene chloride three times. The collected organic 
phases were dried over MgSO4 and evaporated to dryness. The product was purified by means 
of FC with methylene chloride/methanol 98:2 and obtained as a white foam.  
 
Yield:    9.1 g (64.3 %) 
TLC:    Rf = 0.41 (CH2Cl2/MeOH 98:2) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
8.54 (s, 1H, 2H); 7.60 (d, J = 7.8 Hz, 1H, 7H); 7.30 (dt, J = 4.9 Hz, J = 8.1 Hz, 
1H, 6H); 7.10 (dd, J = 7.8 Hz, J = 11.0 Hz, 1H, 5H); 6.34 (d, J = 6.2 Hz, 1H, 
1´H); 5.66 (t, J = 6.3 Hz, 1H, 2´H); 5.43 (dd, J = 4.6 Hz, J = 6.3 Hz, 1H, 3´H); 
4.42 (m, 1H, 4´H); 4.37 (m, 2H, 5´H); 2.13 (s, 3H, CH3-acetyl); 2.07 (s, 3H, 
CH3-acetyl); 2.03 (s, 3H, CH3-acetyl) 
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13C-NMR:  δ [ppm] (62.9 MHz, DMSO-d6) 
170.01 (C=O acetyl); 169.52 (C=O acetyl); 169.22 (C=O acetyl); 143.04 (C2); 
135.37 (C6); 132.24 (C5); 123.94 (C8); 108.02 (C9); 107.87 (C7); 86.47 (C1´); 
79.47 (C4´); 71.75 (C2`); 69.53 (C3´); 62.94 (C5´); 20.50 (CH3-acetyl); 20.36 
(CH3-acetyl); 20.15 (CH3-acetyl) 
ESI (+):  m/z 395.1 ([M+H]
+); 
 
 
2´, 3´, 5´-Tri-O-acetyl-1´-deoxy-1´- (4-fluoro-3-N-benzimidazolyl) -β β β β-D-
ribofuranose 110 
 
 
O
AcO
N
N
AcO OAc
F
 
 
 
C18H19FN2O7 
394.34 g/mol 
 
2´,3´,5´-Tri-O-acetyl-1´-deoxy-1´-(4-fluoro-3-N-benzimidazolyl)-β-D-ribofuranose  110  is 
obtained as a side product in the synthesis of 2´,3´,5´-Tri-O-acetyl-1´-deoxy-1´-(4-fluoro-1-N-
benzimidazolyl)-β-D-ribofuranose 109 . 
 
 
Yield:    1.14 g (8.1 %) 
TLC:    Rf = 0.35 (CH2Cl2/MeOH 98:2) 
1H-NMR:  δ [ppm] (400 MHz, DMSO-d6) 
8.58 (s, 1H, 2H); 7.56 (d, J = 7.9 Hz, 1H, 7H); 7.26 (m, 1H, 6H); 7.19 (m, 1H, 
5H); 6.31 (d, J = 5.9 Hz, 1H, 1´H); 5.66 (t, J = 6.2 Hz, 1H, 2´H); 5.40 (m, 1H, 
3´H); 4.38 (m, 2H, 4´H, 5´H); 4.26 (m, 1H, 5´´H); 2.12 (s, 3H, CH3-acetyl); 
2.05 (s, 3H, CH3-acetyl); 2.03 (s, 3H, CH3-acetyl) 
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13C-NMR:  δ [ppm] (62.9 MHz, DMSO-d6) 
170.01 (C=O acetyl); 169.43 (C=O acetyl); 169.17 (C=O acetyl); 148.24 (C4); 
147.17  (C8);  143.58  (C2);  123.07  (C6);  120.24  (C9);  116.33  (C7);  109.55 
(C5); 87.34 (C1´); 79.10 (C4´); 72.61 (C2´); 69.27 (C3´); 62.64 (C5´); 20.41 
(CH3-acetyl); 20.29 (CH3-acetyl); 20.08 (CH3-acetyl) 
ESI(+):  m/z 395.1 ([M+H]
+); 
 
 
1´-Deoxy-1´-(4-fluoro-1-N-benzimidazolyl)-β β β β-D-ribofuranose 30 
 
 
 
O
HO
N
N
OHOH
F
 
 
 
C12H13FN2O4 
268.23 g/mol 
 
5.46  g  (13.8  mmol)  2´,3´,5´-Tri-O-acetyl-1´-deoxy-1´-(4-fluoro-1-N-benzimidazolyl)-β-D-
ribofuranose 109  were dissolved in 50 ml of methanol and 370 µl of MeONa/MeOH ( 5.4M, 
Fluka) were added at RT and the reaction  TLC controlled. After 60 min the reaction was 
complete, neutralised with DOWEX 50, filtered and evaporated. The product was obtained as 
white foam and purified  by FC with methylene chloride/methanol 4:1 as eluent. 
 
 
Yield:    3.58 g (96.4 %) 
TLC:    Rf = 0.42 (CH2Cl2/MeOH 4:1) 
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1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
8.51 (s, 1H, 2H); 7.60 (d, J = 8.2 Hz, 1H, 7H); 7.26 (dt, J = 5.0 Hz, J = 8.0 Hz, 
1H, 6H); 7.06 (dd, J = 8.0 Hz, J = 11.0 Hz, 1H, 5H); 5.89 (d, J = 6.2 Hz, 1H 
1´H); 5.51 (d, J = 6.4 Hz, 1H, 2´-OH); 5.23 (d, J = 4.7 Hz, 1H, 3´-OH); 5.14 (t, 
J = 5.2 Hz, 1H, 5´-OH); 4.36 (q, J = 5.9 Hz, 1H, 2´H); 4.13 (m, 1H, 3´H); 3.99 
(q, J = 3.4 Hz, 1H, 4´H); 3.64 (m, 2H, 5´H) 
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
142.81  (C2);  136.04  (C6);  132.46  (C5);  123.28  (C8);  108.05  (C7);  107.37 
(C9); 88.89 (C1´); 85.62 (C4´); 73.77 (C2´); 70.04 (C3´); 61.13 (C5´) 
 
19F-NMR:  δ [ppm] (254.2 MHz, DMSO-d6) 
–128.92 (m, 1F, 4F) 
ESI(–):    m/z 267.1 ([M-H]
-); 
 
 
1´-Deoxy -5´-O-(4,4´-dimethoxytriphenylmethyl)-1´-(4-fluoro-1-N-
benzimidazolyl)-β β β β-D-ribofuranose 111 
 
 
O
DMTrO
N
N
OHOH
F
 
 
C33H31FN2O6 
570.59 g/mol 
 
1.08  g  (4.0  mmol)  1´-Deoxy-1´-(4-fluoro-1-N-benzimidazolyl)-β-D-ribofuranose  30  were 
dissolved in 20 ml abs. pyridine and 0.74 ml (6.0 mmol) triethylamine and 1.44 g (4.3 mmol) 
4,4´-dimethoxytriphenylmethyl chloride were added. The reaction mixture was stirred under 
argon at RT for 6.5 h. The reaction was stopped by adding  5 ml of methanol and saturated 
water solution of NaHCO3. It was extracted with methylene chloride three times, organic 
phases were collected, dried over MgSO4 and evaporated to dryness. The product was co-  Exprerimental Part   
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evaporated  with  toluene  twice.  Further  purification  was  done  by  FC  with  methylene 
chloride/methanol 95:5 as eluent. The product was obtained as yellow foam. 
 
 
Yield:    2.04 g (89.1 %) 
TLC:    Rf = 0.40 (CH2Cl2/MeOH 9:1) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
8.42 (s, 1H, 2H); 7.54 (d, J = 9.0 Hz, 1H, 7H); 7.39 – 6.81 (m, 13H, Har); 7.07 
(m, 2H, 5H, 6H); 5.94 (d, J = 5.4 Hz, 1H, 1´H); 5.66 (d, J = 6.0 Hz, 1H, 2´-
OH); 5.30 (d, J = 5.5 Hz, 1H, 3´-OH); 4.52 (q, J = 5.6 Hz, 1H, 2´H); 4.23 (q, J 
= 5.1 Hz, 1H, 3´H); 4.13 (m, 1H, 4´H); 3.71 (s, 6H, OCH3); 3.24 (m, 2H, 5´H) 
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
158.12  (DMTr);  153.34  (C4);  144.76  (DMTr);  142.65  (C2);  135.88  (C6); 
135.42  (DMTr);  135.30  (DMTr);  132.29  (C5);  129.75  (DMTr);  127.86 
(DMTr);  127.73  (DMTr);  126.75  (DMTr);  123.33  (C8);  113.20  (DMTr); 
108.38  (C7);  107.62  (C9);  89.18  (C1´);  85.72  (DMTr);  83.53  (C4´);  73.25 
(C2´); 70.10 (C3´); 63.59 (C5´); 55.05 (OCH3) 
ESI(–):    m/z 569.4 ([M-H]
-); 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(4-fluoro-1-N-benzimidazolyl)-β β β β-D-ribofuranose 112 
 
 
O
DMTrO
N
N
OHOTBDMS
F
 
 
C39H45FN2O6Si 
684.85 g/mol 
 
2.52  g  (4.4  mmol)  5´-O-(4,4´-Dimethoxytriphenylmethyl)-1´-deoxy-1´-β-D-(4-fluoro-1-N-
benzimidazolyl)-ribofuranose 111 were dissolved in 40 ml of a  1:1 mixture  THF/pyridine   Exprerimental Part   
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and  900 mg (5.3 mmol) AgNO3 and 6.2 ml (6.2 mmol) 1 M tert.-butyldimethylsilyl chloride-
solution in THF were added. The reaction mixture was stirred for 20 hours at RT under argon. 
The reaction was stopped by adding 10 ml of saturated water NaHCO3-solution. Left AgCl 
was filtered over celite and the filtrate was extracted with methylene chloride three times. 
Collected  organic  phases  were  dried  over  MgSO4  and  evaporated  to  dryness.  The  crude 
product was co-evaporated with toluene twice. Further purification of the product was done 
by HPLC (MN Nucleoprep 100-20 of Macherey-Nagel, n-hexan/dioxan 5:2). The product  
(fast-Isomer) was obtained as white foam. 
 
 
 
Yield:    1.23 g (40.7 %) 
TLC:    Rf = 0.26 (n-hexan/ethyl acetate 4:1) 
1H-NMR:  δ [ppm] (270 MHz, DMSO-d6) 
8.45 (s, 1H, 2H); 7.57 (d, J = 7.6 Hz, 1H, 7H); 7.41 – 6.83 (m, 13H, Har); 6.98 
(m, 2H, 5H, 6H); 5.97 (d, J = 6.3 Hz, 1H, 1´H); 5.26 (d, J = 5.3 Hz, 1H, 3´-
OH); 4.60 (q, J = 6.0 Hz, 1H, 2´H); 4.35 (m, 1H, 3´H); 4.09 (m, 1H, 4´H); 3.72 
(s,  6H,  OCH3);  3.30  (m,  2H,  5´H);  0.82  (s,  9H,  SiC(CH3)3);  0.07  (s,  3H, 
SiCH3); 0.02 (s, 3H, SiCH3) 
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
158.10  (DMTr);  153.27  (C4);  144.47  (DMTr);  142.78  (C2);  135.63  (C6); 
135.21  (DMTr);  135.14  (DMTr);  132.28  (C5);  129.62  (DMTr);  127.74 
(DMTr);  127.60  (DMTr);  126.69  (DMTr);  123.15  (C8);  113.13  (DMTr); 
108.36  (C7);  107.52  (C9);  89.07  (C1´);  85.85  (DMTr);  83.95  (C4´);  72.64 
(C2´);  71.81  (C3´);  62.99  (C5´);  54.98  (OCH3);  25.67  (SiC(CH3)3);  17.90 
(SiC(CH3)3);  –4.56 (SiCH3); –5.19 (SiCH3) 
ESI(+):  m/z 685.5 ([M+H]
+); 
 
 
 
 
 
 
   Exprerimental Part   
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5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(4-fluoro-1-N-benzimidazolyl)-β β β β-D-ribofuranose 113 
 
 
O
DMTrO
N
N
OH TBDMSO
F
 
 
 
C39H45FN2O6Si 
684.85 g/mol 
 
5´-  O-  (4,4´-Dimethoxytriphenylmethyl)-  3´-O-tert.-butyldimethylsilyl-  1´-deoxy-1´-(4-
fluoro-1-N-benzimidazolyl)-β-D-ribofuranose  113  was  obtained  as  a  side  product  slow-
Isomer) in synthesizing 5´-O-(4,4´-Dimethoxytriphenylmethyl)- 2´-O-tert.-butyldimethylsilyl- 
1´-deoxy-1´-(4-fluoro-1-N-benzimidazolyl)-β-D-ribofuranose 112. 
 
 
Yield:    1.48 g (49.0 %) 
TLC:    Rf = 0.26 (n-hexan/ethyl acetate 4:1) 
1H-NMR:  δ [ppm] (270 MHz, DMSO-d6) 
8.46 (s, 1H, 2H); 7.56 (d, J = 9.0 Hz, 1H, 7H); 7.38 – 6.82 (m, 13H, Har); 7.07 
(m, 2H, 5H, 6H); 5.92 (d, J = 5.9 Hz, 1H, 1´H); 5.53 (d, J = 6.5 Hz, 1H, 2´-
OH); 4.51 (q, J = 6.0 Hz, 1H, 2´H); 4.35 (m, 1H, 3´H); 4.09 (m, 1H, 4´H); 3.72 
(s,  6H,  OCH3);  3.30  (m,  2H,  5´H);  0.82  (s,  9H,  SiC(CH3)3);  0.07  (s,  3H, 
SiCH3); 0.02 (s, 3H, SiCH3) 
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
158.10  (DMTr);  153.27  (C4);  144.47  (DMTr);  142.78  (C2);  135.63  (C6); 
135.21  (DMTr);  135.14  (DMTr);  132.28  (C5);  129.62  (DMTr);  127.74 
(DMTr);  127.60  (DMTr);  126.69  (DMTr);  123.15  (C8);  113.13  (DMTr); 
108.36  (C7);  107.52  (C9);  89.07  (C1´);  85.85  (DMTr);  83.95  (C4´);  72.64   Exprerimental Part   
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(C2´);  71.81  (C3´);  62.99  (C5´);  54.98  (OCH3);  25.67  (SiC(CH3)3);  17.90 
(SiC(CH3)3); –4.56 (SiCH3); –5.19 (SiCH3) 
ESI(+):  m/z 685.5 ([M+H]
+); 
 
 
3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-
triphenylmethyl)-1´-(4-fluoro-1-N-benzimidazolyl)-2´-O-tert.-butyldimethyl-
silyl-β β β β-D-ribofuranose 114 
 
 
O
DMTrO
O OTBDMS
N
N
P
O
CN
N
F
 
 
C48H62FN4O7PSi 
885.05 g/mol 
 
200 mg (0.29 mmol) 5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(4-fluoro-1-N-benzimidazolyl)-β-D-ribofuranose 112 were dissolved in 10 ml abs. 
acetonitrile and 380 µl (2.9 mmol) sym. collidine and 12 µl (0.15 mmol) 1-methylimidazole 
were added. The reaction mixture was cooled in an icebath to 0°C and 96 µl (0.43 mmol) 2-
cyanethyldiisopropylchlorphosphoramidit 96 were added. The reaction mixture was stirred  at 
0°C for 15min and for 45 min. at RT. The reaction was stopped by adding of 10 ml of 0.01 M 
citric acid and extracted with methylene chloride three times. Collected organic phases were 
washed  twice  with  0.01  M  citric  acid,  dried  over  MgSO4  and  evaporated  to  dryness. 
Purification was done by FC with methylene chloride/methanol 99:1 as eluent. The product 
(mixture of two diastereomers) was obtained as white foam. 
 
Yield:    135 mg (52.3 %) 
TLC:    Rf = 0.33; 0.41 (CH2Cl2/MeOH 99:1)   Exprerimental Part   
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1H-NMR:  δ [ppm] (400 MHz, CDCl3) 
8.12, 8.08 (s, 2H, 2H); 7.49 – 6.81 (m, 32H, Har, 5H, 6H, 7H); 5.92, 5.84 (d, J 
= 7.7 Hz, J = 5.8 Hz, 2H, 1´H); 4.75 (m, 2H, 2´H); 4.40 (m, 2H, 3´H); 4.32 (m, 
2H, 4´H); 3.80, 3.79 (s, 12H, OCH3); 3.48 (m, 4H, 5´H); 2.66 (m, 4H, OCH2), 
1.20 ( m, 12H, CH (CH3)2); 0.75 (s, 18H, SiC(CH3)3); –0.12 (s, 6H, SiCH3);     
–0.38 (s, 6H, SiCH3) 
31P-NMR:  δ [ppm] (162 MHz, CDCl3) 
152.49 and 149.32 (ratio 1: 2.7) 
ESI (+):  m/z 885.8 ([M+H]
+); 
 
 
5-fluoro-1H-benzoimidazole 65 
 
N
N
H
F
 
  
C7H5FN2 
136.12 g/mol 
 
3,4-diamino benzofluoride (4g, 32 mmol) was heated for 3h under reflux with 100ml of 90% 
HCOOH.  HCOOH  was  than  evaporated  and  the  crude  product  purified  by  FC 
(CH2Cl2/MeOH, 9:1).  
 
Yield;:   4 g ( 92 %); 
TLC:    Rf=0.55 (CH2Cl2/MeOH, 9:1):  
1H NMR:   δ [ppm] (250MHz, DMSO- d6)  
12.87 (s,1H, NH), 8.23 (s,1H,  2H), 7.57 (m, 1H, 4H), 7.33 (m,1H, 7H), 7.03 
(m,1H, 6H);  
13C NMR :   δ [ppm] (60.9 MHz, DMSO-d6):  
142.05 (C2), 140.50, 138.10, 121.10, 119.10, 119.70, 119.20 (arom C);  
El.Analysis:    Counted:  C: 61.76 %  H: 3.67 %  N: 20.58 % 
      Found:   C: 61.71 %  H: 3.96 %  N: 20.65 %   Exprerimental Part   
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ESI-MS:  136.7 ([M+H]
+); 
2´,3´,5´-Tri-O-acetyl-1´-deoxy-1´-(5-fluoro-1-N-benzimidazolyl)-β β β β-D-
ribofuranose 115 
 
 
O
AcO
N
N
AcO OAc
F
 
 
 
C18H19FN2O7 
394.34 g/mol 
 
7.9 g (58 mmol) 5-fluorobenzimidazole  65  were suspended in 200 ml abs. acetonitrile and 
18.25 ml (74 mmol) N, O-Bis- (trimethylsilyl)-acetamide were added. The reaction mixture 
was refluxed for 15 min. After cooling to room temperature 18.9 g (59 mmol) 1,2,3,5-Tetra-
O-acetyl-β-D-ribofuranose  in  90  ml  abs.  acetonitrile  and  11.00  ml  (60.8  mmol) 
trimethylsilyltrifluoro sulphonate (TMSOTf) were added. The reaction mixture was  refluxed 
for 2.5 h and  cooled to room temperature. After cooling the reaction mixture was treated with 
40 ml 5% NaHCO3-solution and extracted with methylene chloride three times. Combined 
organic phases were dried over MgSO4 and evaporated to dryness. The product was purified 
by means of FC with methylene chloride/methanol 99:1 and  obtained as white foam.  
 
 
Yield:    9.6 g (42 %) 
TLC:    Rf = 0.39 (CH2Cl2/MeOH 98:2) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
8.56 (s, 1H, 2H); 7.78 (m, 1H, 7H); 7.53 (m, 1H, 4H); 7.22 (m, 1H, 5H); 6.33 
(d, J = 6.32 Hz, 1H, 1´H); 5.65 (m,1H, 2´H); 5.53 (m, 1H, 3´H); 4.42 (m, 1H, 
4´H); 4.37 (m, 2H, 5´H); 2.14 (s, 3H, CH3-acetyl); 2.04 (s, 3H, CH3-acetyl); 
2.03 (s, 3H, CH3-acetyl) 
13C-NMR:  δ [ppm] (62.9 MHz, DMSO-d6)   Exprerimental Part   
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170.01 (C=O acetyl); 169.52 (C=O acetyl); 169.22 (C=O acetyl); 143.04 (C2); 
135.37 (C6); 132.24 (C4); 123.94 (C8); 108.02 (C9); 107.87 (C7); 86.47 (C1´); 
79.47 (C4´); 71.75 (C2`); 69.53 (C3´); 62.94 (C5´); 20.50 (CH3-acetyl); 20.36 
(CH3-acetyl); 20.15 (CH3-acetyl) 
ESI (+):  m/z 395.1 ([M+H]
+); 
 
 
2´, 3´, 5´-Tri-O-acetyl-1´-deoxy-1´- (5-fluoro-3-N-benzimidazolyl) -β β β β-D-
ribofuranose 78 
 
 
O
AcO
N
N
AcO OAc
F
 
 
 
C18H19FN2O7 
394.34 g/mol 
 
2´,3´,5´-Tri-O-acetyl-1´-deoxy-1´-(5-fluoro-3-N-benzimidazolyl)-β-D-ribofuranose  78  is 
obtained as second product in the synthesis of 2´,3´,5´-Tri-O-acetyl-1´-deoxy-1´-(5-fluoro-1-
N-benzimidazolyl)-β-D-ribofuranose  115. 
 
 
Yield:    8.7 g (38 %) 
TLC:    Rf = 0.35 (CH2Cl2/MeOH 98:2) 
1H-NMR:  δ [ppm] (400 MHz, DMSO-d6) 
8.58 (s, 1H, 2H); 7.74 (m, 1H, 7H); 7.65 (m, 1H, 4H); 7.15 (m, 1H, 6H); 6.31 
(d, J = 6.7 Hz, 1H, 1´H); 5.64 (m, 1H, 2´H); 5.42 (m, 1H, 3´H); 4.46 (m, 1H, 
4´H); 4.38 (m, 2H, 5´H); 2.18 (s, 3H, CH3-acetyl); 2.09 (s, 3H, CH3-acetyl); 
2.02 (s, 3H, CH3-acetyl)
 
13C-NMR:  δ [ppm] (62.9 MHz, DMSO-d6)   Exprerimental Part   
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170.01 (C=O acetyl); 169.43 (C=O acetyl); 169.17 (C=O acetyl); 148.24 ( C4); 
147.17 ( C8); 143.58 (C2); 123.07 ( C6); 120.24 (C9); 116.33 ( C7); 109.55  
(C5); 87.34 (C1´); 79.10 (C4´); 72.61 (C2´); 69.27 (C3´); 62.64 (C5´); 20.41 
(CH3-acetyl); 20.29 (CH3-acetyl); 20.08 (CH3-acetyl) 
ESI(+):  m/z 395.1 ([M+H]
+); 
 
 
1´-Deoxy-1´-(5-fluoro-1-N-benzimidazolyl)-β β β β-D-ribofuranose  31 
 
 
 
 
O
HO
N
N
OHOH
F
 
 
 
C12H13FN2O4 
268.23 g/mol 
 
2.86  g  (7.25  mmol)  2´,3´,5´-Tri-O-acetyl-1´-deoxy-1´-(5-fluoro-1-N-benzimidazolyl)-β-D-
ribofuranose  115  were dissolved in 25 ml of methanol and 190 µl of MeONa/MeOH ( 5.4M, 
Fluka) were added at RT and the reaction  TLC controlled. After 90 min the reaction was 
complete than neutralised with DOWEX 50, filtered and evaporated. The roduct was obtained 
as white foam and purified  by FC with methylene chloride/methanol 4:1 as eluent. 
 
Yield:    1.9 g (96 %) 
TLC:    Rf = 0.42 (CH2Cl2/MeOH 4:1) 
1H-NMR:  δ [ppm] (400 MHz, DMSO-d6) 
8.51 (s, 1H, 2H); 7.78 (m, 1H, 7H); 7.48 (m, 1H, 4H); 7.13 (m, 1H, 6H); 5.86 
(d, J = 8.0 Hz, 1H 1´H); 5.45 (d, J = 7.8 Hz, 1H, 2´-OH); 5.19 (d, J = 5.7 Hz,   Exprerimental Part   
- 189 - 
1H, 3´-OH); 5.11 (t, J = 8.2 Hz, 1H, 5´-OH); 4.35 (m, 1H, 2´H); 4.11 (m, 1H, 
3´H); 3.98 (m,1H, 4´H); 3.64 (m, 2H, 5´H) 
 
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
142.81 (C2); 136.04 ( C6); 132.46 (C4); 123.28 ( C8); 108.05 (C7); 107.37 
(C9); 88.89 (C1´); 85.62 (C4´); 73.77 (C2´); 70.04 (C3´); 61.13 (C5´) 
19F-NMR:  δ [ppm] (254.2 MHz, DMSO-d6) 
–128.90 (m, 1F, 5F) 
ESI(–):    m/z 267.1 ([M-H]
-); 
 
 
1´-Deoxy -5´-O-(4,4´-dimethoxytriphenylmethyl)-1´-(5-fluoro-1-N-
benzimidazolyl)-β β β β-D-ribofuranose  116 
 
 
O
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F
 
 
 
C33H31FN2O6 
570.59 g/mol 
 
1.00  g  (3.73  mmol)  1´-Deoxy-1´-(5-fluoro-1-N-benzimidazolyl)-β-D-ribofuranose  31  was 
dissolved in 20 ml abs. pyridine and 0.76 ml (6.0 mmol) triethylamine and 1.44 g (4.3 mmol) 
4,4´-dimethoxytriphenylmethyl chloride were added. The reaction mixture was stirred under 
argon  at  RT  for  6.5  hours.  The  reaction  was  stopped  by  adding    5  ml  of  methanol  and 
saturated water solution of NaHCO3. It was extracted with methylene chloride three times, 
organic phases were collected, dried over MgSO4 and evaporated to dryness. The product was 
co-evaporated  with  toluene  twice.  Further  purification  was  done  by  FC  with  methylene 
chloride/methanol 95:5 as eluent. The product was obtained as yellow foam. 
 
   Exprerimental Part   
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Yield:    1.97 g (86 %) 
TLC:    Rf = 0.30 (CH2Cl2/MeOH 95:5) 
1H-NMR:  δ [ppm] (400 MHz, DMSO-d6) 
8.42 (s, 1H, 2H); 7.70 (m, 1H, 7H); 7.39 – 6.81 (m, 13H, Har); 7.07 (m, 2H, 
4H, 6H); 5.94 (d, J = 5.4 Hz, 1H, 1´H); 5.66 (d, J = 6.0 Hz, 1H, 2´-OH); 5.30 
(d, J = 5.4 Hz, 1H, 3´-OH); 4.52 (m, 1H, 2´H); 4.23 (m, 1H, 3´H); 4.13 (m, 1H, 
4´H); 3.74 (s, 6H, OCH3); 3.23 (m, 2H, 5´H) 
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
158.10 (DMTr); 154.34 ( C5); 144.78 (DMTr); 142.65 (C2); 135.88 ( C6); 
135.42  (DMTr);  135.34  (DMTr);  132.39  (C4);  129.75  (DMTr);  127.86 
(DMTr);  127.73  (DMTr);  126.75  (DMTr);  123.33  (C8);  113.20  (DMTr); 
108.38  (C7);  107.62  (C9);  89.18  (C1´);  85.72  (DMTr);  83.53  (C4´);  73.25 
(C2´); 70.10 (C3´); 63.59 (C5´); 55.05 (OCH3) 
ESI(–):    m/z 569.4 ([M-H]
-); 
 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(5-fluoro-1-N-benzimidazolyl)-β β β β-D-ribofuranose  117 
 
 
O
DMTrO
N
N
OHOTBDMS
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C39H45FN2O6Si 
684.85 g/mol 
 
1.26  g  (2.2  mmol)  5´-O-(4,4´-Dimethoxytriphenylmethyl)-1´-deoxy-1´-β-D-(5-fluoro-1-N-
benzimidazolyl)-ribofuranose 116 were dissolved in 20 ml of a 1:1 mixture of THF/pyridine 
and  450 mg (2.6 mmol) AgNO3 and 3.1 ml (3.1 mmol) 1 M tert.-butyldimethylsilyl chloride-
solution in THF were added. The reaction mixture was stirred at RT under argon for 20 hours. 
The reaction was stopped by adding 10 ml of saturated water NaHCO3-solution. Left AgCl   Exprerimental Part   
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was filtered over celite and the filtrate was extracted with methylene chloride three times. 
Collected  organic  phases  were  dried  over  MgSO4  and  evaporated  to  dryness.  The  crude 
product was  co-evaporated with toluene twice. Further purification of the product was done 
by HPLC (MN Nucleoprep 100-20 of Macherey-Nagel, n-hexan/dioxan 5:2). The product  
(fast-Isomer) was obtained as white foam. 
 
 
Yield:    0.60 g (40 %) 
TLC:    Rf = 0.26 (n-hexan/ethyl acetate 4:1) 
1H-NMR:  δ [ppm] (400 MHz, DMSO-d6) 
8.46 (s, 1H, 2H); 7.57 (m, 1H, 7H); 7.41 – 6.83 (m, 13H, Har); 6.98 (m, 2H, 
4H, 6H); 5.87 (d, J = 6.7 Hz, 1H, 3´OH); 5.26 (d, J = 5.3 Hz, 1H, 1´H); 4.60 
(m, 1H, 2´H); 4.35 (m, 1H, 3´H); 4.09 (m, 1H, 4´H); 3.78 (s, 6H, OCH3); 3.30 
(m,  2H,  5´H);  0.86  (s,  9H,  SiC(CH3)3);  0.09  (s,  3H,  SiCH3);  0.01  (s,  3H, 
SiCH3) 
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
158.10  (DMTr);  154.27  (C5);  144.47  (DMTr);  142.78  (C2);  135.63  (C6); 
135.31  (DMTr);  135.14  (DMTr);  132.28    (C4);  129.62  (DMTr);  127.74 
(DMTr);  127.60  (DMTr);  126.69  (DMTr);  125.15  (C8);  113.13  (DMTr); 
108.36  (C7);  107.52  (C9);  89.27  (C1´);  85.95  (DMTr);  83.95  (C4´);  72.64 
(C2´);  71.87  (C3´);  63.00  (C5´);  54.98  (OCH3);  25.67  (SiC(CH3)3);  17.90 
(SiC(CH3)3);  –4.56 (SiCH3); –5.19 (SiCH3) 
ESI(+):  m/z 685.8 ([M+H]
+); 
 
 
 
 
 
 
 
 
 
 
   Exprerimental Part   
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5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(5-fluoro-1-N-benzimidazolyl)-β β β β-D-ribofuranose 118 
 
 
O
DMTrO
N
N
OH TBDMSO
F
 
 
 
C39H45FN2O6Si 
684.85 g/mol 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(5-fluoro-1-
N-benzimidazolyl)-β-D-ribofuranose 118 was obtained as a side product (slow-Isomer) in the 
synthesys of 5´-O-(4,4´-Dimethoxytriphenylmethyl)- 2´-O-tert.-butyldimethylsilyl- 1´-deoxy-
1´-(5-fluoro-1-N-benzimidazolyl)-β-D-ribofuranose 117. 
 
 
Yield:    0.58 g (39.0 %) 
TLC:    Rf = 0.26 (n-Hexan/Ethylacetat 4:1) 
1H-NMR:  δ [ppm] (400 MHz, DMSO-d6) 
8.46 (s, 1H, 2H); 7.56 (m, 1H, 7H); 7.38 – 6.82 (m, 13H, Har); 7.07 (m, 2H, 
4H, 7H); 5.91 (d, J = 5.9 Hz, 1H, 1´H); 5.53 (d, J = 6.5 Hz, 1H, 2´-OH); 4.51 
(m, 1H, 2´H); 4.35 (m, 1H, 3´H); 4.09 (m, 1H, 4´H); 3.72 (s, 6H, OCH3); 3.30 
(m,  2H,  5´H);  0.82  (s,  9H,  SiC(CH3)3);  0.08  (s,  3H,  SiCH3);  0.01  (s,  3H, 
SiCH3) 
13C-NMR:  δ [ppm] (67,9 MHz, DMSO-d6) 
158.10  (DMTr);  17.90  (SiC(CH3)3);    154.27  (C5);  144.47  (DMTr);  142.78 
(C2);  135.63  (C6);  135.31  (DMTr);  135.14  (DMTr);  132.28    (C4);  129.62 
(DMTr);  127.74  (DMTr);  127.60  (DMTr);  126.69  (DMTr);  125.15  (C8); 
113.13 (DMTr); 108.36 (C7); 107.52 (C9); 89.27 (C1´); 85.95 (DMTr); 83.95   Exprerimental Part   
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(C4´); 72.64 (C2´); 71.87 (C3´); 63.00(C5´); 54.98 (OCH3) ;  –4.56 (SiCH3); –
5.19 (SiCH3) 
ESI(+):  m/z 685.5 ([M+H]
+); 
 
 
3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-
triphenylmethyl)-1´-(5-fluoro-1-N-benzimidazolyl)-2´-O-tert.-butyldimethyl-
silyl-β β β β-D-ribofuranose 119 
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C48H62FN4O7PSi 
885,05 g/mol 
 
200 mg (0.29 mmol) 5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(5-fluoro-1-N-benzimidazolyl)-β-D-ribofuranose 117 were dissolved in 10 ml abs. 
acetonitrile and 380 µl (2.9 mmol) sym. collidine and 12 µl (0.15 mmol) 1-methylimidazole 
were added. The reaction mixture was cooled in an icebath to 0°C and 96 µl (0.43 mmol) 2-
cyanethyldiisopropylchlorphosphoramidite  96  were  added.  The  reaction  was  stirred  for 
15min. at 0°C and 45 min. at RT. The reaction was stopped by adding  10ml of 0.01 M citric 
acid and extracted with methylene chloride three times. The combined organic phases were 
washed  with  0.01  M  citric  acid  twice,  dried  over  MgSO4  and  evaporated  to  dryness. 
Purification was done by FC with methylene chloride/methanol 99:1, as eluent. The product ( 
mixture of two diastereomers) was obtained as white foam. 
 
 
Yield:    135 mg (52.3 %) 
TLC:    Rf = 0.33; 0.41 (CH2Cl2/MeOH 99:1)   Exprerimental Part   
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1H-NMR:  δ [ppm] (400 MHz, CDCl3) 
8.12, 8.08 (s, 2H, 2H); 7.49 – 6.81 (m, 32H, Har, 4H, 6H, 7H); 5.92, 5.84 (d, J 
= 5.9, J = 5.8 Hz, 2H, 1´H); 4.75 (m, 2H, 2´H); 4.40 (m, 2H, 3´H); 4.32 (m, 
2H, 4´H); 3.80, 3.79 (s, 12H, OCH3); 3.48 (m, 4H, 5´H); 2.66 (m, 4H, OCH2), 
1.20 ( m, 12H, CH(CH3)2); 0.75 (s, 18H, SiC(CH3)3); –0.12 (s, 6H, SiCH3);     
–0.38 (s, 6H, SiCH3) 
31P-NMR:  δ [ppm] (162 MHz, CDCl3) 
153.12 and 149.92 (ratio 1 : 4) 
ESI(+):  m/z 885.8 ([M+H]
+); 
 
 
1´-Deoxy-1´-(5-fluor-3-N-benzimidazolyl)-β β β β-D-ribofuranose  32 
 
 
O
HO
N
N
OHOH
F
 
 
 
C12H13FN2O4 
268.23 g/mol 
 
1.50  g  (3.8  mmol)  2´,3´,5´-Tri-O-acetyl-1´-deoxy-1´-(5-fluor-3-N-benzimidazolyl)-β-D-
ribofuranose  78  were dissolved in 25 ml  methanol and 190 µl  MeONa/MeOH ( 5,4M, 
Fluka) were added at RT and the reaction  was TLC controlled. After 90 min reaction was 
complete  than  neutralised  with  DOWEX  50,  filtered  and  evaporated.  The  product  was 
obtained as white foam and purified  by FC with methylene chloride/methanol 4:1 as eluent. 
 
 
Yield:    0.96 g (94 %) 
TLC:    Rf = 0.41 (CH2Cl2/MeOH 4:1) 
 
1H-NMR:  δ [ppm] (400 MHz, DMSO-d6)   Exprerimental Part   
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8.47 (s, 1H, 2H); 7.88 (m, 1H, 4H); 7.68 (m, 1H, 7H); 7.13 (m, 1H, 6H); 5.85 
(d, J = 7.5 Hz, 1H 1´H); 5.42 (d, J = 7.6 Hz, 1H, 2´-OH); 5.19 (d, J = 4.56 Hz, 
1H, 3´-OH); 5.11 (t, J = 5.04 Hz, 1H, 5´-OH); 4.35 (m, 1H, 2´H); 4.11 (m, 1H, 
3´H); 3.98 (m,1H, 4´H); 3.65 (m, 2H, 5´H) 
13C-NMR:  δ [ppm] (67,9 MHz, DMSO-d6) 
142.81 (C2); 136.04 ( C6); 132.46 (C4); 123.28 ( C8); 108.05 (C7); 107.37 
(C9); 88.89 (C1´); 85.62 (C4´); 73.77 (C2´); 70.04 (C3´); 61.13 (C5´) 
19F-NMR:  δ [ppm] (254,2 MHz, DMSO-d6) 
–128.90 (m, 1F, 5F) 
ESI(–):    m/z 267,1 ([M-H]
-); 
 
 
1´-Deoxy -5´-O-(4,4´-dimethoxytriphenylmethyl)-1´-(5-fluor-3-N-
benzimidazolyl)-β β β β-D-ribofuranose 93 
 
 
O
DMTrO
N
N
OHOH
F
 
 
 
C33H31FN2O6 
570.59 g/mol 
 
0.95  g  (3.54  mmol)  1´-Deoxy-1´-(5-fluoro-3-N-benzimidazolyl)-β-D-ribofuranose  32  were 
dissolved in 20 ml abs. pyridine and 0.66 ml (5.31 mmol) triethylamine and 1.27 g (3.81 
mmol) 4,4´-dimethoxytriphenylmethyl chloride were added. The reaction mixture was stirred 
under argon at RT for 7 hours. The reaction was stopped by adding of 5 ml of methanol and 
saturated water solution of NaHCO3. It was extracted with methylene chloride three times, 
organic phases were collected, dried over. MgSO4 and evaporated to dryness. The product 
was co-evaporated with toluene twice. Further purification was done by FC with methylene 
chloride/methanol 95:5 as eluent. The product was obtained as yellow foam. 
Yield:    1.7 g (83 %)   Exprerimental Part   
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TLC:    Rf = 0.32 (CH2Cl2/MeOH 95:5) 
1H-NMR:  δ [ppm] (400 MHz, DMSO-d6) 
8.41 (s, 1H, 2H); 7.70 (m, 1H, 7H); 7.49 – 6.86 (m, 13H, Har); 7.17 (m, 2H, 
4H, 6H); 5.96 (d, J = 5.7 Hz, 1H, 1´H); 5.68 (d, J = 6.0 Hz, 1H, 2´-OH); 5.32 
(d, J = 5.4 Hz, 1H, 3´-OH); 4.52 (m, 1H, 2´H); 4.25 (m, 1H, 3´H); 4.10 (m, 1H, 
4´H); 3.76 (s, 6H, OCH3); 3.23 (m, 2H, 5´H) 
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
158.10 (DMTr); 154.34 ( C5); 144.78 (DMTr); 142.65 (C2); 135.88 ( C6); 
135.42  (DMTr);  135.34  (DMTr);  132.39  (C4);  129.75  (DMTr);  127.86 
(DMTr);  127.73  (DMTr);  126.75  (DMTr);  123.33  (C8);  113.20  (DMTr); 
108.38  (C7);  107.62  (C9);  89.18  (C1´);  85.72  (DMTr);  83.53  (C4´);  73.25 
(C2´); 70.10 (C3´); 63.59 (C5´); 55.05 (OCH3) 
ESI(–):    m/z 569.4 ([M-H]
-); 
 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(5-fluoro-3-N-benzimidazolyl)-β β β β-D-ribofuranose 95 
 
 
 
O
DMTrO
N
N
OHOTBDMS
F
 
 
 
C39H45FN2O6Si 
684.85 g/mol 
 
1.8  g  (3.15  mmol)  5´-O-(4,4´-Dimethoxytriphenylmethyl)-1´-deoxy-1´-β-D-(5-fluoro-3-N-
benzimidazolyl)-ribofuranose 93 were dissolved in 20 ml  1:1 of a mixture of THF/pyridine 
and  with  650  mg  (3.8  mmol)  AgNO3  and  4.40  ml  (4.40  mmol)  1  M  tert.-
butyldimethylsilylchloride-solution in THF were added. The reaction mixture was stirred for 
20 hours at RT under argon. The reaction was stopped by adding 10ml of saturated water   Exprerimental Part   
- 197 - 
NaHCO3-solution.  Left  AgCl  was  filtered  over  celite  and  the  filtrate  was  extracted  with 
methylenchloride  three  times.  Combined  organic  phases  were  dried  over  MgSO4  and 
evaporated to dryness. The crude product was  co-evaporated with toluene twicw. Further 
purification of product was done by HPLC (MN Nucleoprep 100-20 of Macherey-Nagel, n-
hexan/dioxan 10:5). The product  (fast-Isomer) was obtained as white foam. 
 
 
Yield:    0.84 g (39 %) 
TLC:    Rf = 0.26 (n-hexan/ethyl acetate 4:1) 
1H-NMR:  δ [ppm] (400 MHz, DMSO-d6) 
8.40 (s, 1H, 2H); 7.68 (m, 1H, 7H); 7.54 (m, 1H, 6H); 7.41 – 6.83 (m, 14H, Har, 
4H); 5.94 (d, J = 5.36 Hz, 1H, 3´OH); 5.19 (d, J = 5.52 Hz, 1H, 1´H); 4.58 (dd, 
J=6.3 Hz, 1H, 2´H); 4.20 (m, 2H, 4’H, 3´H); 3.73 (s, 6H, OCH3); 3.30 (m, 2H, 
5´H); 0.71 (s, 9H, SiC(CH3)3); -0.10 (s, 3H, SiCH3); -0.26 (s, 3H, SiCH3) 
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
158.50  (DMTr);  154.37  (C5);  144.67  (DMTr);  142.98  (C2);  136.63  (C6); 
135.31  (DMTr);  135.14  (DMTr);  133.28    (C4);  129.62  (DMTr);  128.74 
(DMTr);  127.60  (DMTr);  126.69  (DMTr);  125.15  (C8);  114.13  (DMTr); 
108.36  (C7);  107.52  (C9);  89.17  (C1´);  85.95  (DMTr);  84.95  (C4´);  73.64 
(C2´);  71.87  (C3´);  63.00  (C5´);  54.98  (OCH3);  25.67  (SiC(CH3)3);  17.90 
(SiC(CH3)3); –4.59 (SiCH3); –5.21 (SiCH3) 
ESI(+):  m/z 685.8 ([M+H]
+); 
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5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(5-fluoro-3-N-benzimidazolyl)-β β β β-D-ribofuranose 94 
 
 
O
DMTrO
N
N
OH TBDMSO
F
 
 
 
C39H45FN2O6Si 
684,85 g/mol 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(5-fluoro-3-
N-benzimidazolyl)-β-D-ribofuranose 94 was obtained as a side product slow-Isomer) in the 
synthesis of 5´-O-(4,4´-Dimethoxytriphenylmethyl)- 2´-O-tert.-butyldimethylsilyl- 1´-deoxy-
1´-(5-fluoro-3-N-benzimidazolyl)-β-D-ribofuranose 95. 
 
 
Yield:    0.80 g (37.0 %) 
TLC:    Rf = 0.26 (n-Hexan/Ethylacetat 4:1) 
1H-NMR:  δ [ppm] (400 MHz, DMSO-d6) 
8.42 (s, 1H, 2H); 7.69 (dd, 1H, 7H); 7.56 (m, 1H, 6H);7.38 – 6.82 (m, 14H, Har, 
4H); 5.88 (d, J = 5.9 Hz, 1H, 1´H); 5.49 (d, J = 6.5 Hz, 1H, 2´-OH); 4.5 (m, 
1H, 2´H); 4.35 (m, 1H, 3´H); 4.09 (m, 1H, 4´H); 3.72 (s, 6H, OCH3); 3.30 (m, 
2H, 5´H); 0.82 (s, 9H, SiC(CH3)3); 0.06 (s, 3H, SiCH3); 0.005 (s, 3H, SiCH3) 
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
158.10  (DMTr);  154.27  (C5);  144.47  (DMTr);  142.78  (C2);  135.63  (C6); 
135.31  (DMTr);  135.14  (DMTr);  132.28    (C4);  129.62  (DMTr);  127.74 
(DMTr);  127.60  (DMTr);  126.69  (DMTr);  125.15  (C8);  113.13  (DMTr); 
108.36  (C7);  107.52  (C9);  89.27  (C1´);  85.95  (DMTr);  83.95  (C4´);  72.64 
(C2´); 71.87 (C3´); 63.00 (C5´); 54.98 (OCH3) ;  –4.56 (SiCH3); –5.19 (SiCH3) 
ESI(+):  m/z 685.5 ([M+H]
+);   Exprerimental Part   
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3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-
triphenylmethyl)-1´-(5-fluor-3-N-benzimidazolyl)-2´-O-tert.-butyldimethyl-
silyl-β β β β-D-ribofuranose 97 
 
 
O
DMTrO
O OTBDMS
N
N
P
O
CN
N
F
 
 
 
C48H62FN4O7PSi 
885.05 g/mol 
 
200 mg (0.29 mmol) 5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
desoxy-1´-(5-fluor-3-N-benzimidazolyl)-β-D-ribofuranose  95  were  dissolved  in  10  ml  abs. 
acetonitrile and 380 µl (2.9 mmol) sym. collidine and 12 µl (0.15 mmol) 1-methylimidazole 
were added. The reaction mixture was cooled in an icebath to 0°C and 96 µl (0.43 mmol) 2-
cyanethyldiisopropylchlorphosphoramidit 96 were added. The reaction was stirred for 15min. 
at 0°C and 45 min. at RT. The reaction was stopped by adding  10ml of 0.01 M citric acid and 
extracted with methylenchloride three times. Combined organic phases  were washed with 
0.01 M citric acid twice, dried over MgSO4 and evaporated to dryness. Purification was done 
by  FC  with  methylene  chloride/methanol  99:1,  as  eluent.  The  product  (  mixture  of  two 
diastereomers) was obtained as white foam. 
 
 
Yield:    150 mg (58 %) 
TLC:    Rf = 0.34; 0.41 (CH2Cl2/MeOH 99:1) 
1H-NMR:  δ [ppm] (400 MHz, CDCl3) 
8.12, 8.08 (s, 2H, 2H); 7.49 – 6.81 (m, 32H, Har, 4H, 6H, 7H); 5.92, 5.84 (d, J 
= 5.9, J = 5.8 Hz, 2H, 1´H); 4.75 (m, 2H, 2´H); 4.40 (m, 2H, 3´H); 4.32 (m, 
2H, 4´H); 3.80, 3.79 (s, 12H, OCH3); 3.48 (m, 4H, 5´H); 2.66 (m, 4H, OCH2),   Exprerimental Part   
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1.20 ( m, 12H, CH(CH3)2); 0.75 (s, 18H, SiC(CH3)3); –0.02 (s, 6H, SiCH3);     
–0.12 (s, 6H, SiCH3) 
31P-NMR:  δ [ppm] (162 MHz, CDCl3) 
154.22 and 151.92 (ratio 1 : 3.5) 
ESI(+):  m/z 885.8 ([M+H]
+); 
 
 
 
2´,3´,5´-Tri-O-acetyl-1´-deoxy-1´-N-benzimidazolyl-β β β β-D-ribofuranose 77 
 
 
O
AcO
N
N
AcO OAc  
 
 
C18H20N2O7 
376.35 g/mol 
 
5.2 g (44.0 mmol) benzimidazole  were suspended in 80 ml abs. acetonitrile and 10.75 ml (44 
mmol) N,O-Bis-(trimethylsilyl)-acetamide were added. The reaction mixture was refluxed for 
15  min.  After  cooling  to  room  temperature  7.0  g  (22  mmol)  1,2,3,5-Tetra-O-acetyl-β-D-
ribofuranose in 50 ml abs. acetonitrile and 5.0 ml (27.6 mmol) trimethylsilyltrifluorosulfonate 
(TMSOTf) were added. The reaction mixture was  refluxed for 2,5 hours and  cooled to room 
temperature. After cooling the reaction mixture was treated with 10 ml 5% NaHCO3-solution 
and extracted with methylene chloride three times. Combined organic phases were dried over 
MgSO4 and evaporated to dryness. The product was purified by means of FC with methylene 
chloride/methanol 98:2. The product was obtained as white foam.  
 
 
 
Yield:    4.57 g (55.3 %) 
TLC:    Rf =  0.43 (CH2Cl2/MeOH 95:5) 
   Exprerimental Part   
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1H-NMR:  δ [ppm] (400 MHz, DMSO-d6) 
8.49 (s, 1H, 2H); 7.73 (m, 2H, Har); 7.29 (m, 2H, Har); 6.32 (d, J = 6.4 Hz, 1H, 
1´H); 5.68 (t, J = 6.3 Hz, 1H, 2´H); 5.43 (dd, J = 4.6 Hz, 1H, 3´H); 4.41 (m, 
1H,  4´H);  4.37  (m,  2H,  5´H);  2.13  (s,  3H,  CH3-acetyl);  2.08  (s,  3H,  CH3-
acetyl); 2.03 (s, 3H, CH3-acetyl) 
13C-NMR:  δ [ppm] (100.6 MHz, DMSO-d6) 
169.55  (C=O);  169.06  (C=O);  168.76  (C=O);  143.36  (C2);  142.36  (Car); 
131.93 (Car); 122.65 (Car); 119.06 (Car); 110.85 (Car); 85.76 (C1´); 78.11 (C4´); 
71.10 (C2´); 69.09 (C3´); 62.53 (C5´); 20.04 (CH3-acetyl); 19.90 (CH3-acetyl); 
19.69 (CH3-acetyl) 
ESI(+):  m/z 377.2 ([M+H]
+); 
 
 
1´-Deoxy-1´-N-benzimidazolyl-β β β β-D-ribofuranose 40 
 
 
O
HO
N
N
OHOH  
 
 
C12H14N2O4 
250.24 g/mol 
 
2.98  g  (7.9  mmol)  2´,3´,5´-Tri-O-acetyl-1´-deoxy-1´-benzimidazolyl-β-D-ribofuranose  77 
were dissolved in 25 ml of methanol and 175 µl of MeONa/MeoH ( 5.4 M, Fluka) were added 
at  RT  and  the  reaction  was  TLC  controlled.  After  60  min  the  reaction  was  complete 
neutralised with DOWEX 50, filtered and evaporated. The product was obtained as white 
foam and used without further purification.  
 
 
Yield:    1.90 g (95.1 %) 
TLC:    Rf = 0.53 (CH2Cl2/MeOH 4:1)   Exprerimental Part   
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1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
8.45 (s, 1H, 2H); 7.70 (m, 2H, Har); 7.24 (m, 2H, Har); 5.86 (d, J = 6.2 Hz, 1H, 
1´H); 5.46 (d, J = 6.5 Hz, 1H, 2´-OH); 5.21 (d, J = 4.8 Hz, 1H, 3´-OH); 5.10 (t, 
J = 5.2 Hz, 1H, 5´-OH); 4.36 (q, J = 5.3 Hz, 1H, 2´H); 4.12 (m, 1H, 3´H); 3.96 
(q, J = 3.4 Hz, 1H, 4´H); 3.63 (m, 2H, 5´H) 
13C-NMR:  δ [ppm] (62.9 MHz, DMSO-d6) 
143.82  (C2);  142.42  (Car);  132.98  (Car);  122.62  (Car);  122.02  (Car);  119.54 
(Car); 111.54 (Car); 88.64 (C1´); 85.43 (C4´); 73.58 (C2´); 70.13 (C3´); 61.26 
(C5´) 
ESI(+):  m/z 251.1 ([M+H]
+); 
 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl) -1´-deoxy -1´-N-benzimidazolyl-β β β β-D-
ribofuranose  120 
 
 
O
DMTrO
N
N
OHOH  
 
 
C33H32N2O6 
552.59 g/mol 
 
 
2.73 mg (10.9 mmol) 1´-Deoxy-1´-N-benzimidazolyl-β-D-ribofuranose 40 were dissolved in 
100 ml abs. pyridine and 5.17 g (15.4 mmol) 4,4´-dimethoxytriphenylmethylchloride were 
added. The reaction mixture was stirred under argon at RT for 4h. The reaction was stopped 
by adding of 10 ml of methanol and saturated water solution of NaHCO3. It was extracted 
with methylene chloride three times; organic phases were collected and dried over MgSO4 
and than evaporated to dryness. The product was co evaporated with toluol twice. Further   Exprerimental Part   
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purification was done by FC with methylene chloride/methanol 95:5, as eluent. The product 
was obtained as yellow foam. 
 
 
Yield:    4.43 g (73.5 %) 
TLC:    Rf =  0.68 (CH2Cl2/MeOH 9:1) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
8.35 (s, 1H, 2H); 7.68 (m, 2H, Har); 7.38 – 6.81 (m, 15H, Har); 5.91 (d, J = 5.5 
Hz, 1H, 1´H); 5.59 (d, J = 6.1 Hz, 1H, 2´-OH); 5.27 (d, J = 5.4 Hz, 1H, 3´-OH); 
4.36 (q, J = 5.7 Hz, 1H, 2´H); 4.19 (q, J = 5.2 Hz, 1H, 3´H); 4.10 (q, J = 5.2 Hz, 
1H, 4´H); 3.73 (s, 6H, OCH3); 3.23 (m, 2H, 5´H) 
13C-NMR:  δ [ppm] (62.9 MHz, DMSO-d6) 
158.08 (DMTr); 144.78 (DMTr); 143.94 (C2); 142.24 (Car); 135.42 (DMTr); 
135.33  (DMTr);  132.84  (Car);  129.77  (DMTr);  127.84  (DMTr);  127.71 
(DMTr);  126.71  (DMTr);  122.57  (Car);  122.13  (Car);  119.65  (Car);  113.19 
(DMTr); 111.75 (Car); 88.95 (C1´); 85.68 (DMTr); 83.33 (C4´); 73.07 (C2´); 
70.12 (C3´); 63.70 (C5´); 55.02 (OCH3) 
ESI (+):  m/z 553.4 ([M+H]
+); 
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5´-O- (4,4´-Dimethoxytriphenylmethyl) -2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-N-benzimidazolyl-β β β β-D-ribofuranose 121 
 
 
O
DMTrO
N
N
OHOTBDMS  
 
 
C39H46N2O6Si 
666.85 g/mol 
 
 
0.95  g  (1.7  mmol)  5´-O-(4,4´-Dimethoxytriphenylmethyl)-1´-deoxy-1´-N-benzimidazolyl-
ribofuranose 120 were dissolved in 20 ml  of a 1:1 mixture of THF/pyridine and with 380 mg 
(5.3 mmol) AgNO3 and 2.2 ml (2.2 mmol) 1 M tert.-Butyldimethylsilylchloride-solution in 
THF. The reaction mixture was stirred at RT under argon for 24 hours. Adding 10 ml of 
saturated water NaHCO3-solution stopped the reaction. Left AgCl was filtered over celite and 
filtrate was extracted with methylene chloride three times. Combined organic phases were 
dried over MgSO4 and evaporated to dryness. The crude product was  co- evaporated with 
toluene  twice.  Further  purification  of  the  product  was  done  by  FC  using  methylene 
chloride/isopropanol 98:2 as eluent. The product was obtained as white foam. 
 
 
Yield:    310 mg (27.2 %) 
TLC:    Rf = 0.35  (CH2Cl2/iPrOH 98:2) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
8.35 (s, 1H, 2H); 7.66 (m, 2H, Har); 7.41 – 6.82 (m, 15H, Har); 5.92 (d, J = 6.5 
Hz, 1H, 1´H); 5.19 (d, J = 5.5 Hz, 1H, 3´-OH); 4.58 (t, J = 5.7 Hz, 1H, 2´H); 
4.18 (m, 1H, 3´H); 4.13 (m, 1H, 4´H); 3.71 (s, 6H, OCH3); 3.29 (m, 2H, 5´H); 
0.68 (s, 9H, SiC(CH3)3); –0.15 (SiCH3); –0.31 (SiCH3) 
13C-NMR:  δ [ppm] (100.6 MHz, DMSO-d6)   Exprerimental Part   
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158.10 (DMTr); 144.72 (DMTr); 143.95 (C2); 142.59 (Car); 135.21 (DMTr); 
135.11  (DMTr);  132.40  (Car);  129.78  (DMTr);  129.72  (DMTr);  127.79 
(DMTr); 127.61 (DMTr); 126.73 (DMTr); 122.37 (Car); 122.12 (Car); 119.65 
(Car); 113.16 (DMTr); 111.92 (Car); 88.61 (C1´); 85.82 (DMTr); 83.99 (C4´); 
74.51 (C2´); 69.94 (C3´); 63.50 (C5´); 55.00 (OCH3); 25.43 (SiC(CH3)3); 17.69 
(SiC(CH3)3); –5.12 (SiCH3); –5.61 (SiCH3) 
ESI (+):  m/z 667.6 ([M+H]
+); 
 
 
5´-O- (4,4´-Dimethoxytriphenylmethyl) -3´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-N-benzimidazolyl-β β β β-D-ribofuranose 122 
 
 
O
DMTrO
N
N
OH TBDMSO  
 
 
C39H46N2O6Si 
666.85 g/mol 
 
5´- O- (4,4´-Dimethoxytriphenylmethyl)- 3´-O-tert.-butyldimethylsilyl- 1´-deoxy-1´-N -benz-
imidazolyl-β-D ribofuranose 123 was obtained as a side product while preparing  5´-O-(4,4´-
Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-N-benzimidazolyl-β-
D-ribofuranose 120. 
 
Yield:    410 mg (3.0 %) 
TLC:    Rf = 0.32 (CH2Cl2/iPrOH 98:2) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
8.40 (s, 1H, 2H); 7.69 (m, 2H, Har); 7.40 – 6.82 (m, 15H, Har); 5.90 (d, J = 6.1 
Hz, 1H, 1´H); 5.50 (d, J = 6.5 Hz, 1H, 2´-OH); 4.52 (q, J = 5.8 Hz, 1H, 2´H); 
4.35 (m, 1H, 3´H); 4.07 (m, 1H, 4´H); 3.72 (s, 6H, OCH3); 3.24 (m, 2H, 5´H); 
0.82 (s, 9H, SiC(CH3)3); 0.07 (SiCH3); 0.02 (SiCH3)   Exprerimental Part   
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13C-NMR:  δ [ppm] (100.6 MHz, DMSO-d6) 
158.11 (DMTr); 144.58 (DMTr); 143.99 (C2); 142.52 (Car); 135.26 (DMTr); 
135.17  (DMTr);  132.64  (Car);  129.69  (DMTr);  127.81  (DMTr);  127.63 
(DMTr);  126.74  (DMTr);  122.47  (Car);  122.11  (Car);  119.64  (Car);  113.16 
(DMTr); 111.85 (Car); 88.87 (C1´); 85.87 (DMTr); 83.82 (C4´); 72.47 (C2´); 
71.92  (C3´);  63.14  (C5´);  55.03  (OCH3);  25.73  (SiC(CH3)3);  17.99 
(SiC(CH3)3); –4.50 (SiCH3); –5.14 (SiCH3) 
ESI (+):  m/z 667.5 ([M+H]
+); 
 
 
3´-O- (2-Cyanethoxydiisopropylphosphin) -1´-deoxy-5´-O- (4,4´-dimethoxy-
triphenylmethyl) -1´-N-benzimidazolyl-2´-O- (tert.-butyldimethylsilyl) -β β β β-D-
ribofuranose 123 
 
 
O
DMTrO
O OTBDMS
N
N
P
O
CN
N
 
 
C48H63N4O7PSi 
867.05 g/mol 
 
300 mg (0.44 mmol) 5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-N-benzimidazolyl-β-D-ribofuranose 121 were dissolved in 16 ml abs. acetonitril and 
570 µl (4.4 mmol) sym. collidine and 18 µl (0.22 mmol) 1-methylimidazole were added. The 
reaction  mixture  were  cooled  in  an  icebath  to  0°C  and  145  µl  (0.64  mmol)  2-
cyanethyldiisopropylchlorphosphoramidite  96  were  added.  The  reaction  was  stirred  for 
15min. at 0°C and 45 min. at RT. The reaction was stopped by adding of 10 ml of 0.01 M 
citric acid and extracted with methylene chloride three times. Combined organic phases were 
washed  twice  with  0.01  M  citric  acid,  dried  over  MgSO4  and  evaporated  to  dryness.   Exprerimental Part   
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Purification was done by FC with methylene chloride/methanol 99:1 as eluent. The product 
(mixture of two diastereomers) was obtained as white foam. 
 
 
Yield:    210 mg (53.8 %) 
TLC:    Rf = 0.09 (n-hexan: ethyl acetate 4:1) 
1H-NMR:  δ [ppm] (400 MHz, CDCl3) 
8.12, 8.08 (s, 2H, 2H); 7.79 (d, J = 8.0 Hz, 2H, Har);  7.63 (d, J = 8.1 Hz, 2H, 
Har); 7.48 – 6.80 (m, 30H, Har); 5.92, 5.86 (d, J = 7.5 Hz, J = 7.0 Hz, 2H, 1´H); 
4.76 (m, 2H, 2´H); 4.31 (m, 2H, 3´H); 3.95 (m, 2H, 4´H); 3.79, 3.78 (s, 12H, 
OCH3);  3.56  (m,  8H,  5´H,  CH2CN);  2.68  (m,  4H,  OCH2),  1.20  (m,  12H, 
CH(CH3)2); 0.81, 0.74 (s, 18H, SiC(CH3)3); –0.14, –0.37, –0.40, –0.49 (s, 12H, 
SiCH3) 
31P-NMR:  δ [ppm] (162 MHz, CDCl3) 
150.58 and 149.99 (ratio 1 : 1.6) 
ESI (+):  m/z 867.7 ([M+H]
+); 
 
 
2-Nitro-3-trifluoromethyl acetanilide 56 
 
CF3
NO2
NHAc 
 
C9H7N2O3F3 
248.01gmol
-1 
 
 
3-Trifluoromethyl  acetanilide  (10g,  50mmol)  was  added  over  10  min.  (in  1g  portions)  to 
12.5g of mixture of equal parts of HNO3 (d=1.52) and (CH3COO)2O cooled to 0°C (4.2ml 
HNO3 and 5.8ml (CH3COO)2O). The reaction was continued for 15min. at 0°C and continued 
4h at room temperature. The white precipitate (the wanted product) was filtered and washed 
with 5 ml of (CH3COO)2O.   Exprerimental Part   
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Yield:    2.9g (24%)  
 TLC:      Rf= 0.30 (CH2Cl2/MeOH, 98:2) 
1H NMR:  δ [ppm] (250MHz,  DMSO- d6) 
10.19(s, 1H, N-H), 7.94-7.82 (m, 3H, aromH), 2.05 (s, 3H, CH3);  
13C NMR:  δ [ppm] (62.9MHz, DMSO- d6) 
168.73(C=O), 141.54, 131.96, 131.53, 123.72, 123.64, 121.28 (arom C), 112.2 
(CF3), 20.1 (CH3);  
ESI(+):  m/z 266.0 ([M+NH4]
+); 
 
 
6-Nitro-3-trifluoromethyl acetanilide 57 
 
 
CF3
NHAc
NO2  
 
C9H7N2O3F3 
248.01gmol
-1 
 
6-Nitro-3-trifluoromethyl  acetanilide  57  was  obtained  while  synthesing  2-nitro-3-
trifluoromethyl acetanilide 56 as a side product. It stays in solution after filtering 56. Then the 
solution is extracted with methylene chloride and 57 is obtained by FC (methylene chloride/ 
methanol, 98:2).  
 
 
Yield:    4.2 g (35%)  
 TLC:      Rf= 0.44 (CH2Cl2/MeOH, 98:2)  
1H NMR:  δ [ppm] (250MHz,  DMSO- d6) 
10.50(s, 1H, N-H), 8.10 (d, J=7,2 Hz, 1H, H5), 8.00(s, 1H, H2),7.90 (d, J=7.32 
Hz, 1H, H6), 2.05 (s, 3H, CH3);  
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13C NMR:  δ [ppm] (62.9MHz, DMSO- d6) 
169.73(C=O), 141.64, 131.98, 131.53, 125.72, 123.64, 121.28 (arom C), 112.2 
(CF3), 20.1 (CH3);  
ESI(+):  m/z 266.2 ([M+NH4]
+); 
 
 
4-Nitro-3-trifluoromethyl acetanilide 58 
 
 
CF3
NHAc
O2N
 
 
C9H7N2O3F3 
248.01gmol
-1 
 
4-nitro-3-trifluoromethyl  acetanilide  58  was  obtained  while  synthesing  2-nitro-3-
trifluoromethyl acetanilide 56 as a side product. It stays in solution after filtering 56. Then the 
solution is extracted with methylene chloride and 58 is obtained by FC (methylene chloride/ 
methanol, 98:2).  
 
Yield:    1.2 g (10%)  
 TLC:      Rf= 0.68 (CH2Cl2/MeOH, 98:2)  
1H NMR:  δ [ppm] (250MHz,  DMSO- d6) 
10.80(s, 1H, N-H), 8.10 (s, 1H, 2H), 8.00 (d, J=7.8Hz, 1H, 5H), 7.92 (d, J=7.8 
Hz, 1H, 6H), 1.95 (s, 3H, CH3);  
13C NMR:  δ [ppm] (62.9MHz, DMSO- d6) 
168.73(C=O), 141.54, 131.96, 131.53, 123.72, 123.64, 121.28 (arom C), 112.2 
(CF3), 20.1 (CH3);  
ESI(+):  m/z 266.0 ([M+NH4]
+); 
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2-Nitro-3-trifluoromethyl-aniline 59 
 
CF3
NO2
NH2 
 
C7H5N2O2F3 
206.0 g/mol 
 
The solution of  56 (2g, 8.1mmol)  in 25 ml of  0.1 M NaOH  was refluxed for 90 min (TLC 
control). The reaction was  cooled to room temperature, extracted with methylene chloride, 
the organic phase was dried over MgSO4 and evaporated. The product was obtained as yellow 
crystals.  
 
 
Yield:    1.40g  (84%) 
TLC :    Rf= 0.63 (CH2Cl2/MeOH, 99/1)  
1H NMR:   δ [ppm] (250MHz, CDCl3): 
7.37 (m,1H, 5H); 7.11(m, 2H, 4H, 6H); 5.02 (s, 2H, NH2); 
13C NMR:   δ [ppm] (62,9MHz, CDCl3): 
145.1, 136.3, 132.3, 125.1, 120.1, 117.2 (arom C), 111.8(CF3);  
ESI(-):   m/z 205.6 ([M-H]
-); 
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4-Trifluoromethyl benzoimidazole 61 
 
CF3
N
N
H  
 
C8H5N2F3 
186 g/mol 
 
59  (1.4g, 6,8mmol) was dissolved in abs. ethanol (50ml), 150mg PtO2 (0,65mmol) were 
added and reaction was performed in H2 atmosphere for 2h (TLC control, CH2Cl2/MeOH, 
99/1, Rf=0,5). The reaction mixture was then filtered over cellite and filtrate was evaporated. 
The crude product was dissolved in 90% HCOOH (100ml) and heated under reflux for 3h. 
HCOOH was evaporated to obtain crude product, which was purified by FC (CH2Cl2/MeOH, 
9:1).  
 
 
Yield:    1.2g(94%)  
TLC:    Rf= 0.41 (CH2Cl2/MeOH, 9/1) 
1H NMR:  δ [ppm] (250MHz,  DMSO- d6 ) 
8.40 (d, 1H, J=3.83Hz, 7H); 7.90 (s, 1H, N-H); 7.54 (d, 1H, J=4.68Hz, 5H); 
7.36 (m, 1H, 6H);  
13C NMR:  δ [ppm] (62.9MHz, DMSO- d6 ): 
163.62,  145.54,  126.00,  123.30,  121.98,  119.60,  119.20  (arom  C), 
114.10(CF3); 
ESI(-):   m/z 186.7 ([M+H]
+); 
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2',3,5’-Tri-O-acetyl-1’-deoxy-1’-(4-trifluoromethyl-1-N-benzoimidazole- 
1-yl)-β-D-ribofuranose 71 
 
O
AcO
CF3
N
N
AcO OAc  
C19H19F3N2O7 
444.33 g/mol 
 
To  a  suspension  of  61  (1.2  g,  6.4  mmol)  in  acetonitrile  (50  ml)  N,O-
bis(trimethylsilyl)acetamide (2.40 ml, 9.90 mmol) was added and heated under reflux for 15 
min.  After  the  mixture  was  cooled  to  room  temperature,  1,2,3,5-Tetra-O-acetyl-β-D-
ribofuranose  (2.1g,  6.55mmol)  in  acetonitrile  (20ml)  and  trimethylsilyl 
trifluoromethanesulfonate (1.5ml, 8.16mmol) were added and heated under reflux for 2.5h. 
The  reaction  mixture  was  after  cooling  to  room  temperature  treated  with  5%  NaHCO3 
solution and extracted with methylene chloride. The organic phase was dried (over MgSO4) 
and evaporated and the residue purified by means of preparative HPLC (MN Nucleoprep 100-
20 from Macherey-Nagel, n-hexan: ethyl acetate, 10:25). The product was obtained as faster 
migrating isomer, as white foam. 
 
 
 
Yield:    2.0g (70%) 
TLC:    Rf=  0.40 (CH2Cl2/MeOH, 95:5); 
 
1H NMR:  δ [ppm] (400MHz, DMSO- d6)  
8.69 (s, 1H, 2H); 8.10 (d, J=8.2Hz, 1H, 5H); 7.64 (d,  J=7.56Hz, 1H,  7H); 7.49 
(m, 1H, 6H); 6.42 (d, J=6.08Hz, 1H, 1H’); 5.70 (t, J=6.22Hz,  1H, 2H’); 5.05 
(m,1H, 3H’); 4.39 (m, 1H, 4H’); 4.20 (m, 2H, 5H’); 2.11 (s, 3H, CH3); 2.08 (s, 
3H, CH3); 2.04 (s, 3H, CH3);  
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13C NMR:   δ [ppm] (100.6 MHz, DMSO- d6 )  
171.5, 169.08, 169.00 (C=O); 144.36 (C2); 142.40, 133.90, 122.70, 120.25, 
120.20, 120.18 (arom C); 114.5 (CF3); 86.71 (C1’); 78.21 (C4’); 71.30 (C2’); 
69.18 (C3’); 62.53 (C5’); 20.10, 19.91, 19.58 (CH3);  
ESI(+):  m/z 445.4 ([M+H]
+); 
 
 
2’,3’,5’-Tri-O-acetyl-1’-deoxy-1’-(4-trifluoromethyl-3-N-benzoimidazole- 
1-yl)-β-D-ribofuranose 72 
 
O
AcO
N
N
AcO OAc
CF3
 
 
C19H19F3N2O7 
444.33 g/mol 
 
2’,3’,5’-Tri-O-acetyl-1’-deoxy-1’-(4-trifluoromethyl-3-N-benzoimidazole-1-yl)-β-D-
ribofuranose  72    was obtained in the same procedure as 71 but as slower migrating isomer 
during preparative  HPLC (MN Nucleoprep 100-20 from Macherey-Nagel, n-hexan: ethyl 
acetate, 10:25) separation. The product was obtained as white foam. 
 
 
 
Yield:    0.77 g (27%) 
TLC:    Rf=0.40 (CH2Cl2/MeOH, 95:5) 
 
1H NMR:  δ [ppm] (400MHz, DMSO- d6) 
8.67 (s, 1H, 2H); 7.84 (d, J=8.3Hz , 1H,  7H); 7.62 (d, J=8.20Hz, 1H, 5H); 7.50 
(m, 1H, 6H); 6.38 (d, J=6.10Hz, 1H, 1H’); 5.70 (t, J=6.30Hz, 1H, 2H’); 5.10 
(m, 1H, 3H’); 4.42 (m, 1H, 4H’); 4.18 (m, 2H, 5H’); 2.09 (s, 3H, CH3); 2.07 (s, 
3H, CH3); 2.06 (s, 3H, CH3);  
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13C NMR:   δ [ppm] (100.6 MHz, DMSO- d6) 
170.5, 169.10, 169.00 (C=O); 145.10 (C2); 142.40, 134.00, 122.70, 120.30, 
120.20, 120.16 (arom C); 113.5 (CF3); 87.00 (C1’); 78.41 (C4’); 71.10 (C2’); 
69.20 (C3’); 62.50 (C5’); 20.10, 19.90, 19.70 (CH3);  
ESI(+):  m/z 445.4 ([M+H]
+); 
 
 
1’-Deoxy-1’-(4-trifluoromethyl-1-N-benzoimidazole-1-yl)-β-D-ribofuranose 
33 
 
O
HO
OHOH
CF3
N
N
 
 
C13H13F3N2O4 
318.23 g/mol 
 
   2',3,5’-Tri-O-acetyl-1’-deoxy-1’-(4-trifluoromethyl-1-N-benzoimidazole-1-yl)-β-D-
ribofuranose 71 (1g, 2.25mmol) was dissolved in methanol (25ml) and 185 l of MeONa/ 
MeOH (5.4M, Fluka) were added at room temperature and  the reaction was TLC controlled. 
The  reaction  was  complete  after  60  min.  and    neutralised  with  DOWEX  50,  filtered  and 
evaporated.  
The product was obtained as white foam. 
 
 
Yield:    0.66g (92%) ;  
TLC:    Rf=0.28 (CH2Cl2/MeOH, 9:1): 
1H NMR:  δ [ppm] (400MHz, DMSO- d6):  
8.64 (s, 1H, 2H); 8.11 (d, J=8.20 Hz, 1H, 7H); 7.60 (d, J=7.56Hz, 1H, 5H); 
7.42 (m, 1H, 6H); 5.95 (d, J=6.28Hz, 1H, 1H’); 5.51 (d, J=6.44Hz, 1H, 2’OH);   Exprerimental Part   
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5.26 (d, J=4.68Hz, 1H, 3OH’); 5.15 (t, J=5.12Hz, 1H, 5OH’); 4.38 (q, J= 5.84 
Hz, 1H, 2H’); 4.16 (m, 1H, 3H’); 4.01 (m, 1H,  4H’); 3.66 (m, 2H, 5H’);  
13C NMR :  δ [ppm] (100.6 MHz, DMSO- d6):  
143.10 (C2); 136.05, 130.10, 128.10, 125.10, 125.00, 124.10 (arom C); 114.10 
(CF3); 89.00 (C1’); 86.10 (C4’); 74.10 (C2’); 70.00 ( C3’); 62.10 (C5’);  
19F-NMR:  δ [ppm] (254,2 MHz, DMSO-d6) 
–59.45 (s, 3F, CF3) 
ESI(-):   m/z  317.30 ([M-H]
-); 
 
 
1’-Deoxy-1’-(4-trifluoromethyl-3-N-benzimidazole-1-yl)-β-D-ribofuranose 
124 
 
O
HO
OHOH
N
N
CF3
 
 
C13H13F3N2O4 
318.23 g/mol 
 
1’-deoxy-1’-(4-trifluoromethyl-3-N-benzimidazole-1-yl)-β-D-ribofuranose  72  (0.5g, 
1.12mmol) was dissolved in methanol (25ml) and 185 l of MeONa/ MeOH (5.4M, Fluka) 
were  added  at  room  temperature  and  the  reaction  was  TLC  controlled.  The  reaction  was 
complete after 60 min. and than neutralized with DOWEX 50, filtered and evaporated. The 
product was obtained as white foam. 
 
 
Yield:   0.33g  (93%);  
TLC:    Rf=0.28 (CH2Cl2/MeOH, 9:1);  
1H NMR :  δ [ppm] (400MHz, DMSO- d6) 
8.25 (s, 1H, 2H); 7.80 (d, J=8.00 Hz, 1H, 7H); 7.50 (d, J=7.56Hz,1H, 5H); 7.44 
(m, 1H, 6H); 6.00 (d, J=6.30Hz, 1H, 1H’); 5.50 (d, J=6.50Hz, 1H, 2’OH); 5.28   Exprerimental Part   
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(d, J=4.70Hz, 1H, 3OH’); 5.20 (t, J=5.12Hz, 1H, 5OH’); 4.32 (q, J= 5.86 Hz, 
1H, 2H’); 4.10 (m, 1H, 3H’); 4.00 (m, 1H, 4H’); 3.64 (m, 2H, 5H’); 
 
13C NMR:  δ [ppm]  (100.6 MHz, DMSO- d6) 
142.10 (C2); 136.10, 130.10, 128.10, 125.20, 125.05, 124.10 (arom C); 114.20 
(CF3); 89.00 (C1’); 86.20 (C4’); 74.20 (C2’); 70.00 (C3’); 62.10 (C5’);  
19F-NMR:  δ [ppm] (254.2 MHz, DMSO-d6) 
–59.35 (s, 3F, CF3) 
ESI(-):   m/z 316.90 ([M-H]
-); 
 
 
1´-Deoxy-5´-O-(4,4´-dimethoxytriphenylmethyl)-1´-(4-trifluoro-1-N-
benzimidazolyl)-β-D-ribofuranose 125 
 
 
O
DMTrO
OHOH
N
N
CF3
 
 
C34H31F3N2O6 
620.63 g/mol 
 
380  mg  (1.2  mmol)  1´-Deoxy-1´-(4-trifluorbenzimidazolyl)-β-D-ribofuranose  33  were 
dissolved in 10 ml abs. pyridine  and 0.25 ml  (1.8 mmol) triethylamine and 0.45  g (1.30 
mmol) 4,4´-dimethoxytriphenylmethylchloride were added. The reaction mixture was stirred 
under  argon  at  RT  for  20h.  The  reaction  was  stopped  by  adding    3ml  of  methanol  and 
saturated water solution of NaHCO3. It was  extracted with methylene chloride three times, 
the organic phases were collected and dried over. MgSO4 and than evaporated to dryness. The 
product was twice co-evaporated with toluoene. Further purification was done by FC with 
methylenechloride/methanol 95:5, as eluent. The product was obtained as yellow foam. 
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Yield:    500 mg (68%) 
TLC:    Rf=0.18 (CH2Cl2/CH3OH, 95:5) 
1H NMR:  δ [ppm]    (250 MHz, DMSO- d6 ) 
8.53 (s, 1H, 2H); 8.05 (d, J=8,2Hz, 1H, 5H); 7. (d, 1H, J=5.45 Hz, 6H); 7.60-
6.81(m, 15H, Har, 6H, 7H); 6.01 (d, J=5,44 Hz, 1H, 1H’); 5.68 (d, J=6.00Hz, 
1H, 2’OH); 5.30 (d, J=5.44Hz, 1H, 3OH’); 4.52 (m, 1H, 2H’); 4.23(m, 1H, 
3H’); 4.23(m, 1H, 3H'); 4.13 (m, 1H, 4H’); 3.66(s, 6H, 2OCH3); 3.35 (m, 2H, 
5H’);  
13C NMR :  δ [ppm]   (100.6 MHz, DMSO- d6) 
158.10 (DMTr); 144.60 (DMTr); 143.10(C2); 141.10(C5); 135.80(C6); 
135.40(DMTr); 135.30(DMTr); 132.30(C4); 130.85(DMTr); 128.00(DMTr); 
127.80(DMTr); 127.10(DMTr); 123.30(C8); 114310(CF3); 113.20(DMTr); 
109.7(C7); 107.60(C9); 89.60(C1’); 85.80(DMTr); 83.50(C4’); 73.20(C2’); 
70.10(C3’); 63.70(C5’); 55.00(OCH3);  
ESI(-):   m/z 619.5 ([M-H]
-); 
 
5´-O- (4,4´-Dimethoxytriphenylmethyl)-2´-O-tert. -butyldimethylsilyl-1´-
deoxy-1´-(4-trifluoromethyl-1-N-benzimidazolyl)-β β β β-D-ribofuranose 126 
 
 
O
DMTrO
OHOTBDMS
N
N
CF3
 
 
C40H42F3N2O6Si 
734.93 g/mol 
 
500  mg  (0.82  mmol)  5´-O-(4,4´-Dimethoxytriphenylmethyl)-1´-deoxy-1´-β-D-(4-
trifluoromethyl-1-N-benzimidazolyl)-ribofuranose  125  were  dissolved  in  20  ml  of    1:1 
mixture of THF/pyridine and 180 mg (1.06 mmol) AgNO3 and 1.2 ml (6.2 mmol) 1 M tert. -
butyldimethylsilylchloride-solution in THF were added. The reaction mixture was stirred for   Exprerimental Part   
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20 hours at RT under argon. The reaction was stopped by adding 10ml of saturated water 
NaHCO3-solution.  Left  AgCl  was  filtered  over  celite  and  the  filtrate  was  extracted  with 
methylenechloride three times. The combined organic phases were dried over MgSO4 and 
evaporated  to  dryness.  The  crude  product  was    co-evaporated  with  toluol  twice.  Further 
purification of the product was done by. HPLC (MN Nucleoprep 100-20 of Macherey-Nagel, 
n-hexan/ethylacetate  10:3.5]+30%  methylenechloride).  The  product    (slow-Isomer)  was 
obtained as white foam. 
 
 
Yield:    216 mg (36%) 
TLC:    Rf=0.48 (n-hexane/ethyl acetate, 4:1) 
1H NMR:  δ [ppm]    (400 Hz, DMSO- d6) 
8.31 (s, 1H, 2H); 7,94 (d, J=8.2Hz, 1H, 5H); 7.59-6.80(m, 15H, Har, 6H, 7H); 
5,89 (d, J=4.96Hz, 1H, 1H’); 5.68(d, J=6.0Hz, 1H, 2’OH); 4.30(m, 2H, 2H’, 
3H'); 4.35 ( m, 1H, 3H’); 4.11 (m, 1H, 4H’); 3.68 (s, 6H, 2OCH3); 3.50(m, 2H, 
5'CH2); 0.91( s, 9H, SiC(CH3)3); 0.09 (s, 3H, SiCH3); 0.00( s, 3H, SiCH3);  
13C NMR:  δ [ppm] (100.6 MHz, DMSO- d6) 
158.20 (DMTr); 144.90 (DMTr); 144.10(C2); 141.10(C5); 135.80(C6); 
135.70(DMTr); 135.30(DMTr); 132.40(C4); 130.75(DMTr); 128.10(DMTr); 
127.70(DMTr); 127.00(DMTr); 123.30(C8); 114.10(CF3); 113.20(DMTr); 
108.0(C7); 107.75(C9); 89.15(C1’); 85.72(DMTr); 83.50(C4’); 73.25(C2’); 
70.20(C3’); 63.60(C5’); 55.05(OCH3); 25,60(SiC(CH3)3,-5,00(SiCH3), -
5,30(SiCH3); 
ESI(+):   m/z 736.1 ([M+H]
+); 
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5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(4-trifluoromethyl-1-N-benzimidazolyl)-β β β β-D-ribofuranose 127 
 
O
DMTrO
OH
N
N
CF3
TBDMSO  
 
C40H42F3N2O6Si 
734.93 g/mol 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(4-
trifluormethyl-1-N-benzimidazolyl)-β-D-ribofuranose  127  was  obtained  as  a  side  product 
(fast-Isomer)  in  the  synthesis  of  5´-O-(4,4´-Dimethoxytriphenylmethyl)-  2´-O-tert.-
butyldimethylsilyl-  1´-deoxy-1´-(4-trifluoromethyl-1-N-benzimidazolyl)-β-D-ribofuranose  
126. 
 
 
Yield:    198 mg (33%) 
TLC:    Rf=0.48 (n-hexane:EtOAc, 4:1) 
1H NMR:   δ [ppm]   (400 MHz, DMSO- d6) 
8.23 (s, 1H, 2H); 7.94 (d, J=8.2Hz, 1H, 5H); 7.55-6.81(m, 15H, Har, 6H, 7H); 
5,89 (d, J=47.16Hz, 1H, 1H’); 5.65(d, J=6.10Hz, 1H, 3’OH); 4.79(m, 1H, 
2H’); 4.35 ( m, 2H, 3H’, 4H'); 4.11 (m, 1H, 4H’); 3.80 (s, 6H, 2OCH3); 
3.46(m, 2H, 5'CH2); 0.82( s, 9H, SiC(CH3)3); 0.13 (s, 3H, SiCH3); -0.36 (s, 3H, 
SiCH3);  
13C NMR :    δ [ppm]   (100.6 MHz, DMSO- d6) 
158.20 (DMTr); 144.90 (DMTr); 144.50(C2); 141.10(C5); 135.80(C6); 
135.70(DMTr); 135.30(DMTr); 132.40(C4); 131.75(DMTr); 128.10(DMTr); 
127.70(DMTr); 127.00(DMTr); 123.30(C8); 114.10(CF3); 114.20(DMTr); 
108.0(C7); 107.75(C9); 89.15(C1’); 85.72(DMTr); 83.50(C4’); 73.20(C2’);   Exprerimental Part   
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70.20(C3’); 63.60(C5’); 55.00(OCH3); 26,60(SiC(CH3)3,-5,20(SiCH3), -
5,10(SiCH3); 
ESI(+):  m/z 736.3 ([M+H]
+); 
 
 
3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-
triphenylmethyl)-1´-(4-trifluoromethyl-1-N-benzimidazolyl)-2´-O-(tert.-
butyl-dimethylsilyl)-β β β β-D-ribofuranose 128 
 
O
DMTrO
O OTBDMS
N
N
CF3
P
O
CN
N
 
 
 
C49H62F3N4O7PSi 
935.04 g/mol 
 
240 mg (0.33 mmol) 5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(4-trifluoromethyl-1-N-benzimidazolyl)-β-D-ribofuranose 126 were dissolved in 10 
ml  abs.  acetonitrile  and  420  µl  (3.3  mmol)  sym.  collidine  and  16  µl  (0.16  mmol)  1-
methylimidazole were added. The reaction mixture was cooled in an icebath to 0°C and 98 µl 
(0.48 mmol) 2-cyanethyldiisopropylchlorophosphoramidite 96 were added. The reaction was 
stirred for 15 min. at 0°C and 45 min. at RT. The reaction was stopped by adding  10 ml of 
0.01 M citric acid and three times extracted with methylenechloride. The combined organic 
phases were  washed twice with 0.01 M citric  acid, dried over MgSO4  and evaporated to 
dryness. Purification was done by FC with methylenechloride/methanol 99:1 as eluent. The 
product ( mixture of two diastereomers) was obtained as white foam. 
   Exprerimental Part   
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Yield:    305 mg (69%) 
TLC:    Rf=0.55; 0.52; (CH2Cl2/MeOH,99:1); 
1H NMR:  δ [ppm]   (400 MHz, DMSO- d6) 
8.44, 8,39 (s, 2H, 2H); 8.00 (d,J=8,1Hz, 2H, 5H); 7.79-6.80(m, 32H, Har, 5H, 
6H, 7H); 5,93, 5,86(d, J=5,82Hz, J=7,08Hz, 2H, 1H’), 4.80 (m, 2H, 2H’); 4.38 
( m, 2H, 3H’), 3,99 (m, 2H, 4H’), 3.,80, 3,79(s, 12H, 2OCH3), 3.56(m, 4H, 
5'CH2),2.76(mm,4H, OCH2), 1,22(m, 12H, CH(CH3)2), 0,80( s, 18H, Si(CH3)3) 
-0,10( s, 6H, SiCH3), -0,29( s, 6H, SiCH3);  
31P NMR:  δ [ppm]    (162 MHz, CDCl3): 
153.26 and 149.63 (ratio 1:4) 
ESI(+):  m/z 936.1 ([M+H]
+); 
 
5-Trifluoromethyl benzimidazole 63 
 
N
N
H
CF3
 
  
C8H5N2F3 
186 g/mol 
 
3,4-diaminobenzofluorid (2.2g, 12.5mmol) was heated under reflux with 90% HCOOH for 
3h. HCOOH was than evaporated and the crude product purified by FC (CH2Cl2/MeOH, 9:1).  
 
 
Yield;:   2.10g ( 90%); 
TLC:    Rf=0.57 (CH2Cl2/MeOH, 9:1):  
1H NMR :  δ [ppm]   (250MHz, DMSO- d6):  
12.87 (s,1H, NH); 8.46 (s, 1H, 2H); 8.01 (s, 1H, 4H); 7.78 (d, J=8.42Hz, 1H, 
6H); 7.51 (dd, J=8.48Hz, J=1.63Hz, 1H, 7H);  
13C NMR : δ [ppm]   (60.9 MHz, DMSO- d6):  
142.05 (C2); 140.50, 138.10, 121.10, 119.10, 119.70, 119.20 (arom C, CF3);  
ESI(+):  m/z 187.0 ([M+H]
+);   Exprerimental Part   
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2’,3’,5’-Tri-O-acetyl-1’-deoxy-1’-(5-trifluoromethyl-1-N-benzoimidazole- 
1-yl)-β-D-ribofuranose 129 
 
O
AcO
N
N
CF3
AcO OAc  
C19H19F3N2O7 
444.33 g/mol 
 
To a suspension of 5-trifluoromethyl-1H-benzoimidazole 63 (1.5g, 8.05mmol) in acetonitrile 
(50ml) N,O-bis(trimethylsilyl)acetamide (3.00ml, 12.00mmol) was added and heated under 
reflux for 15 min. After the mixture was cooled to room temperature, 1,2,3,5-tetra-O-acetyl-β-
D-ribofuranose  (2.60g,  8.05mmol)  in  acetonitrile  (20ml)  and  trimethylsilyl 
trifluoromethanesulfonate (1.8ml, 10.00mmol) were added and heated under reflux for 2.5h. 
The reaction mixture was cooled room temperature treated with 5% NaHCO3 solution and 
extracted  with  methylene  chloride.  The  organic  phase  was  dried  (over  MgSO4)  and 
evaporated and the residue purified by means of preparative HPLC (MN Nucleoprep 100-20 
from  Macherey-Nagel,  n-hexan:ethyl  acetate,  10:20).  The  product  was  obtained  as  faster 
migrating isomer, as white foam. 
 
Yield:    2.04g (57%) 
TLC:    Rf=  0.55 (CH2Cl2/MeOH, 95:5): 
1H NMR :  δ [ppm]   (400MHz, DMSO- d6): 
8.72 (1H, s, 2H), 8.10 (1H, s, 4H), 7.99 (1H, d, J=8.58Hz, 7H), 7.68 (1H, d, 
J=8.55Hz,  6H), 6.42 ( 1H, d, J=6.20Hz, 1H’), 5.68 (1H, t, J=6.28Hz, 2H’), 
5.44 (1H, m, 3H’), 4.56-4.37 (2H, m, 4H’,5H’), 2.07 (3H, s, CH3), 2.06 (3H, s, 
CH3), 2.04 (3H, s, CH3);  
13C NMR:   δ [ppm]    (100.6 MHz, DMSO- d6): 
170.10, 169.70, 169.00 (C=O); 145.10 (C2); 144.40, 134.00, 123.10, 120.30, 
120.20, 120.16 (arom C); 113.6 (CF3); 87.00 (C1’); 78.40 (C4’); 71.20 ( C2’); 
69.80 ( C3’); 62.70 (C5’); 20.20, 19.90, 19.80 (CH3);  
ESI(+):    m/z 445.0 ([M+H]
+);   Exprerimental Part   
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1’-Deoxy-1’-(5-trifluoromethyl-1-N-benzoimidazole-1-yl)-β-D-ribofuranose 
34 
 
 
O
HO
N
N
CF3
OHOH  
 
C13H13F3N2O4 
318.23 g/mol 
 
2’,3’,5’-Tri-O-acetyl-1’-deoxy-1’-(5-trifluoromethyl-1-N-benzoimidazole-1-yl)-β-D-
ribofuranose 129 (0.74g, 1.67mmol) was dissolved in MeOH (15ml) and 111 l of MeONa/ 
MeOH (5.4M, Fluka) were added at room temperature and reaction was TLC controlled. The 
reaction  was  complete  after  60  min.  and    neutralized  with  DOWEX  50,  filtered  and 
evaporated. The product was obtained as white foam.  
 
Yield:    0.48g (91%);  
TLC:    Rf=0.36 (CH2Cl2/MeOH, 9:1) 
1H NMR:  δ [ppm]    (250MHz, DMSO- d6): 
8.68 (s, 1H, 2H); 8.02 (m, 2H, 4H, 7H);  7.58 (d, J=8.40Hz, 1H, 6H);  5.95 (, d, 
J=6.13Hz, 1H, 1H’), 5.51 (d, J=7.50Hz, 1H, 2’OH); 5.20 (d, J=4.68Hz, 1H, 
3OH’); 5.15 (t, J=5.12Hz , 1H, 5OH’); 4.37 (q, J= 5.50Hz, 1H, 2H’); 4.13 ( m, 
1H,  3H’); 4.00 (m, 1H, 4H’); 3.66 (m, 2H,  5H’); 
13C NMR :   δ [ppm]    (100.6 MHz, DMSO- d6): 
143.10 (C2), 137.05, 132.10, 128.10, 125.10, 125.00, 124.10 (arom C); 114.10 
(CF3), 88.90 (C1’); 86.20 (C4’); 74.20 (C2’); 70.20 ( C3’); 62.300 (C5’);  
19F-NMR:  δ [ppm] (254,2 MHz, DMSO-d6) 
–59.48 (s, 3F, CF3) 
ESI (-):  m/z 316.8([M-H]
-); 
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1´-Deoxy -5´-O-(4,4´-dimethoxytriphenylmethyl)-1´-(5-trifluoromethyl-1-N-
benzimidazolyl)-β β β β-D-ribofuranose 130 
 
 
O
DMTrO
N
N
CF3
OHOH  
C34H31F3N2O6 
620.63 g/mol 
 
400 mg (1.26 mmol) 1´-Deoxy-1´-(5-trifluor-1-N-benzimidazolyl)-β-D-ribofuranose 34 were 
dissolved in 10 ml abs. pyridine  and 0.25 ml  (2.0 mmol) triethylamine and 0.50  g (1.67 
mmol) 4,4´-dimethoxytriphenylmethylchloride were added. The reaction mixture was stirred 
under argon at RT for 20h. The reaction was stopped by adding of 3 ml of methanol and 
saturated water solution of NaHCO3. It was three times extracted with methylene chloride, 
organic phases were collected and dried over MgSO4 and than evaporated to dryness. The 
product was twice co-evaporated with toluoene. Further purification was done by FC with 
methylene chloride/methanol 95:5, as eluent. The product was obtained as yellow foam. 
 
 
Yield:    600 mg(77%) 
TLC:    Rf=0.29 (CH2Cl2:MeOH, 95:5) 
1H NMR:  δ [ppm]    (250 MHz, DMSO- d6) 
8.57 (s, 1H, 2H); 8.07 (s, 1H, 4H); 7.93 (d, J=5.45 Hz, 1H, 6H); 7.86 (d, J= 4.7 
Hz, 1H, 7H); 7.40-6.28(m, 13H, Har); 6.00 ( d, J=6.40 Hz, 1H, 1H’); 5.65 (d, 
J=6.05Hz, 1H, 2’OH); 5.30 (d, J=5.43Hz, 1H, 3OH’); 4.52 (m, 1H, 2H’); 4.19 (  
m, 1H, 3H’);  4.26-4.13 (m, 2H, 3’H, 4H’); 3.25 (m, 2H, 5H’);  
13C NMR :  δ [ppm]   (100.6 MHz, DMSO- d6) 
158.10 (DMTr); 144.80 (DMTr); 143.00(C2); 141.10(C4); 135.80(C6); 
135.40(DMTr); 135.30(DMTr); 132.30(C5); 130.75(DMTr); 128.00(DMTr); 
127.70(DMTr); 127.00(DMTr); 123.30(C8); 114.10(CF3); 113.20(DMTr);   Exprerimental Part   
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108.7(C7); 107.60(C9); 89.10(C1’); 85.72(DMTr); 83.50(C4’); 73.25(C2’); 
70.10(C3’); 63.60(C5’); 55.05(OCH3);  
ESI (-):  m/z 619.20 ([M-H]
-); 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(5-trifluoromethyl-1-N-benzimidazolyl)-β β β β-D-ribofuranose 131 
 
 
O
DMTrO
N
N
CF3
OHOTBDMS  
C40H42F3N2O6Si 
734.93 g/mol 
 
1.80  g  (2.90  mmol)  5´-O-(4,4´-Dimethoxytriphenylmethyl)-1´-deoxy-1´-β-D-(5-
trifluoromethyl-1-N-benzimidazolyl)-ribofuranose 130 were dissolved in 30 ml of 1:1 mixture  
of  THF/pyridine  and  600  mg  (3.53  mmol)  AgNO3  and  4.1  ml  (4.1  mmol)  1  M  tert.-
butyldimethylsilylchloride-solution in THF were added. The reaction mixture was stirred for 
20 hours at RT under argon. The reaction was stopped by adding 10 ml of saturated water 
NaHCO3-solution.  Left  AgCl  was  filtered  over  celite  and  filtrate  was  extracted  with 
methylene chloride three times. The combined organic phases were dried over MgSO4 and 
evaporated  to  dryness.  The  crude  product  was  co-evaporated  with  toluene  twice.  Further 
purification of the product was done by. HPLC (MN Nucleoprep 100-20 of Macherey-Nagel, 
[n-hexan/methylacetat  10:20]+30%  methylenechloride).  The  product    (slow-Isomer)  was 
obtained as white foam. 
 
 
Yield:     915 mg (43%) 
TLC:     Rf=0.45 (hexane/EtOAc,4:1) 
1H NMR:   δ [ppm]    (400 MHz, DMSO- d6)   Exprerimental Part   
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8.59 (s, 1H, 2H); 8.04 (s, 1H, 4H); 7.91 (d, 1H, J=8.56 Hz, 6H); 7.35-6.81(m, 
14H, Har+7H); 5,96 ( d, J=5,92 Hz, 1H, 1H’); 5.51 (d, J=6.52Hz, 1H, 2’OH); 
4.50  (m,  1H,  2H’);  4.34  (  m,  1H,  3H’);  4.11  (m,  1H,  4H’);  3.70(  s,  6H, 
2OCH3); 3.25(m, 2H, 5'CH2);0.90( s, 9H, Si(CH3)3); 0.05( s, 3H, SiCH3), -0,05 
( s, 3H, SiCH3);  
 
13C NMR :    δ [ppm]   (100.6 MHz, DMSO- d6) 
158.20  (DMTr);  144.80  (DMTr);  143.10(C2);  141.10(C4);  135.80(C6); 
135.40(DMTr);  135.30(DMTr);  132.30(C5);  130.75(DMTr);  128.10(DMTr); 
127.70(DMTr);  127.00(DMTr);  123.30(C8);  114.10(CF3);  113.20(DMTr); 
108.7(C7);  107.60(C9);  89.10(C1’);  85.72(DMTr);  83.50(C4’);  73.25(C2’); 
70.10(C3’);  63.60(C5’);  55.05(OCH3);  25,60(SiC(CH3)3;-5,01(SiCH3);    -
5,20(SiCH3); 
ESI(+):  m/z 737.5 ([M+H]
+); 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(5-trifluoromethyl-1-N-benzimidazolyl)-β β β β-D-ribofuranose 132 
 
O
DMTrO
N
N
CF3
OH TBDMSO  
C40H42F3N2O6Si 
734.93 g/mol 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(5-
trifluormethyl-1-N-benzimidazolyl)-β-D-ribofuranose  132  was  obtained  as  a  side  product 
(fast-Isomer)  in  the  synthesis  5´-O-(4,4´-Dimethoxytriphenylmethyl)-  2´-O-tert.-
butyldimethylsilyl-1´-deoxy-1´-(5-trifluoromethyl-1-N-benzimidazolyl)-β-D-ribofuranose  
131. 
 
Yield:    870 mg (41%)   Exprerimental Part   
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TLC:    Rf=0.45 (hexane/EtOAc,4:1) 
 
1H NMR:  δ [ppm]   (400 MHz, DMSO- d6) 
8.58(s, 1H, 2H); 8.04 (s, 1H, 4H); 7.91 (d, 1H, J=8.56 Hz, 6H); 7.34-6.80(m, 
14H, Har, 7H); 6,01 ( d, J=6,32 Hz, 1H, 1H’); 5.24 (d, J=5,60Hz, 1H, 3’OH); 
4.54 (m, 1H, 2H’); 4.17 ( m, 2H, 3H’,4H'); 3.70( s, 6H, 2OCH3); 3.25(m, 2H, 
5'CH2); 0,67( s, 9H, Si(CH3)3);  -0.13( s, 3H, SiCH3); -0.29( s, 3H, SiCH3);  
13C NMR :    δ [ppm]   (100.6 MHz, DMSO- d6) 
158.30  (DMTr);  144.80  (DMTr);  144.10(C2);  141.10(C4);  136.80(C6); 
135.80(DMTr);  135.30(DMTr);  132.30(C5);  130.75(DMTr);  128.60(DMTr); 
127.80(DMTr);  127.00(DMTr);  123.30(C8);  114.20(CF3);  113.20(DMTr); 
109.7(C7);  107.60(C9);  89.10(C1’);  85.72(DMTr);  83.50(C4’);  73.25(C2’); 
70.10(C3’);  63.30(C5’);  55.00(CH3);  25,80(SiC(CH3)3,-5,10(SiCH3),  -
5,20(SiCH3); 
ESI(+):  m/z 736.8 ([M+H]
+); 
 
 
3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-
triphenylmethyl)-1´-(5-trifluoromethyl-1-N-benzimidazolyl)-2´-O-(tert.-
butyl-dimethylsilyl)-β β β β-D-ribofuranose 133 
 
O
DMTrO
O OTBDMS
N
N
P
O
CN
N
CF3
 
 
C49H62F3N4O7PSi 
935.04 g/mol 
   Exprerimental Part   
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250 mg (0.34 mmol) 5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(5-trifluoromethyl-1-N-benzimidazolyl)-β-D-ribofuranose 131 were dissolved in 10 
ml  abs.  acetonitrile  and  450  µl  (3.4  mmol)  sym.  collidine  and  16  µl  (0.16  mmol)  1-
methylimidazole were added. The reaction mixture was cooled in an icebath to 0°C and 113 
µl (0.50 mmol) 2-cyanethyldiisopropylchlorphosphoramidite 96 was added. The reaction was 
stirred for 15min. at 0°C and 45 min. at RT. The reaction was stopped by adding 10ml of 0.01 
M citric acid and three times extracted with methylene chloride. The combined organic phases 
were washed twice with 0.01 M citric acid, dried over MgSO4 and evaporated to dryness. 
Purification was done by FC with methylene chloride/methanol 99:1 as eluent. The product 
(mixture of two diastereomers) was obtained as white foam. 
 
Yield:    245 mg (77%) 
TLC:    Rf=0.50;0.48 (CH2Cl2/MeOH,99:1) 
1H NMR:  δ [ppm] (400 MHz, CDCl3) 
8.22, 8,17 (s, 2H, 2H); 8.05 (s, 2H, 4H); 7.77-6.81(m, 32H, Har, 5H, 6H, 7H); 
5,93, 5,86 (d, J=5,72Hz, J=7,08Hz, 2H, 1H’); 4.75 (m, 2H, 2H’); 4.40 ( m, 2H, 
3H’); 3.95 (m, 2H, 4H’); 3.80, 3.79(s, 12H, 2OCH3); 3.46(m, 4H, 5'CH2); 
2.66(mm,4H, OCH2); 1.20(m, 12H, CH(CH3)2); 0.75( s, 18H, Si(CH3)3); -0.14( 
s, 6H, SiCH3); -0.39( s, 6H, SiCH3);  
31P NMR:   δ [ppm] (162 MHz, CDCl3): 
153.2 and 150.03 (ratio 1:11) 
ESI(+):  m/z 937.0 ([M+H]
+); 
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2’,3’,5’-Tri-O-acetyl-1’-deoxy-1’-(5-trifluoromethyl-3-N-benzoimidazole- 
1-yl)-β-D-ribofuranose 134 
 
O
AcO
N
N
AcO OAc
CF3
 
C19H19F3N2O7 
444.33 g/mol 
 
2’,3’,5’-Tri-O-acetyl-1’-deoxy-1’-(5-trifluoromethyl-3-N-benzoimidazole-1-yl)-β-D-
ribofuranose 134 was obtained in the same procedure as 129 but like slower migrating isomer 
during  preparative  HPLC  separation  (MN  Nucleoprep  100-20  from  Macherey-Nagel,  n-
hexane:ethyl acetate, 10:20). The product was obtained as white foam . 
 
 
Yield:    1.43g (40%)  
 TLC:    Rf=0.55 (CH2Cl2/MeOH, 95:5) 
1H NMR:   δ [ppm]  (400MHz, DMSO- d6)   
8.75  (s,  1H,  2H);  8.21  (s,  1H,  4H);  7.92  (d,    J=8.48Hz,  1H,  7H),;7.61  (d, 
J=8.68Hz, 1H, 6H); 6.49 (d, J=6.16Hz, 1H, 1H’); 5.69 (t, J=6.20Hz, 1H, 2H’); 
5.44 (m, 1H, 3H’); 4.40 (m, 1H, 4H’); 4.37 (m, 2H, 5H’);  2.08 (s, 3H, CH3), 
2.06 (s, 3H, CH3); 2.03 (s, 3H, CH3);  
13C NMR:   δ [ppm] (100.6 MHz, DMSO- d6) 
170.10, 169.70, 169.00 (C=O); 145.00 (C2); 140.40, 134.00, 123.10, 120.30, 
120.20, 120.10 (arom C); 114.0 (CF3); 87.00 (C1’); 78.50 (C4’); 71.20 ( C2’); 
69.90 ( C3’); 62.70 (C5’); 20.20, 19.90, 19.80 (CH3);  
ESI(+):  m/z 445.0 ([M+H]
+); 
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1’-Deoxy-1’-(5-trifluoromethyl-3-N-benzoimidazole-1-yl)-β-D-ribofuranose 
35 
 
O
HO
N
N
OHOH
CF3
 
 
C13H13F3N2O4 
318.23 g/mol 
 
 2’,3’,5’-Tri-O-acetyl-1’-deoxy-1’-(5-trifluoromethyl-3-N-benzoimidazole-1-yl)-β-D-
ribofuranose 134 (0.34g, 0.8mmol) was dissolved in methanol (15ml) and 111 l of MeONa/ 
MeOH (5.4M, Fluka) were added at room temperature and the reaction was TLC controlled. 
The reaction was complete after 60 min. and    neutralized with DOWEX 50, filtered and 
evaporated. The product was obtained as white foam.  
 
 
Yield:    0.22g ( 90%); 
 TLC:    Rf=0.37 (CH2Cl2/MeOH, 9:1): 
1H NMR:   δ [ppm]   (250 MHz, DMSO- d6 ) 
8.68 (s, 1H, 2H); 8.34 (s, 1H, 4H);  7.88 (d, J=6.40Hz, 1H, 7H); 7.55 (d, 
J=8.55Hz,  1H,  6H);  5.99  (d,  J=6.40Hz,  1H,  1H’);  5.52  (d,  J=6.45Hz,  1H, 
2’OH); 5.28 (, d, J=4.70Hz, 1H, 3OH’); 5.20 (t, J=5.12Hz, 1H, 5OH’); 4.36 (q, 
J= 5.40 Hz, 1H, 2H’);  4.13 (m, 1H, 3H’); 4.02 (q, J=2.95Hz, 1H, 4H’); 3.51 
(m, 2H, 5H’);  
19F-NMR:  δ [ppm] (254.2 MHz, DMSO-d6) 
–59.55 (s, 3F, CF3); 
13C NMR:   δ [ppm] (100.6 MHz, DMSO- d6 ) 
141.10 (C2); 136.10, 132.10, 129.10, 125.20, 125.10, 124.10 (arom C); 114.40 
(CF3); 88.10 (C1’); 87.20 (C4’); 75.20 (C2’); 71.00 ( C3’); 62.20 (C5’);  
ESI(-):   m/z 316.90 ([M-H]
-); 
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1´-Deoxy -5´-O-(4,4´-dimethoxytriphenylmethyl)-1´-(5-trifluoromethyl-3-N-
benzimidazolyl)-β β β β-D-ribofuranose  135 
 
O
DMTrO
N
N
OHOH
CF3
 
 
C34H31F3N2O6 
620.63 g/mol 
 
 1.80  g  (5.65  mmol)  1´-deoxy-1´-(5-trifluoromethyl-3-N-benzimidazolyl)-β-D-ribofuranose  
35  were dissolved in 40 ml abs. pyridine and 1.10 ml (8.50 mmol) triethylamine and 2.00 g 
(6.00 mmol) 4,4´-dimethoxytriphenylmethylchloride were added. The reaction mixture was 
stirred under argon at RT for 20h. The reaction was stopped by adding  5 ml of methanol and 
saturated water solution of NaHCO3. It was three times extracted with methylene chloride, 
organic phases were collected and dried over MgSO4 and than evaporated to dryness. The 
product was twice co-evaporated  with toluene. Further purification was done by  FC with 
methylene chloride/methanol 95:5, as eluent. The product was obtained as yellow foam. 
 
 
Yield:    2.21 g (63%) 
TLC:    Rf=0.29 (CH2Cl2/MeOH, 95:5) 
1H NMR:  δ [ppm]  (250 MHz, DMSO- d6) 
8.58 (s, 1H, 2H), 8.09 (s, 1H, 4H),  7.86 (m, 2H, 6H, 7H), 7.58-6,76 (m, 13H, 
Har), 6,08 (d, 1H, J=7.56Hz, 1H’), 5.71 (d, J=9.44Hz, 1H, 2’OH), 5.25 (d, 
J=8.84Hz,1H, 3OH’), 4.51 (m, 1H, 2H’), 4.17 (m, 2H, 3H’, 4H'), 3.65 (s, 6H, 
2OCH3), 3.21 (m, 2H, 5H’);  
13C NMR:  δ [ppm]    (100.6 MHz,  DMSO- d6) 
158.10 (DMTr); 144.80 (DMTr); 143.00(C2); 141.10(C4); 135.80(C6); 
135.40(DMTr); 135.30(DMTr); 132.30(C5); 130.75(DMTr); 128.00(DMTr); 
127.70(DMTr); 127.00(DMTr); 123.30(C8); 114.10(CF3); 113.20(DMTr);   Exprerimental Part   
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108.7(C7); 107.60(C9); 89.10(C1’); 85.72(DMTr); 83.50(C4’); 73.25(C2’); 
70.10(C3’); 63.60(C5’); 55.05(OCH3);  
ESI(-):   m/z 619.20 ([M-H]
-); 
 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(5-trifluoromethyl-3-N-benzimidazolyl)-β β β β-D-ribofuranose 136 
 
O
DMTrO
N
N
OHOTBDMS
CF3
 
 
C40H42F3N2O6Si 
734.93 g/mol 
 
2.00  g  (3.22  mmol)  5´-O-(4,4´-Dimethoxytriphenylmethyl)-1´-deoxy-1´-β-D-(5-
trifluoromethyl-3-N-benzimidazolyl)-ribofuranose 135 were dissolved in 30 ml of 1:1 mixture  
of  THF/pyridine  and  660  mg  (3.90  mmol)  AgNO3  and  6.00  ml  (6.00  mmol)  1  M  tert.-
butyldimethylsilylchloride-solution  in  THF  were  added.  The  reaction  mixture  was  stirred 
under argon for 20 hours at RT. The reaction was stopped by adding 10 ml of saturated water 
NaHCO3-solution.  Left  AgCl  was  filtered  over  celite  and  the  filtrate  was  extracted  with 
methylene chloride three times. The combined organic phases were dried over MgSO4 and 
evaporated  to  dryness.  The  crude  product  was  twice  co-evaporated  with  toluene.  Further 
purification of product was done by. HPLC (MN Nucleoprep 100-20 of Macherey-Nagel, [n-
hexan/ethylacetat  10:6.67]+30%  methylene  chloride).  The  product    (slow-Isomer)  was 
obtained as white foam. 
 
Yield:    923 mg (39%) 
TLC:    Rf=0.45 (hexane/EtOAc,4:1) 
1H NMR:   δ [ppm]   (400 MHz, DMSO- d6) 
8.63(s, 1H, 2H); 8.07 (s, 1H, 4H); 7.88 (d, 1H, J=8.44 Hz, 7H); 7.32-6.77(m, 
14H, Har, 6H); 6,04 ( d, J=5,12 Hz, 1H, 1H’), 5.55 (d, J=6,24Hz, 1H, 2’OH),   Exprerimental Part   
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4.49 (m, 1H, 2H’); 4.25 ( m, 1H, 3H’); 4,03(m, 1H, 4H'); 3.68( s, 6H, 2OCH3); 
3.23(m, 2H, 5'CH2); 0,78( s, 9H, Si(CH3)3); 0.04( s, 3H, SiCH3), -0.03( s, 3H, 
SiCH3);  
13C NMR :    δ [ppm]   (100.6 MHz, DMSO- d6) 
158.30 (DMTr); 144.80 (DMTr); 144.10(C2); 141.10(C4); 136.80(C6); 
135.80(DMTr); 135.30(DMTr); 132.30(C5); 130.75(DMTr); 128.60(DMTr); 
127.80(DMTr); 127.00(DMTr); 123.30(C8); 114.20(CF3); 113.20(DMTr); 
109.7(C7); 107.60(C9); 89.10(C1’); 85.72(DMTr); 83.50(C4’); 73.25(C2’); 
70.10(C3’); 63.30(C5’); 55.00(CH3); 25,80(SiC(CH3)3,-5,10(SiCH3), -
5,20(SiCH3); 
ESI(+):  m/z  736.6 ([M+H]
+); 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(5-trifluoromethyl-3-N-benzimidazolyl)-β β β β-D-ribofuranose 137 
 
O
DMTrO
N
N
OH TBDMSO
CF3
 
 
C40H42F3N2O6Si 
734.93 g/mol 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(5-
trifluormethyl-3-N-benzimidazolyl)-β-D-ribofuranose  137    was  obtained  as  a  side  product 
(fast-Isomer)  in  the  synthesis  of  5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-
butyldimethylsilyl-1´-deoxy-1´-(5-trifluoromethyl-3-N-benzimidazolyl)-β-D-ribofuranose 
136. 
 
Yield:    947 mg (40%) 
TLC:    Rf=0.45 (hexane/EtOAc,4:1) 
1H NMR:   δ [ppm]  (400 MHz, DMSO- d6) 
8.34 (s, 1H, 2H); 7,92 (d, J=7,12Hz, 1H, 7H); 7.80 (s, 1H, 4H); 7.50-6.80(m, 
14H, Har, 6H); 5,96 ( d, J=6,76 Hz, 1H, 1H’); 5.60 (d, J=7,10Hz, 1H, 3’OH);   Exprerimental Part   
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4.62 (m, 1H, 2H’); 4.35 ( m, 1H, 3H’); 4.11 (m, 1H, 4H’); 3.70( s, 6H, 
2OCH3); 3.52(m, 2H, 5'CH2); 0.80( s, 9H, Si(CH3)3); -0.10( s, 3H, SiCH3);  -
0.36( s, 3H, SiCH3);  
13C NMR :    δ [ppm]   (100.6 MHz, DMSO- d6) 
158.40 (DMTr); 145.80 (DMTr); 143.20(C2); 141.10(C4); 135.90(C6); 
135.460(DMTr); 135.30(DMTr); 132.30(C5); 130.80(DMTr); 128.10(DMTr); 
127.70(DMTr); 127.10(DMTr); 123.40(C8); 114.10(CF3); 113.40(DMTr); 
109.70(C7); 107.70(C9); 89.30(C1’); 85.72(DMTr); 83.60(C4’); 73.25(C2’); 
70.40(C3’); 63.60(C5’); 55.05(OCH3); 26.40(SiC(CH3)3;-5.00(SiCH3), -
5.40(SiCH3); 
ESI(+):  m/z 737.5 ([M+H]
+); 
 
3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-
triphenylmethyl)-1´-(5-trifluoromethyl-3-N-benzimidazolyl)-2´-O-(tert.-
butyl-dimethylsilyl)-β β β β-D-ribofuranose 138 
 
O
DMTrO
O OTBDMS
N
N
P
O
CN
N
CF3
 
 
C49H62F3N4O7PSi 
935.04 g/mol 
 
250 mg (0.34 mmol) 5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
desoxy-1´-(5-trifluoromethyl-1-N-benzimidazolyl)-β-D-ribofuranose  136    were  dissolved  in 
10  ml  abs.  acetonitrile  and  450  µl  (3.4  mmol)  sym.  collidine  and  16  µl  (0.16  mmol)  1-
methylimidazole were added. The reaction mixture was cooled in an icebath to 0°C and 113 
µl  (0.50  mmol)  2-cyanethyldiisopropylchlorophosphoramidite  96  was  added.  The  reaction 
was stirred for 15min. at 0°C and 45 min. at RT. The reaction was stopped by adding of 10 ml   Exprerimental Part   
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of 0.01 M citric acid and three times extracted with methylene chloride. Colected organic 
phases were washed twice with 0.01 M citric acid, dryed over MgSO4 and evaporated to 
dryness. The purification was done by FC with methylene chloride/methanol 99:1 as eluent. 
The product (mixture of two diastereomers) was obtained as white foam. 
 
 
Yield:     251  mg (79%) 
TLC:    Rf=0.59; 0.49 (CH2Cl2/MeOH,99:1) 
1H NMR:   δ [ppm]   (400 MHz, CDCl3) 
8.42, 8,37 (s, 2H, 2H); 8.05 (s, 2H, 4H); 7.77-6.81(m, 32H, Har, 5H, 6H, 7H); 
5,93, 5,86(d, J=5,72Hz, J=7,08Hz, 2H, 1H’); 4.75 (m, 2H, 2H’); 4.40 ( m, 2H, 
3H’); 3,95 (m, 2H, 4H’); 3.,80, 3,79(s, 12H, 2OCH3); 3.46(m, 4H, 5'CH2); 
2,66(m,4H, OCH2); 1,20(m, 12H, CH(CH3)2); 0.75( s, 18H, Si(CH3)3); -0.14( s, 
6H, SiCH3); -0.39( s, 6H, SiCH3);  
31P NMR :  δ [ppm]   (162 MHz, CDCl3) 
155.2 and 153.03 (ratio 1:5.5) 
ESI (+):  m/z 937.1 ([M+H] 
+); 
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1-Methyl-ribofuranose  80 
 
O
HO
OHOH
OCH3
 
C6H12O5 
164.16 g/mol 
 
10 g (66.6 mmol) β-D-Ribofuranose   was dissolved in 140 ml abs. methanol and cooled  to 
0°C. Then 0.6 ml conc. H2SO4 were added and the reaction was stirred for 24 hours at 4°C. 
The reaction mixture was  neutralized with amberlite IRA-93 filtrated on vacuum and the 
filtrate  was  evaporated  to  dryness.  The  product  was  obtained  as  light  yellow  oil,  which 
contains both C (1) epimeres and crystallizes upon storage.  
 
 
Yield:    10.92 g (99.9 %) 
TLC:    Rf = 0.52 (β); 0.45 (α) (CH3CN/H2O 4:1) 
1H-NMR:  δ [ppm] (250 MHz, D2O) 
5.03 (d, J = 4.3 Hz, 1H, 1H (α); 4.93 (d, J = 0.8 Hz, 1H, 1H (β); 4.21 – 3.49 (m, 
16H, 2H, 3H, 4H, 5H, 2-OH, 3-OH, 5-OH (α+β); 3.47 (s, 3H, OCH3 (α), 3.44 
(s, 3H, OCH3 (β); 
13C-NMR:  δ [ppm] (62.9 MHz, D2O) 
107.80 (C1 (β)); 103.04 (C1 (α)); 84.36 (C4 (α)); 82.68 (C4 (β)); 74.05 (C2 
(β)); 70.95 (C2 (α)); 70.63 (C3 (β)); 69.55 (C3 (α)); 62.61 (C5 (β)); 61.38 (C5 
(α)); 55.28 (OCH3 (α)); 55.00 (OCH3 (β)) 
ESI (–):   m/z 163.0 ([M-H] 
-); 
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1-Methyl-2,3,5-tri-O-benzyl-ribofuranose  81 
 
O
BnO
OCH3
OBn BnO  
 
C27H30O5 
434.5 g/mol 
 
10.9 g (66.4 mmol) 1-Methyl-ribofuranose 80   were dissolved in 100 ml THF and 50 g (891 
mmol) of powdered KOH and 70 ml of benzyl chloride were added. The reaction mixture was 
refluxed for 24 hours. After cooling to room temperature the reaction mixture was filtrated 
and the filtrate evaporated under reduced pressure. Most  side products were removed while 
heating up to 170°C on the oil bath. Purification of the crude product was done by FC using 
methylene chloride/methanol 98:2 as eluent. The product was obtained as light yellow oil, 
which contains both C (1) epimeres. 
 
Yield:    24.7 g (85.7 %) 
TLC:    Rf = 0.55 (α); 0.49 (β)  (CH2Cl2/MeOH 98:2) 
1H-NMR:  δ [ppm] (250 MHz, CDCl3) 
7.38 – 7.24 (m, 30 H, Har(α+β)); 4.91 (d, J = 0.8 Hz, 1H, 1H(β)); 4.87 (d, J = 
4.0 Hz, 1H, 1H(α)); 4.64 – 4.42 (m, 12H, CH2-benzyl (α+β)); 4.34 (m, 1H, 
4H(β)); 4.24 (m, 1H, 4H(α)); 4.01 (dd, J = 4.7 Hz, J = 7.0 Hz, 1H, 3H(β)); 3.83 
(dd, J = 1.0 Hz, J = 4.7 Hz, 1H, 2H(β)); 3.77 (m, 2H, 2H(α), 3H(α)); 3.55 (m, 
2H,  5H(β));  3.46  (s,  3H,  OCH3(α));  3.37  (m,  2H,  5H(α));  3.30  (s,  3H, 
OCH3(β)) 
13C-NMR:  δ [ppm] (62.9 MHz, CDCl3) 
138.21  (Car);  137.73  (Car);  128.25  (Car);  128.21  (Car);  128.16  (Car);  127.80 
(Car);  127.73  (Car);  127.65  (Car);  127.63  (Car);  127.62  (Car);  127.48  (Car); 
127.43 (Car); 127.35 (Car); 106.25 (C1); 80.35 (C4); 79.62 (CH2-benzyl); 78.29 
(CH2-benzyl); 73.03 (CH2-benzyl); 72.29 (C3); 72.17 (C2); 71.21 (C5); 54.91 
(OCH3) 
ESI(+):  m/z  452.1 ([M+NH4]
+);   Exprerimental Part   
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2,3,5-Tri-O-benzyl-ribofuranose 82 
 
O
BnO
OH
OBn BnO  
 
C26H28O5 
420.48 g/mol 
 
19.9 g (45.8 mmol) 1-Methyl-2,3,5-tri-O-benzyl-ribofuranose 81  were dissolved in 350 ml of 
dioxane and 150 ml 0,1 N HCl solution and reaction mixture was refluxed for 20 hours. After 
cooling to room temperature 15 ml of 1 N NaOH were added to neutralise the solution and the 
reaction  was  evaporated  to  dryness.  Left  oil  was  extracted  with  methylene  chloride  three 
times, dried over MgSO4 and evaporated under reduced pressure. The purification was done 
by FC with methylene chloride/methanol 98:2 as eluent. The product was obtained as light 
yellow oil which contains both C (1) epimeres. 
 
 
Yield:    18.02 g (93.6 %) 
TLC:    Rf = 0.32 (CH2Cl2/MeOH 98:2) 
1H-NMR:  δ [ppm] (250 MHz, CDCl3) 
7.36 – 7.19 (m, 15H, Har); 5.28 (m, 1H, 1H); 4.70 – 4.26 (m, 7H, CH2-benzyl, 
1-OH); 4.19 (m, 1H, 4H); 3.96 (m, 1H, 3H); 3.73 (m, 1H, 2H); 3.44 (m, 2H, 
5H) 
13C-NMR:  δ [ppm] (62.9 MHz, CDCl3) 
137.75  (Car);  137.68  (Car);  137.61  (Car);  137.34  (Car);  137.24  (Car);  128.33 
(Car);  128.30  (Car);  128.26  (Car);  127.68  (Car);  127.79  (Car);  127.71  (Car); 
127.64 (Car); 127.57 (Car); 127.43 (Car); 100.21, 96.09 (C1); 80.90, 80.67 (C4); 
77.64  (CH2-benzyl);  77.58  (CH2-benzyl);  77.16  (CH2-benzyl);  73.35,  72.67 
(C3); 72.32, 72.15 (C2); 69.88, 69.42 (C5) 
ESI (+):  m/z  438.3 ([M+NH4]
+); 
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2,3,5-Tri-O-benzyl-ribono-γ γ γ γ-lacton 83 
 
O
BnO
OBn BnO
O
 
 
C26H26O5 
418.47 g/mol 
 
17.71 g (42.1 mmol) 2,3,5-Tri-O-benzyl-ribofuranose  82  were dissolved in 60 ml of DMSO 
and  42  ml  of  acetic  anhydride  were  added.  The  reaction  mixture  was  stirred  at  room 
temperature 24 hours and pourred in icewater. It was extracted three times with methylene 
chloride and with saturated solution of NaHCO3. Organic phases were collected and dried 
over MgSO4 and evaporated to dryness. Left DMSO was evaporated under reduced pressure 
(oil pump vacuum). Further purification was done by FC using methylene chloride/methanol 
99:1 as eluent. The product was obtained as yellow oil, which crystallizes upon storage. 
 
 
Yield:    16.84 g (95.5 %) 
TLC:    Rf = 0.70 (CH2Cl2/MeOH 98:2) 
1H-NMR:  δ [ppm] (250 MHz, CDCl3) 
7.29 – 7.07 (m, 15H, Har); 4.87 und 4.66 (AB, Ja,b = 12.0 Hz, 2H, CH2-benzyl) 
4.61 und 4.48 (AB, Ja,b = 9.0 Hz, 2H, CH2-benzyl); 4.47 – 4.31 (m, 4H, 2H, 
4H, CH2-benzyl); 4.02 (dd, J = 2.1 Hz, J = 5.6 Hz, 1H, 3H); 3.50 (ψdq, J = 2.8 
Hz, J = 11.0 Hz, J = 14.5 Hz, 2H, 5H); 
13C-NMR:  δ [ppm] (62.9 MHz, CDCl3) 
173.52  (C1);  137.12  (Car);  137.00  (Car);  136.83  (Car);  128.39  (Car);  128.35 
(Car);  128.34  (Car);  128.25  (Car);  128.10  (Car);  127.95  (Car);  127.90  (Car); 
127.83 (Car); 127.63 (Car); 127.45 (Car); 81.64 (C4); 75.26 (C3); 73.61 (C2); 
73.50 (CH2-benzyl); 72.58 (CH2-benzyl); 72.25 (CH2-benzyl); 68.62 (C5); 
ESI(+):  m/z 436.4 ([M+NH4]
+); 
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2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-(2,4-difluorphenyl)-β β β β-D-ribofuranose 139 
 
O
BnO
F
F
OBn BnO  
 
C32H30F2O4 
516.56 g/mol 
 
To the solution that contains 150 µl (1.3 mmol) 1-bromo-2, 4-difluorbenzol in 10 ml abs. 
diethyl ether  at –78°C under argon over 10 minutes 2.4 ml of 1.6 M solution of  n-butyl 
lithium in n-hexane were added. After 20 minutes at –78°C  solution of 2,3,5-tri-O-benzyl-
ribono-γ-lacton  83    (1.0 g, 2.4 mmol)  in 5 ml abs. diethyl ether over 30 minutes was added 
and 1 hour stirred at –78°C. Afterwards the reaction mixture was allowed to warm up to -
20°C over two hours. The reaction was stopped by adding 5 ml of water and three times 
extracted with etar. The combined organic phases were dried over MgSO4 and evaporated to 
dryness. Left oil was immediately dissolved in 10 ml of methylene chloride, cooled to -78°C 
and 600 µl (4.8 mmol) bortrifluorid -ethyletherat and 760 µl (4.8 mmol) triethylsilane were 
added. The reaction mixture was left at -78°C and  allowed to warm up to 10°C over night. 
The  reaction  was  stopped  by  adding  10  ml  of  saturated  water  solution  of  NaHCO3  and 
extracted three times with methylene chloride. The combined organic phases were dried over 
MgSO4 and evaporated under reduced pressure. Further purification was done by FC using  n-
hexane/ethyl acetate 4:1 as eluent. The product was obtained as light orange solid.  
 
 
Yield:    1.04 g (84.6 %) 
TLC:    Rf =  0.35 (n-hexane/ethyl acetate 4:1) 
1H-NMR:  δ [ppm] (270 MHz, DMSO-d6) 
7.59 (Ψq, J = 6.9 Hz, 1H, 6H); 7.29 (m, 16H, Har, 3H); 6.93 (dt, J = 8.4 Hz, J = 
2.2 Hz, 1H, 5H); 5.17 (d, J = 4.5 Hz, 1H, 1´H); 4.55 (m, 6H, CH2-benzyl); 4.22 
(q, J = 3.9 Hz, 1H, 4´H); 4.05 (m, 2H, 2´H, 3´H); 3.67 (m, 2H, 5´H); 
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13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
162.51  (C4);  158.87  (C2);  138.18  (Car);  138.10  (Car);  137.96  (Car);  129.36 
(C6);  128.22  (Car);  128.09  (Car);  127.70  (Car);  127.50  (Car);  127.42  (Car); 
127.11 (Car); 123.61 (C1); 111.30 (C5); 103.62 (C3); 82.10 (C1´); 80.72 (C4´); 
76.84 (C2´); 75.96 (C3´); 72.40 (CH2-benzyl); 71.04 (CH2-benzyl); 69.73 (C5´; 
ESI(+):  m/z 534.4 ([M+NH4] 
+); 
 
 
1´-Deoxy-1´-(2,4-difluorophenyl)-β β β β-D-ribofuranose  9 
 
 
O
HO
OHOH
F
F
 
 
C11H12F2O4 
246.2 g/mol 
 
6.5 g (12.6 mmol) 2´, 3´, 5´-Tri-O-benzyl-1´-deoxy-1´-(2,4-difluorophenyl)-β-D-ribofuranose  
139    was  dissolved  in  100  ml  abs.  ethanol  and  50  ml  cyclohexene  and  1  g  palladium-
hydroxide (20%) on carbon was added. The reaction mixture was refluxed for 3 hours. Than 
the  reaction  mixture  was  filtrated  over  celite  and  filtrate  was  evaporated  under  reduced 
pressure. The purification was done by FC with methylene chloride/methanol 9:1, as eluent. 
Product was obtained as colourless solid. For analytical purposes the product was crystallized 
from water and methanol. 
 
Yield:    3.08 g (99.3 %) 
TLC:    Rf =  0.42 (CH2Cl2/MeOH 9:1) 
1H-NMR:  δ [ppm] (270 MHz, DMSO-d6)   Exprerimental Part   
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7.65 (Ψq, J = 6.9 Hz, 1H, 6H); 7.18 (m, 1H, 3H); 7.07 (dt, J = 8.6 Hz, J = 2.4 
Hz, 1H, 5H); 5.04 (d, J = 6.0 Hz, 1H, 2´-OH); 4.91 (d, J = 5.0 Hz, 3´-OH); 4.84 
(m, 2H, 1´H, 5´-OH); 3.85 (m, 3H, 2´H, 3´H, 4´H); 3.57 (m, 2H, 5´H) 
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
162.58  (C4);  158.94  (C2);  129.67  (C6);  124.40  (C1);  114.74  (C5);  103.42 
(C3); 84.59 (C1´); 77.08 (C4´); 76.65 (C2´); 70.94 (C3´); 61.59 (C5´) 
19F-NMR:  δ [ppm] (254.2 MHz, DMSO-d6) 
–112.0 (1F, 4F); –114.74 (1F, 2F) 
ESI(–):    m/z 245.0 ([M-H]
-); 
 
 
5´-O- (4,4´-Dimethoxytriphenylmethyl)- 1´-deoxy-1´-(2,4-difluorophenyl)-β β β β-
D-ribofuranose 140 
 
 
O
DMTrO
OHOH
F
F
 
 
C32H30F2O6 
548.56 g/mol 
 
1.0 g (4.0 mmol) 1´-Deoxy-1´-(2,4-difluorophenyl)-β-D-ribofuranose 9 was dissolved in 25 
ml  abs.  pyridine  and  0.84  ml  (6.0  mmol)  triethylamine  and  1.63  g  (4.8  mmol)  4,4´-
dimethoxytriphenylmethylchloride were added. The reaction mixture was stirred under argon 
at RT for 2.5 hours. The reaction was stopped by adding of 3 ml of methanol and saturated 
water solution of NaHCO3. It was extracted with methylene chloride three times, organic 
phases were collected and dried over MgSO4 and than evaporated to dryness. The product was 
twice  co-evaporated  with  toluene.  Further  purification  was  done  by  FC  with  methylene 
chloride/methanol 98:2 as eluent. The product was obtained as yellow foam. 
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Yield:    1.86 g (83.4 %) 
TLC:    Rf =  0.48 (CH2Cl2/MeOH 95:5) 
1H-NMR:  δ [ppm] (270 MHz, DMSO-d6) 
7.56 (Ψq, J = 6.8 Hz, 1H, 6H); 7.45 – 6.86 (m, 15H, Har, 3H, 5H); 5.19 (d, J = 
5.4 Hz, 1H, 2´-OH); 4.98 (d, J = 5.2 Hz, 1H, 3´-OH); 4.92 (d, J = 4.3 Hz, 1H, 
1´H); 3.98 (q, J = 5.2 Hz, 1H, 2´H); 3.90 (m, 2H, 3´H, 4´H); 3.74 (s, 6H, 
OCH3); 3.20 (m, 2H, 5´H)  
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
161.71 (C4); 161.53 (C2); 158.04 (DMTr); 144.87 (DMTr); 135.63 (DMTr); 
135.54  (DMTr);  129.71  (DMTr);  129.11  (C6);  127.76  (DMTr);  127.72 
(DMTr); 126.63 (DMTr); 124.28 (C1); 113.13 (DMTr); 111.12 (C5); 103.69 
(C3); 85.40 (DMTr); 82.25 (C1´); 78.10 (C4´); 76.36 (C2´); 70.93 (C3´); 63.77 
(C5´); 54.98 (OCH3) 
ESI(–):    m/z 547.2 ([M-H]
-); 
 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(2,4-difluorophenyl)-β β β β-D-ribofuranose  141 
 
 
O
DMTrO
OHOTBDMS
F
F
 
 
C38H44F2O6Si 
668.1 g/mol 
 
2.35  g  (4.3  mmol)  5´-O-(4,4´-Dimethoxytriphenylmethyl)-1´-deoxy-1´-β-D-(2,4-
difluorophenyl)-ribofuranose 140 were dissolved in 40 ml of  1:1 mixture of THF/pyridine 
and  with  870  mg  (5.2  mmol)  AgNO3  and  6.0  ml  (6.0  mmol)  1  M  tert.-
butyldimethylsilylchloride-solution in THF were added. The reaction mixture was stirred for 
20 hours at RT under argon. Adding 10ml of saturated water NaHCO3-solution stopped the   Exprerimental Part   
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reaction. Left AgCl was filtered over celite and filtrate was extracted with methylene chloride 
three times. Collected organic phases were dried over MgSO4 and evaporated to dryness. The 
crude product was co-evaporated with toluene twice. Further purification of  the product was 
done  by FC with methylene chloride as eluent. The product was obtained as white foam. 
 
 
Yield:    1.01 g (35.5 %) 
TLC:    Rf =  0.18 (CH2Cl2) 
1H-NMR:  δ [ppm] (270 MHz, DMSO-d6) 
7.59 (q, J = 6.7 Hz, 1H, 6H); 7.45 – 6.82 (m, 15H, Har, 3H, 5H); 4.96 (d, J = 
5.7 Hz, 1H, 3´-OH); 4.84 (d, J = 5.7 Hz, 1H 1´H); 4.02 (m, 2H, 3´H, 4´H); 3.93 
(t, J = 5.2 Hz, 1H, 2´H); 3.74 (s, 6H, OCH3); 3.21 (m, 2H, 5´H); 0.79 (s, 9H, 
SiC(CH3)3); –0.05 (SiCH3); –0.11 (SiCH3) 
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
161.69 (C2); 161.51 (C4); 158.04 (DMTr); 144.87 (DMTr); 135.46 (DMTr); 
135.41 (DMTr); 129.71 (DMTr); 129.68 (DMTr); 129.07 (dd, J = 11.6 Hz, J = 
7.8 Hz, C6); 127.73 (DMTr); 127.62 (DMTr); 123.85 (C1); 113.12 (DMTr); 
111.12  (C5);  103.61  (C3);  85.45  (DMTr);  82.94  (C1´);  78.79  (C4´);  77.20 
(C2´);  70.20  (C3´);  63.51  (C5´);  54.97  (OCH3);  25.50  (SiC(CH3)3);  17.78 
(SiC(CH3)3); –4.93 (SiCH3); –5.47 (SiCH3) 
ESI(–):    m/z 661.6 ([M-H]
-); 
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5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-tert.-butyldimethylsilyl-1´-deoxy-
1´-(2,4-difluorophenyl)-β β β β-D-ribofuranose 142 
 
 
O
DMTrO
F
F
OH TBDMSO  
 
 
C38H44F2O6Si 
662.81 g/mol 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(2,4-
difluorophenyl)-β-D-ribofuranose 142   was obtained as a side product while synthesizing  5´-
O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(2,4-difluor-
phenyl)-β-D- ribofuranose 141 . 
 
Yield:    890 mg (31.4 %) 
TLC:    Rf =  0.21 (CH2Cl2) 
1H-NMR:  δ [ppm] (270 MHz, DMSO-d6) 
7.61 (q, J = 8.2 Hz, 1H, 6H); 7.45 – 6.84 (m, 15H, Har, 3H, 5H); 4.96 (d, J = 
6.6 Hz, 1H, 2´OH); 4.83 (d, J = 5.6 Hz, 1H, 1´H); 4.02 (m, 1H, 3´H); 3.94 (m, 
1H; 2´H); 3.73 (s, 6H, OCH3); 3.29 (m, 1H, 4´H); 3.15 (m, 2H, 5´H); 0.76 
(SiC(CH3)3); –0.01 (SiCH3); –0.08 (SiCH3) 
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
161.65 (C2); 161.49 (C4); 158.05 (DMTr); 144.67 (DMTr); 135.46 (DMTr); 
135.42 (DMTr); 129.67 (DMTr); 129.13 (C6); 127.71 DMTr); 127.63 (DMTr); 
126.63 (DMTr); 123.82 (C1); 113.11 (DMTr); 111.30 (C5); 103.59 (C3); 85.46 
(DMTr);  82.52  (C1´);  78.29  (C4´);  75.94  (C2´);  72.63  (C3´);  63.21  (C5´); 
54.97 (OCH3); 25.64 (SiC(CH3)3); 17.82 (SiC(CH3)3); –4.59 (SiCH3); –5.21 
(SiCH3) 
ESI(–):    m/z 661.4 ([M-H]
-); 
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3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-
triphenylmethyl)-1´-(2,4-difluorophenyl)-2´-O-tert.-butyldimethylsilyl-β β β β-D-
ribofuranose  143 
 
 
O
DMTrO
O OTBDMS
F
F
P
O
CN
N
 
 
C47H61F2N2O7PSi 
863.01 g/mol 
 
250 mg (0.38 mmol) 5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(4,6-difluorobenzimidazolyl)-β-D-ribofuranose  141  were  dissolved  in  12  ml  abs. 
acetonitrile and 500 µl (3.8 mmol) sym. collidine and 15 µl (0.19 mmol) 1-methylimidazole 
were added. The reaction mixture was cooled in an icebath to 0°C and 128 µl (0.43 mmol) 2-
cyanethyldiisopropylchlorphosphoramidit 96 were added. The reaction was stirred for 15 min. 
at 0°C and for 1 hour. At RT. The reaction was stopped by adding of 10 ml of 0.01 M citric 
acid  and  three  times  extracted  with  methylene  chloride.  Combined  organic  phases  were 
washed  twice  with  0.01  M  citric  acid,  dried  over  MgSO4  and  evaporated  to  dryness. 
Purification was done by FC with n-hexane/ethyl acetate, 4:1, as eluent. The product (mixture 
of two diastereomers) was obtained as white foam. 
 
 
Yield:    250 mg (76.8 %) 
TLC:    Rf =  0.34; 0.36 (n-hexan/ethylacetat 4:1)
 
1H-NMR:  δ [ppm] (270 MHz, DMSO-d6) 
7.67 (m, 2H, 6H); 7.53 – 6.77 (m, 30H, Har, 3H, 5H); 5.14, 5.12 (d, J = 7.7 Hz, 
J = 6.8 Hz, 2H, 1´H); 4.23 (m, 6H, 2´H, 3´H, 4´H); 3.80, 3.79 (s, 12H, OCH3);   Exprerimental Part   
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3.54 (m, 4H, 5´H); 1.17 (m, 12H, CH(CH3)2); 0.82 (s, 18H, SiC(CH3)3); –0.05 
(s, 6H, SiCH3); –0.17 (s, 6H, SiCH3) 
31P-NMR:  δ [ppm] (162 MHz, CDCl3) 
150.70 and 148.85 (ratio 1 : 3.8) 
ESI(+):  m/z 863.6 ([M+H]
+); 
 
2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-(4-fluorophenyl)-β β β β-D-ribofuranose 144 
 
 
O
BnO
F
OBn BnO  
 
 
C32H31FO4 
498.57 g/mol 
 
To the solution that contains 2.73 ml (25 mmol) 1-Bromo-4-fluorobenzene in 80 ml THF was 
stirred at  –78°C under argon over 10 minutes and 15.6 ml 1.6 M solutiom of  n-butyl lithium 
in n-hexane were added. After 20 minutes at –78°C a solution of 2,3,5-tri-O-benzyl-ribono-γ-
lacton  83  (7.0 g, 16.7 mmol) in 50 ml THF was added over 30 minutes (via cannula) and 1 
hour stirred at  –78°C. Afterwards the reaction mixture was allowed to warm up to -20°C over 
two hours. The reaction was stopped by adding  30 ml of water and three times extracted with 
ether. The collected organic phases were dried over MgSO4 and evaporated to dryness. Left 
oil was immediately dissolved in 10 ml of methylene chloride, cooled to -78°C and 4.2 ml 
(33.4 mmol) bortrifluorid ethyletherat and 5.3 ml (33.4 mmol) triethylsilane were added. The 
reaction mixture was left at -78°C and  over night allowed to warm up to 10°C. The reaction 
was stopped by adding of 10 ml of saturated water solution of NaHCO3, extracted three times 
with  methylene  chloride  .  The  combined  organic  phases  were  dried  over  MgSO4  and 
evaporated under reduced pressure. Further purification was done by FC using  n-hexan/ethyl 
acetate 4:1 as eluent. The product was obtained as light orange solid.  
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Yield:    6.31 g (75.8 %) 
TLC:    Rf =  0.35 (n-hexane/ethyl acetate 4:1) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
7.44 – 7.08 (m, 19H, Har); 4.87 (d, J = 6.8 Hz, 1H, 1´H); 4.61 – 4.42 (m, 6H, 
CH2-benzyl); 4.24 (q, J = 3.8 Hz, 1H, 4´H); 4.07 (dd, J = 4.8 Hz, 3.8 Hz, 1H, 
3´H); 3.87 (dd, J = 5.0 Hz, J = 6.8 Hz, 1H, 2´H); 3.64 (m, 2H, 5´H) 
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
138.19  (Car);  137.95  (Car);  136.63  (C1);  128.18  (Car);  128.11  (Car);  128.05 
(Car);  127.74  (Car);  127.43  (Car);  127.36  (Car);  123.99  (C5);  114.95  (C2); 
114.64 (C6); 83.41 (C1´); 81.23 (C4´); 81.08 (C2´); 77.27 (C3´); 72.41 (CH2-
benzyl); 71.10 (CH2-benzyl); 70.96 (CH2-benzyl); 70.27 (C5´) 
ESI(+):  m/z 516.2 ([M+H]
+); 
 
 
1´-Deoxy-1´-(4-fluorophenyl)-β β β β-D-ribofuranose 36 
 
 
O
HO
OHOH
F
 
 
C11H13FO4 
228.21 g/mol 
 
3.0  g  (6.0  mmol)  2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-(4-fluorophenyl)-β-D-ribofuranose  144  
were dissolved in 60 ml abs. ethanol and 30 ml cyclohexene and 600 mg palladium-hydroxide 
(20%)  on  carbon  were  added.  The  reaction  mixture  was  refluxed  for  5  hours.  Then  the 
reaction  mixture  was  filtrated  over  celite  and  the  filtrate  was  evaporated  under  reduced 
pressure. Purification was done by FC with methylene chloride/methanol 9:1 as eluent. The 
product was obtained as colourless solid. For analytical purposes it was  crystallized from 
water and methanol. 
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Yield:    1.36 g (99.5 %) 
TLC:    Rf = 0.39 (CH2Cl2/MeOH 9:1) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
7.42 (m, 2H, Har); 7.14 (m, 2H, Har); 4.97 (d, J = 7.0 Hz, 1H, 1´H); 4.91 (d, J = 
4.7 Hz, 1H, 3´-OH); 4.82 (t, J = 5.5 Hz, 1H, 5´-OH); 4.56 (d, J = 7.3 Hz, 1H, 
2´-OH); 3.89 (m, 1H, 3´H); 3.81 (m, 1H, 4´H); 3.66 (m, 1H, 2´H); 3.54 (m, 2H, 
5´H) 
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
137.72 (C1); 128.06 (C3); 114.79 (C2); 114.47 (C6); 85.18 (C1´); 82.21 (C4´); 
77.55 (C2´); 71.35 (C3´); 61.97 (C5´) 
19F-NMR:  δ [ppm] (254.2 MHz, DMSO-d6) 
-115.87 (1F, 4F) 
ESI(–):    m/z 227.0 ([M-H]
-); 
 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)- 1´-deoxy-1´-(4-fluorophenyl)-β β β β-D-
ribofuranose  145 
 
 
O
DMTrO
OHOH
F
 
 
 
C32H31FO6 
530.57 g/mol 
1.37 g (6.0 mmol) 1´-Deoxy-1´-(4-fluorophenyl)-β-D-ribofuranose 36 were dissolved in 30 
ml  abs.  pyridine  and  1.25  ml  (9.0  mmol)  triethylamine  and  2.44  g  (7.2  mmol)  4,4´-
dimethoxytriphenylmethylchloride were added. The reaction mixture was stirred under argon 
at RT for 4.5 hours. Adding 3 ml of methanol stopped the reaction and the saturated water 
solution of NaHCO3 was added. It was three times extracted with methylene chloride, organic 
phases were collected and dried over MgSO4 and than evaporated to dryness. The product was   Exprerimental Part   
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twice  co-evaporated  with  toluene.  Further  purification  was  done  by  FC  with  methylene 
chloride/methanol 98:2 as eluent. The product was obtained as yellow foam. 
 
Yield:    2.52 g (79.1 %) 
TLC:    Rf = 0.37 (CH2Cl2/MeOH 98:2) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
7.48 – 6.87 (m, 17H, Har); 5.13 (d, J = 6.7 Hz, 1H, 1´H); 5.01 (d, J = 5.1 Hz, 
1H, 3´-OH); 4.66 (d, J = 6.6 Hz, 1H, 2´-OH); 3.98 (m, 1H, 4´H); 3.89 (q, J  = 
4.9 Hz, 1H, 3´H); 3.74 (s, 7H, 2´H, OCH3); 3.18 m, 2H, 5´H) 
13C-NMR:  δ [ppm] (62.9 MHz, DMSO-d6) 
158.07 (DMTr); 149.63 (C4); 144.95 (DMTr); 137.44 (C1); 135.63 (DMTr); 
129.76  (DMTr);  127.84  (DMTr);  127.78  (DMTr);  126.68  (DMTr);  123.91 
(C5); 115.03 (C2); 114.70 (C6); 113.18 (DMTr); 85.40 (DMTr); 83.19 (C1´); 
82.69 (C4´); 77.60 (C2´); 71.42 (C3´), 64.14 (C5´); 55.03 (OCH3) 
ESI(–):    m/z 529.2 ([M-H]
-); 
 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(4-fluorophenyl)-β β β β-D-ribofuranose  146 
 
 
O
DMTrO
OHOTBDMS
F
 
 
 
C38H45FO6Si 
644.82 g/mol 
 
530  mg  (1.0  mmol)  5´-O-(4,4´-Dimethoxytriphenylmethyl)-1´-deoxy-1´-β-D-(4-
fluorophenyl)-ribofuranose 145 was dissolved in 10 ml of 1:1 mixture of THF/pyridine and 
with 204 mg (1.2 mmol) AgNO3 and 1.4 ml (1.4 mmol) 1 M tert.-Butyldimethylsilylchloride-  Exprerimental Part   
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solution in THF were added. The reaction mixture was stirred for 20 hours at RT under argon. 
Adding 10ml of saturated water NaHCO3-solution stopped the reaction. Precipitated AgCl 
was filtered over celite and filtrate was extracted with methylene chloride three times. The 
combined  organic  phases  were  dried  over  MgSO4  and  evaporated  to  dryness.  The  crude 
product was twice co-evaporated with toluoene. Further purification of product was done by 
FC with methylene chloride as eluent. The product was obtained as white foam. 
 
Yield:    280 mg (43.5 %) 
TLC:    Rf =  0.22 (CH2Cl2) 
1H-NMR:  δ [ppm] (400 MHz, DMSO-d6) 
7.49 – 6.83 (m, 17H, Har); 4.77 (d, J = 4.4 Hz, 1H, 3´-OH); 4.67 (d, J = 6.4 Hz, 
1H, 1´H); 4.00 (m, 1H, 4´H); 3.93 (m, 2H, 2´H, 4´H); 3.73 (s, 6H, OCH3); 3.28 
(m,  1H,  5´H);  3.15  (m,  1H,  5´´H);  0.78  (s,  9H,  SiC(CH3)3);  –0.11  (s,  3H, 
SiCH3); –0.17 (s, 3H; SiCH3) 
13C-NMR:  δ [ppm] (100.6 MHz, DMSO-d6) 
158.07 (DMTr); 144.96 (C4); 144.75 (DMTr); 137.22 (C1); 135.52 (DMTr); 
135.44  (DMTr);  129.74  (DMTr);  129.71  (DMTr);  129.66  (DMTr);  128.88 
(DMTr);  128.19  (DMTr);  127.89  (DMTr);  127.61  (DMTr);  126.67  (C3); 
114.94 (C2); 114.73 (C6); 113.14 (DMTr); 85.57 (DMTr); 83.50 (C1´); 82.68 
(C4´);  79.59  (C2´);  71.56  (C3´);  63.83  (C5´);  55.00  (OCH3);  25.57 
(SiC(CH3)3); 17.85 (SiC(CH3)3); –5.07 (SiCH3); –5.30 (SiCH3) 
ESI(–):    m/z 643.0 ([M-H]
-); 
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5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(4-fluorophenyl)-β β β β-D-ribofuranose  147 
 
 
O
DMTrO
F
OH TBDMSO  
 
 
C38H45FO6Si 
644.82 g/mol 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(4-
fluorophenyl)-β-D-ribofuranose 147  was obtained as a side product in the synthesis of 5´-O-
(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-(4-fluorophenyl)-
β-D-ribofuranose 146.    
 
Yield:    270 mg (42.0 %) 
TLC:    Rf =  0.42 (CH2Cl2) 
1H-NMR:  δ [ppm] (400 MHz, DMSO-d6) 
7.49 – 6.87 (m, 17H, Har); 4.89 (d, J = 7.2 Hz, 1H, 2´-OH); 4.66 (d, J = 6.7 Hz, 
1H, 1´H); 4.01 (m, 1H, 3´H); 3.94 (m, 1H, 4´H); 3.75 (m, 1H, 2´H); 3.73 (s, 
6H, OCH3); 3.29 (m, 1H, 5´H); 3.09 (m, 1H, 5´´H); 0.79 (s, 9H, SiC(CH3)3); 
0.01 (s, 3H, SiCH3); –0.05 (s, 3H; SiCH3) 
13C-NMR:  δ [ppm] (100.6 MHz, DMSO-d6) 
158.07 (DMTr); 144.96 (C4); 144.75 (DMTr); 137.21 (C1); 135.51 (DMTr); 
135.44  (DMTr);  129.74  (DMTr);  129.70  (DMTr);  129.66  (DMTr);  128.19 
(DMTr); 127.77 (DMTr); 127.66 (DMTr); 126.67 (C3); 114.94 (C2); 114.73 
(C6); 113.14 (DMTr); 85.46 (DMTr); 83.93 (C1´); 82.27 (C4´); 77.27 (C2´); 
73.29  (C3´);  63.49  (C5´);  54.99  (OCH3);  25.74  (SiC(CH3)3);  17.95 
(SiC(CH3)3); –4.51 (SiCH3); –5.09 (SiCH3) 
ESI(–):    m/z 643.4 ([M-H]
-);   Exprerimental Part   
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3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-
triphenylmethyl)-1´-(4-fluorophenyl)-2´-O-tert.-butyldimethylsilyl-β β β β-D-
ribofuranose  148 
 
 
O
DMTrO
O OTBDMS
F
P
O
CN
N
 
 
 
C47H62FN2O7PSi 
845.02 g/mol 
 
200 mg (0.31 mmol) 5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(4-fluorophenyl)-β-D-ribofuranose 146 were dissolved in 10 ml abs. acetonitrile and 
440 µl (3.1 mmol) sym. collidine and 14 µl (0.18 mmol) 1-methylimidazole were added. The 
reaction  mixture  was  cooled  in  an  ice  bath  to  0°C  and  112  µl  (0.33  mmol)  2-
cyanethyldiisopropylchlorophosphoramidit 96 were added. The reaction was stirred for 15 
min. at 0°C and 15 min. at RT. The reaction was stopped by adding of 10 ml of 0.01 M citric 
acid and  extracted with methylene chloride three times. The combined organic phases were 
washed  with  0.01M  citric  acid  twice,  dried  over  MgSO4  and  evaporated  to  dryness. 
Purification was done by FC with n-hexane/ethyl acetate, 4:1 as eluent. The product (mixture 
of two diastereomers) was obtained as white foam. 
 
 
Yield:    176 mg (67.22 %) 
TLC:    Rf =  0.42 (n-Hexan/Ethylacetat 4:1)
 
1H-NMR:  δ [ppm] (270 MHz, CDCl3) 
7.51 – 6.81 (m, 34H, Har); 4.75, 4.70 (d, J = 8.2 Hz, J = 8.1 Hz, 2H, 1´H); 4.17 
(m,  2H,  3´H);  4.12  (m,  2H,  2´H);  3.98  (m,  2H,  4´H);  3.79,  3.78  (s,  12H,   Exprerimental Part   
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OCH3); 3.54 (m, 6H, 5´H, CH2CN); 3.19 (m, 2H, 5´´H); 2.66 (m, 4H, OCH2); 
1.17  (m,  12H,  CH(CH3)2);  0.80,  0.79  (m,  18H,  SiC(CH3)3);  –0.10,  –0.12,         
–0.20, –0.28 (s, 12H, SiCH3) 
31P-NMR:  δ [ppm] (162 MHz, CDCl3) 
151.37 and 148.68 (ratio 1 : 3.25) 
ESI (+):  m/z 845.8 ([M+H]
+); 
 
 
2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-(2,4,6-trifluorophenyl)-β β β β-D-ribofuranose  
90 
 
 
O
BnO
F
F
OBn BnO
F
 
 
C32H29F3O4 
534.54 g/mol 
 
To solution that contains 0.8g (5.8 mmol) 2, 4, 6-trifluorobenzene in 10 ml abs. diethyl ether  
at –78°C under argon was  over 30 minutes 3.90 ml 1.5 M (5.8 mmol) solution of  t-butyl 
lithium  in  n-pentane  were  added.  After  30  minutes  at  –78°C  the  solution  of  2,3,5-Tri-O-
benzyl-ribono-γ-lacton (2.0 g, 4.8 mmol) 83 in 20 ml abs. diethyl ether over 30 minutes wasw 
added and 1 hour stirred at –78°C.Afterwards the reaction mixture was allowed to warm up to 
-20°C over two hours. The reaction was stopped by adding  5 ml of water and three times 
extracted with ether. The combined organic phases were dried over MgSO4 and evaporated to 
dryness. Left oil was immediately dissolved in 20 ml of methylene chloride, cooled to -78°C 
and 1.20 ml (9.6 mmol) bortrifluorid ethyletherat and 1.50 µl (9.60 mmol) triethylsilane were 
added. The reaction mixture was left at -78°C and  over night allowed to warm up to 10°C. 
The reaction was stopped by adding of 10 ml of saturated water solution of NaHCO3 and 
extracted three times with methylene chloride. The combined organic phases were dried over 
MgSO4 and evaporated under reduced pressure. Further purification was done by FC using  n-
hexane/ethyl acetate 4:1 as eluent. The product was obtained as white solid.    Exprerimental Part   
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Yield:    1.42g (55%) 
TLC:    Rf=0.38 (n-hexane/EtOAc, 4:1) 
1H NMR:  δ [ppm] ( 270MHz, DMSO-d6) 
7.49-7.23(m, 18H, Har, 3H, 5H); 5.14(d, J=4.6 Hz, 1H, 1’H); 4.60(m, 6H, 
CH2-benzyl); 4.23(q, J=4.0 Hz, 1H, 4’H); 4.06(m, 2H, 2’H, 3’H); 3.70(m, 2H, 
5’CH2); 
13C NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
162.51(C4); 158.9(C2); 158.80(C6); 138.20(Car); 138.12(Car) ; 137.8(Car); 
128.20(Car) ; 128.09(Car); 127.80(Car); 127.50(Car); 127.42(Car); 
127.10(Car); 123.61(C1); 111.40(C5); 103.55(C3); 82.10(C1’); 80.80(C4’); 
76.84(C2’); 75.96(C3’); 72.40(CH2-benzyl); 71.04(CH2-benzyl); 62.10(C5’); 
ESI (+):  552.4 ([M+H]
+)
 ; 
 
 
1´-Deoxy-1´-(2,4,6-trifluorophenyl)-β β β β-D-ribofuranose 37 
 
 
O
HO
OHOH
F
F F
 
 
 
C11H11F3O4 
264.2 g/mol 
 
2.0  g  (3.70  mmol)  2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-(2,4,6-trifluorophenyl)-β-D-
ribofuranose 90  were dissolved in 50 ml abs. ethanol and 25 ml cyclohexene and 400 mg 
palladium-hydroxide (20%) on carbon were added. The reaction mixture was refluxed for 4 
hours. Then the reaction mixture was filtrated over celite and the filtrate was evaporated under 
reduced pressure. The purification was done by FC with methylene chloride/methanol 9:1, as 
eluent. The product was obtained as colourless solid. For analytical purposes the product was 
crystallized from water and from methanol.   Exprerimental Part   
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Yield:    910 mg (92%) 
TLC:    Rf=0.40 (CH2Cl2/MeOH, 9:1) 
1H NMR:  δ [ppm] ( 270MHz, DMSO-d6) 
7.20(t, 12H, J=9.72 Hz, 3H, 5H); 5.06(d, J=4.7 Hz, 1H, 1’H); 4.95(d, J=5.0 Hz, 
1H, 3’OH); 4.83(d, J=7.8 Hz, 1H, 2’OH); 4.70(t, J=5.6 HZ, 1H, 5’OH);   
4.17(m,1H, 2’H); 3.90 (m, 1H, 3’H); 3.74(m, 1H, 4’H); 3.46(m, 2H, 5’CH2); 
13C NMR:  δ [ppm] (67.9 MHz, DMSO-d
6) 
163.39(C4); 156.90(C2); 156.40(C6); 112.03(C1); 102.20(C3); 99.65(C5); 
86.54(C1’); 75.67(C4’); 73.48(C2’); 72.35(C3’); 62.01(C5’); 
19F NMR:  δ [ppm] (235.3 MHz, DMSO-d6) 
-107.5(t, 1F, 4F); -110.7(d, 2F, 2F, 6F); 
ESI (-):  263.0 ([M-H]
-)
 ; 
 
 
5´-O- (4,4´-Dimethoxytriphenylmethyl)- 1´-deoxy-1´-(2,4, 6-
trifluorophenyl)-β β β β-D-ribofuranose  149 
 
 
O
DMTrO
OHOH
F
F F
 
 
 
C32H29F3O6 
566.56 g/mol 
 
0.75 g (2.84 mmol) 1´-Deoxy-1´-(2,4,6-trifluorophenyl)-β-D-ribofuranose 37 were dissolved 
in 20 ml abs. pyridine and 0.60 ml (4.25 mmol) triethylamine and 1.20 g (3.50 mmol) 4,4´-
dimethoxytriphenylmethylchloride were added. The reaction mixture was stirred under argon 
at RT for 5 hours. The reaction was stopped by adding  3 ml of methanol and saturated water 
solution of NaHCO3. It was three times extracted with methylene chloride, organic phases   Exprerimental Part   
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were collected and dried over MgSO4 and than evaporated to dryness. The product was twice 
co-evaporated  with  toluene.  Further  purification  was  done  by  FC  with  methylene 
chloride/methanol 98:2 as eluent. The product was obtained as yellow foam. 
 
 
Yield:    1.60 g (81.3%) 
TLC:    Rf=0.61 (CH2Cl2:MeOH, 95:5) 
1H NMR:  δ [ppm] ( 270MHz, DMSO-d6) 
7.42-6.82 (m, 15H, Har, 3H, 5H); 5.26(d, J= 5.0 Hz, 1H, 1’H); 5.16(d, J=6.2 
Hz, 1H, 2’OH); 5.02(d, J=6.3 Hz, 1H, 3’OH); 4.83(d, J=7.8 Hz, 1H, 2’OH); 
4.17(q, J=5.75Hz, 1H, 2’H); 3.83 (m, 2H, 3’H, 4H); 3.73(s, 6H, 
2OCH3);3.17(m, 2H, 5’H); 
13C NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
158.07(DMTr); 149.63(C4); 144.95(DMTr); 137.44(C1); 135.63(DMTr); 
129.76(DMTr); 127.84(DMTr);127.78(DMTr); 126.70(DMTr); 123.91(C5); 
115.03(C2); 114.70(C6); 113.1 (DMTr); 85.40(DMTr); 83.19(C1’); 
82.69(C4’); 77.60(C2’); 71.20(C3’); 64.14(C5’), 55.03 (OCH3);  
ESI (-):  565.5 ([M-H]
-); 
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5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(2, 4, 6-trfluorophenyl)-β β β β-D-ribofuranose  150 
 
 
O
DMTrO
OHOTBDMS
F
F F
 
 
 
C38H43F3O6Si 
680.81 g/mol 
 
1.15  g  (2.03  mmol)  5´-O-(4,4´-Dimethoxytriphenylmethyl)-1´-deoxy-1´-β-D-(2,4,6-
trifluorophenyl)-ribofuranose 149 were dissolved in 20 ml of  1:1 mixture of THF/pyridine 
and  with  410  mg  (2.4  mmol)  AgNO3  and  2.80  ml  (2.80  mmol)  1  M  tert.-
Butyldimethylsilylchloride-solution in THF were added. The reaction mixture was stirred for 
20 hours at RT under argon. Adding 10ml of saturated water NaHCO3-solution stopped the 
reaction. Left AgCl was filtered over celite and the filtrate was extracted with methylene 
chloride three times. The combined organic phases were dried over MgSO4 and evaporated to 
dryness. The crude product was twice co-evaporated with toluene. Further purification of 
product  was  done  by  HPLC  (MN  Nucleoprep  100-20  of  Machrey-Nagel, 
[hexane/ethylacetate10:0.5]+30%  methylene  chloride).  The  product  was  obtained  as  the 
slower-migrating isomer and as white foam. 
 
 
Yield:    566 mg (41%) 
TLC:    Rf=0.60 (CH2Cl2) 
1H NMR:  δ [ppm] ( 270MHz, DMSO-d6) 
7.42-6.82 (m, 15H, Har, 3H, 5H); 4.81 (d, J= 7.60 Hz, 1H, 1’H); 4.72 (d, 
J=5.96 Hz, 1H, 3’OH); 4.21 (m, 1H, 2’H); 3.82 (m, 1H, 3’H); 3.61 (s, 6H, 
2OCH3); 2.98(m, 2H, 5’CH2); 0.67 (s, 3H, Si(OCH3)3); -0.17(s, 3H, SiCH3); -
0.27 (s, 3H, SiCH3); 
13C NMR:  δ [ppm] (67.9 MHz, DMSO-d6)   Exprerimental Part   
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157.48(DMTr); 149.05(Car); 144.35(DMTr); 134.54(Car); 133.13(Car); 
129.14(DMTr); 127.18(DMTr); 125.04(DMTr); 123.32(Car); 112.96(Car); 
111.39(Car); 100.90(DMTr); 100.43(DMTr) ; 100.00(DMTr) ; 84.80(C1’); 
82.96(C4’) ; 74.67(C2’) ; 73.03(C3’) ; 63.43(C5’) ; 54.46(OCH3) ; 
25.80(SiC(CH3)3); 17.87(SiC(CH3)3); -5.08(SiCH3); 
-5.35(SiCH3); 
ESI (-):   679.0 ([M-H]
-);
 
 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-tert.-butyldimethylsilyl-1´-deoxy-
1´-(2,4,6-trifluorophenyl)-β β β β-D-ribofuranose 151 
 
 
O
DMTrO
F
F
OH TBDMSO
F
 
 
 
C38H43F3O6Si 
680.81 g/mol 
 
5´- O- (4,4´-Dimethoxytriphenylmethyl)- 3´-O-tert.-butyldimethylsilyl- 1´-deoxy-1´- (2,4,6-
trifluorophenyl)-β-D-ribofuranose    151    was  obtained  as  a  side  product  (faster-migrating 
isomer)  in  the  synthesis  of  5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-
butyldimethylsilyl-1´-deoxy-1´-(2,4,6-trifluorophenyl)-β-D- ribofuranose  150. 
 
Yield:    590 mg (43 %) 
TLC:    Rf=0.60 (CH2Cl2) 
1H NMR:  δ [ppm] ( 270MHz, DMSO-d6) 
7.41-6.80 (m, 15H, Har, 3H, 5H); 4.97 (d, J= 7.04 Hz, 1H, 1’H); 4.87 (d, 
J=6.88 Hz, 1H, 2’OH); 4.08(m, 1H, 2’H); 3.92 (m, 1H, 3’H); 3.77(s, 6H, 
2OCH3);3.75(m, 2H, 5’H); 3.10(m, 2H, 5’CH2); 0.78(s, 3H, Si(OCH3)3); -
0.08(s, 3H, SiCH3); -0.18(s, 3H, SiCH3);   Exprerimental Part   
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13C NMR:   δ [ppm] (67.9 MHz, DMSO-d6) 
157.48(DMTr); 149.05(Car); 144.35(DMTr); 135.54(Car); 135.13(Car); 
129.14(DMTr); 127.18(DMTr); 126.04(DMTr); 123.32(Car); 112.56(Car); 
111.38(Car); 100.90(DMTr); 100.43(DMTr) ; 100.01(DMTr) ; 84.75(C1’); 
82.96(C4’) ; 74.57(C2’) ; 73.03(C3’) ; 63.43(C5’) ; 54.46(OCH3) ; 
25.60(SiC(CH3)3); 17.85(SiC(CH3)3); -5.07(SiCH3); -5.30(SiCH3); 
ESI (-):  679.0 ([M-H]
-); 
 
 
 
3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-desoxy-5´-O-(4,4´-dimethoxy-
triphenylmethyl)-1´-(2,4,6-trifluorophenyl)-2´-O-tert.-butyldimethylsilyl-β β β β-
D-ribofuranose  152 
 
 
O
DMTrO
O OTBDMS
F
F
P
O
CN
N
F
 
 
 
C47H60F3N2O7PSi 
881.01 g/mol 
 
460 mg (0.68 mmol) 5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
desoxy-1´-(2,4,6-trifluorophenyl)-β-D-ribofuranose  150  were  dissolved  in  20  ml  abs. 
acetonitrile and 900 µl (6.80 mmol) sym. collidine and 27 µl (0.34 mmol) 1-methylimidazole 
were added. The reaction mixture was cooled in an icebath to 0°C and 230 µl (1.02 mmol) 2-
cyanethyldiisopropylchlorphosphoramidite 96 were added. The reaction  was stirred for 15 
min. at 0°C and 1 hour at RT. The reaction was stopped by adding of 10 ml of 0.01M citric 
acid and  extracted with methylene chloride three times. The combined organic phases were 
washed  with  0.01M  citric  acid  twice,  dried  over  MgSO4  and  evaporated  to  dryness.  The   Exprerimental Part   
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purification was done by FC with n-hexane/ethyl acetate, 4:1, as eluent. The product (mixture 
of two diastereomers) was obtained as white foam. 
 
 
Yield:    477 mg (80%) 
TLC:    Rf =0.37 (hexane/EtOAc, 4:1) 
1H NMR:  δ [ppm] ( 400MHz, CDCl3) 
7.49-6.64 (m, 15H, Har, 3H, 5H); 5.14 (d, J= 8.84 Hz, 1H, 1’H); 4.52 (m, 1H, 
2’H); 4.20 (m, 1H, 3’H); 3.97 (m, 1H, 4’H); 3.78 (s, 6H, 2OCH3); 3.55 (m, 2H, 
CH2CN); 3.25 (m, 2H, 5’CH2);  2.67 (m, 2H, OCH2); 1.10 (m, 6H, CH(CH3)2); 
0.78 (s, 9H, SiC(CH3)3); -0.04 (s, 3H, SiCH3); -0.18 (s, 3H, SiCH3); 
31P NMR:  δ [ppm] ( 162 MHz, CDCl3) 
151.93 and 149.24 (ratio 1:19.8) 
ESI (+):   903.7  ([M+Na]
+)
 ; 
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2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-(2,4,5-trifluorophenyl)-β β β β-D-ribofuranose 
86 
 
 
O
BnO
F
F
OBn BnO
F
 
 
C32H29F3O4 
534.54 g/mol 
 
To the solution that contains 1.52 g (7.20 mmol) 1-bromo-2, 4, 5-trifluorobenzene in 15 ml 
abs. diethyl ether  at –78°C under argon over 30 minutes 4.50 ml 1.6 M (7.20 mmol) solution 
of  n-Butyl lithium in n-hexane were added. After 30 minutes at –78°C solution of 2,3,5-Tri-
O-benzyl-ribono-γ-lacton (2.0 g, 4.8 mmol)  83 in 20 ml abs. diethyl ether was added over 30 
minutes and 1 hour stirred at –78°C. Afterwards the reaction mixture was allowed to warm up 
to -20°C over two hours. The reaction was stopped by adding  5 ml of water and three times 
extracted with ether. The combined organic phases were dried over MgSO4 and evaporated to 
dryness. Left oil was immediately dissolved in 20 ml of methylene chloride, cooled to -78°C 
and 1.90 ml (15.0 mmol) bortrifluorid ethyletherat and 2.40 ml (15.0 mmol) triethylsilan were 
added. The reaction mixture was left at -78°C and  over night was allowed to warm up to 
10°C. The reaction was stopped by adding of 10 ml of saturated water solution of NaHCO3 
and extracted three times with methylene chloride. The combined organic phases were dried 
over MgSO4 and evaporated under reduced pressure. Further purification was done by FC 
using  n-hexane/ethyl acetate 4:1 as eluent. The product was obtained as yellow oil.  
 
 
Yield:     2.50 g (65%) 
TLC:    Rf=0.57 (hexane,EtOAc, 4:1) 
1H NMR:  δ [ppm] ( 270MHz, DMSO-d6) 
7.60-7.21(m, 17H, Har, 3H, 6H); 5.16(d, J=4.655Hz, 1H, 1’H); 4.55(m, 6H, 
CH2-benzyl); 4.22( m, 1H, 2’H); 4.07(m, 2H, 3’H, 4’H); 3.70(m, 2H, 5’CH2);   Exprerimental Part   
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13C NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
162.50(C4); 158.9(C2); 158.80(C5); 138.20(Car); 138.12(Car) ; 137.8(Car); 
128.20(Car) ; 128.09(Car); 127.80(Car); 127.50(Car); 127.42(Car); 
127.10(Car); 123.61(C1); 111.40(C6); 103.55(C3); 82.10(C1’); 80.82(C4’); 
76.84(C2’); 75.98(C3’); 72.38(CH2-benzyl); 71.06(CH2-benzyl); 62.10(C5’); 
ESI(+):  552.4 ([M+NH4 ]
+); 
 
1´-Deoxy-1´-(2,4,5-trifluorophenyl)-β β β β-D-ribofuranose 38 
 
 
O
HO
OHOH
F
F
F
 
 
 
C11H11F3O4 
264.2 g/mol 
 
2.20  g  (4.05  mmol)  2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-(2,4,5-trifluorophenyl)-β-D-
ribofuranose 86  were dissolved in 40 ml abs. ethanol and 20 ml cyclohexen and 450 mg 
palladium-hydroxide (20%) on carbon were added. The reaction mixture was refluxed for 5 
hours. Than the reaction mixture was filtrated over celite and the filtrate was evaporated under 
reduced pressure. The purification was done by FC with methylene chloride/methanol 9:1, as 
eluent. The product was obtained as colourless solid. For analytical purposes the product was 
crystallized from water and from methanol. 
 
 
 
Yield:    1.02 g (93.6 %) 
TLC:    Rf=0.40 (CH2Cl2/MeOH, 9:1)   Exprerimental Part   
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1H NMR:  δ [ppm] ( 400 MHz, DMSO-d6) 
7.72(m, 1H, 3H); 7.49(m, 1H, 6H); 5.10 (d, J=6.08 Hz, 1H, 1’H); 4.92(m, 3H, 
3’OH, 2’OH, 5’OH);   4.85(m,1H, 2’H); 3.91 (m, 2H, 3’H, 4’H); 3.82(m, 2H, 
5’CH2); 
13C NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
163.39(C4); 159.69(C5); 159.5(C2); 112.03(C1); 102.20(C3); 99.65(C6); 
86.55(C1’); 75.68(C4’); 73.50(C2’); 72.35(C3’); 62.00(C5’); 
ESI (-):  262.9  ([M-H]
-); 
 
 
5´-O- (4,4´-Dimethoxytriphenylmethyl)- 1´-deoxy-1´-(2,4,,5-
trifluorophenyl)-β β β β-D-ribofuranose 153 
 
 
O
DMTrO
OHOH
F
F
F
 
 
 
C32H29F3O6 
566.56 g/mol 
1.20g ( 4.54 mmol) 1´-Deoxy-1´-(2,4,5-trifluorophenyl)-β-D-ribofuranose  38 were dissolved 
in 20 ml abs. pyridine and 0.95 ml (6.80 mmol) triethylamine and 1.90 g (5.58 mmol) 4,4´-
Dimethoxytriphenylmethylchloride were added. The reaction mixture was stirred under argon 
at RT for 5 hours. The reaction was stopped by adding  3 ml of methanol and saturated water 
solution of NaHCO3. It was three times extracted with methylene chloride, organic phases 
were  collected  and  dried  over.  MgSO4  and  then  evaporated  to  dryness.  Product  was  co-
evaporated  with  toluene.  Further  purification  was  done  by  FC  with  methylene 
chloride/methanol 98:2 as eluent. The product was obtained as yellow foam. 
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Yield:    1.30 g (51%) 
TLC:    Rf=0.50 (CH2Cl2/MeOH, 95:5) 
1H NMR:  δ [ppm] ( 270MHz, DMSO-d6) 
7.69-6.76 (m, 15H, Har, 3H, 6H); 5.15(d, J= 5.48 Hz, 1H, 1’H); 4.88(d, J=5.68 
Hz, 1H, 2’OH); 4.81(m, 1H, 3’OH);  3.88-3.78 (m, 3H,2’H,  3’H, 4H); 3.73(s, 
6H, 2OCH3); 3.10(m, 2H, 5’H); 
13C NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
158.06(DMTr); 150.01(C4); 144.95(DMTr); 137.44(C1); 135.65(DMTr); 
130.00(DMTr); 128.10(DMTr);127.85(DMTr); 126.80(DMTr); 124.10(C5); 
115.03(C2); 114.70(C6); 113.18(DMTr); 85.40(DMTr); 83.19(C1’); 
82.70(C4’); 77.60(C2’); 71.10(C3’); 64.20(C5’), 55.00 (OCH3);  
ESI (-):  565.3 ([M-H]
-); 
 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(2, 4, 5-trfluorophenyl)-β β β β-D-ribofuranose 154 
 
 
O
DMTrO
OHOTBDMS
F
F
F
 
 
 
C38H43F3O6Si 
680.81 g/mol 
 
1.20  g  (2.12  mmol)  5´-O-(4,4´-Dimethoxytriphenylmethyl)-1´-deoxy-1´-β-D-(2,4,5-
trifluorophenyl)-ribofuranose 153 were dissolved in 20 ml  of 1:1 mixture of  THF/pyridine 
and with 450 mg (2.6 mmol) AgNO3 and 3.20 ml (3.20 mmol) 1 M tert.-butyldimethylsilyl 
chloride-solution in THF were added. The reaction mixture was stirred for 20 hours at RT 
under argon. Adding 10ml of saturated water NaHCO3-solution stopped the reaction. Left 
AgCl was filtered over celite and the filtrate was extracted with methylene chloride three 
times. Collected organic phases were dried over MgSO4 and evaporated to dryness. The crude 
product was twice co-evaporated with toluene. Further purification of the product was done   Exprerimental Part   
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by HPLC (MN Nucleoprep 100-20 of Machrey Nagel, [hexane/ethylacetate, 10:0.6])+30% 
methylene chloride. The product was obtained as the slower-migrating isomer and as white 
foam. 
 
Yield:    590 mg (41 %) 
TLC:    Rf=0.58 (CH2Cl2) 
1H NMR:  δ [ppm] ( 400MHz, DMSO-d6) 
7.58-6.82 (m, 15H, Har, 3H, 6H); 4.94 (d, J= 5.32 Hz, 1H, 1’H); 4.91 (d, 
J=5.84 Hz, 1H, 3’OH); 4.03 (m, 2H, 2’H,3’H); 3.98(m, 1H, 4’H); 3.72 (s, 6H, 
2OCH3);3.21 (m, 2H, 5’H); 0.80 (s, 9H, SiC(CH3)3); -0.05 (s, 3H, SiCH3); -
0.10 (s, 3H, SiCH3); 
13C NMR:  δ [ppm] (100.6 MHz, DMSO-d6) 
158.00 (DMTr); 151.00 (Car), 144.30 (DMTr); 135.50 (Car); 135.13 ( Car); 
129.15 (DMTr); 127.18 (DMTr); 126.04 (DMTr); 123.32 (Car); 112.56 (Car); 
111.10 (Car); 100.95 (DMTr); 100.48 (DMTr); 100.08 (DMTr); 84.76 (C1’); 
82.98 (C4’); 74.47 (C2’); 73.00 (C3’) ; 63.43 (C5’); 54.50 (OCH3) ; 24.8 
(SiC(CH3)3); 17.88 (SiC(CH3)3); -5.12 (SiCH3); -5.35 (SiCH3);  
ESI (-):   680.0 ([M-H]
-);
 
 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-tert.-butyldimethylsilyl-1´-deoxy-
1´-(2,4,5-trifluorophenyl)-β β β β-D-ribofuranose 155 
 
 
O
DMTrO
F
F
OH TBDMSO
F
 
 
 
C38H43F3O6Si 
680.81 g/mol 
 
5´- O- (4,4´-Dimethoxytriphenylmethyl)- 3´-O-tert.-butyldimethylsilyl- 1´-deoxy-1´- (2,4,5-
trifluorophenyl)-β-D-ribofuranose  155    was  obtained  as  a  side  product  (faster-migrating   Exprerimental Part   
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isomer)  while  synthesizing  5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-
butyldimethylsilyl-1´-deoxy-1´-(2,4,5-trifluoro-phenyl)-β-D- ribofuranose 154. 
 
 
Yield:    530 mg (37%) 
TLC:    Rf =0.58 (CH2Cl2) 
1H NMR:  δ [ppm] (400 MHz, DMSO-d6) 
7.54-6.85 (m, 15H, Har, 3H, 6H); 5.06 (d, J= 6.48 Hz, 1H, 1’H); 4.92 (d, 
J=5.88 Hz, 1H, 2’OH); 4.00 (m, 3H, 2’H,3’H, 4’H); 3.72 (s, 6H, 2OCH3);3.30 
(m, 2H, 5’H); 0.80 (s, 9H, Si(OCH3)3); -0.03 (s, 3H, SiCH3); -0.10 (s, 3H, 
SiCH3); 
13C NMR:  δ [ppm] (100.6 MHz, DMSO-d6) 
157.50 (DMTr); 149.05 (Car), 144.35 (DMTr); 135.50 (Car); 135.13 ( Car); 
129.14 (DMTr); 127.18 (DMTr); 126.04 (DMTr); 123.32 (Car); 112.56 (Car); 
111.40 (Car); 100.90 (DMTr); 100.43 (DMTr); 100.01 (DMTr); 84.75 (C1’); 
82.96 (C4’); 74.57 (C2’); 73.03 (C3’) ; 63.43 (C5’); 54.46 (OCH3) ; 25.6 
(SiC(CH3)3); 17.85 (SiC(CH3)3); -5.10 (SiCH3); -5.30 (SiCH3);  
ESI (-):  679.90 ([M-H]
-); 
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3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-
triphenylmethyl)-1´-(2,4,5-trifluorophenyl)-2´-O-tert.-butyldimethylsilyl-β β β β-
D-ribofuranose 156 
 
 
O
DMTrO
O OTBDMS
F
F
P
O
CN
N
F
 
 
C47H60F3N2O7PSi 
881.01 g/mol 
 
230 mg (0.34 mmol) 5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(2,4,5-trifluorophenyl)-β-D-ribofuranose  154  were  dissolved  in  10  ml  abs. 
acetonitrile and 450 µl (3.40 mmol) sym. collidine and 14 µl (0.17 mmol) 1-methylimidazole 
were added. The reaction mixture was cooled in ean icebath to 0°C and 115 µl (0.51 mmol) 2-
cyanethyldiisopropylchlorophosphoramidite  96  was  added.  The  reaction  was  stirred  for 
15min. at 0°C and 1 hour at RT. The reaction was stopped by adding of 10 ml of 0.01 M citric 
acid and three times extracted with methylene chloride. The combined organic phases were 
washed  with  0.01  M  citric  acid  twice,  dried  over  MgSO4  and  evaporated  to  dryness. 
Purification was done by FC with n-hexane/ethyl acetate, 4:1, as eluent. The product (mixture 
of two diastereomers) was obtained as white foam. 
 
 
Yield:    190 mg (79%) 
TLC:    Rf =0.39 (hexane/EtOAc, 4:1) 
1H NMR:   δ [ppm] ( 400MHz, DMSO-d6) 
7.52-6.80 (m, 15H, Har, 3H, 6H); 5.12 (d, J= 7.48 Hz, 1H, 1’H); 4.19 (m, 2H, 
2’H,3’H); 3.97 (m, 1H, 4’H); 3.74 (s, 6H, 2OCH3); 3.55 (m, 4H, CH2CN, 
5’CH2); 2.70 (m, 2H, OCH2); 1.16 (m, 6H, 2CHCH3); 0.80 (s, 9H, SiC(CH3)3); 
-0.13 (s, 3H, SiCH3); -0.30 (s, 3H, SiCH3);   Exprerimental Part   
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31P NMR:  δ [ppm] ( 162 MHz, DMSO-d6) 
151.61 and 149.63 (ratio 1:4.6) 
ESI (+):   883.0 ([M+H]
+); 
 
 
2,3,5-Tri-O-benzyl-1-deoxy-D-ribofuranose 98 
 
 
O
BnO
OBn BnO  
 
 
C26H28O4 
404.48 g/mol 
1.0 g (2.4 mmol) 2,3,5-tri-O-benzyl-ribofuranose  was dissolved in 10 ml of acetonitrile and 
0.6 ml (9.6 mmol) triethylsilane and 0.6 ml (4.8 mmol) BF3*OEt2 were added. The reaction 
mixture was refluxed 1.5 hours at room temperature in argon atmosphere. The reaction was 
stopped by adding 10 ml  of saturated water solution of NaHCO3. The mixture was extracted 
three times with methylene chloride. The combined organic phases were dried over MgSO4 
and evaporated to dryness. Purification was done by FC, with n-hexane/ethylacetate 4:1, as 
eluent.The product was obtained as colourless oil. 
 
Yield:    850 mg (88.4 %) 
TLC:    Rf = 0.49 (CH2Cl2/MeOH 99:1) 
1H-NMR:  δ [ppm] (270 MHz, DMSO-d6) 
7.29 – 7.17 (m, 15H, Har); 4.58 – 4.41 (m, 6H, CH2-benzyl); 4.09 (m, 1H, 4H); 
3.89 (m, 4H, 1H, 2H, 3H); 3.50 (m, 2H, 5H) 
13C-NMR:  δ [ppm] (62.9 MHz, DMSO-d6) 
138.05  (Car);  137.88  (Car);  137.80  (Car);  128.25  (Car);  128.21  (Car);  128.18 
(Car); 127.80 (Car); 127.72 (Car); 127.61 (Car); 127.49 (Car); 127.42 (Car); 80.35 
(C4); 78.18 (C1); 76.42 (C2); 73.28 (CH2-benzyl), 72.05 (CH2-benzyl), 71.66 
(CH2-benzyl); 70.45 (C3); 69.93 (C5). 
ESI(+):  422.2 ([M+NH4]
+);   Exprerimental Part   
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1-Deoxy-D-ribofuranose 42 
 
 
O
HO
OH HO  
 
 
C5H10O4 
134.13 g/mol 
 
3.9 g (9.6 mmol) 2,3,5-Tri-O-benzyl-1-deoxy-D-ribofuranose  98 were dissloved in 70 ml of 
abs. ethanol and 35 ml of cyclohexen and 800 mg palladium hydroxid (20%) on carbon were 
added.  The  reaction  mixture  was  refluxed  for  4  hours.  The  palladium  catalyst  was  than 
filtered over celite and the filtrate was evaporated to dryness. Further purification was done by 
FC with methylene chloride/methanol 9:1, as eluent. The product was obtained as colourless 
solid.  
 
 
Yield:    1.23 g (95.3 %) 
TLC:    Rf = 0.22 (CH2Cl2/MeOH 9:1) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
4.69 (m, 2H, 2-OH, 3-OH); 4.57 (t, J = 5.7 Hz, 1H, 5-OH); 3.96 (m, 1H, 4H); 
3.83 (m, 1H, 2H); 3.74 (q, J = 5.5 Hz, 1H, 3H); 3.52 (m, 3H, 1H, 5H); 3.35 (m, 
1H, 5H) 
13C-NMR:  δ [ppm] (62.9 MHz, DMSO-d6) 
    83.20 (C4), 71.99 (C1); 71.55 (C2); 70.41 (C3); 61.76 (C5) 
ESI(–):    133.0 ([M-H]
-); 
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5-O-(4,4´-Dimethoxytriphenylmethyl)-1-deoxy-D-ribofuranose 99 
 
 
O
DMTrO
OH HO  
 
 
C26H28O6 
436.49 g/mol 
 
1.22 g (9.1 mmol) 1-Deoxy-D-ribofuranose 42 were dissolved in 40 ml of abs. pyridine and 
1.9  ml  (19  mmol)  of  triethylamine  and  3.7  g  (10.9  mmol)  4,4´-dimethoxytriphenyl-
methylchloride were added. The reaction was stirred for 4 hours at room temperature in argon 
atmosphere. The reaction was stopped by adding 3 ml of methanol and saturated NaHCO3-
solution was added. It was extracted then three times with methylene chloride. The combined 
organic phases were dried over MgSO4 and evaporated to dryness. The crude product was 
twice  with  toluene  co-evaporated.  Purification  was  done  by  FC  with  methylene 
chloride/methanol 98:2, as eluent. The product was obtained as white foam. 
 
 
Yield:    3.41 g (85.9 %) 
TLC:    Rf = 0.13 (CH2Cl2/MeOH 98:2) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
7.42-6.86 (m, 13H, Har); 4.77 (d, J = 4.5 Hz, 1H, 2-OH); 4.73 (d, J = 6.2 Hz, 1H, 
3-OH); 4.01 (m, 1H, 2H); 3.94 (m, 1H, 1H); 3.77 (m, 2H, 3H, 4H); 3.73 (s, 6H, 
OCH3); 3.60 (dd, J = 8.9 Hz, J = 3.1 Hz, 1H, 1H); 3.02 (m, 2H, 5H) 
13C-NMR:  δ [ppm] (62.9 MHz, DMSO-d6) 
158.02  (DMTr);  145.06  (DMTr);  135.79  (DMTr);  129.70  (DMTr);  127.74 
(DMTr); 126.58 (DMTr); 113.14 (DMTr); 85.15 (DMTr); 80.97 (C4); 72.50 
(C1); 72.24 (C2); 70.30 (C3); 64.45 (C5); 55.01 (OCH3) 
ESI(–):    435.2 ([M-H]
-); 
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5-O-(4,4´-Dimethoxytriphenylmethyl)-2-O-tert.-butyldimethylsilyl-1-deoxy-
D-ribofuranose 101 
 
 
 
O
DMTrO
OTBDMS HO  
 
 
C32H42O6Si 
550.74 g/mol 
 
3.2  g  (7.3  mmol)  5-O-(4,4´-Dimethoxytriphenylmethyl)-1-deoxy-D-ribofuranose  99  was 
dissolved in mixture 60 ml of 1:1 of THF/pyridine and 1.5 g (13.3 mmol) silvernitrate and 
10.2 ml (10.2 mmol) 1 M tert.-butyldimethylsilylchloride solution in THF were added. The 
reaction  mixture  was  stirred  for  20  hours  at  room  temperature  in  argon  atmosphere.  The 
reaction was stopped by adding  10 ml of saturated water NaHCO3-solution. Silverchloride 
was than filtered over celite and the filtrate was  extracted with methylene chloride three 
times. The combined organic phases were dried over MgSO4 and evaporated to dryness. The 
crude product was  co-evaporated with toluene twice. The purification was done by FC with 
methylene chloride as eluent. The product was obtained as white foam 
 
Yield:    2.43 g (60.3 %) 
TLC:    Rf = 0.43 (CH2Cl2) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
7.40 - 6.83 (m, 13H, Har); 4.49 (d, J = 6.0 Hz, 1H, 3-OH); 4.19 (m, 1H, 2H); 
3.96 (m, 1H, 1H); 3.77 (m, 2H, 3H, 4H); 3.73 (s, 6H, OCH3); 3.58 (m, 1H, 
1H); 3.00 (m, 2H, 5H); 0.88 (s, 9H, SiC(CH3)3); 0.07 (s, 3H, SiCH3); 0.06 (s, 
3H, SiCH3) 
13C-NMR:  δ [ppm] (100.6 MHz, DMSO-d6) 
158.05  (DMTr);  145.09  (DMTr);  135.75  (DMTr);  129.73  (DMTr);  127.78 
(DMTr); 127.73 (DMTr); 127.42 (DMTr); 126.51 (DMTr); 113.16 (DMTr); 
85.17 (DMTr); 80.92 (C4); 73.56 (C1); 72.57 (C2); 70.24 (C3); 64.33 (C5);   Exprerimental Part   
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55.05  (OCH3);  25.88  (SiC(CH3)3);  18.11  SiC(CH3)3);  –4.54  (SiCH3);  –4.87 
(SiCH3) 
ESI(–):    549.4 ([M-H]
-); 
 
 
5-O-(4,4´-Dimethoxytriphenylmethyl)-3-O-tert.-butyldimethylsilyl-1-deoxy-
D-ribofuranose 100 
 
 
 
O
DMTrO
OH TBDMSO  
 
 
C32H42O6Si 
550.74 g/mol 
 
5-O-(4,4´-Dimethoxytriphenylmethyl)-3-O-tert.-butyldimethylsilyl-1-deoxy-D-ribofuranose 
100      was  obtained  as  a  side  product  in  the  synthesis  of    5-O-(4,4´-Dimethoxy-
triphenylmethyl)-2-O-tert.-butyldimethylsilyl-1-deoxy-D-ribofuranose  101 . 
 
 
Yield:    1.1 g (27.3 %) 
TLC:    Rf = 0.64 (CH2Cl2) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
7.42 - 6.82 (m, 13H, Har); 4.53 (d, J = 4.7 Hz, 1H, 2-OH); 4.17 (q, J = 4.4 Hz, 
1H, 2H); 3.95 (m, 1H, 1H); 3.89 (m, 1H, 3H); 3.79 (m, 1H, 4H); 3.72 (s, 6H, 
OCH3); 3.57 (m, 1H, 1H); 3.02 (m, 2H, 5H); 0.72 (s, 9H, SiC(CH3)3); –0.04 (s, 
3H, SiCH3); –0.15 (s, 3H, SiCH3) 
13C-NMR:  δ [ppm] (62.9 MHz, DMSO-d6) 
158.07  (DMTr);  144.94  (DMTr);  135.56  (DMTr);  129.68  (DMTr);  127.76 
(DMTr);  127.65  (DMTr);  126.61  (DMTr);  113.82  (DMTr);  85.33  (DMTr);   Exprerimental Part   
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81.42 (C4); 73.36 (C1); 72.13 (C2); 71.77 (C3); 63.85 (C5); 54.99 (OCH3); 
25.61 (SiC(CH3)3); 17.65 SiC(CH3)3); –4.71 (SiCH3); –5.29 (SiCH3) 
ESI(–):    549.3 ([M-H]
-); 
 
 
3-O-(2-Cyanethoxydiisopropylphosphin)-1-deoxy-5-O-(4,4´-dimethoxy-
triphenylmethyl)-2-O-tert.-butyldimethylsilyl-D-ribofuranose 102 
 
 
O
DMTrO
O OTBDMS
P
O
CN
N
 
 
 
C41H59N2O7PSi 
750.94 g/mol 
 
200  mg  (0.36  mmol)  5-O-(4,4´-Dimethoxytriphenylmethyl)-2-O-tert.-butyldimethylsilyl-1-
deoxy-D-ribofuranose 101  were dissolved in  11 ml of abs. acetonitrile and 480  µl (3.7 
mmol) sym. collidine and 15 µl (0.19 mmol) 1-methylimidazole were added. The reaction 
mixture  was  cooled  on  in  icebath  to  0°C  and  122  µl  (0.54  mmol)  2-cyanethyl-
diisopropylchlorophosphoramidite  96  was added. The reaction was stirred 15 minutes at 0°C 
and 35 minutes at room temperature. The reaction was stooped by adding 3 ml of saturated 
water  NaHCO3-solution. The mixture was three times extracted with methylene chloride and 
collected organic phasesd were dried over MgSO4 and evaporated to dryness. The purification 
was done by FC with methylene chloride/methanol 99:1, as eluent. The product (mixture of 
two diastereoisomers ) was obtained as white foam.  
 
 
Yield:    130 mg (47.8 %) 
TLC:    Rf = 0.49; 0.55 (CH2Cl2/MeOH 99:1)  
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1H-NMR:  δ [ppm] (400 MHz, CDCl3) 
7.40 – 6.72 (m, 34H, Har); 4.36, 4.30 (q, J = 4.9 Hz, J = 5.3 Hz, 2H, 2H); 4.07 
(m, 2H, 1H); 4.00 (m, 4H, 3H, 4H); 3.72, 3.71 (s, 12H, OCH3); 3.46 (m, 6H, 
1H,  CH2CN);  3.28  (m,  4H,  5H);  2.53  (m,  4H,  OCH2);  1.05  (m,  12H, 
CH(CH3)2); 0.85, 0.83 (m, 18H, SiC(CH3)3); 0.05, 0.04, 0.02, 0.01 (s, 12H, 
SiCH3) 
31P-NMR:  δ [ppm] (162 MHz, CDCl3) 
149.67 and 149.15 (ratio 1 : 1.3) 
ESI(+):  751.1 ([M+H]
+); 
 
 
2-Cyanoethoxy-dichlorophosphin 157 
 
 
P
O
Cl
Cl
CN
 
 
 
C3H4Cl2NOP 
171.95 g/mol 
 
175 ml (2 mol) phosphorustrichloride was mixed with 100 ml of abs. diethylether in a round 
flask and over 20 minutes a mixture of  19.5 ml (285 mmol) 3-hydroxypropionitrile and 120 
ml abs. diethylether was added dropwise. The reaction mixture was stirred 1 hour at room 
temperature.  Ether  was  evaporated  at  temperature  lower  than  40°C  and    the  left  oil  was 
separated by fractional destillation in vacuum. The product was obtained as colourlesss liquid 
at 68 – 70 °C ( 4*10
-5 mbar). 
 
 
Yield:    31.3 g (63.6 %) 
1H-NMR:  δ [ppm] (250 MHz, CDCl3) 
    4.36 (q, J = 7.7 Hz, 2H, CH2CN); 2.73 (t, J = 6.9 Hz, 2H, OCH2) 
31P-NMR:  δ [ppm] (101.2 MHz, CDCl3) 
    175.02   Exprerimental Part   
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2-Cyanoethyldiisopropylchlorophosphoamidite 96 
 
 
P
O
Cl
N
CN
 
 
 
C9H18ClN2OP 
236.68 g/mol 
 
29.7 g (173 mmol) 2-cyanoethoxydichlorophosphine  157  and 150 ml from abs. Ether were 
mixed in a round flask and a  mixture of 47.2 ml (336 mmol) diisopropylamine in 70 ml abs. 
Diethylether were slowely added over 90 minutes at -30°C. The reaction mixture was stirred 
over night. White precipitate was filtrated and ether was evaporated. Left oil was fractionally 
distilled in vacuum. The product was obtained as oil boiling at 78 – 80°C (1*10
-5 mbar). 
 
Yield:    22.66 g (55.8 %) 
1H-NMR:  δ [ppm] (250 MHz, CDCl3) 
4.05 (qt, J = 6.9 Hz, 2H, CH2CN); 3.80 (m, 2H, CH2 isopropyl); 2.74 (q, J = 
6.9 Hz, 2H, OCH2); 1.25 (m, 12H, CH3 isopropyl) 
31P-NMR:  δ [ppm] (162 MHz, CDCl3) 
    181.22 
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2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-phenyl-β β β β-D-ribofuranose 91 
 
 
O
BnO
OBn BnO  
 
 
C32H32O4 
480.57 g/mol 
 
To solution of  0.76 ml (7.1 mmol) bromobenzene in 20 ml abs. THF  at  –78°C in argon 
atmosphere within 10 minutes 4.5 ml 1.6 M solution of n-butyllithium in n-hexan were added 
dropwise. After 20 minutes at -78°C solution of 2,3,5-Tri-O-benzyl-ribono-γ-lacton 83   (2.0 
g, 4.8 mmol) in 20 ml abs. THF was added over 30 minutes  dropwise and 1 hour stirred at -
78°C. Than the reaction mixture was allowed to warm up to -30°C over two hours. The 
reaction was stopped by adding 5 ml of water and extracted three times with diethylether. The 
combined organic phases were dried over MgSO4 and evaporated to dryness. Left oil was 
dissolved  in  20  ml  methylene  chloride,  cooled  to  -78°C  and  then  1.2  ml  (9.5  mmol) 
bortrifluorid  ethyletherat  and  1.5  ml  (9.5  mmol)  triethylsilane  were  added.  The  reaction 
mixture was than stirred 1 hour at -78°C and than allowed to warm up over night to 10°C. 
Adding of 10 ml of saturated water solution of NaHCO3  stopped the reaction. Extractioon 
with methylene chloride was done three times and collected organic phases were dried over 
MgSO4 and evaporated to dryness. Further purification was done by FC with n-hexane/ethyl 
acetate 4:1. The product was obtained as orange solid.  
 
 
Yield:    1.71 g (74.7 %) 
TLC:    Rf = 0.45 (n-hexane/ethy lacetate 4:1) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
7.40 – 7.19 (m, 20H, Har); 4.88 (d, J = 6.5 Hz, 1H, 1´H); 4.61 – 4.43 (m, 6H, 
CH2-benzyl); 4.24 (q, J = 4.0 Hz, 1H, 4´H); 4.06 (t, J = 4.4 Hz, 1H, 3´H); 3.90 
(m, 1H, 2´H); 3.64 (m, 2H, 5´H)   Exprerimental Part   
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13C-NMR:  δ [ppm] (62.9 MHz, DMSO-d6) 
140.60  (Car);  138.30  (Car);  138.20  (Car);  138.07  (Car);  128.26  (Car);  128.21 
(Car);  128.15  (Car);  127.84  (Car);  127.56  (Car);  127.50  (Car);  127.40  (Car); 
126.25 (Car); 83.42 (C1´); 81.90 (C4´); 81.07 (C2´); 77.28 (C3´); 72.42 (CH2-
benzyl); 71.07 (CH2-benzyl); 70.98 (CH2-benzyl); 70.32 (C5´) 
ESI(+):  498.4 ([M+NH4]
+); 
 
1´-Deoxy-1´-phenyl-β β β β-D-ribofuranose 41 
 
 
O
HO
OHOH  
 
C11H14O4 
210.2 g/mol 
 
0.2  g  (0.42  mmol)  2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-phenyl-β-D-ribofuranose  91    were 
dissolved  in  8  ml.  of  abs.  methylene  chloride  and  cooled  to  -78°C.  Than  1  ml  of 
borontribromide (1M in methylene chloride) was added and for 1.5 hours stirred at - 78°C. 
The reaction was stopped by adding  5 ml of 1:1 mixture methylene chloride/methanol and 
evaporated  to  dryness.  Left  brown  oil  was  twice  purified  by  FC  with  methylene 
chloride/methanol 9:1 , as eluent. The product was obtained as light yellow solid.  
 
 
Yield:    60 mg (69.0 %) 
TLC:    Rf = 0.24 (CH2Cl2/MeOH 9:1) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
7.41 – 7.22 (m, 5H, Har); 4.93 (d, J = 6.8 Hz, 1H, 1´H); 4.86 (d, J = 4.7 Hz, 1H, 
3´-OH); 4.77 (t, J = 5.5 Hz, 1H, 5´-OH); 4.54 (d, J = 7.1 Hz, 1H, 2´-OH); 3.88 
(m, 1H, 4´H); 3.80 (m, 1H, 3´H); 3.68 (q, J = 5.6 Hz, 1H, 2´H); 3.53 (m, 2H, 
5´H) 
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13C-NMR:  δ [ppm] (62.9 MHz, DMSO-d6) 
141.42 (Car); 127.96 (Car); 127.23 (Car); 126.24 (Car); 85.06 (C1´); 82.99 (C4´); 
77.63 (C2´); 71.44 (C3´); 62.06 (C5´) 
ESI(–):    209.0 [(M-H]
-); 
 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)- 1´-deoxy-1´-phenyl-β β β β-D-
ribofuranose 158 
 
 
O
DMTrO
OHOH  
 
 
C32H32O6 
512.56 g/mol 
 
1.0  g  (4.75  mmol)  1´-Deoxy-1´-phenyl-β-D-ribofuranose  41  was  dissolved  in  25  ml  abs. 
pyridine  and  1.0  ml  (7.2  mmol)  triethylamine  and  1.93  g  (5.7  mmol)  4,4´-
dimethoxytriphenylmethylchloride were added. The reaction mixture was stirred under argon 
at RT for 4 hours. The reaction was stopped by adding 3 ml of methanol and saturated water 
solution of NaHCO3. It was three times extracted with methylene chloride, organic phases 
were collected, dried over MgSO4 and than evaporated to dryness. The product was twice co -
evaporated  with  toluene.  Further  purification  was  done  by  FC  with  methylene 
chloride/methanol 98:2,  as eluent. The product was obtained as yellow foam. 
 
 
Yield:    1.83 g (75.3 %) 
TLC:    Rf = 0.23 (CH2Cl2/MeOH 98:2) 
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1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
7.47 – 6.86 (m, 18H, Har); 5.07 (d, J = 6.5 Hz, 1H, 1´H); 4.93 (d, J = 5.2 Hz, 
1H, 3´-OH); 4.66 (d, J = 6.3 Hz, 1H, 2´-OH); 3.99 (m, 1H, 4´H); 3.88 (q, J = 
4.9 Hz, 1H, 3´H); 3.74 (m, 1H, 2´H); 3.73 (s, 6H, OCH3); 3.18 (m, 2H, 5´H) 
13C-NMR:  δ [ppm] (62.9 MHz, DMSO-d6) 
158.08  (DMTr);  149.62  (Car);  144.98  (DMTr);  141.29  (Car);  136.11  (Car); 
135.69  (DMTr);  129.77  (DMTr);  128.06  (DMTr);  127.79  (DMTr);  127.29 
(Car); 126.66 (Car); 125.96 (Car); 123.89 (Car); 113.17 (DMTr); 85.40 (DMTr); 
83.56 (C1´); 82.99 (C4´); 77.60 (C2´); 71.41 (C3´); 64.18 (C5´); 55.03 (OCH3) 
ESI(–):     511.4 ([M-H]
-); 
 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-phenyl-β β β β-D-ribofuranose 159 
 
 
O
DMTrO
OHOTBDMS 
 
 
C38H46O6Si 
626.82 g/mol 
 
1.09  g  (2.1  mmol)  5´-O-(4,4´-Dimethoxytriphenylmethyl)-1´-deoxy-1´-phenyl-β-D-
ribofuranose  158  were dissolved in 20 ml of 1:1 mixture of THF/pyridine and with 430 mg 
(2.5 mmol) AgNO3 and 2.5 ml (2.5 mmol) 1 M tert.-butyldimethylsilylchloride-solution in 
THF were added. The reaction mixture was stirred for 20 hours at RT under argon. Adding 
10ml of saturated water NaHCO3-solution stopped the reaction. Left AgCl was filtered over 
celite  and  the  filtrate  was  extracted  with  methylene  chloride  three  times.  The  combined 
organic phases were dried over MgSO4 and evaporated to dryness. The crude product was 
twice  co-evaporated  with  toluene.  Further  purification  of  the  product  was  done  FC  with 
methylene chloride/isopropanol 95:5, as eluent. The product was obtained as white foam.   Exprerimental Part   
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Yield:    390 mg (29.3 %) 
TLC:    Rf = 0.24 (CH2Cl2) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
7.46 – 6.82 (m, 18H, Har); 4.74 (d, J = 5.2 Hz, 1H, 3´-OH); 4.67 (d, J = 6.4 Hz, 
1H, 1´H); 3.95 (m, 3H, 2´H, 3´H, 4´H); 3.73 (s, 6H, OCH3); 3.23 (m, 2H, 5´H); 
0.78 (s, 9H, SiC(CH3)3); –0.12 (SiCH3); –0.17 (SiCH3) 
13C-NMR:  δ [ppm] (100.6 MHz, DMSO-d6) 
158.06 (DMTr); 145.02 (DMTr); 140.54 (Car); 140.21 (Car); 135.54 (DMTr); 
135.47 (DMTr); 129.75 (DMTr); 128.88 (Car); 128.17 (Car); 128.03 (DMTr); 
127.76 (DMTr); 127.37 (Car); 126.65 (Car); 126.22 (DMTr); 113.13 (DMTr); 
85.43  (DMTr);  83.66  (C1´);  83.13  (C4´);  79.66  (C2´);  71.55  (C3´);  63.88 
(C5´); 55.01 (OCH3); 25.63 (SiC(CH3)3); 17.89 (SiC(CH3)3); –4.98 (SiCH3);   
–5.28 (SiCH3) 
ESI(–):    625.6 ([M-H]
-); 
 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-phenyl-β β β β-D-ribofuranose 160 
 
 
O
DMTrO
OH TBDMSO  
 
C38H46O6Si 
626.82 g/mol 
 
5´- O- (4,4´-Dimethoxytriphenylmethyl)- 3´-O-tert.-butyldimethylsilyl- 1´-deoxy-1´- phenyl- 
β-D-ribofuranose  160  was  obtained  as  a  side  product  in  the  synthesis  of  5´-O-(4,4´-
Dimethoxytriphenylmethyl)- 2´-O-tert.-butyldimethylsilyl- 1´-deoxy- 1´- phenyl- β- D- ribo-
furanose 160. 
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Yield:    560 mg (42.1 %) 
TLC:    Rf = 0.27 (CH2Cl2) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
7.42 – 6.82 (m, 18H, Har); 4.89 (d, J = 7.2 Hz, 1H, 2´-OH); 4.67 (d, J = 6.4 Hz, 
1H, 1´H); 4.01 (m, 1H, 3´H); 3.94 (m, 1H, 2´H); 3.74 (m, 1H, 4´H); 3.72 (s, 
6H, OCH3); 3.22 (m, 2H, 5´H); 0.78 (s, 9H, SiC(CH3)3); –0.01 (SiCH3); –0.06 
(SiCH3) 
13C-NMR:  δ [ppm] (62.9 MHz, DMSO-d6) 
157.78 (DMTr); 145.01 (DMTr); 140.54 (Car); 140.22 (Car); 135.44 (DMTr); 
135.48 (DMTr); 129.75 (DMTr); 128.89 (Car); 128.04 (Car); 127.75 (DMTr); 
127.64 (DMTr); 127.37 (Car); 126.39 (Car); 126.22 (DMTr); 112.73 (DMTr); 
85.43  (DMTr);  83.72  (C1´);  83.38  (C4´);  79.88  (C2´);  71.63  (C3´);  63.84 
(C5´); 54.98 (OCH3); 25.73 (SiC(CH3)3); 17.88 (SiC(CH3)3); –5.01 (SiCH3);   
–5.25 (SiCH3) 
ESI(–):     625.5 ([M-H]
-); 
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3´-O-(2-Cyanethoxydiisopropyl-phosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-
triphenylmethyl)-1´-phenyl-2´-O-tert.-butyldimethylsilyl-β β β β-D-ribofuranose  
161 
 
 
O
DMTrO
O OTBDMS
P
O
CN
N
 
 
 
C47H63N2O7PSi 
827.02 g/mol 
 
200 mg (0.32 mmol) 5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
desoxy-1´-phenyl-β-D-ribofuranose 159 were dissolved in 10 ml abs. acetonitrile and 430 µl 
(3.0 mmol) sym. collidine and 13 µl (0.17 mmol) 1-methylimidazole were added. The reaction 
mixture  was  cooled  in  an  icebath  to  0°C  and  110  µl  (0.50  mmol)  2-
cyanethyldiisopropylchlorophosphoramidit  96 were added. The reaction was stirred for 15 
min. at 0°C and 1 hour at RT. The reaction was stopped by adding of 5 ml of 0.01 M citric 
acid and  extracted with methylene chloride. The combined organic phases were washed  with 
0.01 M citric acid twice, dried over MgSO4 and evaporated to dryness. Purification was done 
by FC with n-hexane/ethyl acetate, 4:1, as eluent. The product (mixture of two diastereomers) 
was obtained as white foam. 
 
 
Yield:    152 mg (57.6 %) 
TLC:    Rf = 0.39 (n-hexan/ethylacetat 4:1) 
1H-NMR:  δ [ppm] (400 MHz, CDCl3) 
7.56 – 6.83 (m, 36H, Har); 4.77 (m, 2H, 1´H); 4.16 (m, 4H, 2´H, 3´H); 3.95 (m, 
2H, 4´H); 3.79, 3.78 (s, 12H, OCH3); 3.55 (m, 8H, 5´H, CH2CN); 2.66 (m, 4H,   Exprerimental Part   
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OCH2); 1.16 (m, 12H, CH(CH3)2); 0.80, 0.79 (s, 18H, SiC(CH3)3); –0.13,        –
0.15, –0.29, –0.30 (SiCH3) 
31P-NMR:  δ [ppm] (162 MHz, CDCl3) 
151.88 and 149.35 (ratio 1 : 4.5) 
ESI(+):   827.6 ([M+H]
+); 
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2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-pentafluorophenyl-β β β β-D-ribofuranose 162 
 
 
O
BnO
F
F
OBn BnO
F
F F
 
 
 
C32H27F5O4 
570.54 g/mol 
 
To the solution that contains 5.5 g (22 mmol) pentafluorobromobenzene in 20 ml abs. diethyl 
ether at –78°C under argon over 30 minutes 13 ml 1.7 M (22 mmol) solution of  n-Butyl 
lithium in n-hexane were added. After 30 minutes at –78°C  solution of 2,3,5-Tri-O-benzyl-
ribono-γ-lacton (3.4 g, 8.16 mmol) 83  in 20 ml abs. diethyl ether was added over 20 minutes 
and 1 hour stirred at –78°C. Afterwards the reaction mixture was allowed to warm up to -
20°C over two hours. The reaction was stopped by adding  10 ml of water and three times 
extracted with ether. The combined organic phases were dried over MgSO4 and evaporated to 
dryness. Left oil was immediately dissolved in 20 ml of methylene chloride, cooled to -78°C 
and 2.1 ml ( 16.8 mmol) borontrifluoride ethyletherate and 2.62 ( 16.8 mmol) triethylsilane 
were added. The reaction mixture was left at -78°C and than  allowed to warm up to 10°C 
over night. The reaction was stopped by adding  10 ml of saturated water solution of NaHCO3 
and extracted  with methylene chloride three times. The combined organic phases were dried 
over MgSO4 and evaporated under reduced pressure. Further purification was done by FC 
using  n-hexane/ethyl acetate 4:1 as eluent. The product was obtained as white solid.  
 
 
Yield:    2.30 g (50 %) 
TLC:    Rf=0.60 (n-hexane/EtOAc, 4:1)  
1H NMR:  δ [ppm] ( 400 MHz, DMSO-d6) 
7.38-7.27(m, 15H, Har); 5.04(d, J=7.92 Hz, 1H, 1’H); 4.69-4.12(m, 9H, CH2-
benzyl, 4’H, 3’H, 2’H); 3.55(m, 2H, 5’CH2); 
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13C NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
138.36(Car); 138.19(Car); 137.76(C6); 135.70(Car); 135.70(Car) ; 129.86 
(Car); 128.80(Car) ; 128.09(Car); 128.24(Car); 128.21(Car); 128.18(Car); 
127.0(Car); 113.66(C1); 113.65(C5); 112.39(C2), 112.28 (C4), 
112.10(C3);112.00(C1) ; 82.10(C1’); 80.80(C4’); 76.84(C2’); 75.96(C3’); 
72.46(CH2-benzyl); 71.07(CH2-benzyl); 62.12(C5’); 
ESI (+):  593.10 ([M+Na]
+);
  
 
 
1´-Deoxy-1´-pentafluorophenyl-β β β β-D-ribofuranose 39 
 
 
O
HO
OHOH
F
F F
F F
 
 
 
C11H9F5O4 
300.2 g/mol 
 
1.4  g  (2.45  mmol)  2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-pentafluorophenyl-β-D-ribofuranose 
162  were dissolved in 40 ml of abs. ethanol and 20 ml cyclohexene and 400 mg palladium-
hydroxide (20%) on carbon were added. The reaction mixture was refluxed for 4 hours. Then 
the reaction mixture was filtrated over celite and the filtrate was evaporated under reduced 
pressure. The purification was done by FC with methylene chloride/methanol 9:1, as eluent. 
The  product  was  obtained  as  colourless  solid.  For  analytical  purposes  the  product  was 
crystallised from water and methanol. 
 
 
Yield:    669 mg (91%) 
TLC:    Rf=0.40 (CH2Cl2/MeOH, 9:1)   Exprerimental Part   
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1H NMR:  δ [ppm] ( 400 MHz, DMSO-d6) 
5.19(d, J=6.56 Hz, 1H, 1’H); 5.08 (d, J=5.24 Hz, 1H, 3’OH); 4.89(d, J=7.5 Hz, 
1H, 2’OH); 4.76(t, J=5.6 HZ, 1H, 5’OH);   4.20(m,1H, 4’H); 3.94 (m, 1H, 
3’H); 3.80 (m, 1H, 2’H); 3.50 (m, 2H, 5’CH2); 
19F NMR:  δ [ppm] (235.3 MHz, DMSO-d6) 
-142.89 (m, 2F, 1F, 5F); -155.35 (t, 1F, J=23,5 Hz, 3F); -163.21 (m, 2F, 2F, 
4F); 
ESI (-):  298.9 ([M-H]
-); 
 
 
5´-O- (4,4´-Dimethoxytriphenylmethyl)- 1´-deoxy-1´-pentafluorophenyl-β β β β-
D-ribofuranose 163 
 
 
O
DMTrO
OHOH
F
F F
F F
 
 
 
C32H27F5O6 
602.56 g/mol 
 
0.50 g (1.66 mmol) 1´-Deoxy-1´-pentafluorophenyl-β-D-ribofuranose 39 were dissolved in 15 
ml  abs.  pyridine  and  0.60  ml  (4.25  mmol)  triethylamine  and  1.00  g  (2.90  mmol)  4,4´-
dimethoxytriphenylmethyl chloride were added. The reaction mixture was stirred under argon 
at RT for 24 hours. The reaction was stopped by adding  3 ml of methanol and saturated water 
solution of NaHCO3. It was  extracted with methylene chloride three times, organic phases 
were collected and dried over  MgSO4 and than evaporated to dryness. Product was twice co-
evaporated  with  toluene.  Further  purification  was  done  by  FC  with  methylene 
chloride/methanol 98:2 as eluent. The product was obtained as yellow foam. 
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Yield:    830 mg (83 %) 
TLC:    Rf=0.30 (CH2Cl2:MeOH, 95:5) 
1H NMR:  δ [ppm] ( 270MHz, DMSO-d6)  
7.41-6.89 (m, 13H, Har); 5.26(d, J= 5.8 Hz, 1H, 1’H); 5.13(d, J=5.28 Hz, 1H, 
2’OH); 4.93 (d, J=6.92 Hz, 1H, 3’OH); 4.17(m, 1H, 2’H); 3.91 (m, 2H, 3’H, 
4H); 3.73(s, 6H, 2OCH3);3.14(m, 2H, 5’H); 
13C NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
158.03(DMTr); 149.60(C4); 149.30(C3); 149.10(C5); 135.59(DMTr); 
129.67(DMTr); 127.73(DMTr);127.66(DMTr); 127.60(C2); 
1127.69(C2);127.50(C6); 127.00(C1); 113.11 (DMTr); 85.40(DMTr); 
83.20(C1’);  82.70 (C4’); 77.65 (C2’); 71.10 (C3’) ; 64.15 (C5’); 54.99 
(OCH3) ;  
ESI (-):   601.2 ([M-H]
-);
 
 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´-(pentafluorophenyl)-β β β β-D-ribofuranose 164 
 
 
O
DMTrO
OHOTBDMS
F
F F
F F
 
 
 
C38F5O6Si 
716.81 g/mol 
 
750  mg  (1.24  mmol)  5´-O-(4,4´-Dimethoxytriphenylmethyl)-1´-deoxy-1’-(pentafluoro 
phenyl)-β-D ribofuranose 163 were dissolved in 20 ml of 1:1 mixture of  THF/pyridine and 
with  250  mg  (1.46  mmol)  AgNO3  and  1.80  ml  (1.80  mmol)  1 M  tert.-butyldimethylsilyl 
chloride-solution in THF were added. The reaction mixture was stirred for 20 hours at RT 
under argon. Adding 10 ml  saturated water NaHCO3-solution stopped the reaction. Left AgCl   Exprerimental Part   
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was filtered over celite and the filtrate was extracted with methylene chloride three times. The 
combined  organic  phases  were  dried  over  MgSO4  and  evaporated  to  dryness.  The  crude 
product was twice co-evaporated with toluene. Further purification of product was done by 
HPLC (MN Nucleoprep 100-20 of Machrey-Nagel, hexane/methyl acetate, 10:1). The product 
was obtained as the slower-migrating isomer and as white foam. 
 
 
Yield:    347 mg (39%) 
TLC:    Rf=0.50 (CH2Cl2) 
1H NMR:  δ [ppm] ( 270MHz, DMSO-d6) 
7.41-6.85 (m, 13H, Har); 5.15 (d, J= 7.04 Hz, 1H, 3’OH); 4.94 (d, J=6.96 Hz, 
1H, 1’H); 4.17 (m, 1H, 2’H); 4.10 (m, 1H, 3’H); 3.93 (s, 6H, 2OCH3); 3.08(m, 
2H, 5’CH2); 0.80 (s, 3H, Si(OCH3)3); 0.03(s, 3H, SiCH3); -0.02 (s, 3H, SiCH3); 
13C NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
158.03(DMTr); 149.60(C4); 149.30(C3); 149.10(C5); 135.59(DMTr); 
129.67(DMTr); 127.73(DMTr);127.66(DMTr); 127.60(C2); 
1127.69(C2);127.50(C6); 127.00(C1); 113.11 (DMTr); 85.40(DMTr); 
83.20(C1’);  82.70 (C4’); 77.65 (C2’); 71.10 (C3’) ; 64.15 (C5’); 54.99 
(OCH3) ; 25.80(SiC(CH3)3); 17.87(SiC(CH3)3); -5.08(SiCH3);-5.35(SiCH3); 
ESI (-):   715.50 ([M-H]
-); 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Exprerimental Part   
- 290 - 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-tert.-butyldimethylsilyl-1´-deoxy-
1´-(pentafluorophenyl)-β β β β-D-ribofuranose 165 
 
 
O
DMTrO
F
F
OH TBDMSO
F
F F
 
 
 
C38H41F5O6Si 
716.81 g/mol 
 
5´-O-(4,4´-Dimethoxytriphenylmethyl)-3´-O-tert.-butyldimethylsilyl-1´-deoxy-1´-
(pentafluorophenyl)-β-D-ribofuranose  165  were obtained as a side product (faster-migrating 
isomer)  while  synthesising  5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-
butyldimethylsilyl-1´-deoxy-1´-(pentafluorophenyl)-β-D- ribofuranose  164 . 
 
 
Yield:    320 mg (36 %) 
TLC:    Rf=0.50 (CH2Cl2) 
1H NMR:  δ [ppm] ( 270MHz, DMSO-d6)  
7.41-6.80 (m, 13H, Har); 5.12 (d, J= 7.04 Hz, 1H, 1’H); 4.90 (d, J=6.88 Hz, 
1H, 2’OH); 4.12(m, 1H, 2’H); 3.92 (m, 1H, 3’H); 3.77(s, 6H, 2OCH3);3.75(m, 
2H, 5’H); 3.10(m, 2H, 5’CH2); 0.81(s, 3H, Si(OCH3)3); 0.02(s, 3H, SiCH3); -
0.04(s, 3H, SiCH3); 
13C NMR:   δ [ppm] (67.9 MHz, DMSO-d6) 
158.03(DMTr); 149.60(C4); 149.30(C3); 149.10(C5); 135.59(DMTr); 
129.67(DMTr); 127.73(DMTr);127.66(DMTr); 127.60(C2); 
1127.69(C2);127.50(C6); 127.00(C1); 113.11 (DMTr); 85.40(DMTr); 
83.20(C1’);  82.70 (C4’); 77.65 (C2’); 71.10 (C3’) ; 64.15 (C5’); 54.99 
(OCH3) ; 25.60(SiC(CH3)3); 17.85(SiC(CH3)3); -5.07(SiCH3); -5.30(SiCH3); 
ESI (-):  715.60 ([M-H]
-); 
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3´-O-(2-Cyanethoxydiisopropylphosphin)-1´-deoxy-5´-O-(4,4´-dimethoxy-
triphenylmethyl)-1´-(pentafluorophenyl)-2´-O-tert.-butyldimethylsilyl-β β β β-D-
ribofuranose  166 
 
 
O
DMTrO
O OTBDMS
F
F
P
O
CN
N
F
F F
 
 
 
C47H58F5N2O7PSi 
917.01 g/mol 
 
200 mg (0.22 mmol) 5´-O-(4,4´-Dimethoxytriphenylmethyl)-2´-O-tert.-butyldimethylsilyl-1´-
desoxy-1´-(pentafluorophenyl)-β-D-ribofuranose 164 were dissolved in 10 ml abs. acetonitrile 
and 290 µl (2.2 mmol) sym. collidine and 9 µl (0.12 mmol) 1-methylimidazole were added. 
The  reaction  mixture  was  cooled  in  an  icebath  to  0°C  and  75  µl  (0.33  mmol)  2-
cyanethyldiisopropylchloro  phosphoramidite  96    was  added.  The  reaction  was  stirred  for 
15min. at 0°C and 1 hour at RT. The reaction was stopped by adding  10 ml of 0.01 M citric 
acid and three times extracted with methylene chloride. The combined organic phases were 
washed  twice  with  0.01  M  citric  acid,  dried  over  MgSO4  and  evaporated  to  dryness. 
Purification was done by FC with n-hexane/ethyl acetate, 4:1, as eluent. The product (mixture 
of two diastereomers) was obtained as white foam. 
 
 
Yield:    125 mg (62 %) 
TLC:    Rf =0.33 (hexane/EtOAc, 4:1)  
1H NMR:  δ [ppm] ( 400MHz, CDCl3) 
7.49-6.68 (m, 15H, Har); 5.12 (d, J= 7.54 Hz, 1H, 1’H); 4.52 (m, 1H, 2’H); 
4.20 (m, 1H, 3’H); 3.96 (m, 1H, 4’H); 3.78 (s, 6H, 2OCH3); 3.60 (m, 2H,   Exprerimental Part   
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CH2CN); 3.28 (m, 2H, 5’CH2);  2.68 (m, 2H, OCH2); 1.12 (m, 6H, CH(CH3)2); 
0.78 (s, 9H, SiC(CH3)3); 0.05 (s, 3H, SiCH3); -0.04 (s, 3H, SiCH3); 
31P NMR:  δ [ppm] ( 162 MHz, CDCl3) 
155.93 and 152.24 (ratio 1:4.2) 
ESI (+):   941.7  ([M+Na]
+)
 ; 
 
 
2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-(4-chlorophenyl)-β β β β-D-ribofuranose 167 
 
 
O
BnO
Cl
OBn BnO  
 
C32H31ClO4 
515.02 g/mol 
 
 
To the solution that contains 1.5 g (7.8 mmol) 1-Bromo-4-chloro benzene in 40 ml THF at      
–78°C under argon over 10 minutes 4.9 ml 1.6 M (7.84 mmol) solution of  n-butyl lithium in 
n-hexane were added. After 20 minutes at –78°C  solution of 2,3,5-tri-O-benzyl-ribono-γ-
lacton  83  (2.81g, 6.7 mmol) in 20 ml THF was added over 30 minutes (via cannula) and 1 
hour stirred at  –78°C. Afterwards the reaction mixture was allowed to warm up to -20°C over 
two hours. The reaction was stopped by adding of 30 ml of water and three times extracted 
with ether. The combined organic phases were dried over MgSO4 and evaporated to dryness. 
Left oil was immediately dissolved in 50 ml of methylene chloride, cooled to -78°C and 1.7 
ml (13.4 mmol) borontrifluoride ethyletherat and 2.10 ml (13.4 mmol) triethylsilane were 
added. The reaction mixture was left at -78°C and than over night allowed to warm up to 
10°C. The reaction was stopped by adding  10 ml of saturated water solution of NaHCO3, 
extracted three times with methylene chloride. The combined organic phases were dried over 
MgSO4 and evaporated under reduced pressure. Further purification was done by FC using  n-
hexane/ethyl acetate 4:1 as eluent. The product was obtained as light orange solid.  
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Yield:    2.4 g (73 %) 
TLC:    Rf =  0.50 (n-hexan/ethyl acetate 4:1) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
7.44 – 7.08 (m, 19H, Har); 4.87 (d, J = 6.8 Hz, 1H, 1´H); 4.61 – 4.42 (m, 6H, 
CH2-benzyl); 4.24 (q, J = 3.8 Hz, 1H, 4´H); 4.07 (dd, J = 4.8 Hz, 3.8 Hz, 1H, 
3´H); 3.87 (dd, J = 5.0 Hz, J = 6.8 Hz, 1H, 2´H); 3.64 (m, 2H, 5´H) 
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
138.19  (Car);  137.95  (Car);  136.63  (C1);  128.18  (Car);  128.11  (Car);  128.05 
(Car);  127.74  (Car);  127.43  (Car);  127.36  (Car);  123.99  (C5);  114.95  (C2); 
114.64 (C6); 83.41 (C1´); 81.23 (C4´); 81.08 (C2´); 77.27 (C3´); 72.41 (CH2-
benzyl); 71.10 (CH2-benzyl); 70.96 (CH2-benzyl); 70.27 (C5´) 
ESI(+):  m/z 515.5 ([M+H]
+); 
 
 
1´-Deoxy-1´-(4-chlorophenyl)-β β β β-D-ribofuranose 43 
 
 
O
HO
OHOH
Cl
 
 
C11H13ClO4 
244.45 g/mol 
 
2.0 g (3.9 mmol) 2´,3´,5´-Tri-O-benzyl-1´-deoxy-1´-(4-chlorophenyl)-β-D-ribofuranose 167  
were dissolved in 40 ml abs. ethanol and 20 ml cyclohexene and 300 mg palladium-hydroxide 
(20%)  on  carbon  were  added.  The  reaction  mixture  was  refluxed  for  3  hours.  Then  the 
reaction  mixture  was  filtrated  over  celite  and  the  filtrate  was  evaporated  under  reduced 
pressure. The purification was done by FC with methylene chloride/methanol 9:1 as eluent. 
The product was obtained as colourless solid. For analytical purposes it was crystallized from 
water and methanol. 
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Yield:    0.92 g (95 %) 
TLC:    Rf = 0.42 (CH2Cl2/MeOH 9:1) 
1H-NMR:  δ [ppm] (250 MHz, DMSO-d6) 
7.42 (m, 4H, Har); 4.91 (d, J = 4.7 Hz, 1H, 3´-OH); 4.82 (t, J = 5.5 Hz, 1H, 5´-
OH); 4.67 (d, J = 7.0 Hz, 1H, 1´H); 4.56 (d, J = 7.3 Hz, 1H, 2´-OH); 3.89 (m, 
1H, 3´H); 3.81 (m, 1H, 4´H); 3.66 (m, 1H, 2´H); 3.24 (m, 2H, 5´H) 
13C-NMR:  δ [ppm] (67.9 MHz, DMSO-d6) 
137.72 (C1); 128.06 (C3); 114.79 (C2); 114.47 (C6); 85.18 (C1´); 82.21 (C4´); 
77.55 (C2´); 71.35 (C3´); 61.97 (C5´) 
ESI(–):    m/z 242.7 ([M-H]
-); 
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10.6  Synthesis of Oligonucleotides 
 
RNA  Synthesis  was  done  on  1 mol  scale  on  the  Synthesizer  from  company  PerSeptive 
Biosystems  (Model  Expedite  8905).  We  used  500  Å  CPG  solid  phase  from  Perseptive 
Biosystems.  Standard  coupling  times  of  10  minutes  were  used  for  all  RNA  nucleosides. 
Coupling yields were similar in-between all synthesised oligonucleotides. The RNA amidites 
were used for synthesis in 0.01M concentration. After the synthesis DMTr-group was cleaved.  
Oligonucleotides  were  kept  at  55°C  over  night  after  treatment  with  ammonia/methanol 
mixture (3:1). The mixture was than filtrated through 0,2 mol sterile filter with cellulose 
membrane and filtrate was evaporated in a Speed Vac concentrator. To left solid was added 1 
ml of triethylaminetrihydrofluoride and after 24h at room temperature the 2'TBDMS groups 
were cleaved. Than 3ml of n-butanol, cooled to -20°C, was added and the mixture was left at 
´20°C for three hours. At the end the mixture was centrifuged for 15 minutes at 12000 at 4 °C. 
Afterwards the solution was decanted and left solid dissolved in 150  l of DEPC water and 
150  l 1-methyl-2-pyrrolidinone dissolved. The dissolved oligonucleotide was purified with 
ion exchange-HPLC.  
 
 
10.7  Purification and Analytics of Oligonucleotides 
 
 
10.7.1   HPLC-purification 
 
The RNA oligonucleotides were synthesised in ''Trityl off'' modus and with ion-exchange-
HPLC purified. We used HPLC machine from JASCO, which has PU-980 pump, LG-980-02 
mixer, UV-970 detector, column heating oven and computer. As analytical column was used 
Dionex NucleoPac
TMPA100 column ( 250*4mm). With the flow of 5ml/min. As preparative 
column was used Dionex NucleoPac
TMPA100 column ( 250*9mm). The linear gradient from 
0% to 70% of B in A (in 40 min.) was used (Puffer A: DEPC-water (pH=8,00), puffer B: 1M 
LiCl (pH=8,00)). The UV-detection was preformed at 260 nm. After separation the oligo was 
over Sephadex PD 10 column with G25 material desalted. Than the amount of synthesised 
oligonucleotide  was  determined  through  measuring  of  OD260.  The  purity  of  product  was 
controlled with MALDI.  
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10.7.2   The amounts of synthesised oligonucleotides 
 
Purified and desalted oligonucleotide was dissolve in 1,00 ml of DEPC water. Than 10  l of 
the solution was taken and added into the 10mm quartz cuvette with DEPC water filled up to 
1000   l.  Absorbance  or  optical  density  at  260  nm  was  measured.  The  value  read  at  the 
machine was multiplied with 100. The result is the yield in OD260 that is in 1ml dissolved. 
This leaves us with the possibility to count the extinction coefficient ε and the concentration. 
 
10.7.3   The Extinction coefficient of Oligonucleotides 
 
The molar  extinction coefficient of oligonucleotides could be  calculated from the sum of 
known extinction coefficients for natural nucleosides. According to Eckstein ( Eckstein, 1991) 
the following is known: 
 
ε = ( 8,8•nT+ 7,3•nC+ 11,7•nG+ 15,4•nA )• 0,9 [1000 cm
2 mol
-1] 
 
The n is the number of each nucleoside in oligonucleotide. The factor 0,9 corrects the 
UV absorbance concerning the influence of the bases in single strain oligonucleotide. 
The exact method for determination of molar extinction coefficient is given from Puglisi 
and Tinoco ( Tinoco, 1989) and also  Gray (Gray et al., 1995). In the determination is also 
calculated the influence of chromophores with neighbours. This tells us that the extinction 
coefficient of dinucleotide is not sum of extinction coefficients of nucleosides. The values are 
given in table  .The extinction coefficient is determined through following: 
 
ε(ACGU…) = 2 [ε (AC) + ε (CG) + ε (GU)+….]-[ ε (C) + ε (G) + ε (U) +…] 
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Building block  RNA    Building block  RNA 
A  15,34    CG  9,39 
C  7,60    CU  8,37 
G  12,16    GA  12,92 
U  10,21    GC  9,19 
AA  13,65    GG  11,43 
AC  10,67    GU  10,96 
AG  12,79    UA  12,52 
AU  12,14    UC  8,90 
CA  10,67    UG  10,40 
CC  7,52    UU  10,11 
 
Figure 10.1.  The extinction coefficients of monomer and dimers at 260 nm after Puglisi and 
Tinoco ( 1989) also Gray et al. (1995). The values are given at 25 °C, pH07, 00 and ion 
strength of 0.1. 
 
The extinction coefficients of analogues that are not known, in this case are calculated as the 
values for U or G. 
The concentration of oligonucleotide solution in mol
 dm
-3 and d, in cm, is in connection with 
OD260, absorbance at 260 nm,  in the following sense: 
 
  OD260 = ε · c · d 
 
  c = OD260 / ε · d 
 
10.8  UV-Melting Curves 
 
The  UV-  melting  curves  were  measured  using  UV-/VIS-Spectrophotometer  Cary  1,  from 
Varian company. As a puffer was used phosphate puffer 140 mM NaCl, 10 mM Na2HPO4 and 
10 mM NaH2PO4. The solution's pH value was with solution of HCl fixed to pH=7,00. The 
used water was DEPC water. For DEPC water was made 0,1% solution of DEPC in water, left 
over night and than 30 min. autoclaved.  
For performing a measurement as a reference was used 1ml of puffer in a reference civet. The 
sample cuvette, with the same d, was fulfilled with a same puffer and the 0 was set up at   Exprerimental Part   
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machine.  Than  the  concentration  of  2 mol  of  each  strain  that  together  make  duplex  was 
measured in cuvette. The oligonucleotides are dissolved in known volume of DEPC water .  
Before  we  begin  to  measure  we  close  teflon  cover.  The  measurement  begins  with 
denaturation. Therefore we heat the cuvettes 10 min up to 80°C and afterwards at 5°C for a 
min. we renaturate them. Than the system was cooled up to the starting temperature (5 or 
10°C) and kept on starting temperature for 10 minutes. The measurement is done with heating 
rate from 0,5°C/min at 260 nm and 274 nm. Every 30 seconds data are registered. This is 
concidered  precise  enough  (Varian,  1998).  After  measurement  is  finished  the  data  are 
automatically shown in a graph and the sample cooled to 25°C. All measurements were done 
at least twice. Comparing measurements at 260 nm and 274 nm no significant differences 
were registered. The Tm value was from α = f (T) curve calculated. For all the measurements 
below 20°C the cuvettes were purged with N2, to put way the influence of condensation of air 
water on the walls of cuvettes.  
For the better comparing the OD values are normalized in the following way: 
ODnorm=(OD (T)-ODB) / ( ODE-ODB) 
were ODB is the beginning value of absorbance and ODE the end value of absorbance. 
 
 
10.9  CD-Spectroscopy of Oligonucleotides 
 
The  CD  spectra  were  measured  with  JASCO  J-170  Spectropolarimeter,  with  thermostatic 
cuvette ( Neslab RTE-100) holder. The same samples that were used for UV measurements 
were used. For each measurement five measurements were accumulated from 350 nm to 200 
nm. Following conditions were used: 0,2 nm, scan speed 50 nm/min., response 1 sec. And 
band at 1 nm. In this way measured spectra at each temperature of measurement the spectra of 
buffer was leaved off.  
 
10.10  Determination of Partition Coefficient 
 
For determination of partition coefficients the nucleosides were dissolved in water, using the 
concentrations that have absorbance between 0,8-1,2. From this solution 2 ml were mixed 
with the same volume of 1-octanol over 10 minutes. Than the samples were centrifuged over 
10 min. with 10 000 rpm and two faces were separated. The absorbance of water and 1-  Exprerimental Part   
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octanol phase were measured. The partition coefficient was calculated from the following 
equotion: 
 
log P =Aoctanol/Awater 
 
 
10.11  Determination of HPLC Retention Times 
 
 
For determination of retention times were used solutions that were also used for determination 
of partition coefficients of unprotected nucleosides. The retention times were measured on 
HPLC  machine  designed  by  JASCO,  with  PU-980  pump,  LG-980-02-mixer,  UV-970 
detector, heating oven for column and computer. As analytic column was used RP-18 (5 m) 
from Merck company ( lichrosphere EcoCART 125-3, Nr. 647318) with flow of 0,6 ml/min. 
As eluent was used a 5% solution of acetonitrile in water. Identification was done at 260 nm.  
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12 Attachment 
 
 
 
 
 
12.1  Crystal Data of Crystalized Compounds 
 
12.1.1   Crystal data of  1’-deoxy-1’-(2,4,6-trifluorophenyl)-β-D-ribofuranose 
 
 
A single crystal ( colorless rod with dimensions 0.14 x 0.30 x 0.55 mm ) was measured on a 
SIEMENS SMART diffractometer at a temperature of about -131 °C. Repeatedly measured 
reflections remained stable.  A numerical absorption correction using six indexed crystal faces 
gave a transmission factor between 0.930 and 0.980 .  Equivalent reflections were averaged. 
Friedel opposites were not averaged.  R(I)internal = 0.032 .  The structure was determined by 
direct methods using program SHELXS. The H atoms were taken from a difference synthesis 
and  were  refined  with  isotropic  thermal  parameters.  The  non-H  atoms  were  refined  with 
anisotropic  thermal  parameters.  The  structure  was  refined  on  F^2  values  using  program 
SHELXL-97.  The  final  difference  density  was  between  -0.18  and  +0.31  e/Å  . 
 The five-membered furanose ring approximately has a C2-endo-envelope  conformation. The 
hydroxyl group attached to C2 is in an equatorial  position, the hydroxyl group attached to C3 
is in a pseudo-axial position and the phenyl group attached to C1 is in a pseudo-equatorial 
position with  respect to the furanose ring. The trifluorophenyl group adopts a position with 
an  almost  syn-periplanar  orientation  of  the  C11-F3  bond  and  the  C1-H1  bond.  The 
intramolecular H1...F3 distance of 2.34 Å is slightly shorter than the van der Waals contact 
distance.  The phenyl group shows a small deviation from planarity: substituent atoms C1 and 
F1 deviate 0.11 Å in opposite directions from the phenyl plane.  This deviation from planarity 
may result from a steric interaction between atoms F1 and O4. The observed F1...O4 distance 
of  2.819  Å  is  slightly  shorter  than  the  van  der  Waals  contact  distance.  The  ribofuranose 
groups  are  connected  by  intermolecular  O-H...O  hydrogen  bonds  to  a  two-dimensional 
network parallel to the a,b - plane. These molecular layers are connected in the c - direction   Attachment   
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by  an    intermolecular  C-H...O  interaction  with  a  H...O  distance  of  2.48  Å  and  two 
intermolecular C-H...F interactions (involving the para-F atom) with H...F distances of 2.54 
and 2.63 Å. 
 
Intermolecular hydrogen bonds 
 
   O  - H  ...  O   O - H   H...O  O...O  O-H-O    symmetry 
                                [Å]     [Å]    [Å]   [deg] 
   O2 - H02 ... O5  0.79   2.04   2.816   167    2-x, y-1/2, 3/2-z 
   O3 - H03 ... O4  0.82   1.99   2.815   175    2-x, y-1/2, 3/2-z 
   O5 - H05 ... O2  0.82   1.95   2.772   173    1-x, 1/2+y, 3/2- 
 
Table 1.  Crystal data and structure refinement for 1’-deoxy-1’-(2,4,6-trifluorophenyl)-β-D-
ribofuranose 
 
      Identification code               engels 
  
      Empirical formula                 C11 H11 F3 O4 
  
      Formula weight                    264.20 
  
      Temperature                       142(2) K 
  
      Wavelength                        0.71073 A 
  
      Crystal system, space group       Orthorhombic,  P22121 
  
      Unit cell dimensions                a = 4.9699(12) A   alpha = 90 deg. 
                                                 b = 11.209(3) A    beta = 90 deg. 
                                                      c = 20.221(5) A   gamma = 90 deg. 
  
      Volume                                      1126.4(5) A^3 
  
      Z, Calculated density                4,  1.558 Mg/m^3 
  
      Absorption coefficient            0.148 mm^-1 
  
      F(000)                                      544 
  
      Crystal size                               0.55 x 0.30 x 0.14 mm 
  
      Theta range for data collection   2.01 to 32.45 deg. 
  
      Limiting indices                           -7<=h<=7, -16<=k<=16, -30<=l<=29   Attachment   
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      Reflections collected / unique    19923 / 3826 [R(int) = 0.0320] 
  
      Completeness to theta = 32.45     96.0 % 
  
      Absorption correction                    Numerical (SHELXTL, Sheldrick, 1996) 
  
      Max. and min. transmission           0.980 and 0.930 
  
      Refinement method                         Full-matrix least-squares on F^2 
  
      Data / restraints / parameters          3826 / 0 / 207 
  
      Goodness-of-fit on F^2                    1.169 
  
      Final R indices [I>2sigma(I)]           R1 = 0.0325, wR2 = 0.0810 
  
      R indices (all data)                            R1 = 0.0361, wR2 = 0.0839 
  
      Absolute structure parameter           0.2(5) 
  
      Largest diff. peak and hole       0.306 and -0.182 e.A^-3 
   
 
    Table 2.  Atomic coordinates ( x 10^5) and equivalent isotropic   displacement parameters 
(A^2 x 10^4) for engels.U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
 
          
                                x                y                    z                U(eq) 
  
          O(2)        80656(18)     38745(7)      84091(4)      191(2) 
          O(5)        68850(18)     77417(7)      65235(4)      196(2) 
          F(1)        52333(15)     74945(7)      83724(4)      227(2) 
          O(4)        97123(17)     67038(7)      76383(4)      154(2) 
          F(3)       127271(17)     56800(8)      93713(4)      287(2) 
          O(3)       110565(19)     41761(8)      72085(4)      223(2) 
          F(2)        78260(30)     86047(11)    105099(5)      538(3) 
          C(7)        69780(20)     73966(10)     88818(6)      192(2) 
          C(1)        97380(20)     59148(9)      82027(5)      134(2) 
          C(6)        90970(20)     65953(10)     88245(5)      161(2) 
          C(4)        88710(20)     60369(9)      70531(5)      140(2) 
          C(5)        63230(20)     65688(10)     67670(6)      183(2) 
          C(3)        85220(20)     47456(9)      72776(5)      162(2) 
          C(8)        65130(30)     80962(12)     94334(7)      283(3) 
          C(2)        78110(20)     49061(9)      80115(5)      145(2) 
          C(9)        82250(30)     79270(14)     99623(7)      333(3) 
          C(10)      102980(30)     71130(15)     99673(7)      319(3) 
          C(11)      106740(20)     64720(11)     93888(6)      219(2) 
              Attachment   
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Table 3.  Bond lengths [Å] and angles [deg] for 1’-deoxy-1’-(2,4,6-trifluorophenyl)-β-
D-ribofuranose 
 
            O(2)-C(2)                     1.4140(13) 
            O(5)-C(5)                     1.4313(14) 
            F(1)-C(7)                     1.3508(14) 
            O(4)-C(1)                     1.4438(12) 
            O(4)-C(4)                     1.4606(13) 
            F(3)-C(11)                    1.3531(15) 
            O(3)-C(3)                     1.4191(14) 
            F(2)-C(9)                     1.3574(15) 
            C(7)-C(8)                     1.3829(17) 
            C(7)-C(6)                     1.3890(16) 
            C(1)-C(6)                     1.5048(15) 
            C(1)-C(2)                     1.5313(15) 
            C(6)-C(11)                    1.3913(16) 
            C(4)-C(5)                     1.5146(15) 
            C(4)-C(3)                     1.5269(15) 
            C(3)-C(2)                     1.5360(15) 
            C(8)-C(9)                     1.380(2) 
            C(9)-C(10)                    1.376(2) 
            C(10)-C(11)                   1.3855(18) 
            C(1)-O(4)-C(4)              109.23(8) 
            F(1)-C(7)-C(8)              117.51(11) 
            F(1)-C(7)-C(6)              118.39(10) 
            C(8)-C(7)-C(6)              124.09(12) 
            O(4)-C(1)-C(6)              110.37(8) 
            O(4)-C(1)-C(2)              104.31(8) 
            C(6)-C(1)-C(2)              116.92(9) 
            C(7)-C(6)-C(11)             115.02(10) 
            C(7)-C(6)-C(1)              123.92(10) 
            C(11)-C(6)-C(1)             121.05(10) 
            O(4)-C(4)-C(5)              110.32(9) 
            O(4)-C(4)-C(3)              106.07(8) 
            C(5)-C(4)-C(3)              113.05(9)   Attachment   
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            O(5)-C(5)-C(4)              109.26(9) 
            O(3)-C(3)-C(4)              107.22(9) 
            O(3)-C(3)-C(2)              110.61(9) 
            C(4)-C(3)-C(2)              101.67(8) 
            C(9)-C(8)-C(7)              116.39(13) 
            O(2)-C(2)-C(1)              113.84(9) 
            O(2)-C(2)-C(3)              115.65(9) 
            C(1)-C(2)-C(3)              100.75(8) 
            F(2)-C(9)-C(10)             118.33(14) 
            F(2)-C(9)-C(8)              117.72(14) 
            C(10)-C(9)-C(8)             123.95(12) 
            C(9)-C(10)-C(11)            116.01(13) 
            F(3)-C(11)-C(10)            117.64(11) 
            F(3)-C(11)-C(6)             117.94(11) 
            C(10)-C(11)-C(6)            124.41(12) 
            Symmetry transformations used to generate equivalent atoms 
Table 4.  Anisotropic displacement parameters (A^2 x 10^4) for engels1’-deoxy-1’-(2,4,6-
trifluorophenyl)-β-D-ribofuranose. The anisotropic displacement factor exponent takes the 
form   -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
 
  
               U11        U22        U33        U23        U13        U12 
    _______________________________________________________________________ 
  
    O(2)    190(4)     130(3)     255(4)      59(3)      35(3)      -5(3) 
    O(5)    181(4)     150(4)     257(4)      31(3)     -10(3)      26(3) 
    F(1)    187(3)     219(3)     273(3)      12(3)      -4(3)      39(3) 
    O(4)    207(4)     114(3)     143(3)       6(2)     -14(3)     -37(3) 
    F(3)    253(4)     348(4)     260(3)      76(3)     -74(3)      21(3) 
    O(3)    267(4)     130(4)     272(4)      11(3)      74(3)      62(3) 
    F(2)    606(7)     712(7)     297(4)    -301(5)     140(5)     -82(6) 
    C(7)    193(5)     182(5)     200(5)      -3(4)      39(4)     -21(4) 
    C(1)    135(4)     120(4)     149(4)      15(3)      -2(3)     -13(3) 
    C(6)    181(5)     153(5)     149(4)       6(3)      11(3)     -28(4) 
    C(4)    156(4)     121(4)     143(4)      -8(3)     -16(3)      -7(3) 
    C(5)    175(4)     149(4)     224(5)      17(4)     -49(4)     -15(4) 
    C(3)    188(5)     110(4)     187(4)     -13(3)      -6(4)      -5(4) 
    C(8)    286(6)     262(6)     302(6)     -86(5)     116(5)     -22(5) 
    C(2)    134(4)     105(4)     197(4)      19(3)      14(4)     -13(3) 
    C(9)    386(7)     413(8)     201(5)    -121(5)     108(5)    -109(6) 
    C(10)   344(7)     446(8)     165(5)     -21(5)       2(5)    -104(6) 
    C(11)   215(5)     257(6)     184(5)      32(4)      -6(4)     -39(4) 
               Attachment   
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Table 5.  Hydrogen coordinates ( x 10^4) and isotropic displacement parameters (A^2 x 10^3) 
for 1’-deoxy-1’-(2,4,6-trifluorophenyl)-β-D-ribofuranose 
 
                                   x             y             z              U(eq) 
         ________________________________________________________________ 
  
          H(5B)        4940(40)      6565(16)      7088(9)       23(4) 
          H(4)        10250(30)      6126(14)      6713(7)       14(3) 
          H(2)         5940(30)      5231(15)      8059(8)       18(4) 
          H(1)        11560(30)      5542(12)      8252(7)       13(3) 
          H(3)         7160(30)      4331(14)      7032(8)       19(4) 
          H(5A)        5770(40)      6088(16)      6389(8)       23(4) 
          H(8)         5050(50)      8649(19)      9460(11)      46(6) 
          H(10)       11520(40)      7037(18)     10369(10)      41(5) 
          H(02)        9520(40)      3605(18)      8371(10)      31(5) 
          H(05)        5440(40)      8097(18)      6512(9)       32(5) 
          H(03)       10940(40)      3450(20)      7260(10)      34(5) 
         ________________________________________________________________ 
   
       
Table 6.  Torsion angles [deg] for 1’-deoxy-1’-(2,4,6-trifluorophenyl)-β-D-ribofuranose 
 
         ________________________________________________________________ 
  
          C(4)-O(4)-C(1)-C(6)                                -149.30(8) 
          C(4)-O(4)-C(1)-C(2)                                 -22.92(10) 
          F(1)-C(7)-C(6)-C(11)                               -174.89(10) 
          C(8)-C(7)-C(6)-C(11)                                  4.30(17) 
          F(1)-C(7)-C(6)-C(1)                                   6.37(16) 
          C(8)-C(7)-C(6)-C(1)                                -174.44(11) 
          O(4)-C(1)-C(6)-C(7)                                  46.94(14) 
          C(2)-C(1)-C(6)-C(7)                                 -72.02(14) 
          O(4)-C(1)-C(6)-C(11)                               -131.73(11)   Attachment   
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          C(2)-C(1)-C(6)-C(11)                                109.31(12) 
          C(1)-O(4)-C(4)-C(5)                                 119.51(9) 
          C(1)-O(4)-C(4)-C(3)                                  -3.26(11) 
          O(4)-C(4)-C(5)-O(5)                                  65.88(11) 
          C(3)-C(4)-C(5)-O(5)                                -175.54(9) 
          O(4)-C(4)-C(3)-O(3)                                 -88.38(10) 
          C(5)-C(4)-C(3)-O(3)                                 150.60(9) 
          O(4)-C(4)-C(3)-C(2)                                  27.75(11) 
          C(5)-C(4)-C(3)-C(2)                                 -93.27(10) 
          F(1)-C(7)-C(8)-C(9)                                 176.16(12) 
          C(6)-C(7)-C(8)-C(9)                                  -3.04(19) 
          O(4)-C(1)-C(2)-O(2)                                 163.82(9) 
          C(6)-C(1)-C(2)-O(2)                                 -74.01(12) 
          O(4)-C(1)-C(2)-C(3)                                  39.37(9) 
          C(6)-C(1)-C(2)-C(3)                                 161.54(9) 
          O(3)-C(3)-C(2)-O(2)                                 -49.88(12) 
          C(4)-C(3)-C(2)-O(2)                                -163.51(9) 
          O(3)-C(3)-C(2)-C(1)                                  73.32(10) 
          C(4)-C(3)-C(2)-C(1)                                 -40.30(10) 
          C(7)-C(8)-C(9)-F(2)                                 179.73(12) 
          C(7)-C(8)-C(9)-C(10)                                 -0.5(2) 
          F(2)-C(9)-C(10)-C(11)                              -177.97(13) 
          C(8)-C(9)-C(10)-C(11)                                 2.2(2) 
          C(9)-C(10)-C(11)-F(3)                               178.73(12) 
          C(9)-C(10)-C(11)-C(6)                                -0.7(2) 
          C(7)-C(6)-C(11)-F(3)                                178.21(10) 
          C(1)-C(6)-C(11)-F(3)                                 -3.01(16) 
          C(7)-C(6)-C(11)-C(10)                                -2.32(18) 
          C(1)-C(6)-C(11)-C(10)                               176.46(11) 
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Crystal structure of 1’-deoxy-1’-(2,4,6-trifluorophenyl)-ȕ-D-ribofuranose 
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12.1.2   Crystal data of 1’-deoxy-1’-(2,4,5-trifluorophenyl)-ȕ-D-ribofuranose 
 
   
 
  A single crystal ( colorless plate with dimensions 0.10 x 0.38 x 0.60 mm ) was measured on 
a SIEMENS SMART diffractometer at a temperature of about -130  °C. Repeatedly measured 
reflections remained stable. An empirical absorption correction with program SADABS 
(Sheldrick, 2000) gave a correction factor between 0.867 and 1.000 . Equivalent reflections 
were averaged. Friedel opposites were not averaged.R(I)internal = 0.033 . The structure was 
determined by direct methods using program SHELXS. The H atoms were taken from a 
difference synthesis and were treated as  riding atoms. The non-H atoms were refined with 
anisotropic thermal parameters.The structure was refined on F^2 values using program 
SHELXL-97. The final difference density was between -0.21 and +0.35 e/Å . 
The crystal structure of the title compound is isomorphous with the structure of 1-deoxy-1-(2-
fluorophenyl)-beta-D-ribofuranose (Bats, Parsch & Engels, Acta Cryst., C55, 1999, 
IUC9900069).  The five-membered furanose ring approximately has a C2-endo-envelope 
conformation. The phenyl group attached to C1 and the hydroxyl group attached to C2 are in 
pseudo-equatorial positions, the hydroxyl group  attached to C3 is in a pseudo-axial position 
with respect to the furanose ring.The phenyl group is planar within experimental uncertainty. 
The ribofuranose groups are connected by intermolecular O-H...O hydrogen bonds to a two-
dimensional network parallel to the a,b - plane. The molecules  are further stabilized in the a,b 
-direction by a number of weak C-H...F interactions (involving F1 and F3) with H...F 
distances between 2.60 and 2.75 Å. Neighboring molecules are connected in the b - direction 
by a rather short intermolecular C-H...O interaction with a H...O distance of 2.32 Å. No 
significant intermolecular interactions are observed in the  crystallographic c - direction: the 
shortest intermolecular C8-H8...F2 interactions have a H...F distance of 2.90 Å which is too 
long to be  significant. Surprisingly the C-H...pi(phenyl) interaction which was observed in 
the isomorphous 2-fluoro-phenyl compound is replaced in the title compound by an 
intermolecular C10-F3...C9 interaction with a F...C distance of 3.05 Å, which is slightly 
shorter than the van der Waals contact distance. The nature of this interaction is unclear. 
Similar C-H...C interactions with F...C distances between 2.96 and 3.15 Å are found in the 
crystal structure of  hexafluorobenzene (Boden et al., Mol. Phys., 25, 1973, 81). 
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 Intermolecular hydrogen bonds 
 
 
   O  - H  ...  O   O - H   H...O  O...O  O-H-O    symmetry 
                                 [Å]     [Å]    [Å]   [deg] 
   O2 - H02 ... O5  0.84   2.07   2.890   165    x-1/2, y-1/2, z 
   O3 - H03 ... O5  0.84   1.96   2.775   164    1/2-x, y-1/2, -z 
   O5 - H05 ... O2  0.84   1.95   2.779   168    1/2+x, y-1/2, z 
 
 
   Table 1.  Crystal data and structure refinement for 1-deoxy-1-(2,4,5-trifluorophenyl)-ȕ-                          
D-ribofuranose 
 
  
  
      Identification code               M2 
  
      Empirical formula                 C11 H11 F3 O4 
  
      Formula weight                    264.20 
  
      Temperature                       143(2) K 
  
      Wavelength                        0.71073 A 
  
      Crystal system, space group       Monoclinic,  C2 
  
      Unit cell dimensions              a = 13.248(2) A   alpha = 90 deg. 
                                                      b = 4.9913(10) A    beta = 100.18(2) deg. 
                                                      c = 16.312(6) A   gamma = 90 deg. 
  
      Volume                                      1061.6(5) A^3 
  
      Z, Calculated density                 4,  1.653 Mg/m^3 
  
      Absorption coefficient              0.157 mm^-1 
  
      F(000)                              544 
  
      Crystal size                      0.60 x 0.38 x 0.10 mm 
  
      Theta range for data collection   2.54 to 34.23 deg. 
  
      Limiting indices                  -19<=h<=20, -7<=k<=7, -24<=l<=24 
  
      Reflections collected / unique    11905 / 3784 [R(int) = 0.0334] 
  
      Completeness to theta = 34.23     91.0 % 
  
      Absorption correction                   Empirical (SADABS, Sheldrick, 2000) 
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      Max. and min. transmission          1.000 and 0.867 
  
      Refinement method                         Full-matrix least-squares on F^2 
  
      Data / restraints / parameters           3784 / 1 / 166 
  
      Goodness-of-fit on F^2                      1.052 
  
      Final R indices [I>2sigma(I)]          R1 = 0.0343, wR2 = 0.0794 
  
      R indices (all data)                          R1 = 0.0429, wR2 = 0.0834 
  
      Absolute structure parameter           -0.1(5) 
  
      Largest diff. peak and hole             0.352 and -0.212 e.A^-3 
   
 
Table 2.  Atomic coordinates ( x 10^5) and equivalent isotropic displacement parameters 
(A^2 x 10^4) for 1’-deoxy-1’-(2,4,5-trifluorophenyl)-ȕ-D-ribofuranose 
         U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 
        ________________________________________________________________ 
  
                         x             y             z           U(eq) 
         ________________________________________________________________ 
  
          O(2)         3841(6)       3212(19)     10938(6)      204(2) 
          O(4)        27508(6)     -17160(20)     24102(5)      209(2) 
          O(5)        43563(6)       1953(19)      8896(6)      212(2) 
          F(3)        28907(7)      61530(20)     43079(6)      334(2) 
          F(1)        -1654(6)      -5748(18)     29416(5)      294(2) 
          O(3)        16453(7)     -38751(19)      7283(6)      207(2) 
          F(2)        10539(7)      64010(20)     47908(6)      363(2) 
          C(6)        15410(8)       9050(20)     30039(7)      173(2) 
          C(4)        30677(8)     -18140(20)     16080(7)      159(2) 
          C(11)       23190(10)     26440(30)     33690(8)      207(2) 
          C(5)        39003(8)       2790(30)     16231(8)      186(2) 
          C(2)        14428(8)       2950(20)     14487(7)      154(2) 
          C(7)         6073(9)      11060(30)     32755(8)      205(2) 
          C(1)        16895(8)      -9900(20)     23188(7)      165(2) 
          C(3)        21090(8)     -13440(20)      9547(7)      158(2) 
          C(8)         4069(10)     29200(30)     38678(9)      248(3) 
          C(10)       21410(10)     44690(30)     39564(8)      229(2) 
          C(9)        11941(11)     46080(30)     42058(8)      244(3) 
         ________________________________________________________________ 
   
Table 3.  Bond lengths [A] and angles [deg] for 1’-deoxy-1’-(2,4,5-trifluorophenyl)-ȕ-D-
ribofuranose 
 
           _____________________________________________________________ 
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            O(2)-C(2)                     1.4198(13) 
            O(4)-C(1)                     1.4340(13) 
            O(4)-C(4)                     1.4440(15) 
            O(5)-C(5)                     1.4331(15) 
            F(3)-C(10)                    1.3494(15) 
            F(1)-C(7)                     1.3605(14) 
            O(3)-C(3)                     1.4245(14) 
            F(2)-C(9)                     1.3449(16) 
            C(6)-C(7)                     1.3893(15) 
            C(6)-C(11)                    1.3975(17) 
            C(6)-C(1)                     1.5034(17) 
            C(4)-C(5)                     1.5164(15) 
            C(4)-C(3)                     1.5249(16) 
            C(11)-C(10)                   1.3720(19) 
            C(2)-C(3)                     1.5326(16) 
            C(2)-C(1)                     1.5391(16) 
            C(7)-C(8)                     1.3839(18) 
            C(8)-C(9)                     1.378(2) 
            C(10)-C(9)                    1.3873(19) 
            C(1)-O(4)-C(4)              110.56(9) 
            C(7)-C(6)-C(11)             116.79(11) 
            C(7)-C(6)-C(1)              121.54(10) 
            C(11)-C(6)-C(1)             121.60(10) 
            O(4)-C(4)-C(5)              106.81(9) 
            O(4)-C(4)-C(3)              106.76(9) 
            C(5)-C(4)-C(3)              114.77(10) 
            C(10)-C(11)-C(6)            120.32(11) 
            O(5)-C(5)-C(4)              112.28(10) 
            O(2)-C(2)-C(3)              114.19(10) 
            O(2)-C(2)-C(1)              114.42(9) 
            C(3)-C(2)-C(1)              102.37(9) 
            F(1)-C(7)-C(8)              117.35(10) 
            F(1)-C(7)-C(6)              118.52(11) 
            C(8)-C(7)-C(6)              124.13(12) 
            O(4)-C(1)-C(6)              109.66(9) 
            O(4)-C(1)-C(2)              104.22(9) 
            C(6)-C(1)-C(2)              112.89(10) 
            O(3)-C(3)-C(4)              108.22(9) 
            O(3)-C(3)-C(2)              110.34(9) 
            C(4)-C(3)-C(2)              101.58(9) 
            C(9)-C(8)-C(7)              117.03(11) 
            F(3)-C(10)-C(11)            120.39(12) 
            F(3)-C(10)-C(9)             118.69(12) 
            C(11)-C(10)-C(9)            120.92(12) 
            F(2)-C(9)-C(8)              120.07(12) 
            F(2)-C(9)-C(10)             119.13(12) 
            C(8)-C(9)-C(10)             120.79(12) 
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Table 4.  Anisotropic displacement parameters (A^2 x 10^4) for 1’-deoxy-1’-(2,4,5-
trifluorophenyl)-ȕ-D-ribofuranose. The anisotropic displacement factor exponent takes the 
form: -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
 
 
 
   _______________________________________________________________________ 
  
              U11        U22        U33        U23        U13        U12 
    _______________________________________________________________________ 
  
    O(2)    144(3)     223(4)     241(4)      17(4)      23(3)      23(3) 
    O(4)    161(3)     287(5)     186(4)      56(4)      52(3)      58(3) 
    O(5)    154(3)     239(4)     258(5)      69(4)      77(3)      14(3) 
    F(3)    363(4)     333(4)     293(4)     -82(4)      23(3)    -148(4) 
    F(1)    199(3)     348(4)     354(5)    -121(4)      99(3)     -76(3) 
    O(3)    241(4)     176(4)     206(4)     -22(3)      45(3)     -56(3) 
    F(2)    460(5)     346(5)     304(5)    -145(4)     121(4)     -15(4) 
    C(6)    187(5)     174(5)     162(5)      23(4)      37(4)       0(4) 
    C(4)    151(4)     141(5)     194(5)      12(4)      51(4)       9(4) 
    C(11)   203(5)     232(6)     186(6)      21(4)      32(4)     -33(4) 
    C(5)    164(4)     171(5)     230(6)       3(5)      50(4)     -20(4) 
    C(2)    135(4)     147(4)     183(5)      19(4)      31(4)      12(4) 
    C(7)    184(5)     230(5)     204(6)     -14(5)      44(4)     -15(4) 
    C(1)    137(4)     176(5)     187(6)      20(4)      43(4)       6(4) 
    C(3)    162(4)     146(5)     175(5)      18(4)      54(4)     -17(4) 
    C(8)    234(6)     291(6)     237(6)     -34(5)      90(5)      19(5) 
    C(10)   269(6)     213(5)     192(6)       2(5)       9(5)     -60(5) 
    C(9)    329(6)     236(6)     171(6)     -23(5)      51(5)      20(5) 
    _______________________________________________________________________ 
   
Table 5.  Hydrogen coordinates ( x 10^4) and isotropic displacement parameters (A^2 x 10^3) 
for M2. 
  
         ________________________________________________________________ 
  
                         x             y             z           U(eq) 
         ________________________________________________________________ 
  
          H(02)         180         -1256           991          31 
          H(05)        4704         -1212           892          32 
          H(03)        1340         -3820           231          31 
          H(4)         3354         -3627          1524          19 
          H(11)        2974          2563          3210          25 
          H(5A)        3603          2079          1673          22 
          H(5B)        4439           -16          2119          22 
          H(2)         1699          2183          1489          19 
          H(1)         1261         -2630          2339          20 
          H(3)         2264          -342           461          19 
          H(8)         -245          2999          4034          30 
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Table 6.  Torsion angles [deg] for M2 
. 
         ________________________________________________________________ 
  
          C(1)-O(4)-C(4)-C(5)                                 118.16(10) 
          C(1)-O(4)-C(4)-C(3)                                  -5.07(12) 
          C(7)-C(6)-C(11)-C(10)                                -0.98(18) 
          C(1)-C(6)-C(11)-C(10)                               175.91(12) 
          O(4)-C(4)-C(5)-O(5)                                 173.98(9) 
          C(3)-C(4)-C(5)-O(5)                                 -67.92(13) 
          C(11)-C(6)-C(7)-F(1)                               -179.26(11) 
          C(1)-C(6)-C(7)-F(1)                                   3.84(17) 
          C(11)-C(6)-C(7)-C(8)                                  0.86(19) 
          C(1)-C(6)-C(7)-C(8)                                -176.04(13) 
          C(4)-O(4)-C(1)-C(6)                                -139.85(10) 
          C(4)-O(4)-C(1)-C(2)                                 -18.74(12) 
          C(7)-C(6)-C(1)-O(4)                                -153.93(11) 
          C(11)-C(6)-C(1)-O(4)                                 29.32(15) 
          C(7)-C(6)-C(1)-C(2)                                  90.34(13) 
          C(11)-C(6)-C(1)-C(2)                                -86.41(13) 
          O(2)-C(2)-C(1)-O(4)                                 158.82(10) 
          C(3)-C(2)-C(1)-O(4)                                  34.74(11) 
          O(2)-C(2)-C(1)-C(6)                                 -82.24(12) 
          C(3)-C(2)-C(1)-C(6)                                 153.67(9) 
          O(4)-C(4)-C(3)-O(3)                                 -89.61(10) 
          C(5)-C(4)-C(3)-O(3)                                 152.26(9) 
          O(4)-C(4)-C(3)-C(2)                                  26.56(11) 
          C(5)-C(4)-C(3)-C(2)                                 -91.57(11) 
          O(2)-C(2)-C(3)-O(3)                                 -46.41(13) 
          C(1)-C(2)-C(3)-O(3)                                  77.82(10) 
          O(2)-C(2)-C(3)-C(4)                                -161.01(9) 
          C(1)-C(2)-C(3)-C(4)                                 -36.78(10) 
          F(1)-C(7)-C(8)-C(9)                                 179.73(12) 
          C(6)-C(7)-C(8)-C(9)                                  -0.4(2) 
          C(6)-C(11)-C(10)-F(3)                              -179.83(12) 
          C(6)-C(11)-C(10)-C(9)                                 0.68(19) 
          C(7)-C(8)-C(9)-F(2)                                -179.32(13) 
          C(7)-C(8)-C(9)-C(10)                                  0.0(2) 
          F(3)-C(10)-C(9)-F(2)                                 -0.33(19) 
          C(11)-C(10)-C(9)-F(2)                               179.17(13) 
          F(3)-C(10)-C(9)-C(8)                               -179.68(13) 
          C(11)-C(10)-C(9)-C(8)                                -0.2(2) 
         ________________________________________________________________ 
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Crystal structure of  1’-deoxy-1’-(2,4,5-trifluorophenyl)-ȕ-D-ribofuranose 
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12.1.3    Crystal data of 1’-deoxy-1’-(4-chlorophenyl)-ȕ-D-ribofuranose 
 
 
  A single crystal ( colorless transparent rod with dimensions  0.14 x 0.20 x 0.50 mm ) was 
measured on a SIEMENS SMART diffractometer at a temperature of about -128  °C. 
Repeatedly measured reflections remained stable. A numerical absorption correction using six 
indexed crystal faces gave a  transmission factor from 0.872 to 0.955 . Equivalent reflections 
were averaged. Friedel opposites were not averaged.R(I)internal = 0.041 .  The structure was 
determined by direct methods using program SHELXS.  The H atoms were geometrically 
positioned and were treated as riding atoms. The structure was refined on F^2 values using 
program SHELXL-97. The final difference density was between -0.45 and +0.31 e/Å .The 
absolute configuration of the compound was confirmed by the value of the Flack x - 
parameter [ x = 0.00(6) ]. The crystal structure of the title compound is isomorphous with the 
crystal    structure of one of the two modifications of 1-deoxy-1-(4-fluorophenyl-beta- D-
ribofuranose reported by Bats, Parsch and Engels (Acta Cryst., C56, 2000,201-205. The 
ribofuranose ring has a conformation which is intermediate between a C2'-endo,C3'-exo twist 
and a C2'-endo envelope. The conformation of the molecule is rather similar to the 
conformation observed in 1-deoxy-1- (3-fluorophenyl)-ȕ -D-ribofuranose ( Bats, Parsch and 
Engels, 1999, Acta Cryst., C55, IUC9900070) and the conformation observed in 1-deoxy-1-
phenyl-beta-D-ribofuranose ( Matulic-Adamic et al., 1996, J. Org. Chem., 61, 3909 ). The 
phenyl group attached to C1 and the hydroxyl group attached to C2 are in pseudo-equatorial 
positions, the hydroxyl group attached to C3 and the  methanol group attached to C4 are in a 
pseudo-axial positions with respect to the five-membered ring. The shortest intramolecular 
contact distance is 2.43 Å between O4 and H11.  
The crystal packing shows three intermolecular hydrogen bonds: 
 
   
  O - H ... O      O - H   H ... O   O ... O  O - H - O   symmetry 
                    [A]      [A]       [A]      [deg] 
  O2 - H02 ... O5  0.84     1.91     2.718(1)  160     x-1, y, z 
  O3 - H03 ... O2  0.84     1.89     2.720(1)  169     -x, y-0.5, 1.5-z 
  O5 - H05 ... O3  0.84     1.97     2.807(1)  175     1-x, y-0.5, 1.5-z 
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In this way each molecule is connected by hydrogen bonding to six  different neighboring 
molecules leading to a two-dimensional network in the a,b - direction. The bonding in the c - 
direction consists of weak intermolecular C8-H8...Cl interactions with a H...Cl distance of 
2.74 Å and a C-H-Cl angle of 150° . 
A search of the Cambridge Data Base for structures containing intermolecular C(phenyl)-
Cl...H-C(phenyl) interactions with a Cl...H distance shorter than 2.8 Å  revealed 149 possible 
crystal structures. Intermolecular C-H...Cl contacts with a H...Cl distance of 2.78 Å very 
similar to those in the title compound occur in the crystal structure of N-(4-chloropheny) -
mannopyranosylamine (Ojala, Ostman & Ojala, Carbohydr. Res., 326, 2000, 104-112). 
 
Table 1.  Crystal data and structure refinement for 1’-deoxy-1’-(4-chlorophenyl)-ȕ-D-
ribofuranose 
  
  
      Identification code               Engels5 
  
      Empirical formula                 C11 H13 Cl O4 
  
      Formula weight                    244.66 
  
      Temperature                       145(2) K 
  
      Wavelength                        0.71073 A 
  
      Crystal system, space group       Orthorhombic,  P 212121 
  
      Unit cell dimensions                a = 6.7097(9) A   alpha = 90 deg. 
                                            b = 6.8447(9) A    beta = 90 deg. 
                                             c = 23.948(4) A   gamma = 90 deg. 
  
      Volume                               1099.9(3) A^3 
  
      Z, Calculated density               4,  1.478 Mg/m^3 
  
      Absorption coefficient            0.343 mm^-1 
  
      F(000)                                     512 
  
      Crystal size                      0.50 x 0.20 x 0.14 mm 
  
      Theta range for data collection   1.70 to 34.25 deg. 
  
      Limiting indices                  -10<=h<=10, -10<=k<=10, -35<=l<=37 
  
      Reflections collected / unique    24403 / 4226 [R(int) = 0.0407] 
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      Completeness to theta = 34.25     95.2 % 
  
      Absorption correction             Numerical (SHELXTL, Sheldrick, 1996) 
  
      Max. and min. transmission        0.955 and 0.872 
  
      Refinement method                 Full-matrix least-squares on F^2 
  
      Data / restraints / parameters    4226 / 0 / 145 
  
      Goodness-of-fit on F^2            1.072 
  
      Final R indices [I>2sigma(I)]     R1 = 0.0407, wR2 = 0.0885 
  
      R indices (all data)              R1 = 0.0572, wR2 = 0.0952 
  
      Absolute structure parameter      0.00(6) 
  
      Largest diff. peak and hole       0.305 and -0.452 e.A^-3 
 
   
Table 2.  Atomic coordinates ( x 10^5) and equivalent isotropic displacement parameters (A^2 
x 10^4) for 1’-deoxy-1’-(4-chlorophenyl)-ȕ-D-ribofuranose. U(eq) is defined as one third of 
the trace of the orthogonalized Uij tensor. 
  
         ________________________________________________________________ 
  
                         x             y             z           U(eq) 
         ________________________________________________________________ 
  
          Cl          33380(9)      60913(7)      46291(2)      515(2) 
          O(2)        -6742(13)      4113(14)     67754(4)      202(2) 
          O(3)        13676(15)    -11775(15)     76751(4)      218(2) 
          O(4)        46391(14)      3337(14)     68726(5)      241(2) 
          O(5)        72925(13)    -30075(15)     66828(5)      231(2) 
          C(1)        28080(18)     12872(18)     67318(6)      177(2) 
          C(2)        12591(18)     -3539(18)     66912(6)      165(2) 
          C(3)        19915(18)    -17979(19)     71342(6)      174(2) 
          C(4)        42583(18)    -16278(18)     70706(6)      171(2) 
          C(5)        51633(18)    -31020(20)     66742(6)      217(3) 
          C(6)        30090(20)     24940(20)     62077(6)      205(2) 
          C(7)        13830(20)     35970(20)     60277(6)      257(3) 
          C(8)        14880(30)     47130(20)     55444(7)      318(3) 
          C(9)        32610(30)     47300(20)     52455(6)      324(4) 
          C(10)       48960(30)     37010(30)     54194(7)      351(4) 
          C(11)       47710(20)     25640(20)     59031(7)      292(3) 
         ________________________________________________________________ 
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Table 3.  Bond lengths [Å] and angles [deg] for Engels5. 
           _____________________________________________________________ 
  
            Cl-C(9)                       1.7465(16) 
            O(2)-C(2)                     1.4134(15) 
            O(2)-H(02)                    0.8400 
            O(3)-C(3)                     1.4260(16) 
            O(3)-H(03)                    0.8400 
            O(4)-C(1)                     1.4315(16) 
            O(4)-C(4)                     1.4466(16) 
            O(5)-C(5)                     1.4303(15) 
            O(5)-H(05)                    0.8400 
            C(1)-C(6)                     1.5088(19) 
            C(1)-C(2)                     1.5334(18) 
            C(1)-H(1)                     1.0000 
            C(2)-C(3)                     1.5310(18) 
            C(2)-H(2)                     1.0000 
            C(3)-C(4)                     1.5331(17) 
            C(3)-H(3)                     1.0000 
            C(4)-C(5)                     1.5126(18) 
            C(4)-H(4)                     1.0000 
            C(5)-H(5A)                    0.9900 
            C(5)-H(5B)                    0.9900 
            C(6)-C(11)                    1.390(2) 
            C(6)-C(7)                     1.395(2) 
            C(7)-C(8)                     1.389(2) 
            C(7)-H(7)                     0.9500 
            C(8)-C(9)                     1.388(2) 
            C(8)-H(8)                     0.9500 
            C(9)-C(10)                    1.369(3) 
            C(10)-C(11)                   1.398(2) 
            C(10)-H(10)                   0.9500 
            C(11)-H(11)                   0.9500 
             C(2)-O(2)-H(02)             109.5 
            C(3)-O(3)-H(03)             109.5 
            C(1)-O(4)-C(4)              110.41(9) 
            C(5)-O(5)-H(05)             109.5 
            O(4)-C(1)-C(6)              111.64(11) 
            O(4)-C(1)-C(2)              105.23(10) 
            C(6)-C(1)-C(2)              114.15(11) 
            O(4)-C(1)-H(1)              108.5 
            C(6)-C(1)-H(1)              108.5 
            C(2)-C(1)-H(1)              108.5 
            O(2)-C(2)-C(3)              115.78(11) 
            O(2)-C(2)-C(1)              109.97(10) 
            C(3)-C(2)-C(1)              102.21(10) 
            O(2)-C(2)-H(2)              109.5 
            C(3)-C(2)-H(2)              109.5 
            C(1)-C(2)-H(2)              109.5 
            O(3)-C(3)-C(2)              110.06(10) 
            O(3)-C(3)-C(4)              111.04(11)  Attachment  
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            C(2)-C(3)-C(4)              101.56(10) 
            O(3)-C(3)-H(3)              111.3 
            C(2)-C(3)-H(3)              111.3 
            C(4)-C(3)-H(3)              111.3 
            O(4)-C(4)-C(5)              110.04(11) 
            O(4)-C(4)-C(3)              106.16(10) 
            C(5)-C(4)-C(3)              114.21(11) 
            O(4)-C(4)-H(4)              108.8 
            C(5)-C(4)-H(4)              108.8 
            C(3)-C(4)-H(4)              108.8 
            O(5)-C(5)-C(4)              111.20(11) 
            O(5)-C(5)-H(5A)             109.4 
            C(4)-C(5)-H(5A)             109.4 
            O(5)-C(5)-H(5B)             109.4 
            C(4)-C(5)-H(5B)             109.4 
            H(5A)-C(5)-H(5B)            108.0 
            C(11)-C(6)-C(7)             118.99(14) 
            C(11)-C(6)-C(1)             122.11(13) 
            C(7)-C(6)-C(1)              118.90(12) 
            C(8)-C(7)-C(6)              121.03(15) 
            C(8)-C(7)-H(7)              119.5 
            C(6)-C(7)-H(7)              119.5 
            C(9)-C(8)-C(7)              118.54(16) 
            C(9)-C(8)-H(8)              120.7 
            C(7)-C(8)-H(8)              120.7 
            C(10)-C(9)-C(8)             121.73(15) 
            C(10)-C(9)-Cl               120.52(13) 
            C(8)-C(9)-Cl                117.74(14) 
            C(9)-C(10)-C(11)            119.35(15) 
            C(9)-C(10)-H(10)            120.3 
            C(11)-C(10)-H(10)           120.3 
            C(6)-C(11)-C(10)            120.34(15) 
            C(6)-C(11)-H(11)            119.8 
            C(10)-C(11)-H(11)           119.8 
           _____________________________________________________________ 
  
           Symmetry transformations used to generate equivalent atoms: 
            
  
Table 4.  Anisotropic displacement parameters (A^2 x 10^4) for 1’-deoxy-1’-(4-
chlorophenyl)-ȕ-D-ribofuranose. The anisotropic displacement factor exponent takes the 
form: -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
  
    _______________________________________________________________________ 
  
              U11        U22        U33        U23        U13        U12 
    _______________________________________________________________________ 
  
    Cl      827(4)     446(2)     272(2)      76(2)      63(2)    -268(3) 
    O(2)    120(4)     180(4)     306(5)     -19(4)      -4(4)      -3(3) 
    O(3)    242(5)     195(4)     217(4)      12(4)      56(4)     -11(4)  Attachment  
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    O(4)    126(4)     153(4)     445(6)      23(4)     -31(4)     -14(3) 
    O(5)    133(4)     195(4)     364(6)       2(4)       3(4)      11(3) 
    C(1)    145(5)     138(5)     247(6)     -14(5)     -14(5)       0(4) 
    C(2)    121(4)     155(5)     218(6)     -13(5)      -3(4)      -6(4) 
    C(3)    151(5)     154(5)     217(6)      -7(5)      14(5)     -12(4) 
    C(4)    150(5)     141(6)     221(6)     -11(4)     -17(4)      -7(4) 
    C(5)    150(5)     190(6)     310(7)     -61(5)      -9(5)      -8(4) 
    C(6)    218(6)     158(5)     239(6)     -23(5)      32(5)     -26(5) 
    C(7)    261(6)     244(7)     266(6)      37(5)      40(6)      -3(5) 
    C(8)    392(8)     265(7)     296(7)      57(6)       7(7)     -32(7) 
    C(9)    508(10)    248(7)     217(6)     -10(6)      73(7)    -158(7) 
    C(10)   406(9)     304(8)     342(8)     -55(7)     182(7)     -93(7) 
    C(11)   260(7)     236(6)     380(8)     -47(6)     104(6)     -29(6) 
    _______________________________________________________________________ 
   
Table 5.  Hydrogen coordinates ( x 10^4) and isotropic displacement parameters (A^2 x 10^3) 
for 1’-deoxy-1’-(4-chlorophenyl)-ȕ-D-ribofuranose 
 
  
         ________________________________________________________________ 
  
                         x             y             z           U(eq) 
         ________________________________________________________________ 
  
          H(02)       -1523          -466          6716          30 
          H(03)        1211         -2158          7882          33 
          H(05)        7746         -3966          6861          35 
          H(1)         2427          2172          7046          21 
          H(2)         1336          -976          6314          20 
          H(3)         1523         -3155          7052          21 
          H(4)         4889         -1788          7446          21 
          H(5A)        4729         -4432          6782          26 
          H(5B)        4681         -2844          6291          26 
          H(7)          185          3584          6239          31 
          H(8)          372          5449          5421          38 
          H(10)        6105          3758          5213          42 
          H(11)        5895          1835          6024          35 
         ________________________________________________________________ 
   
         
 
 
Table 6.  Torsion angles [deg] for 1’-deoxy-1’-(4-chlorophenyl)-ȕ-D-ribofuranose 
 
          C(4)-O(4)-C(1)-C(6)                                -140.08(11) 
          C(4)-O(4)-C(1)-C(2)                                 -15.74(14) 
          O(4)-C(1)-C(2)-O(2)                                 156.78(11) 
          C(6)-C(1)-C(2)-O(2)                                 -80.48(14) 
          O(4)-C(1)-C(2)-C(3)                                  33.26(13) 
          C(6)-C(1)-C(2)-C(3)                                 156.01(11)  Attachment  
- 344 - 
          O(2)-C(2)-C(3)-O(3)                                 -38.87(14) 
          C(1)-C(2)-C(3)-O(3)                                  80.64(12) 
          O(2)-C(2)-C(3)-C(4)                                -156.57(10) 
          C(1)-C(2)-C(3)-C(4)                                 -37.06(12) 
          C(1)-O(4)-C(4)-C(5)                                 115.67(12) 
          C(1)-O(4)-C(4)-C(3)                                  -8.39(14) 
          O(3)-C(3)-C(4)-O(4)                                 -88.29(13) 
          C(2)-C(3)-C(4)-O(4)                                  28.70(13) 
          O(3)-C(3)-C(4)-C(5)                                 150.28(11) 
          C(2)-C(3)-C(4)-C(5)                                 -92.72(13) 
          O(4)-C(4)-C(5)-O(5)                                  67.33(14) 
          C(3)-C(4)-C(5)-O(5)                                -173.42(12) 
          O(4)-C(1)-C(6)-C(11)                                  2.20(18) 
          C(2)-C(1)-C(6)-C(11)                               -116.98(15) 
          O(4)-C(1)-C(6)-C(7)                                -176.90(12) 
          C(2)-C(1)-C(6)-C(7)                                  63.92(16) 
          C(11)-C(6)-C(7)-C(8)                                  1.6(2) 
          C(1)-C(6)-C(7)-C(8)                                -179.25(14) 
          C(6)-C(7)-C(8)-C(9)                                  -0.8(2) 
          C(7)-C(8)-C(9)-C(10)                                 -0.9(2) 
          C(7)-C(8)-C(9)-Cl                                   178.31(12) 
          C(8)-C(9)-C(10)-C(11)                                 1.6(2) 
          Cl-C(9)-C(10)-C(11)                                -177.59(13) 
          C(7)-C(6)-C(11)-C(10)                                -0.9(2) 
          C(1)-C(6)-C(11)-C(10)                               179.99(14) 
          C(9)-C(10)-C(11)-C(6)                                -0.7(2) 
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Crystal structure of 1’-deoxy-1’-(4-chlorophenyl)-ȕ-D-ribofuranose 
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12.1.4   Crystal data of  5´-O- (4,4´-Dimethoxytriphenylmethyl) -2´-O-tert.-
butyldimethylsilyl-1´-deoxy-1´- (4,6-difluoro-1-N-benzimidazolyl) -ȕ-
D-ribofuranose 106 at -123 C 
    
A single crystal ( colorless rod with dimensions 0.04 x 0.08 x 1.0 mm ) was measured on a 
SIEMENS SMART diffractometer at a temperature of about -123 °C. Repeatedly measured 
reflections remained stable. An empirical absorption correction with program SADABS 
(Sheldrick, 2000)  gave a correction factor between 0.799 and 1.000 . Equivalent reflections 
were averaged. Friedel opposites were not averaged.  R(I)internal = 0.087 .  The structure was 
determined by direct methods using program SHELXS. The two methoxy groups were found 
to be statistically distributed over three possible positions. The occupancy factors of the 
methoxy groups  were refined: O6-C26 0.572(8), O7-C33 0.800(9) and O8-C40 0.663(7). The 
H atoms were geometrically positioned and were treated as riding atoms. The non-H atoms 
were refined with anisotropic thermal parameters.The structure was refined on F^2 values 
using program SHELXL-97. The final difference density was between -0.52 and +0.75 e/Å . 
    The five-membered furanose ring has a twisted O4-endo, C1-exo conformation. The C1-
N1, C2-O2 and C4-C5 bonds are in pseudo-equatorial positions, the C3-O3 bond is in a 
bisecting position with respect to the furanose ring. A different conformation (C2-endo) has 
been reported for the related 2-chloro-(ȕ-D-ribofuranosyl)-benzimidazole (Sprang & 
Sundaralingam, ActaCryst., B29, 1973, 1910). The bond distances in the ribofuranosyl group 
are very similar in the title compound and in the 2-chloro-(ȕ-D-ribofuranosyl)-benzimidazole 
structure  with rather short O4-C1 and C4-C5 bonds and a long O4-C4 bond. The 
benzimidazole group addopts a syn orientation about the glycosyl bond with a torsion angle 
O4-C1-N1-C12 of 62.5° .  The benzimidazole group is planar (mean deviation from plane: 
0.008 A). The orientation about the exocyclic C4-C5 bond is +sc(gauche,gauche). The 
shortest intramolecular contacts are O5...H3 2.40, O5...H32 2.42 and  O5...H35 2.41 Å. The 
angles between the planes of the three phenyl groups attached to C19 are 64.5, 74.5 and 85.2. 
The molecules are connected by intermolecular hydrogen bonds between the hydroxyl group 
and the imidazole group to chains running in the crystallographic b-direction, which also 
corresponds to the long macroscopic dimension of the crystal. The hydrogen bonded chains 
are also stabilized by intermolecular C3-H3...F1 contacts with a H...F distance of 2.43 Å and a 
C-H..F angle of 150 . The crystal packing also shows an additional intermolecular C-H...F 
contact, an intermolecular C-H...O contact and three intermolecular C-H...pi(phenyl) contacts.  Attachment  
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hydrogen bond 
                  
  O - H   ... N      O-H   H...N   O...N   O-H-N     symmetry 
                                [Å]    [Å]     [Å]    [deg] 
  O3 -H03 ... N2     0.84   1.98   2.805   167       x, y-1, z 
  ------------------------------------------------------------------------- 
   
Table 1.  Crystal data and structure refinement for 5´-O- (4,4´-Dimethoxytriphenylmethyl) -
2´-O-tert.-butyldimethylsilyl-1´-deoxy-1´- (4,6-difluoro-1-N-benzimidazolyl) -ȕ-D-
ribofuranose 
  
  
      Identification code               zivkovic1 
  
      Empirical formula                 C39 H44 F2 N2 O6 Si 
  
      Formula weight                    702.85 
  
      Temperature                       150(2) K 
  
      Wavelength                        0.71073 A 
  
      Crystal system, space group       Monoclinic,  C 2 
  
      Unit cell dimensions              a = 30.832(3) A   alpha = 90 deg. 
                                                     b = 9.1318(9) A    beta = 91.296(5) deg. 
                                                      c = 13.2625(15) A   gamma = 90 deg. 
  
      Volume                                 3733.1(7) A^3 
  
      Z, Calculated density             4,  1.251 Mg/m^3 
  
      Absorption coefficient            0.120 mm^-1 
  
      F(000)                                      1488 
  
      Crystal size                                1.0 x 0.08 x 0.04 mm 
  
      Theta range for data collection   1.54 to 28.51 deg. 
  
      Limiting indices                          -39<=h<=40, -12<=k<=12, -17<=l<=17 
  
      Reflections collected / unique    22479 / 8294 [R(int) = 0.0866] 
  
      Completeness to theta = 28.51     91.0 % 
  
      Absorption correction                    Empirical, SADABS (Sheldrick, 2000) 
  
      Max. and min. transmission        1.000 and 0.799 
  
      Refinement method                 Full-matrix least-squares on F^2  Attachment  
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      Data / restraints / parameters    8294 / 1 / 476 
  
      Goodness-of-fit on F^2            1.010 
  
      Final R indices [I>2sigma(I)]     R1 = 0.0749, wR2 = 0.1443 
  
      R indices (all data)              R1 = 0.1696, wR2 = 0.1766 
  
      Absolute structure parameter      0.1(2) 
  
      Largest diff. peak and hole       0.744 and -0.519 e.A^-3 
 
Table 2.  Atomic coordinates ( x 10^5) and equivalent isotropic displacement parameters (A^2 
x 10^4) for zivkovic1. U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor 
 
         ________________________________________________________________ 
  
                         x             y             z           U(eq) 
         ________________________________________________________________ 
  
          Si          83137(5)      48975(17)     83006(11)     518(4) 
          O(2)        80665(9)      53770(30)     93531(19)     330(7) 
          O(5)        87593(9)      37690(30)    126780(20)     339(7) 
          O(4)        81889(10)     62030(30)    119670(20)     318(7) 
          F(1)        90485(10)    121600(30)    101890(20)     597(9) 
          N(1)        82470(12)     80680(40)    107770(30)     301(9) 
          N(2)        82376(13)    104270(40)    103550(30)     359(9) 
          C(29)       95381(13)     50470(50)    157930(30)     351(11) 
          O(3)        78343(11)     31530(30)    106040(20)     420(8) 
          C(1)        80742(15)     65990(40)    109650(30)     278(10) 
          C(12)       86821(15)     84960(50)    107930(30)     341(11) 
          F(2)        98233(10)     79310(40)    110180(30)     925(12) 
          C(20)       87834(14)     18160(50)    139200(30)     330(11) 
          C(6)        80027(15)     92490(50)    105190(30)     339(11) 
          C(27)       91477(14)     43310(50)    142610(30)     307(11) 
          C(22)       84442(15)     -5330(50)    135990(40)     404(12) 
          C(34)       94514(15)     26790(50)    130090(30)     329(11) 
          C(3)        81864(14)     40070(50)    109720(30)     349(11) 
          C(8)        90510(19)    107280(50)    104380(40)     453(13) 
          C(4)        80842(14)     46520(40)    120160(30)     298(10) 
          C(11)       90680(16)     77590(60)    109960(40)     489(14) 
          C(19)       90274(14)     31560(50)    134880(30)     320(11) 
          O(7)        96124(15)     76370(40)    161360(30)     560(17) 
          C(7)        86623(16)     99820(50)    105060(30)     356(11) 
          C(28)       93802(15)     39930(50)    151380(30)     389(12) 
          C(39)       97079(15)     16060(50)    134260(40)     390(12) 
          C(30)       94616(16)     65210(50)    155720(40)     435(12)  Attachment  
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          C(31)       92286(16)     68870(50)    147250(40)     461(13) 
          C(36)      100075(17)     30620(60)    117970(40)     479(14) 
          C(37)      102634(17)     19520(60)    122450(40)     509(14) 
          C(35)       96101(16)     34130(50)    121760(30)     394(12) 
          C(32)       90714(15)     58250(50)    140540(40)     375(12) 
          C(5)        83104(14)     39510(50)    128840(30)     328(11) 
          O(6)        79260(19)    -13540(60)    148330(40)     440(20) 
          C(21)       87160(15)      6100(50)    133080(30)     370(12) 
          C(2)        82635(14)     53860(40)    103090(30)     306(10) 
          C(13)       89069(17)     50730(80)     84760(40)     780(20) 
          C(25)       85846(15)     18540(50)    148540(40)     401(12) 
          C(24)       83156(16)      7330(50)    151510(40)     440(13) 
          C(38)      101090(17)     12390(60)    130680(40)     438(13) 
          C(23)       82442(16)     -4650(60)    145110(40)     455(13) 
          O(8)       106439(16)     15960(60)    118340(40)     511(19) 
          C(9)        94393(19)    100580(60)    106220(40)     570(15) 
          C(10)       94300(18)     85810(70)    108820(50)     619(16) 
          C(14)       81770(20)     29650(70)     79890(50)     820(20) 
          C(26)       78130(30)    -25350(100)   142210(70)     610(30) 
          C(15)       80940(20)     61110(70)     72890(40)     694(18) 
          C(17)       82610(30)     55380(90)     62490(40)    1070(30) 
          C(33)       98790(20)     73050(80)    169820(50)     580(20) 
          C(18)       76140(20)     61310(80)     72290(50)     840(20) 
          C(16)       82460(30)     77220(80)     75510(70)    1400(40) 
          C(40)      108900(30)      3680(90)    122380(60)     600(30) 
         ________________________________________________________________ 
   
Table 3.  Bond lengths [A] and angles [deg] for zivkovic1. 
           _____________________________________________________________ 
  
            Si-O(2)                       1.664(3) 
            Si-C(13)                      1.845(6) 
            Si-C(15)                      1.856(6) 
            Si-C(14)                      1.859(6) 
            O(2)-C(2)                     1.394(5) 
            O(5)-C(5)                     1.427(5) 
            O(5)-C(19)                    1.453(5) 
            O(4)-C(1)                     1.415(5) 
            O(4)-C(4)                     1.454(5) 
            F(1)-C(8)                     1.349(5) 
            N(1)-C(6)                     1.355(5) 
            N(1)-C(12)                    1.397(6) 
            N(1)-C(1)                     1.467(5) 
            N(2)-C(6)                     1.318(6) 
            N(2)-C(7)                     1.381(6) 
            C(29)-C(28)                   1.379(6) 
            C(29)-C(30)                   1.396(6) 
            O(3)-C(3)                     1.415(5) 
            C(1)-C(2)                     1.532(6) 
            C(12)-C(11)                   1.388(7) 
            C(12)-C(7)                    1.410(6)  Attachment  
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            F(2)-C(10)                    1.358(6) 
            C(20)-C(21)                   1.381(6) 
            C(20)-C(25)                   1.395(6) 
            C(20)-C(19)                   1.553(6) 
            C(27)-C(28)                   1.386(6) 
            C(27)-C(32)                   1.410(6) 
            C(27)-C(19)                   1.524(6) 
            C(22)-C(23)                   1.372(7) 
            C(22)-C(21)                   1.398(6) 
            C(34)-C(39)                   1.369(6) 
            C(34)-C(35)                   1.390(6) 
            C(34)-C(19)                   1.529(6) 
            C(3)-C(4)                     1.545(6) 
            C(3)-C(2)                     1.557(6) 
            C(8)-C(9)                     1.362(7) 
            C(8)-C(7)                     1.383(7) 
            C(4)-C(5)                     1.478(6) 
            C(11)-C(10)                   1.356(7) 
            O(7)-C(30)                    1.341(6) 
            O(7)-C(33)                    1.410(7) 
            C(39)-C(38)                   1.376(7) 
            C(30)-C(31)                   1.361(6) 
            C(31)-C(32)                   1.396(6) 
            C(36)-C(35)                   1.373(7) 
            C(36)-C(37)                   1.408(7) 
            C(37)-O(8)                    1.345(7) 
            C(37)-C(38)                   1.365(7) 
            O(6)-C(23)                    1.350(7) 
            O(6)-C(26)                    1.390(10) 
            C(25)-C(24)                   1.381(6) 
            C(24)-C(23)                   1.399(7) 
            O(8)-C(40)                    1.450(9) 
            C(9)-C(10)                    1.393(8) 
            C(15)-C(18)                   1.479(8) 
            C(15)-C(17)                   1.574(8) 
            C(15)-C(16)                   1.580(10) 
             O(2)-Si-C(13)               110.1(2) 
            O(2)-Si-C(15)               106.4(2) 
            C(13)-Si-C(15)              112.6(3) 
            O(2)-Si-C(14)               109.3(2) 
            C(13)-Si-C(14)              109.3(3) 
            C(15)-Si-C(14)              109.2(3) 
            C(2)-O(2)-Si                124.5(3) 
            C(5)-O(5)-C(19)             116.2(3) 
            C(1)-O(4)-C(4)              103.9(3) 
            C(6)-N(1)-C(12)             108.0(3) 
            C(6)-N(1)-C(1)              124.7(4) 
            C(12)-N(1)-C(1)             127.3(4) 
            C(6)-N(2)-C(7)              105.0(4) 
            C(28)-C(29)-C(30)           119.1(4) 
            O(4)-C(1)-N(1)              108.0(3)  Attachment  
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            O(4)-C(1)-C(2)              105.0(3) 
            N(1)-C(1)-C(2)              114.8(3) 
            C(11)-C(12)-N(1)            133.3(4) 
            C(11)-C(12)-C(7)            123.4(5) 
            N(1)-C(12)-C(7)             103.3(4) 
            C(21)-C(20)-C(25)           118.6(4) 
            C(21)-C(20)-C(19)           118.6(4) 
            C(25)-C(20)-C(19)           122.3(4) 
            N(2)-C(6)-N(1)              112.8(4) 
            C(28)-C(27)-C(32)           117.3(4) 
            C(28)-C(27)-C(19)           121.4(4) 
            C(32)-C(27)-C(19)           120.8(4) 
            C(23)-C(22)-C(21)           119.6(5) 
            C(39)-C(34)-C(35)           117.1(5) 
            C(39)-C(34)-C(19)           121.8(4) 
            C(35)-C(34)-C(19)           120.8(4) 
            O(3)-C(3)-C(4)              110.4(4) 
            O(3)-C(3)-C(2)              112.2(3) 
            C(4)-C(3)-C(2)              103.6(3) 
            F(1)-C(8)-C(9)              118.7(5) 
            F(1)-C(8)-C(7)              119.6(5) 
            C(9)-C(8)-C(7)              121.8(5) 
            O(4)-C(4)-C(5)              110.8(3) 
            O(4)-C(4)-C(3)              106.3(3) 
            C(5)-C(4)-C(3)              115.5(4) 
            C(10)-C(11)-C(12)           114.4(5) 
            O(5)-C(19)-C(27)            110.6(3) 
            O(5)-C(19)-C(34)            106.3(3) 
            C(27)-C(19)-C(34)           106.4(3) 
            O(5)-C(19)-C(20)            107.7(3) 
            C(27)-C(19)-C(20)           114.7(3) 
            C(34)-C(19)-C(20)           110.8(3) 
            C(30)-O(7)-C(33)            118.0(5) 
            N(2)-C(7)-C(8)              131.7(4) 
            N(2)-C(7)-C(12)             110.9(4) 
            C(8)-C(7)-C(12)             117.3(5) 
            C(29)-C(28)-C(27)           122.8(4) 
            C(34)-C(39)-C(38)           123.4(5) 
            O(7)-C(30)-C(31)            116.3(5) 
            O(7)-C(30)-C(29)            124.1(4) 
            C(31)-C(30)-C(29)           119.5(4) 
            C(30)-C(31)-C(32)           121.7(5) 
            C(35)-C(36)-C(37)           120.6(5) 
            O(8)-C(37)-C(38)            122.1(5) 
            O(8)-C(37)-C(36)            119.2(6) 
            C(38)-C(37)-C(36)           118.6(5) 
            C(36)-C(35)-C(34)           120.8(5) 
            C(31)-C(32)-C(27)           119.6(4) 
            O(5)-C(5)-C(4)              110.1(3) 
            C(23)-O(6)-C(26)            117.1(6) 
            C(20)-C(21)-C(22)           121.1(4)  Attachment  
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            O(2)-C(2)-C(1)              110.9(3) 
            O(2)-C(2)-C(3)              116.1(3) 
            C(1)-C(2)-C(3)              101.5(3) 
            C(24)-C(25)-C(20)           120.9(5) 
            C(25)-C(24)-C(23)           119.6(4) 
            C(37)-C(38)-C(39)           119.5(5) 
            O(6)-C(23)-C(22)            126.6(5) 
            O(6)-C(23)-C(24)            112.6(5) 
            C(22)-C(23)-C(24)           120.2(5) 
            C(37)-O(8)-C(40)            119.4(5) 
            C(8)-C(9)-C(10)             117.2(5) 
            C(11)-C(10)-F(2)            118.5(5) 
            C(11)-C(10)-C(9)            125.8(5) 
            F(2)-C(10)-C(9)             115.6(5) 
            C(18)-C(15)-C(17)           107.7(6) 
            C(18)-C(15)-C(16)           107.0(6) 
            C(17)-C(15)-C(16)           113.6(6) 
            C(18)-C(15)-Si              113.3(5) 
            C(17)-C(15)-Si              108.2(4) 
            C(16)-C(15)-Si              107.1(5) 
           _____________________________________________________________ 
  
           Symmetry transformations used to generate equivalent atoms: 
            
   
Table 4.  Anisotropic displacement parameters (A^2 x 10^4) for zivkovic1. The anisotropic 
displacement factor exponent takes the form: -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
  
    _______________________________________________________________________ 
  
              U11        U22        U33        U23        U13        U12 
    _______________________________________________________________________ 
  
    Si      601(10)    503(10)    455(8)      55(7)     135(7)      90(8) 
    O(2)    411(18)    258(17)    320(16)     21(13)     22(14)     15(14) 
    O(5)    347(19)    272(17)    396(18)     58(14)    -19(14)     -7(14) 
    O(4)    470(20)    128(15)    356(17)    -17(13)    -55(14)    -28(14) 
    F(1)    780(20)    240(15)    780(20)    -16(14)    169(18)   -222(15) 
    N(1)    410(20)    117(19)    380(20)     41(16)    -24(17)    -59(17) 
    N(2)    480(30)    160(20)    450(20)     55(17)     19(19)    -34(19) 
    C(29)   340(30)    350(30)    360(20)    -30(20)    -80(20)     80(20) 
    O(3)    570(20)    110(16)    570(20)     -6(15)   -167(17)    -43(15) 
    C(1)    390(30)    130(20)    320(20)     21(18)     50(20)      0(20) 
    C(12)   450(30)    220(20)    350(30)    -60(20)     20(20)    -50(20) 
    F(2)    430(20)    710(20)   1630(40)     20(30)   -210(20)    -28(19) 
    C(20)   360(30)    300(30)    330(30)     90(20)    -20(20)     10(20) 
    C(6)    400(30)    190(20)    430(30)      0(20)    -70(20)     50(20) 
    C(27)   320(30)    230(20)    370(30)     13(19)     60(20)     60(20) 
    C(22)   440(30)    310(30)    450(30)     50(20)   -110(20)    -40(20) 
    C(34)   380(30)    180(20)    410(30)    -10(20)   -110(20)    -50(20) 
    C(3)    320(30)    240(30)    490(30)     10(20)   -100(20)     20(20)  Attachment  
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    C(8)    630(40)    230(30)    510(30)    -30(20)    110(30)   -110(30) 
    C(4)    350(30)    110(20)    440(30)     -5(19)    -30(20)    -25(19) 
    C(11)   450(30)    260(30)    750(40)     30(30)    -80(30)     30(30) 
    C(19)   360(30)    210(20)    390(30)      0(20)    -70(20)    -30(20) 
    O(7)    740(30)    320(30)    610(30)   -150(20)   -260(20)     10(20) 
    C(7)    490(30)    230(30)    350(20)    -20(20)     50(20)    -90(20) 
    C(28)   450(30)    290(30)    430(30)    -20(20)    -10(20)     50(20) 
    C(39)   370(30)    330(30)    470(30)    -40(20)    -60(20)    -20(20) 
    C(30)   410(30)    320(30)    570(30)    -80(30)    -70(30)    -10(20) 
    C(31)   500(30)    250(30)    630(30)    -10(30)    -90(30)      0(20) 
    C(36)   520(30)    450(30)    470(30)    -70(30)     80(30)   -210(30) 
    C(37)   420(30)    440(30)    660(40)   -260(30)    -10(30)     30(30) 
    C(35)   380(30)    310(30)    490(30)     10(20)    -20(20)    -20(20) 
    C(32)   380(30)    220(30)    520(30)     50(20)    -20(20)     20(20) 
    C(5)    330(30)    270(30)    380(30)     70(20)    -60(20)    -50(20) 
    O(6)    510(40)    270(30)    530(40)     40(30)     80(30)   -120(30) 
    C(21)   470(30)    310(30)    340(30)     20(20)     20(20)      0(20) 
    C(2)    350(30)    160(20)    410(30)    -30(20)     40(20)      0(20) 
    C(13)   660(40)   1000(50)    690(40)    170(40)    280(30)    210(40) 
    C(25)   420(30)    290(30)    500(30)    -10(20)     50(20)    -30(20) 
    C(24)   510(30)    400(30)    410(30)      0(20)     80(20)    -50(30) 
    C(38)   430(30)    400(30)    480(30)    -80(30)    -70(30)      0(30) 
    C(23)   480(30)    430(30)    450(30)     70(20)     10(20)   -110(30) 
    O(8)    470(40)    390(30)    670(40)     50(30)    200(30)     70(30) 
    C(9)    520(40)    340(30)    860(40)   -100(30)     70(30)   -190(30) 
    C(10)   330(30)    650(40)    880(40)    -70(30)    -30(30)    -60(30) 
    C(14)  1380(60)    420(40)    670(40)   -150(30)    240(40)     10(40) 
    C(26)   800(80)    490(60)    540(60)     20(50)    -20(50)   -390(60) 
    C(15)   740(40)    840(50)    510(30)    200(30)    200(30)    300(40) 
    C(17)  1520(70)   1140(60)    560(40)    240(40)    520(40)    580(60) 
    C(33)   750(50)    440(40)    550(40)    -80(30)   -170(40)    -50(40) 
    C(18)   860(50)    960(50)    690(40)   -140(40)   -130(30)    490(40) 
    C(16)  1590(80)    660(50)   1940(100)   790(60)   -270(70)   -300(60) 
    C(40)   490(50)    490(50)    810(60)      0(50)    120(40)     80(50) 
    _______________________________________________________________________ 
   
Table 5.  Hydrogen coordinates ( x 10^4) and isotropic displacement parameters (A^2 x 10^3) 
for zivkovic1. 
  
         ________________________________________________________________ 
  
                         x             y             z           U(eq) 
         ________________________________________________________________ 
  
          H(29A)       9697          4775         16386          42 
          H(03)        7923          2312         10457          63 
          H(1A)        7751          6611         10881          33 
          H(6A)        7695          9229         10462          41 
          H(22A)       8398         -1352         13167          48 
          H(3A)        8456          3400         11016          42 
          H(4A)        7765          4560         12116          36  Attachment  
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          H(11A)       9078          6762         11199          59 
          H(28A)       9433          2992         15293          47 
          H(39A)       9604          1087         13992          47 
          H(31A)       9171          7890         14588          55 
          H(36A)      10111          3573         11226          57 
          H(35A)       9442          4166         11866          47 
          H(32A)       8914          6107         13462          45 
          H(5A)        8279          4565         13493          39 
          H(5B)        8178          2984         13017          39 
          H(21A)       8857           557         12679          44 
          H(2A)        8582          5547         10244          37 
          H(13A)       8980          6093          8634         117 
          H(13B)       9050          4780          7854         117 
          H(13C)       9006          4439          9031         117 
          H(25A)       8635          2663         15292          48 
          H(24A)       8180           775         15786          53 
          H(38A)      10277           496         13390          53 
          H(9A)        9705         10576         10575          68 
          H(14A)       7862          2870          7887         123 
          H(14B)       8273          2327          8544         123 
          H(14C)       8323          2679          7370         123 
          H(26A)       8062         -3194         14166          92 
          H(26B)       7727         -2179         13549          92 
          H(26C)       7570         -3065         14516          92 
          H(17A)       8152          6174          5705         160 
          H(17B)       8158          4536          6135         160 
          H(17C)       8579          5548          6259         160 
          H(33A)      10148          6844         16758          87 
          H(33B)       9726          6631         17426          87 
          H(33C)       9950          8208         17350          87 
          H(18A)       7518          6795          6688         126 
          H(18B)       7500          6469          7872         126 
          H(18C)       7506          5141          7086         126 
          H(16A)       8137          8396          7030         210 
          H(16B)       8564          7759          7579         210 
          H(16C)       8133          8008          8207         210 
          H(40A)      10739          -547         12065          89 
          H(40B)      10916           459         12973          89 
          H(40C)      11179           361         11949          89 
         ________________________________________________________________ 
   
Table 6.  Torsion angles [deg] for zivkovic1. 
         ________________________________________________________________ 
  
          C(13)-Si-O(2)-C(2)                                  -21.6(4) 
          C(15)-Si-O(2)-C(2)                                 -143.9(4) 
          C(14)-Si-O(2)-C(2)                                   98.4(4) 
          C(4)-O(4)-C(1)-N(1)                                -168.9(3) 
          C(4)-O(4)-C(1)-C(2)                                 -45.9(4) 
          C(6)-N(1)-C(1)-O(4)                                -119.9(4) 
          C(12)-N(1)-C(1)-O(4)                                 62.5(5)  Attachment  
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          C(6)-N(1)-C(1)-C(2)                                 123.3(4) 
          C(12)-N(1)-C(1)-C(2)                                -54.3(6) 
          C(6)-N(1)-C(12)-C(11)                              -179.6(5) 
          C(1)-N(1)-C(12)-C(11)                                -1.6(8) 
          C(6)-N(1)-C(12)-C(7)                                 -1.2(4) 
          C(1)-N(1)-C(12)-C(7)                                176.8(4) 
          C(7)-N(2)-C(6)-N(1)                                   0.6(5) 
          C(12)-N(1)-C(6)-N(2)                                  0.4(5) 
          C(1)-N(1)-C(6)-N(2)                                -177.6(4) 
          C(1)-O(4)-C(4)-C(5)                                 161.5(3) 
          C(1)-O(4)-C(4)-C(3)                                  35.2(4) 
          O(3)-C(3)-C(4)-O(4)                                -131.2(3) 
          C(2)-C(3)-C(4)-O(4)                                 -11.0(4) 
          O(3)-C(3)-C(4)-C(5)                                 105.4(4) 
          C(2)-C(3)-C(4)-C(5)                                -134.4(4) 
          N(1)-C(12)-C(11)-C(10)                              177.1(5) 
          C(7)-C(12)-C(11)-C(10)                               -1.0(7) 
          C(5)-O(5)-C(19)-C(27)                               -80.1(4) 
          C(5)-O(5)-C(19)-C(34)                               164.8(3) 
          C(5)-O(5)-C(19)-C(20)                                46.0(4) 
          C(28)-C(27)-C(19)-O(5)                              176.0(4) 
          C(32)-C(27)-C(19)-O(5)                              -11.7(6) 
          C(28)-C(27)-C(19)-C(34)                             -69.0(5) 
          C(32)-C(27)-C(19)-C(34)                             103.3(5) 
          C(28)-C(27)-C(19)-C(20)                              53.9(5) 
          C(32)-C(27)-C(19)-C(20)                            -133.8(4) 
          C(39)-C(34)-C(19)-O(5)                             -155.4(4) 
          C(35)-C(34)-C(19)-O(5)                               30.3(5) 
          C(39)-C(34)-C(19)-C(27)                              86.7(5) 
          C(35)-C(34)-C(19)-C(27)                             -87.6(5) 
          C(39)-C(34)-C(19)-C(20)                             -38.6(5) 
          C(35)-C(34)-C(19)-C(20)                             147.0(4) 
          C(21)-C(20)-C(19)-O(5)                               65.4(5) 
          C(25)-C(20)-C(19)-O(5)                             -106.6(4) 
          C(21)-C(20)-C(19)-C(27)                            -171.0(4) 
          C(25)-C(20)-C(19)-C(27)                              17.0(6) 
          C(21)-C(20)-C(19)-C(34)                             -50.5(5) 
          C(25)-C(20)-C(19)-C(34)                             137.6(4) 
          C(6)-N(2)-C(7)-C(8)                                 179.6(5) 
          C(6)-N(2)-C(7)-C(12)                                 -1.4(5) 
          F(1)-C(8)-C(7)-N(2)                                   0.4(7) 
          C(9)-C(8)-C(7)-N(2)                                -179.9(5) 
          F(1)-C(8)-C(7)-C(12)                               -178.6(4) 
          C(9)-C(8)-C(7)-C(12)                                  1.1(7) 
          C(11)-C(12)-C(7)-N(2)                              -179.8(4) 
          N(1)-C(12)-C(7)-N(2)                                  1.6(5) 
          C(11)-C(12)-C(7)-C(8)                                -0.6(7) 
          N(1)-C(12)-C(7)-C(8)                               -179.2(4) 
          C(30)-C(29)-C(28)-C(27)                               0.1(7) 
          C(32)-C(27)-C(28)-C(29)                              -0.5(7) 
          C(19)-C(27)-C(28)-C(29)                             172.1(4)  Attachment  
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          C(35)-C(34)-C(39)-C(38)                               0.5(7) 
          C(19)-C(34)-C(39)-C(38)                            -174.0(4) 
          C(33)-O(7)-C(30)-C(31)                             -175.9(5) 
          C(33)-O(7)-C(30)-C(29)                                2.7(8) 
          C(28)-C(29)-C(30)-O(7)                             -177.6(5) 
          C(28)-C(29)-C(30)-C(31)                               0.9(7) 
          O(7)-C(30)-C(31)-C(32)                              177.1(5) 
          C(29)-C(30)-C(31)-C(32)                              -1.5(8) 
          C(35)-C(36)-C(37)-O(8)                              177.6(5) 
          C(35)-C(36)-C(37)-C(38)                              -0.3(7) 
          C(37)-C(36)-C(35)-C(34)                              -0.2(7) 
          C(39)-C(34)-C(35)-C(36)                               0.1(6) 
          C(19)-C(34)-C(35)-C(36)                             174.7(4) 
          C(30)-C(31)-C(32)-C(27)                               1.1(8) 
          C(28)-C(27)-C(32)-C(31)                              -0.1(7) 
          C(19)-C(27)-C(32)-C(31)                            -172.8(4) 
          C(19)-O(5)-C(5)-C(4)                                177.1(3) 
          O(4)-C(4)-C(5)-O(5)                                 -74.5(4) 
          C(3)-C(4)-C(5)-O(5)                                  46.5(5) 
          C(25)-C(20)-C(21)-C(22)                               1.9(7) 
          C(19)-C(20)-C(21)-C(22)                            -170.4(4) 
          C(23)-C(22)-C(21)-C(20)                              -0.6(7) 
          Si-O(2)-C(2)-C(1)                                   147.9(3) 
          Si-O(2)-C(2)-C(3)                                   -97.0(4) 
          O(4)-C(1)-C(2)-O(2)                                 161.5(3) 
          N(1)-C(1)-C(2)-O(2)                                 -80.0(5) 
          O(4)-C(1)-C(2)-C(3)                                  37.6(4) 
          N(1)-C(1)-C(2)-C(3)                                 156.1(3) 
          O(3)-C(3)-C(2)-O(2)                                 -16.3(5) 
          C(4)-C(3)-C(2)-O(2)                                -135.4(4) 
          O(3)-C(3)-C(2)-C(1)                                 104.0(4) 
          C(4)-C(3)-C(2)-C(1)                                 -15.1(4) 
          C(21)-C(20)-C(25)-C(24)                              -1.9(7) 
          C(19)-C(20)-C(25)-C(24)                             170.1(4) 
          C(20)-C(25)-C(24)-C(23)                               0.6(7) 
          O(8)-C(37)-C(38)-C(39)                             -176.9(5) 
          C(36)-C(37)-C(38)-C(39)                               0.9(7) 
          C(34)-C(39)-C(38)-C(37)                              -1.0(7) 
          C(26)-O(6)-C(23)-C(22)                                5.8(10) 
          C(26)-O(6)-C(23)-C(24)                              176.6(6) 
          C(21)-C(22)-C(23)-O(6)                              169.4(5) 
          C(21)-C(22)-C(23)-C(24)                              -0.7(7) 
          C(25)-C(24)-C(23)-O(6)                             -170.6(5) 
          C(25)-C(24)-C(23)-C(22)                               0.8(8) 
          C(38)-C(37)-O(8)-C(40)                                3.4(8) 
          C(36)-C(37)-O(8)-C(40)                             -174.5(6) 
          F(1)-C(8)-C(9)-C(10)                                179.8(5) 
          C(7)-C(8)-C(9)-C(10)                                  0.1(8) 
          C(12)-C(11)-C(10)-F(2)                             -176.9(5) 
          C(12)-C(11)-C(10)-C(9)                                2.4(9) 
          C(8)-C(9)-C(10)-C(11)                                -2.0(9)  Attachment  
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          C(8)-C(9)-C(10)-F(2)                                177.3(5) 
          O(2)-Si-C(15)-C(18)                                 -51.8(5) 
          C(13)-Si-C(15)-C(18)                               -172.4(5) 
          C(14)-Si-C(15)-C(18)                                 66.1(5) 
          O(2)-Si-C(15)-C(17)                                -171.1(5) 
          C(13)-Si-C(15)-C(17)                                 68.2(6) 
          C(14)-Si-C(15)-C(17)                                -53.3(6) 
          O(2)-Si-C(15)-C(16)                                  66.0(5) 
          C(13)-Si-C(15)-C(16)                                -54.6(6) 
          C(14)-Si-C(15)-C(16)                               -176.1(5) 
         ________________________________________________________________ 
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Crystal data of  5´-O- (4,4´-Dimethoxytriphenylmethyl) -2´-O-tert.-butyldimethylsilyl-1´-
deoxy-1´- (4,6-difluoro-1-N-benzimidazolyl) -ȕ-D-ribofuranose 106 at -123 C 
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12.2 Abreviations 
 
A 
A   Adenosine 
Å   Ångstrom 
 abs.   absolute 
 Ac   acetyl 
 ACN   acetonitrile 
 ATP   adenosine-5`-triphosphate 
B 
   Bp    base  pair 
   BSA    N,O-Bis(trimethylsilyl)acetamide 
C 
   C   active  carbon 
   C   cytosine 
   C. elegans  Caenorhabditis elegans 
   CD    Circular  dichroismus 
   conc.      concentrated 
D 
   d   dublett 
   D. melano gaster -     Drosiphila melanogaster 
 dest.   Destilled 
 DMAP   N,N’-dimethylaminopyridine  
 DMTr   4,4’-dimethoxytriphenylmethyl 
 DNA   deoxyribonucleic  acid 
 dNTP   natural  2’-deoxynucleoside-5’-triphosphate 
 dsRNA doblestranded  RNA 
E  
  E.coli   Escherichia  coli 
  ESI(-)-MS   Electronspray-Ionisation in negative modus 
 ESI(+)-MS    Electronspray-Ionisation in positive modus 
  et al.        et alii 
F 
  FC   Flash  chromatography  Attachment  
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G  
  G   Guanosine 
H 
 HCV   Hepatitis C Virus 
 HIV   Human Iimmunodefiency Virus 
  HPLC   high performance liquid chromatography 
 h   hour 
I 
  i   iso- 
J 
  J[Hz]    Coupling constant in NMR spectroscopy (in Herz) 
L 
  LDA   Lithiumdiisopropylamide 
M 
  Me   methyl 
 MeOH   methanol 
 min.   minutes 
 mRNA   messenger  RNA 
N 
 nt   nucleotide 
P 
  p.a.   pro analysi 
  pH                   potentia hydrogenii 
 polyA   poly  adenosine 
 PPi   inorganic  pyrophosphate 
 Py   pyridine 
Q 
 q   quartett  
R 
 Rf   retention  factor 
 RNA   ribonucleic  acid 
 RNAi   RNA  interference 
 RNAse   ribonuclease 
 RT   room  temperature  Attachment  
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S 
 s   singlett 
 siRNA   small  interfering  RNA 
T 
 T   Thymidine 
 T   Temperature 
 t   triplett 
 TBAF   tetrabutylammoniumfluoride 
 TBDMS  tert.-butyldimethylsilyl 
 TCA   trichloroacetic  acid 
 techn.   technical 
  tert.    Tertiary 
 THF   tetrahydrofurane 
 T m
   melting point of oligonucleotide doble helix 
 TOM   Triisopropyloxymethyl 
 tRNA   transfer  RNA 
 TLC   thin  layer  chromatography 
U 
  U   Uridine 
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